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Abstract
The interpretation of metabolic information is crucial to understanding the functioning of a bio-
logical system. Latent information about the metabolic state of a sample can be acquired using
analytical chemistry methods, which generate spectroscopic profiles. Thus, nuclear magnetic reso-
nance spectroscopy and mass spectrometry techniques can be employed to generate vast amounts
of highly complex data on the metabolic content of biofluids and tissue, and this thesis discusses
ways to process, analyse and interpret these data successfully.
The evaluation of J -resolved spectroscopy in magnetic resonance profiling and the statistical
techniques required to extract maximum information from the projections of these spectra are
studied. In particular, data processing is evaluated, and correlation and regression methods are
investigated with respect to enhanced model interpretation and biomarker identification. Addi-
tionally, it is shown that non-linearities in metabonomic data can be effectively modelled with
kernel-based orthogonal partial least squares, for which an automated optimisation of the kernel
parameter with nested cross-validation is implemented. The interpretation of orthogonal variation
and predictive ability enabled by this approach are demonstrated in regression and classification
models for applications in toxicology and parasitology. Finally, the vast amount of data generated
with mass spectrometry imaging is investigated in terms of data processing, and the benefits of
applying multivariate techniques to these data are illustrated, especially in terms of interpretation
and visualisation using colour-coding of images. The advantages of methods such as principal
component analysis, self-organising maps and manifold learning over univariate analysis are high-
lighted.
This body of work therefore demonstrates new means of increasing the amount of biochemical
information that can be obtained from a given set of samples in biological applications using
spectral profiling. Various analytical and statistical methods are investigated and illustrated with
applications drawn from diverse biomedical areas.
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Abbreviations and notations
These tables list the common abbreviations and notations used throughout this thesis.
Abbreviations:
αchca Alpha-cyano-4-hydroxycinnamic acid
auc Area under the receiver operating
characteristic curve
bmi Body-mass-index
cpmg Carr–Purcell–Meiboom–Gill
cv Cross-validation
fid Free induction decay
GalN Galactosamine
isomap Isometric feature mapping
jres J-resolved nmr pulse-sequence
k-opls Kernel-based opls
kpls Kernel-based pls
maldi Matrix-assisted laser desorption/ionisation
mccv Monte Carlo cross-validation
mccvb Class-balanced mccv
mrsi Magnetic resonance spectroscopy imaging
ms Mass spectrometry
msi Mass spectrometry imaging
m/z Mass-to-charge ratio
nmr Nuclear magnetic resonance
oc Orthogonal component
opls Orthogonal partial least squares
opls-da opls discriminant analysis
osc Orthogonal signal correction
PC Glycerophosphatidylcholine
pc Principal component
pca Principal component analysis
pls Partial least squares
pqn Probabilistic quotient normalisation
rgb Red–Green–Blue
sa Simulated annealing
sa-k-opls Simulated annealing optimised k-opls
sims Secondary ion mass spectrometry
SM Sphingomyelin
s/n Signal-to-noise ratio
som Self-organising map
stocsy Statistical total correlation spectroscopy
storsy Statistical total regression spectroscopy
svm Support vector machine
TBB Trypanosoma brucei brucei
tic Total ion count
tof Time-of-flight
t-sne t-Distributed stochastic neighbour embedding
tsp 3-(Trimethylsilyl)-[2,2,3,3-2H4]-propionic acid
whr Waist-to-hip ratio
Notations:
a Number of components
δ or ppm Chemical shift
E X-residuals [n× k]
F Y-residuals [n×m]
k Number of descriptor variables
m Number of response variables
n Number of observations
P Model loadings [k× a]
q2y Goodness of prediction
r Pearson’s correlation coefficient
T Model scores [n× a]
X Descriptor data [n× k]
Y Response data [n×m]
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Chapter 1
Introduction
1.1 Systems biology
Understanding the human body, health and disease, has classically been performed with the tradi-
tional molecular biology ‘one at a time’ reductionist approach.1,2 In contrast, the modern top-down
-omics approaches representing the interdisciplinary field of systems biology are capable of giving
a holistic overview of the interaction of any multi-cellular superorganism with the environment,
through integration of information acquired at different levels of biomolecular organisation.3,4 This
is achieved by use of high-throughput techniques that allow the quantification of the molecular con-
stituents of cells, biofluids, organs or even whole organisms. Examples include genomics, transcrip-
tomics, proteomics and metabonomics. Genomics,5 where various generations of dna sequencing
techniques enable the sequencing of the genetic make-up,6 provides a large amount of information,
however genomics does not create a complete picture of biology. For example, epigenetic structural
changes eventually influence which regions of the dna are actually being transcribed7 and not all
genes and their functions are known. Transcriptomics attempts to evaluate genetic information
in action, as it quantifies messenger rna transcripts, which is related to the dna that is actually
being expressed at a time point.6,8 The next downstream step in the traditional molecular biology
paradigm, shown in figure 1.1 A, is proteomics, which quantifies protein expression, usually with
gel-electrophoresis separation followed by mass spectrometry identification.9 This is a very inter-
esting branch of systems biology, although inconsistent method performance and a limited number
of comprehensive libraries for protein identification have hampered the implementation of reliable
large-scale proteomic approaches. A further way to directly investigate the overall physiological
status of an organism is by evaluating the concentrations of the metabolites present, as these are
indicative of biochemical reactions in cells and can also act as response mechanisms and crucial
effectors of biological systems,10,11 see figure 1.1 B.
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Figure 1.1: (A) The central dogma of molecular biology traditionally consists of dna, rna and proteins
connected by transcription and translation processes. However, this dogma is expanded here to demonstrate
the key role metabolites play in the biological regulation and effector processes. Metabolites are reporters of
the genomic, transcriptomic and proteomic events, but also the mediators and effectors of cellular processes.
(B) An overview of the different metabolic pathways (taken from www.iubmb.org).
1.2 Metabonomics
Metabolites are the low molecular weight substrates, intermediates and products of metabolism,
the chemical reactions occurring within a living organism that are necessary for the maintenance of
life. Examples of metabolites include amino acids, nucleotides, antioxidants, organic acids, polyols,
vitamins and alcohols. A large amount of information on metabolic pathways and function is known
and has been captured in databases such as kegg,12 MetaCyc13 and chebi,14 see figure 1.1 B.
The study of the complete metabolic content of an organism and how this is changed by some
stimulus or external perturbation is known as metabonomics, which is defined as ‘the quantitative
measurement of the dynamic multiparametric metabolic response of living systems to pathophys-
iological stimuli or genetic modification’.15 The related field of metabolomics has been defined
in plant biology and microbiology as ‘the systematic study of the metabolic complement of the
cell’.16 The analytical and measurement procedures for both are the same, and thus the two terms
are often used interchangeably. The evaluation of a large set of metabolic descriptors can also be
referred to more generally as metabolic profiling.
Metabolic profiling is a fast and cost-effective method to obtain a biological snapshot of an
organism. Metabolic profiles are of great aid in the evaluation of both genetic and environmental
factors. For example, this approach has been successfully applied in the diagnosis of inborn errors
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of metabolism17 and temporary or chronic exposure to stress factors also causes changes in con-
centrations of certain metabolites.18,19 Other examples of metabolic profiling studies include the
modelling of drug use by the observation of exogenous metabolites, that are not normally present in
healthy organisms,20 and toxicity, by studying altered levels of endogenous metabolites. In general,
any change in metabolic concentration is typically caused by some biological underpinning, which
may or may not be easy to uncover, depending on the severity and complexity of the challenge
and the system.
Metabolic profiling is a versatile tool for investigating biological functions at the cell and sys-
tems levels, and thus inter alia for improving our understanding of biology, for studying disease
and other pathological processes and for innovating pharmacological treatments.21–24 Examples
of metabonomic applications include the study of cancer,25,26 parasitic infection,27,28 drug toxic-
ity29–32 and personalised medicine.33,34 Metabolism is also influenced by such factors as genetics,35
gut microbial metabolism,36 and the consumption of food37,38 and drugs,20 as illustrated in figure
1.2. The interplay of the different exogenous factors and upstream effects, e.g. transcriptomic and
proteomic changes, is reflected in the measured metabolite levels downstream. This is illustrated
by a metabolome-wide association study, where the metabolite profiles of four population groups
were assessed: whereas genomics would find that, for example, the ancestry of a person is the
(main) determinant for genomic status, metabonomics is influenced by diet, lifestyle, environment
and self-medication. The study showed that metabolite profiles were closely related to risk factors
of interest, thus emphasising the value of metabonomics in systems biology.37
GENETICS
EPIGENETICS
DISEASE
DRUG USE
MICROBIOME
STRESS
POLLUTANTSMETABOLISM
PARASITES
NUTRITION
Figure 1.2: Some of the various endogenous and exogenous factors influencing metabolism and the observed
metabolic profile.
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Metabolic profiling can be performed on readily available biofluids, such as urine and plasma39,40
or other biofluids such as cerebrospinal fluid,41,42 sperm43,44 and saliva.45 More invasive methods
can be used to obtain tissue samples, such as biopsies or surgical specimens, appropriate measure-
ments on which can provide compartmentalisation information. Different information is obtained
from the various biofluids: urine, for example, gives a snapshot profile of the excretion products,46
whereas plasma is typically less variable since it is under homoeostatic control and is thus expresses
subtle concentration variations.
Experimental designs for metabonomic studies with animals are often based on different classes,
e.g. healthy versus diseased. Various exposure levels can be studied, such as different doses of toxin,
and temporal studies can be performed, where data are acquired for a series of time points to give
a more dynamic model of the system under study. In human populations, observational studies
are typically used, where samples are acquired from a pre-selected cohort. For such studies, a
large number of participants is often necessary, because there are many factors besides the study
objective that can influence the metabolic profile, as is illustrated in figure 1.2.
The metabolic content of the collected biofluid or tissue sample is then measured with a high
throughput analytical technique such as mass spectrometry (ms) or nuclear magnetic resonance
(nmr) spectroscopy.47 Spectral analysis allows the untargeted (partial) resolution of the compo-
nents in the complex mixture of metabolites. The advantage of nmr and ms over other analytical
techniques is that both methods are capable of providing structural and compositional information,
which is of paramount importance for unambiguous metabolite identification. nmr, discussed in
§2.1, is a non-destructive method requiring minimal sample preparation. Although the sensitivity
of nmr is lower than ms, a great number of diverse metabolite signals can be observed, especially at
high magnetic field strengths.48,49 The study of biofluids with ms, discussed in §2.2, is commonly
preceded by a chromatography-based separation step, providing a second measurement dimension
to reduce signal overlap and aid peak identification.50 The sensitivity of ms is higher than nmr
and a smaller sample volume is required, but the analytical reproducibility of ms spectra is lower
than for nmr spectra.47 A recently introduced approach to performing mass spectrometry, which
is typically performed on liquids, is based on imaging of tissue samples, where mass spectra are
acquired at different positions of the sample.51 Mass spectrometry imaging (msi) generates a large
amount of high-dimensional data and has already been used in protein and lipid profiling studies.
It shows great promise for metabolic profiling, as spectral information as well as spatial information
is obtained, allowing the localisation of different compounds across tissue sections to be studied.
1.3 Metabonomic data analysis
The spectral data that are acquired with nmr and ms can be very complex, as illustrated in figure
1.3 A. In this example, the different dose levels and time points before (0 hr) and after (> 0 hr)
administration of mercuric chloride demonstrate that the variation related to time and dose level
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needs to be accounted for before the interpretation of the main response to the toxic challenge,
including inter-individual differences. An example of mass spectrometry imaging data is shown in
figure 1.3 B, where the mass spectra of a few selected pixels are shown. Analysis of a full mass
spectrometry imaging data set needs to address both the spatial and spectroscopic aspects of the
data.
While visual analysis of spectral data is biased towards existing biological knowledge and peaks
with high intensity, pattern recognition provides a more thorough and reliable analysis. Thus,
computational multivariate data analysis can be performed to discriminate and evaluate different
Figure 1.3: (A) The raw 1H nmr spectral data from the mercuric chloride toxicity study, that will be discussed
more thoroughly in chapter 4, are superimposed. It is clear that a lot of inherent variation needs to be
accounted for, related to dose level as well as time-course. These plots demonstrate that a visual analysis would
be cumbersome and unlikely to reveal all underlying information. (B) Mass spectrometry imaging data, where
mass spectra are acquired at 10000’s of spatial positions, create a large amount of data (only 15 spectra are
shown here for clarity). The analysis of these data, which will be discussed in chapter 5, must take into account
both the spatial and spectral nature of the data.
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classes of samples, or to perform regression, e.g. modelling of time-courses, based on multivariate
spectral inputs.52–55 Modelling strategies should account for various effects influencing the data,
including:
• the complexity of the spectra, e.g. the large number of measured metabolites;
• the experimental design of the study, for example the different classes, dose levels and time
points; and the interactions of these different factors;
• the possibility of confounding factors known as orthogonal variation, such as batch effects,
analytical instrument drift and gender and age differences.
The complexity of metabolic networks, as shown in figure 1.1 B, indicates that the response
to a perturbation of homoeostasis is unlikely to incur a change in only one variable; in contrast, a
collection of up- and downregulated metabolites is expected. Additionally, a metabolite is typically
represented by a number of variables. Thus, there is a need to use methods of multivariate nature
which are able to deal with complex, collinear spectral data. Moreover, the selected algorithm
should be relatively insensitive to noise and able to cope with more variables (spectral data points)
than observations (samples). The analysis of spectral information from the metabolic species
present in a number of samples can be successfully performed using multivariate statistics, also
known as pattern recognition and chemometrics;23,52,55,56 these terms are used interchangeably
in this thesis.
Two widely used multivariate approaches are principal component analysis (pca) and partial
least squares (pls, also known as projections to latent structures); these methods can be used
to give an overview of the data and perform predictive modelling, respectively. Both methods
project the data onto a low-dimensional space based on the variance structure.56 In addition to
these linear modelling approaches, non-linear and stochastic models have been found useful for
metabolic analysis. For example, a non-linear descendant of pls known as k-opls allows for
predictive non-linear modelling and shows great promise for metabolic studies.57,58 Additionally,
data analysis with self-organising maps, also known as Kohonen maps, can aid the visualisation of
complex non-linear data and will be used to study msi data.59
A plethora of other statistical methods, including both uni- and multivariate approaches, can
be used in metabonomic studies but are not discussed in this thesis. These include anova-based60
and multi-way methods that allow the inclusion of a third data set axis, e.g. different bodily
compartments.61 Other types of non-linear and stochastic approaches used in metabolic profiling
include neural networks,62 genetic algorithms63 and random forests.64 In addition, various other
projection-based techniques exist, such as independent component analysis, ridge regression, prin-
cipal components regression etc. that can be used for data modelling, but which are not commonly
used in metabonomics.65,66
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A main goal of metabonomics is biomarker identification, and to this end, the variables re-
sponsible for e.g. clustering of different classes need to be available and transparent. After a
selection of ‘interesting’ peaks is made, a first step towards compound identification is with statis-
tical, correlation-based approaches, as discussed in §2.3.7.67 Further validation consists of multi-
dimensional nmr experiments that allow the study of structural connectivity of a compound, or
msn approaches that accurately determine the mass and fragments of a pre-selected peak. Finally,
the pure compound can be added (‘spiked’) into a sample of interest to verify that the suggested
peaks indeed show the corresponding increased intensity.
Some researchers choose to identify and quantify the metabolites prior to statistical analy-
sis.42,68 This approach, however, does not allow for biomarker discovery, as unknowns are not
tabulated. Moreover, with such an approach substantial effort might be focussed on the identifi-
cation of peaks that are of minor interest, as many of the peaks might not directly be involved in
the biological process, and therefore might not be of great importance in the subsequent model.
In this thesis, the spectroscopic profiling data are used rather than the quantified metabolites.
1.4 Development and application of chemometric methods
for modelling metabolic spectral profiles
The work presented in this thesis aims to extract a maximum amount of information from a set
of biological samples, using spectroscopic techniques. In particular, the focus is on combining
analytical spectroscopy and statistical multivariate modelling of the resulting data sets. Three
results chapters are presented to show how a combination of appropriate techniques can allow
metabolic profiling to be performed successfully on different experimental and analytical systems.
A key factor that should be considered is that different data sets, acquired with different analytical
methods or experimental designs, should be addressed with processing and modelling algorithms
best suited to the particular study.
The first example, as seen in chapter 3, discusses the necessity of acquisition of a simplified
version of the complex spectroscopic fingerprints typically generated in nmr-based metabolic pro-
filing studies. nmr can be used to observe a wide range of relatively high-concentration hydrogen-
containing molecules, but this very strength of nmr is simultaneously a weakness: the large number
of chemical species that are nmr-visible, often with multiple peaks for each compound, causes the
spectrum to appear relatively crowded, especially for low-field nmr spectrometers. Thus, the in-
formation latent in the samples can be obscured, as smaller peaks can go unnoticed if they overlap
with other peaks. This crowding can be overcome elegantly through the usage of multi-dimensional
spectroscopy, whereby the signals are dispersed on a second dimension. One particularly fast 2D
nmr experiment, J -resolved spectroscopy (jres), has been suggested to overcome this overlap
problem and the associated over-representation of certain abundant molecules. The full-resolution
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projections of these jres spectra, which effectively show proton-decoupled 1H nmr spectra, were
evaluated in this thesis in terms of the various processing steps, such as projection method and
peak alignment, and the quantitative properties were assessed. Most importantly, the use of
full-resolution jres projections in biomarker discovery with multivariate modelling and metabolite
annotation based on statistical approaches was demonstrated. Therefore, it is suggested that future
studies involving complex mixtures should consider the use of jres nmr spectra in their protocols,
especially if complex multiplet structures, such as those arising from carbohydrate compounds, are
likely to occur and dominate the spectra, obscuring smaller signals.
The second example of development and application of chemometric methods to model meta-
bonomic data, discussed in chapter 4, shows that certain data sets can display non-linear character-
istics, and multivariate modelling provides better predictive ability and more robust and meaningful
models if this non-linearity is taken into account. Kernel-based orthogonal partial least squares
(k-opls) enables the non-linear modelling of data sets and separates the orthogonal variation from
the predictive variation. Good predictive ability is possible using a simulated annealing approach
to find the optimal kernel parameter value, which is essential for kernel-based modelling. The
simulated annealing-based k-opls (sa-k-opls) was implemented in the existing software using a
nested cross-validation to report reliable predictive performance. The use of sa-k-opls in meta-
bonomic studies is demonstrated with regression and classification problems in toxicology and
parasitology based on 1H nmr urinary and plasma data sets. Superior prediction compared to
the linear equivalent opls, and meaningful interpretation of the orthogonal components are re-
ported. Methods for obtaining information on the variables involved in the non-linear sa-k-opls
modelling, which is normally not available due to the absence of usable loadings in kernel-based
models, are introduced. The results from this study show the potential of non-linear modelling in
time-course studies and in personalised medicine settings. The freely available sa-k-opls software
should find use in various high-dimensional non-linear prediction problems, including the modelling
of metabolic spectral data.
The final example, presented in chapter 5, entails the analysis of mass spectrometry imaging
(msi) data. The processing and analysis of these highly complex spectral imaging data is still in
its infancy. An intuitive and robust approach to processing msi data is presented. The suggested
methods use the presence of matrix peaks in addition to informative signals to perform the nec-
essary but non-trivial peak and pixel selection steps. After a clean and reasonably-sized data set
was obtained, multivariate modelling was performed. The use of correlation analysis, principal
component analysis and self-organising maps in the visualisation and interpretation of processed
msi data is illustrated, with a strong emphasis on both the multivariate as well as the imaging
nature of the data. Additionally, the visualisation with manifold learning techniques of msi data
is demonstrated: the clustering of image pixels in multi-dimensional space corresponds to their
spatial distribution and known anatomy. A comparison between the two analytical spectroscopic
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techniques msi and in vivo magnetic resonance spectroscopic imaging is made. Thus, it is shown
how a large amount of information can be extracted from the msi hyper-spectral data, consisting
of spatial information and spectral signatures, with the presented set of processing, visualisation
and modelling tools.
A typical ‘metabonomic workflow’ is schematically shown in figure 1.4, and the developed meth-
ods are highlighted; these include the different types of analytical spectroscopy followed by the
controls diseased
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Figure 1.4: The metabonomic workflow consisting of the experimental design, sample collection, analytical
spectroscopy, data processing and analysis steps. The focus of this thesis is on the generation of spectro-
scopic metabolic profiles with analytical techniques followed by data processing and unbiased analysis of the
large amount of spectroscopic data with statistical and pattern recognition techniques. Chapter 3 focuses on
J-resolved 1H nmr spectra and the subsequent data processing and analysis steps; Chapter 4 details the opti-
misation of the kernel parameter in k-opls with simulated annealing and the use of this non-linear sa-k-opls
method in metabolic profiling; Chapter 5 concerns the de novo development of a data processing approach
for mass spectrometry imaging data followed by the introduction of several methods for data modelling and
visualisation.
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appropriate data processing, modelling and visualisation steps. The application of the described
approaches to biological samples should help the experienced researcher to extract a maximum
amount of information from the study efficiently and successfully. This would aid biological inter-
pretation, for example through improved biomarker identification based on J -resolved spectroscopy,
the generation of transparent, high-quality predictive models with sa-k-opls and simultaneous in-
terpretation of spatial and spectral profiles of msi spectra. Thus, a greater amount of biological
information can be obtained from the samples, and predictive models and visualisation tools to
evaluate interventions and interpret metabolic variables are developed.
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Chapter 2
Theory and methods
This chapter will describe the analytical spectroscopic methods discussed in this thesis and the
multivariate modelling techniques employed. Certain sections were adapted from an article that
was published recently, which is included as appendix C.56
2.1 NMR: nuclear magnetic resonance
2.1.1 Spins and magnetic field
Nuclear magnetic resonance (nmr) is based on a fundamental property of atoms: the nuclear
spin (I). This quantum mechanical property is related to the total angular momentum of the
nucleus, and the discrete values that can be assumed are determined by the number of protons
and neutrons constituting the nucleus, the spin number is therefore different per isotope. nmr
spectra are easiest to interpret when they are generated by isotopes that have only two allowed
values for the spin quantum number (spin I = 12 nuclei, with 2I + 1 = 2 eigen states and hence
two spin projection quantum numbers ms = +
1
2 and ms = −
1
2 ). Table 2.1 lists nuclei commonly
measured in biomolecular nmr, only spin systems with I = 12 will be discussed here. The presence
of protons in a large number of biological molecules, combined with high natural abundance and
large magnetogyric ratio γ (see equation 2.1 and table 2.1) makes 1H the most relevant nucleus
for generating metabolic fingerprints.39,40
Table 2.1: Nuclei that are commonly measured in biomolecular nmr.69
Isotope Ground state spin Natural abundance Magnetogyric ratio γ (rad/s·T)
1H 12 ∼100% 267.522× 106
13C 12 1.1% 67.283× 106
15N 12 0.37% −27.126× 106
19F 12 ∼100% 251.815× 106
31P 12 ∼100% 108.394× 106
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When a nucleus is placed in an external magnetic field B0, there will be an energetic advantage
for spins to align with the magnetic field. The energy difference between the states ms = +
1
2 and
ms = −
1
2 in a magnetic field is described by equation 2.1, where γ is the magnetogyric ratio (see
table 2.1) and  h is the reduced Planck constant (1.0546× 10−34 J·s).
E = −γms hB0 (2.1)
The result is a net overall magnetisation of the sample caused by a slight excess population of
spins in the lower energy state, as described by the Boltzmann distribution, given in equation 2.2.
N−
N+
= e
−∆E
kT . (2.2)
In equation 2.2, ∆E is the energy difference between the spin states, T is the temperature, k is
Boltzmann’s constant (1.38066 J/K), and N+ and N− are the number of spins in the lower and
higher energy levels, respectively.
2.1.2 Detection of the NMR spectrum
For each nucleus with a non-zero spin quantum number, there is an associated magnetic moment.
This magnetic moment is parallel to the spin angular momentum (if the magnetogyric ratio γ is
positive, or anti-parallel otherwise) and precesses around the axis of the direction of the B0 field
(e.g. the z-axis), which is indicated in figure 2.1 A. The angular frequency of the precession is
called the resonance or Larmor frequency, and is related to the strength of the external magnetic
field and the magnetogyric ratio γ as shown in equation 2.3. For commercial nmr spectrometers
with a B0 of 14.1 T, this Larmor frequency ω0 corresponds to 600 MHz for 1H detection.
ω0 = −γB0 (2.3)
If the magnetisation of the ensemble of spins is calculated, a net magnetisation vector aligned
with the B0 field results (M0 in figure 2.1 B). It is possible to introduce transitions of the spins
between the 2 states (for I = 12 ) by applying an oscillating voltage that exactly matches the energy
difference in equation 2.1: the Larmor frequency. The irradiation at ω0 is applied in the form
of a short radio frequency pulse to rotate the net magnetisation for each type of nucleus (e.g.
different protons in a molecule), present when a sample is at thermal equilibrium in an external
magnetic field, see figure 2.1 B. Commonly used pulses rotate the magnetisation vector by either
90◦, to achieve maximum orthogonal magnetisation (i.e. no magnetisation component remains in
the direction of the B0 field, and the two spin energy level populations are equalised), or 180◦, to
invert the current magnetisation (and thus to invert the spin energy level populations).
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Figure 2.1: (A) Each nuclear spin has a magnetic moment that will precess around the applied magnetic B0 field
at the Larmor frequency. (B) Rather than evaluating all the precessing individual spins, a vector representation
is used, where the net nuclear magnetic moment for each type of nucleus will be aligned with the B0 field at
thermal equilibrium. The applied radio frequency (rf) pulse rotates the direction of the magnetic moment.
(C) Once the rf pulse is stopped, the nuclear spins will again precess around the B0 field at the Larmor
frequency, see equation 2.3. This magnetisation precession can now be detected as it induces a current in the
receiver coil, which is measured as the free induction decay (fid). (D) Through T1 relaxation processes, the net
magnetic moment will over time become realigned with the B0 field, and thus if this field was along the z-axis,
magnetisation along the z-axis, Mz gradually returns to thermal equilibrium. (E) The T2 relaxation mechanisms
(e.g. inhomogeneous magnetic fields, different local magnetic fields) cause the gradual loss of synchronisation
of the precessing spins. This causes the decay of the net transverse relaxation (Mxy if B0 was along the z-axis).
When the radio frequency pulse is stopped, the nuclear spin polarisations will once again precess
around the B0 field with a periodicity governed by the Larmor frequency, see equation 2.3 and figure
2.1 C. This precession of the spins around the magnetic field induces a weak radio frequency signal
in the transverse plane, which is detected and amplified to give the ‘free induction decay’ (fid),
which will be the sum of all the individual contributions of the precessing nuclei in the sample.
This time-domain signal is Fourier transformed to create a spectrum representing the resonance
frequencies of the nuclei. nmr can be considered a quantitative technique, as the induced signal
and thus the intensity of the peak in the Fourier transformed spectrum is proportional to the
number of nuclei at a given resonance frequency.
2.1.3 Chemical shift
The exact magnetic field experienced by a given nucleus is determined by a combination of both
B0 and the local electronic environment, because the external magnetic field induces a magnetic
field in the electron cloud. For example, the lactic acid (lactate, CH3CH(OH)COO
-) protons
in the CH3 moiety will experience an increased electron density which effectively decreases the
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Figure 2.2: The different nuclei in the lactic acid molecule will resonate at different frequencies, displayed on
the ‘ppm’ or chemical shift scale. Note how the chemical shifts are reported relative to the reference molecule
defined to resonate at 0.00 ppm. The intensities of the peaks are related to the number of protons giving rise
to the signal (indicated in red in the chemical structures). The J-coupling that causes the appearance of the
quartet (4 peaks) and the doublet (two peaks) will be described in §2.1.5.
experienced magnetic field, as the nucleus is relatively shielded from the magnetic field compared
to the proton close to the electronegative carboxylic acid group. Thus, the CH3 proton nuclei
precess with a lower resonance frequency than the CH proton, resulting in a lower chemical shift
(sometimes referred to as ‘upfield’, see figure 2.2 for nomenclature).
The chemical shift, defined in equation 2.4, is a field-independent difference in Larmor frequency
for two nuclei (ν and νref), often the nucleus of interest and a pre-defined reference nucleus.
δ = 106 × ν− νref
νref
(2.4)
This chemical shift is a unitless entity denoted as ‘δ’ or ‘ppm’, the latter denotes parts per million,
as the difference is typically in the order of Hz whereas the Larmor frequency is measured in
MHz (hence the multiplication with 106 in equation 2.4). This definition results in consistent
chemical shift values, irrespective of the machine field strength: thus at both 80 MHz and 600
MHz 1H observation frequency, the chemical shift of succinate will be 2.41 ppm from tsp (3-
(trimethylsilyl)-[2,2,3,3-2H4]-propionic acid sodium salt, a commonly used reference molecule, for
which the chemical shift will be defined as δ 0.00).
2.1.4 Relaxation
After the radio frequency pulse has been applied, the net magnetisation, that is precessing around
the B0 field, will slowly return to the thermal equilibrium magnetisation (i.e. aligned with the
externally applied B0 field) through a process known as relaxation, see figure 2.1 D and E. T1 or
spin–lattice relaxation is the build-up of the longitudinal magnetisation, that is the Boltzmann
distribution, through the dissipation of gained excess energy from the radio frequency pulse (com-
pared to equilibrium) with thermal motion. T1 relaxation therefore is related to the restoration
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of the net magnetisation in the direction of the B0 field, see Mz in figure 2.1 D. In addition to
this relaxation mechanism, T2 or transverse relaxation is caused by the disappearance of the co-
herence between the large number of precessing nuclei, caused by the small microscopic magnetic
field differences experienced by each spin. This is sometimes referred to as ‘dephasing’ or chemical
exchange, see figure 2.1 E, and results in a loss of transverse magnetisation Mxy.
2.1.5 J -coupling
An expansion of a typical nmr spectrum of a biofluid is presented in figure 2.3. In this figure, it is
clear that the complexity in composition of biological fluids is mirrored in the nmr spectrum, with
a multitude of (overlapping) signals. Some of the observed complexity in the spectra is the result of
a phenomenon known as ‘J -coupling’. In addition to the local electronic environment, the Larmor
frequency is also dependent on the presence of other magnetic nuclei in the same molecule, e.g.
whether a neighbouring nucleus has a ms = +
1
2 or ms = −
1
2 . For example, the lactate CH3 group
has 3 ‘chemically equivalent’ protons, which means all protons are of the same isotopic species
and are exchangeable through a molecular symmetry operation.69,70 This CH3 group will split
the neighbouring CH proton into 4 peaks, as there are 4 combinatorial possibilities of 3 spins with
value ms = ± 12 , see figure 2.4. The energy difference between spins in a multiplet is known as
J -coupling (typically a few Hz for 1H–1H coupling). The splitting pattern thus gives information
about the number and chemical equivalence of the neighbouring nuclei: for a CHx group, the
multiplicity will be x+1 (e.g. a quartet for a CH3 group peak splitting) and the relative intensities
of the multiplet can be deduced from Pascal’s triangle, see figure 2.4.
Figure 2.3: The complexity of a biofluid spectrum is clear from this ‘1D’ spectrum of a urine sample from
a healthy rat acquired at 800 MHz as part of the galactosamine toxicity study described in chapter 3. The
expansion illustrates that there is a large degree of overlap between the different peaks constituting the spectrum.
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Split by -H
Split by -H2
Split by -H3
1:1 (0.5:0.5)
1:2:1 (0.25:0.5:0.25)
1:3:3:1 (0.125:0.375:0.375:0.125)
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Figure 2.4: Depending on the number of chemically equivalent neighbouring nuclei x, a signal is split into x+ 1
peaks, based on the combinatorial combinations of ms = ± 12 (for I = 12 ); the relative intensities are shown on
the right and can be deduced from Pascal’s triangle (the values in brackets are normalised to a peak area of 1).
The coupling constant and splitting information is of great importance for structure elucidation
and peak identification. However, the drawback is that the presence of J -coupling also increases
the complexity of the acquired nmr spectra, and results in an increased overlap between peaks,
especially in complex mixtures. Methods to obtain proton-decoupled proton spectra, i.e. spectra
where no J -coupling is present, have been suggested early in the history of nmr71 and will be
thoroughly discussed in the context of metabonomics in chapter 3.
2.1.6 ‘1D’ and Carr–Purcell–Meiboom–Gill spectra
The nmr spectrum presented in figure 2.3 was acquired from a urine sample. To achieve such a
spectrum, the solvent peak (water in biological samples) has to be suppressed in order to avoid
an overflow of the analogue-to-digital signal converter, which would hinder the digitisation and
detection of the much smaller metabolite signals. In order to achieve quantitative, interpretable
spectra, the sample is commonly ‘irradiated’ at the water peak frequency, which effectively dephases
the water resonance. The standard ‘1D’ experiment typically performed in metabonomics consists
of the following pulse sequence:
(d1–90x–4 µs–90x–tm–90x–acquire fid)
with water peak suppression during d1 (the relaxation delay) and tm (the ‘mixing’ time). In
this sequence, the three repeated 90◦ pulses give a ‘standard’ pulse-and-acquire spectrum, while
enhancing the suppression of the residual water resonances from sample regions outside the receiver
coil, that have a small contribution to the spectral appearance.
The pulse sequence known as the Carr–Purcell–Meiboom–Gill sequence (cpmg) may be used
to suppress the resonances from larger molecules due to their shorter T2 relaxation time constants:
(d1–90x–[τ–180y–τ]n–acquire fid)
The spin–spin relaxation delay 2nτ is the key feature of the sequence, attenuating signals from
slow tumbling molecules with small T2 values. The cpmg pulse sequence is particularly useful
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Figure 2.5: The baseline signal consisting of the ‘protein envelope’ for this plasma sample is reduced with a
cpmg spectrum (red) compared to the standard ‘1D’ spectrum (black).The sample was from a healthy rat and
acquired at 800 MHz as part of the galactosamine toxicity study described in chapter 3.
for analysis of blood plasma samples, where large macromolecules (proteins, lipids, etc.) can
dominate the spectral appearance. The cpmg pulse sequence effectively creates a ‘relaxation-
edited’ spectrum that is the representation of smaller metabolites in the sample, e.g. in figure 2.5
the baseline protein signal of this plasma sample has been greatly reduced in the cpmg spectrum.
2.1.7 Two-dimensional NMR methods
One approach to overcome the overlap of signals in one-dimensional nmr spectra of complex
mixtures is to disperse the signals using a second frequency axis to create two-dimensional (2D)
nmr spectra. This second axis is generated by incrementing a time-delay (t1) in the pulse sequence
and collecting an fid during time t2 at each delay value. Thus, the nmr signal is recorded as a
function of two time variables, t1 and t2. A general 2D sequence contains a preparation period,
often to generate transverse magnetisation, an evolution period to allow the spins to interact, a
mixing period to manipulate the spins and create observable signals, which are recorded during
the detection period. This 2D array of data, created by increments in the evolution time t1, is then
Fourier transformed twice to create a spectrum where the two axes correspond to the frequencies
F1 and F2. The arraying concept is easily extended to three or more dimensions.
The nature of the preparation and mixing pulse sequences determine the information that is
measured in the spectrum, and with different approaches, information on various structural prop-
erties can be obtained. Multidimensional encoding of nmr spectra can be based on correlation
techniques, which allows the investigation of spin connectivity via chemical bonds (through J -
coupling in cosy, tocsy, etc.) or the distance between nuclei, based on the nuclear Overhauser
effect (through dipolar coupling in noesy, roesy, etc.). This information aids spectral interpre-
tation in two ways: 1) determining which peaks arise from the same molecule, 2) reducing the
overlap between the peaks that was visible in the 1D spectrum.
Another form of 2D spectral encoding is based on J -resolved techniques (jres, see chapter 3),
where the encoding in the second dimension is not based on chemical shifts, but the J -coupling,
for example 1H–1H coupling (homonuclear jres) or 1H–13C coupling (heteronuclear jres). The
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encoding of a second axis can also be based on diffusion coefficients, an experiment known as
diffusion edited spectroscopy.
Usually, 2D pulse sequences are repeated many times to build up sensitivity, and with numerous
increments in t1. Thus, the experiment time of 2D nmr pulse sequences is often much greater than
for 1D nmr experiments and in general, any form of 2D spectroscopy suffers from lower sensitivity
than a 1D experiment.
2.2 MS: mass spectrometry
2.2.1 Basics of mass spectrometry
The molecular composition of samples can also be studied with mass spectrometry (ms),72,73
which has a high sensitivity and the ability to measure a diverse array of metabolites, and is thus
considered one of the main techniques for metabolic profiling complementary to nmr, discussed
in §2.1. Molecules with different chemical compositional formulae including different naturally
abundant isotopes will have different molecular weights. Therefore, molecular information can be
extracted by measuring the molecular weight of the species, and this is what ms achieves. ms uses
the property that a charged particle placed in an electric or magnetic field experiences a Lorentz
force F. This force is dependent on the ion charge (q), the electric field (E), the ion velocity
(v) and the magnetic field (B), according to equation 2.5 (where × represents the vector cross
product).74,75
F = q(E+ v× B) (2.5)
Because the exerted force equals the product of the acceleration a and the mass m (Newton’s
second law, see equation 2.6), these equations can be combined into a differential equation from
which the ratio m
q
can be determined, see equation 2.7. The charge q is often divided by the
elementary charge e (1.602×10−19 C) to obtain the charge number z. This ratio of mass to charge
number is often referred to as mass-to-charge ratio, and represented as m/z in this thesis.
F = ma (2.6)
m
q
a = E+ v× B (2.7)
The first step in ms is the ionisation of molecules (to create the charge q), which can be
performed in various ways. The focus in this thesis will be on a method known as matrix-assisted
laser desorption/ionisation (maldi). This is an ionisation method that allows molecular ions to be
formed, in contrast to other methods that can create a large number of charged fragments from
each molecular ion. It is therefore known as a ‘soft’ ionisation technique and is very suitable for
large biomolecules, as those are very fragile and would be comprehensively fragmented if subjected
to other ionisation approaches. A matrix is applied to the sample of interest and the matrix
molecules will co-crystallise with the analyte upon vaporisation of the solvents, and when a laser
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Figure 2.6: An example mass spectrum (acquired as part of the mass spectrometry imaging study described in
chapter 5), ions with m/z = 50− 1000 were measured.
beam is targeted to the sample plate, the matrix molecules will absorb the energy of the laser
irradiation to become desorbed and ionised. Gas-phase chemistry causes the transfer of ionisation
to the matrix-trapped analyte molecule [M] to create ionised analyte molecules such as [M+H]+,
[M+Na]+ and [M+K]+; double or multiple charged ions can also be formed.74,75
The ions can then be measured using time-of-flight (tof) ms, where the ions experience an
electric field. The potential energy Ep based on the electric potential V is converted to a kinetic
energy that will be equivalent for equally charged molecules, see equation 2.8.
qV = Ep = Ek =
1
2
mv2 (2.8)
The velocity v of the molecule will depend on the mass m and charge q. Thus, by measuring
the time-lapse to reach the detector one can infer the mass of the molecule: the heavier particles
will travel more slowly, hence reaching the detector at later times.74,75 The detector monitors the
charge induced or the current produced when an ion passes by or hits a surface, and this signal
is amplified and recorded for the different flight times to produce a mass spectrum. An example
mass spectrum (acquired as part of the maldi imaging of the sample discussed in chapter 5) is
shown in figure 2.6.
2.2.2 MSI: mass spectrometry imaging
Rather than acquiring a mass spectrum from a biofluid sample, e.g. after separation by chromato-
graphy, it is possible to directly analyse a tissue or other sample of interest using a maldi imaging
approach. Whereas in conventional maldi, the sample (e.g. a protein purified from a gel) is ‘spot-
ted’ on a plate, and then the matrix is applied to that in order to get a mass spectrum, one can
simply use the tissue as a ‘plate’. For example, a cryo-sectioned tissue slice can be mounted on
a slide, see figure 2.7 A1 and A2, and after the matrix is applied to the sample, figure 2.7 A3, a
mass spectrum can be generated without additional preparation, as shown in 2.7 A4.
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Matrices used for maldi on biological substrates need to efficiently absorb the laser irradiation,
have good vaporisation characteristics and be able to act as a proton source to encourage ionisation;
examples of crystallising matrix molecules are 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic
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Figure 2.7: (A) A sample is cryo-sectioned (step A1) and mounted on a plate (step A2), to which a matrix is
applied (step A3) in preparation for mass spectrometry imaging (step A4). In mass spectrometry imaging, a
mass spectrum is acquired for each position along a grid. (B) The msi data can be presented in a data tensor of
size x×y×n (step B1) and analysed with multi-way methods such as parafac. Alternatively, the full data set
can be unfolded into a x∗y×n matrix (step B2) and analysed with two-way chemometric techniques. Common
univariate data analysis involves the evaluation of each of the n individual m/z values, represented as an image
(step B3), or each of the x ∗ y pixels, which can be represented by a characteristic mass spectrum (step B4).
acid) and alpha-cyano-4-hydroxycinnamic acid (αchca). The matrix molecules are dissolved in
a mixture of organic and aqueous solvent to facilitate both hydrophobic and hydrophilic analyte
molecules to dissolve and subsequently co-crystallise with the matrix molecules.
The acquisition of a spectrum using maldi-imaging is analogous to the approach frequently
taken in metabonomics, where instead of purifying, identifying and quantifying each individual
constituent, a characteristic fingerprint of the sample composition is generated with a powerful
analytical approach. As a result, the information density of spectra generated in this manner is
very high.
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Once a spectrum has been acquired in one location, the set-up is repositioned in order to
acquire a mass spectrum from a different part of the sample; using this mass spectrometry imaging
(msi) approach, a ‘grid’ of mass spectra across the sample is obtained, see figure 2.7.51,76,77 Thus,
localised information is obtained, reporting the chemical make-up of the different regions with
mass spectrometry-based molecular fingerprints. It is not hard to imagine that these distribution
maps of biomolecules, e.g. shown in figure 2.7 B3, should consistently reflect properties of different
tissue regions. This can, for example, aid characterisation of a tissue into different structural
units, and additionally make molecular masses available that typify these segments.78 A plethora
of data analysis objectives and methods are available to evaluate the images and the spectroscopic
data, and this will be the main topic of chapter 5: how to extract the maximum amount of useful
information from an msi data set. In general, these approaches can be divided into univariate
methods:
• Studying single m/z images, as shown in figure 2.7 B3.
• Evaluation of selected mass spectra for different regions in a ‘profiling’ manner, shown in
figure 2.7 B4.
and multivariate methods:
• Analysis of the complete 3-way data tensor with multi-way analysis methods such as parafac
and tucker, see figure 2.7 B1.
4,79
• Unfolding the data into a two-way matrix, where the pixels are displayed in the different rows
and the m/z variables in the different columns, shown in figure 2.7 B2. Then multivariate
methods such as principal component analysis and self-organising maps can be performed.
There are a large number of other ionisation, mass analysing and detection methods, which were
not discussed here. It should be noted though, that some of these can also be used in an imaging
set-up, for example secondary ion mass spectrometry (sims). However, maldi is the method of
choice for biological matrices as it is a soft ionisation technique and therefore the compounds are not
fully fragmented, and tof is the most used complementary mass analyser companion. maldi and
tof are compatible through the pulse-process nature of the laser-based ionisation, moreover, tof
is able to analyse a large mass range. Imaging data acquired with the maldi-tof msi experiment
are discussed in chapter 5.
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2.3 Multivariate modelling
Multivariate statistical modelling is essential for a thorough and systematic analysis of spectral
data: it evaluates the patterns of variance within the spectra reflecting biochemical properties.
Metabonomic spectral data have some characteristics that prohibit the application of many con-
ventional univariate and regression methods. This section will discuss chemometric methods that
can successfully model and visualise the measured spectral data.65,66
Notation
The obtained experimental spectroscopic data are conventionally arranged in matrices with rows
representing different samples or measurements and columns corresponding to variables. Matrices
will be represented in bold upper-case, vectors in bold lower case and scalars in plain lower case.
Let X be the matrix of descriptor variables of dimensionality [n × k] for n observations and k
variables and Y be the matrix of response variables of dimensionality [n×m] for m variables in Y .
In the case of classification, Y is a ‘dummy’ matrix consisting of ones and zeros, forming a design
matrix indicating the class of each observation. The matrix transpose is indicated as T .
2.3.1 Data processing
Normalisation
When performing any data analysis, it is important to consider the need and cause for normal-
isation. Spectral data such as those generated by nmr and ms have to be normalised (a row
operation) because the specific settings of acquisition as well as dilution due to sample preparation
or inter-sample variability, e.g. urine concentration, can influence peak intensity levels. There are
several methods available for normalisation of metabonomic data:80,81
• Samples can be normalised to total area, i.e. unit integral. For this method of normalisation,
it is necessary to remove large, non-quantitative peaks such as water or other solvent peaks,
and urea in urinary nmr spectra acquired with pre-saturation.
• Normalisation to the absolute concentration of a reference compound, e.g. tsp or creatinine.
• Probabilistic quotient normalisation (pqn, also known as median fold change normalisation)82
is a robust method to calculate the most probable dilution factor with respect to a chosen
reference spectrum xref (which is e.g. the median of all samples), see equation 2.9, where x
is the original spectrum and xn is the normalised spectrum.
xn =
x
median(x× 1
xref
)
(2.9)
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Centring and scaling
Generally, the most interesting aspect from the data is its variation, rather than the magnitude
of the actual values: information about change and continuity is often of great biological interest.
Hence, data are normally mean-centred prior to further analysis, which is achieved by subtracting
the mean of each variable as a column operation, to remove the effect from the average.
Equalisation of the importance of all variables, by reducing the effect of high valued variables
and emphasising small variables, is achieved through scaling each variable.80,83 A common scaling
method divides each column by its standard deviation, in order to achieve unit variance. Other
methods include pareto scaling (division by the square root of the standard deviation), range and
log scaling, and a combination of different approaches can be used as well. In general, data are
mean-centred before any scaling is applied. Although scaling to unit variance changes the relative
influence of the variables on the model, so that the study of low-concentration metabolites is
possible, it simultaneously increases the influence of spectral noise on the model.
2.3.2 Univariate versus multivariate approaches
Initially, analysis of metabolic spectral profiles was performed visually,84 but it was soon recognised
that pattern recognition methods had great potential for metabonomic studies.85 High-dimensional
metabonomic data are commonly analysed by multivariate (latent-variable based) methods; where
a latent variable is a weighted linear combination of the original spectral variables. These latent
variables can delineate groupings, which are often not visible with any classical univariate analytical
approach, where one variable is considered at a time. Only multivariate methods can really take
into account the relationships between variables: multi-variable patterns can be significant, even
if the individual variables are not.
Two commonly used multivariate methods are principal component analysis (pca86) and partial
least squares regression (pls87). With these projection methods, the enormous spectroscopic data
set can be represented by a few interpretable latent variables, as the dimensionality of the data is
greatly reduced. These projection approaches are advantageous for a reliable and flexible analysis of
nmr and ms data as they can handle the multicollinearity and information redundancy commonly
observed in spectral data sets.
Multicollinearity is a prominent characteristic of metabolic data sets, as a chemical species
may contain multiple signals (ions, multiplets) in several spectral regions, and multiple variables
constitute one peak. The data are high-dimensional, with the number of variables exceeding the
number of samples, which is problematic for classical linear regression methods. Additionally, the
different variables are often correlated;52,55 all of these issues are appropriately addressed through
the use of latent variable methods.
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Unsupervised and supervised methods
A distinction between methods to model spectral data is whether they are unsupervised or super-
vised methods, see figure 2.8 for some examples used in this thesis. Unsupervised methods are
based solely on the measured data, and no information about different classes or other response
variables of interest are provided to the model. Examples of this approach are principal component
analysis (pca) and self-organising maps (soms). The other branch consists of supervised models,
which model the relationship between the (spectral) descriptor data, X, and the response data, Y .
Examples of these are partial least squares (pls) and its derivative methods such as orthogonal
partial least squares (opls) and the kernel-based version of opls, k-opls (see chapter 4).
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Figure 2.8: Statistical approaches used in this thesis can be divided into (A) univariate statistics and (B)
multivariate statistics, which can be further subdivided into unsupervised and supervised approaches.
2.3.3 PCA: principal component analysis
Principal component analysis (pca) describes the main directions of variation in a high-dimensional
data set through multivariate projection. pca models are commonly used for global exploration of
the data and identification of outliers. The data are summarised in a new coordinate system that
explains the variation from the original data set using a number of orthogonal latent variables,
which are the axes, or principal components (pcs) in the new coordinate system and are linear
combinations of the original variables. The first principal component is in the direction that
explains the largest variance in the data, subsequent components are orthogonal to the previous
ones and explain the largest remaining variance.
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The method is based on a singular value matrix decomposition of the X-data matrix, see
equation 2.10.
X = TPT + E (2.10)
The X data can be projected on the new axes (principal components): the new coordinates of
the objects are called ‘scores’ (T , [n×a], where a is the number of principal components calculated).
The weights of the original variables that create the principal components are represented by the
loadings (P, [k × a]), see figure 2.9. The remaining variance is contained in the residual matrix
(E, [n × k]). There is a direct relation between the scores and loadings: scores having a higher
coordinate on a pc have higher values for the loading on that principal component, so in figure
Figure 2.9: (A) 3D plot of three collinear variables: age, body-mass-index (bmi) and waist-to-hip ratio (whr).
pca created two principal components, indicated with red lines, and the newly created coordinate plane spanned
by them is indicated. (B) The score plot shows the position of the samples in the new pca coordinate system.
(C) The contribution of the original variables to the new principal component axes are shown in the loadings
plot. In the first component, higher bmi, whr and age are related, but the second component models variation
of subjects with lower age and high bmi and increased whr. The colour-coding of the points is related to
internal fat levels (high levels are red) to aid identification of corresponding points in A and B. Data were
acquired by members of the Metabolic and Molecular Imaging group at the Hammersmith Hospital Campus,
Imperial College London, UK.
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2.9 B the green points on the right hand side have a higher age, body-mass-index and waist-to-hip
ratio, as can be seen in the loadings plot in figure 2.9 C.
As additional components are included in the pcamodel, the variation that is modelled typically
contains more noise, whereas the first components represent the global data structure. The number
of necessary components is often a lot smaller than the number of original variables, and thus
pca is suitable for data compression. The percentage of total variance that is explained by each
component in pca can be used to assess the importance of the individual pcs and to determine
the number of components that should be used in the model.
Projections created with pca allow an unbiased overview of the data set, and can directly
summarise and visualise the prominent metabolic changes, see for example the chemical reactions
monitored in figure 2.10.
Figure 2.10: To demonstrate the use of pca on spectral data, this model is calculated from mean-centred nmr
data of a sample that changes in composition over time. Plotted are the scores of pc 1 versus pc 2 (top), the
order in which spectra were acquired is indicated with a colour (blue for the first experiment), demonstrating
the effect of time. The corresponding loadings of pc 1 (bottom), demonstrate how the global shape of the
nmr spectrum changes over time. These data88 were also used to evaluate ‘storsy’ in chapter 3.
2.3.4 PLS: partial least squares
Partial least squares (pls, also known as ‘projections to latent structures’) models the variation in
X, whilst being directed by a response data set Y : pls derives the components from the descriptor
data set X which best describe the specified Y structure. This is done by maximising the covariance,
expressing the common structure between the X and Y matrices.65,66,87 It can therefore be used
for prediction purposes, and is a ‘supervised’ technique. This is useful for regression cases such as
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prediction of time after a certain event (e.g. infection, exposure to a toxin) or discriminant analysis
of groups, e.g. ‘control’ versus ‘diseased’.
pls decomposes the X and Y matrices according to equations 2.11 and 2.12, where T [n×a] and
U [n× a] are the score matrices and P [k× a] and C [m× a] are the loading matrices for X and Y ,
respectively. The unmodelled residuals are contained in the E [n×k] and F [n×m] matrices.65,66,87
X = TPT + E (2.11)
Y = UCT + F (2.12)
An alternative way to formulate the relation between X and Y is by means of the pls regression
coefficients bPLS in equation 2.13, where G represents the model residuals. This equation can be
used to predict Y from X data, Yˆ .
Y = XbPLS +G (2.13)
pls is sometimes subdivided into regression analysis (pls-re) and discriminant analysis (pls-
da). In classification or discriminant analysis, samples are allocated to discrete classes, which are
represented by so-called ‘dummy’ variables (encoded with 0 and 1).
pls, and supervised approaches in general, are often applied to tackle more subtle problems
in metabonomics, in which the large data sets require an approach that permits relationships
buried in a background of other large and multiplexed effects to be uncovered. Several processes
and their metabolic contributions control the composition of the same biosample, as was seen
in figure 1.2, and the main source of variation may not address the biological question: not all
influences are relevant to the variable of interest and these should be disregarded or down-weighted
during analysis. For example, human urine can display large differences between individuals,46
and different metabolic phenotypes have been suggested,89 which can complicate studies on effects
such as physiological challenges, the effect of probiotics and prebiotics, and nutritional status
on the metabolome. A virtue of latent variable projection methods such as pls compared to
other predictive modelling approaches, is the transparency of the models with respect to the
scores, that would allow the identification of e.g. possible sub-groupings, and loadings, which allow
metabolic interpretation. Latent variables may be visually presented in pseudo-spectral form, to
aid interpretation by evaluation through a spectroscopic appearance.90
2.3.5 OPLS: orthogonal partial least squares
Orthogonal signal correction
Orthogonal signal correction (osc) is a filtration procedure that was introduced for pls in order to
remove the information orthogonal to Y from the X matrix.91 This procedure can be seen as a filter
aimed at cleaning X of the information unrelated to Y , such as caused by run order, temperature
drift or batch effects.92
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OPLS: integration of OSC and PLS
Orthogonal partial least squares (opls) is a supervised latent variable approach, similar to pls,
but with an integrated osc filter.93 Originally, osc was applied as a separate step in a data
processing sequence, and, as such, was troublesome regarding validation and detection of over-
fitting. Therefore, osc and pls were integrated within a single-procedure decomposition, opls,
which performs a regression with orthogonal filtration of X on a vector or matrix Y . This resolved
the validation difficulties of osc-pls and was a powerful addition to the repertoire of pls methods,
because the variance in a data set can be split by opls into predictive and orthogonal variance.
The opls algorithm decomposes the descriptor data matrix X into a set of predictive (response-
related) latent variables and a set of response-orthogonal latent variables.93 Let Tp [n × ap] and
To [n × ao] represent the predictive and response-orthogonal score matrices respectively, with ap
predictive components and ao orthogonal components (oc). Pp [k × ap] and Po [k × ao] are the
corresponding loading matrices. The opls model is outlined in equation 2.14, where E [n × k] is
the residual matrix.
X = TpPp
T + ToPo
T + E (2.14)
The orthogonal components should be evaluated to suggest or determine the basis of this ‘struc-
tured noise’.92,94 The variation described in the orthogonal components can, if not filtered, decrease
the interpretability of the resulting model, which happens in classical pls models. opls allows
an enhanced focus on variation of interest, whilst minimising other variation, which can be of e.g.
biological or analytical source. Importantly, these orthogonal components add an extra dimension
in which the data can be interpreted: both predictive and orthogonal components display highly
relevant information from the data set. For example, the predictive and orthogonal components
can be interpreted in relation to the experimental design, sample run order and other external
variables.
In the discriminant analysis (da) version of opls, opls-da,95 the maximum separation between
the class samples encoded in Y (with n dummy variables for n classes) is achieved using the
input data X, by decomposing the covariance matrix (YTX) into n− 1 predictive components and
a sufficient number of orthogonal components, which can be determined by for example cross-
validation (see §2.3.6). Subsequently, the loadings identify the variables associated with a specific
class. The predictive ability of opls models is identical to pls models for a single response variable,
i.e. a y-vector.
An example of modelling and interpretation of spectral data with opls is shown in figure 2.11.
This figure shows the results of an opls model that was calculated using mean-centred nmr data
of a sample that changes in composition over time (the same data set as in figure 2.10).88
In figure 2.11 A, a 3D plot of raw data from three chemical shift values is shown, representing
three typical spectral regions: noise (x-axis, δ 0.8), a peak that decreases over time (from the
starting compound, on the y-axis, δ 1.54) and a peak that increases over time (from a product
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compound, on the z-axis, δ 6.13). In figure 2.11 B, the ‘inner relation’ plot of U versus T shows
the degree to which the pls components are of predictive value. To avoid over-optimism in the
presented results, cross-validated values were plotted. A slight non-linear effect can be observed
at the tails of this plot. A score plot of the predictive and orthogonal component, see figure 2.11
C, demonstrates the clear relation of the predictive component with time (again encoded with
colour). Additionally, the orthogonal axis indicates the presence of orthogonal variation, which
is possibly explained by the formation of intermediate compounds, that appear and disappear
over time and are therefore of no value for the linear prediction, yet form ‘structured’ orthogonal
Figure 2.11: Demonstration of opls on a mean-centred nmr data set of a sample that changes in composition
over time.88 Using 100 mccv rounds (see §2.3.6, 75% of the data in the training set) and 1 oc, q2y = 0.995.
The order in which spectra were acquired is indicated with a colour (blue for the first experiment). (A) 3D plot
of raw data of three typical spectral regions: noise (x-axis, δ 0.8), a peak that decreases over time (from the
starting compound, on the y-axis, δ 1.54) and a peak that increases over time (from a product compound, on the
z-axis, δ 6.13). (B) The ‘inner relation’ plot based on cross-validated values. (C) A score plot of the predictive
and orthogonal component. (D) The weights of the predictive component of the opls model demonstrate how
the global shape of the nmr spectrum changes over time, an expansion is shown for the three spectral values
plotted in A.
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variation. Finally, metabolic interpretation is possible using figure 2.11 D, where the weights of
the variables in the predictive component of the opls model demonstrate how the global shape
of the nmr spectrum changes over time. An expansion of the three peaks shown in figure 2.11
A shows that the noise region has no weight (zoomed in 100× at δ 0.8), the original compound
decreases, and was of high concentration, hence a high weight value (negative weight, δ 1.54) and
a low-concentration product is beginning to form (positive weight, zoomed in 100× at δ 6.13).
2.3.6 Model validation
One of the main advantages of pls and opls is the predictive ability of the obtained models.
However, without caution, any supervised modelling is prone to over-fitting.96 This section will
discuss several validation approaches, and these are equally applicable to pls, opls and k-opls
(see chapter 4) models.
Ideally, the availability of a second, independent data set would allow for validation of the
calculated pls models.97 Alternatively, there are a number of methods to perform cross-validation
(cv) based on the data that are used for modelling. These include methods that leave either one or
a fraction of the samples out (such as n-fold cross-validation), but preference might be given to the
use of resampling techniques, such as Monte Carlo cross-validation (mccv)98 and bootstrapping.99
Monte Carlo techniques create a cross-validation training data set by randomly selecting e.g. 75%
of the possible samples. This training data set is used to build a predictive model, and the model
is validated using the test set, which consists of the samples that were not selected for the training
set; this procedure is repeated a number of times.
Cross-validation gives predictions for the left-out samples, the test set, and one can advanta-
geously use these test set predictions to create cross-validated score and inner relation plots, in
order to get more realistic information on the predictivity and quality of the model. Moreover,
cross-validation permits the calculation of model statistics such as r2 and q2y.
r2 describes the proportion of variance modelled from the X and Y matrices and is sometimes
referred to as the ‘goodness of fit’ of the model, i.e. how well the model actually explains the data,
see equations 2.15 and 2.16 (assuming mean-centred data).
r2x = 1−
∑
E2∑
X2
(2.15)
r2y = 1−
∑
G2∑
Y2
(2.16)
The prediction performance of regression models will be evaluated with q2y, commonly referred
to as the ‘goodness of prediction’, which is inversely proportional to the generalisation error, see
equation 2.17.
q2y = 1−
∑
(Yˆcv − Y)
2∑
Y2
(2.17)
Here, Yˆcv is the vector (or matrix) of predicted values for Y using cross-validation and the sum-
mation is over all elements of Y .
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In discriminant analysis, class membership is determined by the decision function fmax(Yˆcv,i),
returning the class label for which Yˆcv,i has the highest value; Yˆcv,i is a vector of the predicted
values for each class for observation i. The prediction performance of discriminant analysis models
can be evaluated with the ‘mean sensitivity’, which is calculated across all k classes via equation
2.18, where tpi is the number of true positives (i.e. number of detected cases) for class i and the
denominator is the total number of cases for class i, equivalent to the sum of the number of false
negatives (fni) and true positives. A mean sensitivity equal to 1 implies perfect discrimination
between the classes.
mean sensitivity =
1
k
k∑
i=1
tpi
tpi + fni
(2.18)
In the special case of two classes, an alternative performance metric for discriminant analysis models
uses a standard trapezoid approximation of the area under the receiver operating characteristic
curve (auc). This is calculated with equation 2.19, where the classification threshold is set at the
predicted value (these numbers were sorted) for each of the n observations subsequently.100
auc =
n−1∑
1
∆(1− specificity)× ∆sensitivity
2
(2.19)
Here, ∆ indicates the difference between two subsequent sensitivity (or specificity) values. The
sensitivity is defined above, and the specificity is the ratio of true negatives to the total number
of controls (true negatives + false positives). The auc is interpreted as the probability that the
model will rank a true positive observation higher than a true negative observation and is related
to the non-parametric Wilcoxon rank sum test as well as the Mann-Whitney U test. An auc
value of 1 corresponds to perfect classification, a value of 0.5 is equivalent to random performance.
The auc metric has favourable properties in classification scenarios as it is independent of the
class frequencies and does not depend on a cut-off point between the classes, which is used for
dichotomisation.
Interestingly, the number of components in pls and opls models is often determined based on
predictive measurements such as the q2y value, but as the q
2
y is later used to report the predic-
tive ability, some degree of ‘over-fitting’ is likely. Nested cross-validation can be used to give an
unbiased optimisation of the number of orthogonal components whilst still reporting valid predic-
tion results,101 and was employed in this thesis to optimise a parameter necessary in kernel-based
opls, see §4.3.4. Another sophisticated validation approach is to use computer-intensive model re-
sampling under the null hypothesis: a population of models is generated by random permutations
of the Y data (i.e. the correspondence between X and Y is no longer present).102,103 By evaluating
the prediction performance of these ‘random’ models in comparison to the original model, the
value of the predictive measures can be interpreted. These approaches enable the validation of
the obtained prediction, resulting in increased confidence in the results obtained with supervised
modelling.
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Whichever method of validation is chosen, it should be stressed that proper experimental design,
data acquisition and cautious modelling are necessary to prevent over-interpretation of resultant
models: a predictive model that cannot be generalised or has not been validated is of no value!104
2.3.7 STOCSY: statistical total correlation spectroscopy
A widely used univariate method, primarily employed to aid metabolite assignments, is statistical
total correlation spectroscopy (stocsy).67 Although this method is not multivariate, it is often
used in conjunction with multivariate models as it constitutes a powerful tool for biomarker iden-
tification and structural elucidation. stocsy is based on the multicollinearity of spectral peaks
arising from the same compound across a series of samples: the relative peak intensities of a given
molecule remain constant, as is illustrated in figure 2.12. Hence, stocsy can be used to evaluate
whether signals are from the same molecule.
Figure 2.12: The peak heights of 2-oxoglutarate in the galactosamine toxicity study discussed in chapter 3 are
directly related for the different samples. stocsy uses this property: the constant relative peak heights of a
compound result in a high correlation between peaks from the same molecule across a series of samples.67
The Pearson correlation r(Xδ,Xδref) between the signal intensities Xδ at any resonance frequency
δ and the signal intensities Xδref at the selected frequency of interest δref is calculated based on the
n available spectra, following equation 2.20. This equation shows that the correlation is equivalent
to the covariance of the intensities Xδ and Xδref divided by the standard deviations σ of the peak
intensities.
r(Xδ,Xδref) =
∑n
i=1(Xi,δ −mean(Xδ))(Xi,δref −mean(Xδref))
(n− 1)σXδσXδref
(2.20)
The set of correlations calculated for all values of δ is often visualised by producing a pseudo-
spectral appearance, on which the correlation coefficient r is projected as a colour, see figure 2.13.
In this figure, the correlations of the spectral intensities with the driver peak at δ 2.45 confirms the
identity of this peak as 2-oxoglutarate. These peak-like displays are generated from, for example,
sample or mean spectra, or by using the covariance between the X and Y data to generate a
spectral representation. Alternatively, stocsy can be displayed in a 2D fashion, analogous to a 2D
tocsy (nmr) spectrum.67,105 stocsy has proven useful for biomarker identification, especially
45
in metabonomic studies, because the need for time-consuming two-dimensional nmr experiments
is reduced. Moreover, for nmr data, stocsy may provide a larger and more complete number of
correlations than obtained by pulse sequence approaches, which are limited by bond connectivities
and intra-molecular distances. Exemplar studies using stocsy included evaluation of analgesic
usage in a large epidemiological study106 and the study of drug metabolism kinetics.88
The correlation-based approach of stocsy not only highlights signals from the same molecule,
but also other highly-correlated and anti-correlated signals, which can for example be pathway-
based, e.g. connectivities in relation to metabolic effects of a renal toxin.107 An example of inter-
molecular correlation is seen in figure 2.13, where stocsy driven from a peak of 2-oxoglutarate
also highlights the peaks from citrate (δ 2.69 and δ 2.55), both compounds are intermediates in the
citric acid cycle. An approach to differentiate between intra- and inter-molecular correlations based
on the slope of the regression coefficient, a method named statistical total regression spectroscopy
(storsy), has been investigated and is described in §3.3.6 of this thesis.
Figure 2.13: Statistical total correlation spectroscopy (stocsy) was performed on the urinary jres data set
described in chapter 3. The correlations with the resonance at δ 2.45 (*) are presented as a colour projected
onto an expansion of one of the spectra, and the red peak at δ 3.02 (•) would confirm the assignment of
2-oxoglutarate (see also figure 2.12). The molecular structure of 2-oxoglutarate is shown. Slightly lower inter-
molecular correlations are seen with the two citrate peaks at δ 2.69 and δ 2.55 (·).
2.3.8 SOM: self-organising map
Self-organising maps (soms), initially developed by Kohonen, are a class of unsupervised artificial
neural networks that map the high-dimensional input data into a low-dimensional space, in a
topology-preserving manner.59 After training the map, the weight vectors associated with each
unit (or neuron) comprising the map should approximate the patterns of the objects that were used
to train the map, for example the molecular spectral profiles. The units are typically hexagons
connected in a rectangular map shape. Units become more dissimilar to each other as the distance
in the map between two units increases, leading to a ‘self-organised’ appearance that allows an
instant overview of the data, an example is shown in figure 2.14.59,108–110
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Figure 2.14: Results of a self-organising map109 based on in vivo 1H hepatic spectral nmr data acquired
by members of the Metabolic and Molecular Imaging group at the Hammersmith Hospital Campus, Imperial
College London, UK. (A) Raw 1H spectral data of the 338 volunteers, the two visible peaks are from water (4.7
ppm) and lipids (1.3 ppm). The spectra were coloured with increasing body-mass-index (bmi); generally higher
bmi values correspond to high lipid:water ratios. (B) The weight vectors corresponding to each unit of the
self-organising map resemble the spectral data that were used to build the map. Higher fat levels are observed
in the lower part of the map. (C) The distance map compares the weight vectors of neighbouring units, with
similar units in black, and increasing levels of blue for units differing from their surrounding units. The bottom
left units are highly dissimilar from the rest of the map and indicate a different class of spectra, as seen in B
these have higher lipid and lower water peaks. (D) After training, the data are projected onto the map and the
best matching unit is found for each spectrum, based on comparison of the measured spectral profile and the
weight vectors shown in B. One unit will then be representing a number of objects, each represented as a pie
slice in this hit map. The size of the pie corresponds to the number of objects that it was the best matching
unit for. The colouring of each pie slice is based on the bmi value also used in A (higher bmi values are red),
and show a correspondence to the organisation of the map based on spectral data: higher bmi values tend to
map on units with higher internal hepatic fat levels.
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To create a self-organising map, a map of pre-defined size is initialised with weight vectors
for every unit, corresponding to intensities for each variable that has to be modelled (comparable
to a loading in pca). These weight vectors can be chosen randomly, but are commonly based
on the first two principal components of the data set to decrease computational time and give a
deterministic som and therefore reproducible result. Subsequently, the map is ‘trained’ to start
resembling the topology of the data, allowing for non-linearities to be mapped efficiently. This is
done by presenting an item from the training data set (e.g. a spectrum) to the map, and finding
the ‘best matching unit’ by evaluation of the, typically Euclidean, distance between the training
item x and each neuron on the map. This competitive learning step identifies the weight vector
of the map with closest resemblance to the training item, and this weight vector wj(t) is then
updated, wj(t+ 1), to more closely resemble the data, by ‘learning’ from the training item x. This
is done in a topology-preserving manner, whereby neighbouring units also get updated to a degree
dependent on their distance on the map to the best matching unit, see equation 2.21.108
wj(t+ 1) = wj(t) + η(t)N(t, r)[x−wj(t)] (2.21)
The learning is governed by the learning rate η(t), which decreases linearly as a function of the
time t during the overall training time T , see equation 2.22; η(t0) is the initial training rate.
η(t) = η(t0)(1−
t
T
) (2.22)
The neighbourhood function N(t, r), see equation 2.23, determines the degree to which units are
updated, and is dependent on the training time t as well as the distance r on the map grid to the
best matching unit. This is similar to a smoothing kernel, and in this work a Gaussian shape with
a neighbourhood radius of σ(t), defining the region of influence of the training sample at time t,
was used.
N(t, r) = exp(
r2
2σ(t)2
) (2.23)
The gradually decreasing neighbourhood radius enables a global mapping of the som based on the
samples, followed by a fine-tuning of the appearance of the map. The updating of units is repeated
by subsequently presenting all items in the training data set, and can be performed efficiently in
a batch algorithm. This process of presenting the training data set to update the som is repeated
until convergence. The result of the learning process is that the weight vectors start to represent
the data, see figure 2.14 A and B.109 Similarities, measured as distances, between neighbouring
units can be visualised using a distance map (based on U-matrix methods) and can be used to
identify clusters and outliers, shown in figure 2.14 C.111
Data, either training or newly acquired (test) data, can be presented to the converged som and
best matching units for each of the items can be calculated and visualised,110 see figure 2.14 D. The
mapping of data to the som highlights their visualisation capabilities: soms enable the detection
of clusters and classes, show relative (dis)similarities of samples and present the responsible weight
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vectors, see figure 2.14. soms allow non-linear mapping of data in low dimensions and are relatively
insensitive to outliers, as they will occupy their own region in the map.
The use of som in metabonomic studies was nicely illustrated with a study of 1H nmr plasma
lipoprotein data, where the unsupervised som approach was able to characterise the lipoprotein
subclass profiles in a clinically relevant way.112,113 som maps have also been used for variable
importance and selection.114
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Chapter 3
The use of 1D projections of
J -resolved NMR spectra in
metabonomics
3.1 Aims and objectives
Spectroscopic profiling of biological samples is an integral part of metabolically-driven top-down
systems biology and can be used for identifying biomarkers of toxicity and disease. However, op-
timal biomarker information recovery and resonance assignment still pose significant challenges in
nmr-based complex mixture analysis. This chapter describes a method for reducing peak overlap,
which is achieved when projecting two-dimensional J -resolved (jres) nmr spectra, and is based
on the published work included in appendix B.115 This is done by means of:
1. Evaluating different processing steps to obtain high quality full-resolution jres spectral pro-
jections;
2. Demonstrating the necessity of peak alignment for modelling of full-resolution jres projec-
tions;
3. Investigation of the application of statistical total correlation spectroscopy to jres data;
4. Development and assessment of the feasibility of a newly proposed method: statistical total
regression spectroscopy;
5. Comparing the recoverable information content in full-resolution 1H jres projections with
conventional one-dimensional spectroscopy.
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3.2 Introduction
1H nmr based metabolic profiling suffers from the considerable peak overlap in biofluid spectra,
especially when chemical shift variation occurs or the data are binned into discrete chemical shift
regions for intensity calculations (bucketing), and this often inhibits complete interpretation of the
spectra and accompanying pattern recognition models.90,116,117
One specific problem for nmr spectroscopy is that many metabolites give rise to a considerable
number of spin-coupled multiplets over a range of chemical shifts, see also figure 2.3. This has
two consequences: impaired peak dispersion due to spectral overlap and over-representation of
the metabolite in any statistical classification exercise, as illustrated in figure 3.1. One method
for reducing peak overlap is to disperse signals into a second dimension. J -resolved (jres) nmr
spectroscopy71 is one of the simplest two-dimensional nmr experiments with which 2D spectra can
be rapidly obtained. This can be more efficient than physical separation of the compounds (for
example using a chromatography step before nmr analysis)118 or the use of lower sensitivity 2D
nmr experiments (such as homo- and heteronuclear correlation spectroscopy).119
The jres experiment is formed of an array of spin–echo pulse elements, in which an incremented
delay period is used to define a second frequency dimension. After suitable data processing,40 the
chemical shift and J -coupling information are resolved on two orthogonal axes, thereby increasing
signal dispersion. The 2D jres spectrum can be projected onto the chemical shift axis,120,121
effectively yielding a 1H broadband decoupled proton spectrum consisting exclusively of ‘singlets’,
as will be discussed in figure 3.3, which can then be subjected to pattern recognition analysis.
Potentially, this approach can reduce the overlap and over-representation problems encountered in
biological samples.
PEAK OVERLAP OVER-REPRESENTATION
Figure 3.1: The presence of multiplets in nmr spectra has a major effect on the complexity as well as the
information content of the spectra. Although the multiplicity of peaks contains vital structural information, it
also increases the level of peak overlap and gives a metabolite peak a wider base in a spectroscopic data table,
causing highly-split multiplets to be ‘over-represented’.
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The value of jres nmr spectra in metabolic profiling studies of biofluids was demonstrated two
decades ago122–125 and jres spectra have since then been routinely acquired40,126–128 including,
inter alia, studies of human urine,122 plasma48,123 and cerebrospinal fluid.124 jres nmr spec-
troscopy has also been utilised in studies of the components of plants,129 fish130 and beer,131 in
kinetic drug metabolism studies,88 and combined with magic-angle spinning nmr methods on tis-
sues132 and even in vivo.133 The most readily apparent advantages of jres nmr spectroscopy
stem from improved dispersion, through reduced peak congestion. The refocusing character of
the pulse sequence also results in T2-editing, which attenuates broad macromolecular signals as
well as resonances from motionally constrained compounds and species with chemical exchange
processes at intermediate rates on the nmr time-scale. The spin–spin coupling information is re-
tained in the 2D spectrum and can aid peak identification. jres has proven to be particularly
useful in metabolic profiling studies122,128,134 because many of the nuclear spin systems of such
small molecules exhibit first-order nmr spectra; hence, artefactual peaks associated with second-
order effects are rare. However, there are limitations caused by the non-standard line-shape and
T2-editing in jres nmr spectra and the effects on metabolite quantitation will be discussed in
§3.4.6.135 Other studies have investigated the effect of jres nmr data acquisition parameters ap-
plied to metabonomics.40,136 Improved spectral clustering of data in pca models built from jres
data versus conventional one-dimensional (1D and Carr–Purcell–Meiboom–Gill (cpmg)) spectra
has been reported.127
To date, most studies evaluating jres spectra have used binned (or bucketed) data based
on a low-resolution representation of the peak intensities rather than the full-resolution spectral
data.127–130,132 The limitations of binning spectral data on data interpretation and information
recovery are well-documented80,137 and are illustrated in figure 3.2: an nmr peak can be divided
across different bins, or a bin may contain a number of peaks. Therefore, statistical effects become
Figure 3.2: Full datapoint resolution spectra (red, 44001 points: δ 0.1–4.5, 6.0–10) will allow for better
biomarker recovery than the binned equivalent, shown as grey bars. For clarity, only a part of the full spectral
region is shown.
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less pronounced and small peaks may become completely obscured. The main reason for binning
data is to minimise the effects of chemical shift variability, which is necessary when statistical
techniques are applied. The development of alignment algorithms for nmr data have lessened the
need for this compromise, because they resolve all peak positional variation whilst retaining the
high resolution of the data.116,117,138,139
Here, the jres nmr experiment will be comprehensively re-evaluated with respect to its use in
mathematical modelling of biological spectra. Full-resolution one-dimensional projections are used,
and it is anticipated that the increased level of apparent resolution will aid biomarker identification,
especially for complicated, highly overlapped spectral regions. The processing steps required for
routine and robust use of jres nmr spectra in metabonomics will be considered, including peak
alignment (following a recommendation from Dr. M. Coen, Imperial College London, UK). The
qualitative and quantitative aspects in conjunction with correlation spectroscopy approaches will
be assessed, and a method based on regression for peak assignment based on jres projections will
be evaluated. Finally, the degree of information recovery compared to conventionally acquired one-
dimensional 1H nmr spectra (1D and cpmg) will be considered. As an example where nmr peak
overlap and over-representation are acute, spectra acquired from plasma and urine samples from
a galactosamine toxicity study in the rat were used.140 These contain exogenous and endogenous
metabolites that are spectrally high-represented, caused by the presence of many multiplets, thus
obscuring a considerable portion of the spectral range.
3.3 Materials and methods
3.3.1 Sample preparation
Samples were collected and analysed previously as part of the COMET-2 project141,142 and were
stored at -80 ◦C. Rats were administered 10 mL/kg vehicle (0.9% saline, n = 8) or galN (galac-
tosamine hydrochloride dissolved in 0.9% saline to give a free base concentration of 41.5 mg/mL,
n = 8).140 Urine specimens were collected for 24 hr after administration of galactosamine or
dosing vehicle, and plasma was obtained upon sacrifice, 24 hr after administration, as described
previously.140 Urine samples were thawed, vortexed and allowed to stand for 10 minutes prior to
mixing aliquots (400 µL) with phosphate buffer (200 µL, 0.2 M containing 10% deuterium oxide
(D2O), 3 mM tsp (3-(trimethylsilyl)-[2,2,3,3-
2H4]-propionic acid sodium salt) and 3 mM sodium
azide) and centrifuged at 13000 rpm for 10 minutes. Samples (550 µL) were placed in 5 mm outer
diameter nmr tubes. Stored plasma samples, previously prepared and in 5 mm outer diameter
nmr tubes140 were thawed and used for analysis.
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3.3.2 1H NMR spectroscopy
Proton nmr spectra were acquired on a Bruker Avance-800 spectrometer operating at an 800.32
MHz 1H frequency and a temperature of 27 ◦C. D2O provided a field frequency lock and tsp
provided a chemical shift reference for the urine samples. Urine and plasma ‘1D’ 1H nmr spectra
were acquired with water peak pre-saturation using the pulse sequence (d1–90x–4 µs–90x–tm–90x–
acquire fid). For each sample, 64 transients were collected into 64k data points using a spectral
width of 16025 Hz, with a relaxation delay (d1) of 2 s, an acquisition time of 2.04 s and a mixing
time (tm) of 100 ms. The water resonance was selectively irradiated during d1 and tm. cpmg 1H
nmr spectra of urine and plasma, acquired with the pulse sequence (d1–90x–[τ–180y–τ]n–acquire
fid), with a spin–spin relaxation delay 2nτ of 102.4 ms (τ = 0.4 ms, n = 128) were collected with 64
transients and a d1 of 2 s into 64k data points with a spectral width of 16025 Hz and an acquisition
time of 2.04 s. The water peak was irradiated during d1. The 2D jres urine and plasma 1H nmr
spectra were acquired with the pulse sequence, (d1–90y–τ–180–τ–acquire fid, with suppression of
the water resonance during d1) into 64k data points in F2 with a d1 of 2 s and 8 transients using
32 increments of τ; the spectral widths in F2 and F1 were 16025 and 50 Hz, respectively.
Initially, the magnet could not be shimmed adequately for the urinary data, which could be
reduced by equilibrating the sample in the nmr machine for about 30 minutes before acquisition.
Some samples showed bad shimming and peak splitting, especially evident in the jres projec-
tions, which was resolved by shimming in the ‘gs mode’ of the jres experiment. The replicated
spectra were plotted and the highest quality spectra were selected. Two of the urine samples
were reprepared (with an extra centrifuge step and careful pipetting, resulting in a dilution). The
repreparation, however, did not reduce the need for the sample to settle. The main result of
repreparation is dilution of the sample, which can easily be compensated for by using correct
normalisation methods. All samples have gone through a number (3–5) of freeze-thaw cycles.
3.3.3 Data processing
A line broadening function of 1 Hz and one level of zero filling were applied to all 1D and cpmg
spectra prior to Fourier transformation (ft). Automated phase and baseline correction and refer-
encing to tsp (δ 0.000) or α-glucose (δ 5.233) resonances for urine and plasma, respectively, were
performed using in-house software (NMRproc v0.3, Drs. T.M.D. Ebbels and H.C. Keun, private
communication). jres data were zero filled to 128k data points in F2, and up to 256 increments
in F1. Apodisation of the jres data was carried out using an unshifted sine-bell function in both
dimensions prior to ft. As is necessary, the absolute value spectra were calculated. Data were
tilted, symmetrised with respect to the horizontal through the centre of F1, and skyline or sum
projected as indicated. The jres projections were referenced and baseline corrected as above.
All spectra were imported to matlab (R2008a, The Mathworks, MA, USA) and data were
interpolated to form a vector running from δ -1.0 to δ 10.0 in steps of δ 0.00025. This maintains the
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resolution of the spectral data while allowing for increased accuracy in chemical shift referencing.
Following removal of the tsp, water and urea regions, the data between δ 0.1–4.5 and δ 6.0–10.0
were used for further analysis (resulting in 44001 data points per spectrum) and subjected to
probabilistic quotient normalisation, see §2.3.1.82
There were six data sets in total: urine and plasma data for each of the three types of nmr
experiment (1D, cpmg and jres). To investigate the effect of peak alignment, recursive segment-
wise peak alignment116 was performed, where the reference spectrum for each set of 16 samples
was chosen to be the one with maximum correlation with the other spectra for that particular
experiment and biofluid type.
3.3.4 Signal-to-noise ratio and line width analyses
The signal-to-noise ratio (s/n) for different processing options of the jres projections was cal-
culated as the mean ratio across the 16 samples of a given peak maximum with respect to the
standard deviation of noise (δ 0.2–0.5 for jres (1201 data points), δ 9.8–10.0 for cpmg (800 data
points)). The s/n was calculated for the alanine methyl signal at δ 1.47 and the lactate methyl
signal at δ 1.33 in both urine and plasma and the tsp singlet at δ 0.00 and the succinate singlet
at δ 2.41 in urine; for the cpmg and untilted jres spectra, the maximum value of the lactate and
alanine doublet signals was used. It should be noted that the term noise is not absolutely correct
in jres spectra since it is not truly random having no negative components in the absolute value
mode, prior to any baseline correction.
The line widths of the jres projections were approximated as the median of the full width at
half height. The line widths were calculated for the lactate methyl singlet and the alanine methyl
singlet in plasma and urine in addition to the tsp and succinate singlets in urine; for the untilted
data, the higher frequency component of the lactate and alanine doublets was used.
3.3.5 Statistical and chemometric analyses
Various multivariate modelling methods and univariate correlation approaches were employed:
• pca86 models (see §2.3.3) were generated using mean-centred spectral data to evaluate the
data before and after alignment. The direction of differentiation between the scores of the
two groups was used to evaluate the pc at which separation occurred.
• To evaluate if alignment removed orthogonal variation, opls93 models (see §2.3.5) were
constructed with in-house software on mean-centred data scaled to unit variance, with a
dummy vector representing the two classes (encoded as 0 = control, 1 = dosed).
• Pearson’s correlation coefficient (r) was calculated between spectra to estimate the similarity
between different samples and experiments. The correlation r(s1, s2) is calculated based on
all data points in two spectra s1 and s2.
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• Statistical total correlation spectroscopy (stocsy)67 displays the Pearson correlation between
the signal intensities Xδ at each resonance frequency δ and a reference variable of interest,
see §2.3.7. The used reference values were: the alanine CH3 resonance (for doublets the high
frequency peak was used) and the creatinine CH3 resonance at δ 3.05 (for figure 3.12), or a
dummy vector representing the class (in figures 3.6 and 3.11).
3.3.6 STORSY: statistical total regression spectroscopy
Peak intensities from the same molecule should, in principle, approximate the proportional ratio
of the contributing protons. Whether this proportionality can be used for improved correlation
analysis is investigated by using a regression of two signal intensities from the same molecule across
a series of samples, which is a method coined statistical total regression spectroscopy (storsy).
It is hypothesised that calculating a regression slope of two resonances, similar to the correlation
in stocsy, would aid peak identification and could differentiate significant correlations into inter-
and intra-molecular correlations.143 For example, if storsy is performed for the CH-proton of
lactate, one would expect the methyl group to have a relative regression slope of 3, whereas other
pathway or related high correlations may have regression values high or low enough to indicate
these cannot arise from the same molecule; e.g. a peak ratio exceeding 10 is unlikely to arise from
signals within the same metabolite.
The most straightforward way in which storsy could be implemented in standard metabon-
omic research is by performing this calculation on jres projections, since that eliminates the need
to take multiplicity patterns into account, such as present in typical one-dimensional proton spec-
tra. Theoretically, the sum projection retains the quantitative information whereas the skyline
projection does not. The projections are performed along F1, which is the J -coupling direction
(the vertical direction in figure 3.3). In the skyline projection, the maximum signal along F1 is
retained and will be a fraction of the original intensity, dependent on the splitting pattern, hence
peak integrals of the skyline projection will not correspond to the original proton ratios.121 With a
CH3 integral set to 3, the ratio of the lactate peaks for the sum projection, which sums all signals
along F1, should remain 1:3, whilst the ratio would be 0.75:3 for the skyline projection (the relative
intensities for the CH quartet at δ 4.11 are 0.125:0.375:0.375:0.125, and for the CH3 doublet at δ
1.33 these are 1.5:1.5, with the retained skyline intensity displayed bold, see also figure 2.4).
Inclusion of an intercept in the regression equation can be used to allow for baseline offset and
overlapping peaks, although both are diminished in jres spectra. A verification of the proportions
is to perform a regression from peak B to peak A: the slope should be the inverse of the slope from
peak A to peak B. Before interpretation of the storsy values, it should be verified that the results
are not affected by outliers in the peak intensity data, as these can have a large leverage effect on
the regression slope value.
56
STORSY analysis of glucuronidation time-series
To evaluate storsy, data from a previous study were used,88 where the data were reprocessed with
and without symmetrisation as indicated and zero filled to 128k in F2 and 256 in F1. Data were sum
projected, baseline corrected (zero-order polynomial correction using Topspin, Bruker Biospin) and
referenced to tsp (by NMRproc v0.3, Drs. T.M.D. Ebbels and H.C. Keun) and interpolated from δ
-0.1 to δ 9.0 in steps of δ 0.00025 (36401 data points). As all data were acquired from one sample,
normalisation was performed using tsp area (δ -0.02 to δ 0.02) and peak positional variability is
minimal, alleviating the need for alignment.
STORSY for galactosamine toxicity study
Correlation and regression analyses were performed on the peak maxima (peak height) or peak
integrals (peak area) of the CH and CH3 peaks of lactate. Pearson correlations were calculated
between the CH and CH3 data, and a standard linear regression for the CH versus CH3 data was
calculated with and without intercept, i.e. y = bx and y = bx+ a.
3.4 Results and discussion
3.4.1 Projection of JRES spectra
jres spectra may be projected in the chemical shift dimension after tilting the 2D spectrum, to
effectively produce a homonuclear decoupled 1D proton spectrum. The effect of this ‘collapse’ of
multiplets is demonstrated in figure 3.3: the multiple, highly overlapped glucose resonances can
now be unambiguously assigned in the jres spectrum from their chemical shift and coupling pat-
tern information. Two types of projection are routinely employed: the sum projection, summing
all signals along F1, and the skyline projection, retaining the highest signal along F1.120,121 Gen-
erally, the skyline projection results in signals with a better signal-to-noise ratio (s/n).136 This
is illustrated in figure 3.3, where a representative ‘control’ 2D spectrum from the galactosamine
toxicity study and associated projections are shown, scaled to equivalent noise levels.
In table 3.1, the mean s/n is displayed for the various processing methods as applied to both
urine and plasma spectral peaks, demonstrating that for both symmetrised and unsymmetrised
projections, the s/n is better for skyline than sum projections. Because most increments of the
jres spectrum do not contain signal, the commonly observed s/n increase with the square root of
summed increments is not achieved.136 Naturally, this s/n advantage of skyline projection is more
pronounced for singlets than multiplets. For example, in figure 3.3 the highly split H5 β-glucose
resonance at δ 3.464 (ddd) shows similar sum and skyline projection peak intensities after scaling
to constant noise levels. Moreover, it is expected that the level of noise is distributed normally, and
so taking the maximum signal along F1, as in a skyline projection, could effectively decrease the
noise level, if the noise maxima are similar in value;136 this results in a slightly increased height of
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Figure 3.3: Example of a symmetrised 2D jres 1H nmr spectrum acquired at 800 MHz from plasma of a control
rat in the galactosamine study. Sum (blue) and skyline (red) projections without symmetrisation are shown,
scaled to identical noise levels (measured at δ 0.2–0.5). For comparison, the conventional 1D 1H nmr spectrum
is shown (black). The use of increased dispersion of the jres experiment and the incorporation of multiplicity
information in peak identification is demonstrated with assignment of all individual glucose resonances of both
the α- and the β-anomers (structures are shown on the bottom).48
the baseline, but with a lower standard deviation of the noise level, hence resulting in an apparent
increase in s/n.
It has been reported that the skyline projection gives the best spectral quality based on binned
data combined with a sine-bell-exponential apodisation function in the direct dimension.136 Most
applications of jres projections in metabonomics have used the skyline projection, with only a few
exceptions.126,142 Although the s/n is lower for all of the jres projections compared to the cpmg
results with the current acquisition parameters (see table 3.1), this can be remedied by adjustment
of the spectral acquisition parameters such as an increased number of scans or increments.
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Table 3.1: The mean signal-to-noise ratios (×103, arbitrary units) of various spectral data types.
Tilt Symmetrisation Projection Urinary Plasma Urinary Plasma Urinary Urinary
alanine alanine lactate lactate succinate tsp
yes no skyline 0.277 0.413 0.733 2.026 4.958 18.456
yes no sum 0.074 0.136 0.215 0.630 0.711 2.662
yes yes skyline 0.262 0.485 0.702 2.316 5.860 21.814
yes yes sum 0.077 0.141 0.218 0.639 0.728 2.794
no no skyline 0.198 0.358 0.636 1.752 4.324 16.057
no no sum 0.039 0.075 0.127 0.378 0.887 3.334
cpmga 0.616 1.271 1.347 4.921b 5.381 19.974
a Results for cpmg and untilted jres nmr spectra are based on values from the higher peak in each listed dou-
blet. The standard 1D nmr spectrum values are not given, because the peak height and noise measurements
for plasma are confounded, due to the presence of macromolecular signals.
b Plasma lactate peaks in the cpmg spectra were overlapped with a broad peak around δ 1.28.
It is shown (vide infra) that the disadvantage of the lower overall s/n of jres spectra is
outweighed by a considerably improved apparent resolution due to reduced peak overlap in the
projections.
3.4.2 Symmetrisation of JRES spectra
The full widths at half height of specified peaks are given in table 3.2 and these show little difference
between symmetrised skyline and sum jres projection peaks. Symmetrisation of the jres data
results in narrower peaks of the subsequent projections, a phenomenon which is directly related
to the symmetrisation procedure. Without symmetrisation, sum projections resulted in broader
peaks than skyline projections, see table 3.2, and this is in agreement with the superior resolution
of skyline projections found previously.121 Symmetrisation can either create or eliminate spec-
tral artefacts;144 however neither effect was noticed here. The s/n values for symmetrised and
unsymmetrised spectra were comparable, see table 3.1.
Table 3.2: The median line width (Hz) measured as the full width at half height of various processed projections
of jres nmr spectra.
Tilt Symmetrisation Projection Plasma Plasma Urinary Urinary
alanine lactate succinate tsp
yes no skyline 3.0 3.0 2.8 2.8
yes no sum 3.6 3.6 3.4 3.2
yes yes skyline 2.0 1.7 1.4 1.4
yes yes sum 1.8 1.8 1.3 1.2
no no skyline 2.0 1.8 1.4 1.4
no no sum 1.9 1.8 1.4 1.2
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3.4.3 Peak alignment of full-resolution JRES projections
Urinary 1H nmr spectra show more peak positional variation than plasma spectra, which is caused
by, for example, greater variability in pH, metal and ion concentrations; metabolite–protein in-
teractions and chemical exchange processes can also interfere. jres data are more sensitive to
misalignment effects compared to 1D and cpmg spectra because the reduction in ‘chemical shift
bandwidth’ for each resonance (multiplets are collapsed into singlets and are even more narrow
if symmetrised, see figure 3.1) causes small variations in chemical shift to manifest as marked
misalignments in jres projections. Figure 3.4 shows jres projections of 1H nmr spectra of urine
from the dosed and control groups of the galactosamine toxicity study before and after recursive
segment-wise peak alignment,116 with expansions demonstrating the substantial improvement by
alignment.
Figure 3.4: Symmetrised skyline projections of 800 MHz 1H jres spectra of urine samples from the galac-
tosamine toxicity study before (top) and after (bottom) alignment.116 Spectra from dosed animals are coloured
red and those from control rat spectra are shown in blue; expansions are shown for δ 2.67–2.74 and δ 3.42–
3.48. Asterisks (*) denote that the creatinine δ 4.06 and H2 β-galactosamine δ 3.14 resonances are not aligned
perfectly with the used algorithm and settings.
60
Previous analyses of jres data of metabolite mixtures did not require peak alignment, because
binned integral data were used.127–130,132 However, it should be appreciated that peak alignment
is preferable to binning, as multiple signals may become concatenated, or individual signals split in
the latter procedure (see also figure 3.2). Moreover, the use of bins precludes direct interpretation
of multivariate models.116,117 Previously, some major peak shifts had to be accounted for by
combining multiple bins, indicating that even binning itself may not compensate for all peak shifts
(e.g. citrate in urine).127–130 Of course, it would be possible in theory to stabilise the pH of all
samples, but this is prohibitive for large sample sets such as from biobank or metabolome-wide
association studies.37,145 Moreover, stabilisation of urine samples to neutral pH is only temporary
since precipitation within the sample tends to cause a shift in the pH, and samples stabilised
to acidic pH will result in chemical shifts that are different from those in most commonly used
databases.
Therefore, it appears appropriate to perform peak alignment,116 which proved to be uncompli-
cated for the singlets in jres projections (in figure 3.4 most peaks are well aligned, and possibly
other algorithms will give equally good results). A similar situation occurs in the alignment of 13C
nmr spectra, where peak shift correction is more straightforward than for overlapping 1H nmr
spectra, because 13C shifts are less affected by pH changes and there are fewer or no complicated
multiplet resonances.137 Improvements in applicable alignment algorithms can be tailor-made
for the specific data structure found in jres spectra (e.g. the absence of multiplets) to increase
effectiveness and further decrease the computational time.
3.4.4 Necessity of alignment of JRES projections for statistical analysis
Using the unsupervised statistical method principal component analysis (pca), it was clear that
discrimination of galactosamine treated and control groups for urinary jres projections in the first
principal component (pc) is conditional on proper peak alignment, see figure 3.5 and table 3.2.116
Alignment significantly improved the pca model, with a much higher proportion of the variance
explained in pc 1 (76.4% versus 33.2% for the symmetrised skyline projection) and the separation
of classes on the basis of toxicity being promoted to higher principal components (compare figure
3.5 A and B).
It is not only important to align the data to create improved models, but additionally the inter-
pretation of the data is greatly increased upon alignment.116 Before alignment, the resultant dis-
persive line shape of the loadings due to peak position variability makes it ambiguous as to whether
a certain peak is actually contributing positively or negatively to a pca loading. Peak positional
variation was indicated for virtually all resonances, e.g. taurine, dimethylamine, succinate, citrate,
2-oxoglutarate and creatinine (see figure 3.5 C). The galactosamine and N -acetylglucosamine res-
onances are unaligned to such a high degree that these variables do not contribute significantly
to the variance modelled in the first principal component, much in contrast to the aligned model
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Figure 3.5: (A, B) Scores of the pca model calculated for the mean-centred symmetrised skyline projections of
jres urine spectra before and after alignment;116 for galactosamine-dosed animals (red squares) and vehicle-
dosed controls (blue circles). pc: principal component and associated percentage of explained variance. (C,
D) The corresponding pca loadings displayed for the region δ 2.0–4.3 clearly demonstrate the disappearance
of dispersive shapes upon peak alignment for, e.g., taurine (1), dimethylamine (2), succinate (3), citrate (4),
2-oxoglutarate (5) and creatinine (6), while resonances of galactosamine (7) and N-acetylglucosamine (8, a
galactosamine metabolite) become a dominant source of variance in the first pc.
(figure 3.5 D). For plasma data, only small improvements in loading interpretation are observed
after alignment, and a good separation between the two classes is present in both aligned and
unaligned data, this is due to much lower positional variation in the original data.
The parameters for each pca model of the differently processed urinary data sets are given in
table 3.3. Symmetrised skyline projections separated in pc 3, whereas the unsymmetrised skyline
projections separated in pc 2. This effect of symmetrisation is most likely related to peak width,
as established in table 3.2, which reduces the number of variables representing a proton resonance.
This results in an even smaller span of the data peak and thus if these data are not well-aligned,
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Table 3.3: Principal component analysis results before and after spectral peak alignment, models were based on
the mean-centred nmr urine data. Principal component models were evaluated in terms of variance explained
(Var. exp.), which is the fraction of variance in the total data set contained by the indicated principal component
(pc), and the pc at which separation between the galactosamine dosed and control classes was observed.
UNALIGNED
Tilt Symmetrisation Projection Var. exp. pc 1 Var. exp. pc 2 pc of separation
yes no skyline 0.37 0.21 2
yes no sum 0.40 0.24 1
yes yes skyline 0.33 0.17 3
yes yes sum 0.31 0.23 1
no no skyline 0.29 0.21 2
no no sum 0.26 0.26 1 and 2
1D 0.61 0.14 1
cpmg 0.56 0.15 1
ALIGNED
Tilt Symmetrisation Projection Var. exp. pc 1 Var. exp. pc 2 pc of separation
yes no skyline 0.80 0.08 1
yes no sum 0.79 0.07 1
yes yes skyline 0.76 0.07 1
yes yes sum 0.82 0.07 1
no no skyline 0.76 0.07 1
no no sum 0.79 0.06 1
1D 0.90 0.03 1
cpmg 0.88 0.04 1
the classes are not separated in the pca model. The models based on sum projections separate in
pc 1, possibly because highly split signals, for example the galactosamine multiplet peaks, manifest
higher intensity and hence greater importance in the sum projection than the corresponding peak
in the skyline projection. The pca models of 1D and cpmg data without alignment did split in
pc 1, which could be explained by the ‘over-representation’ of relevant peaks. The resonances of
interest are highly split multiplets and therefore dominate the variance in the pca model, even
when not perfectly aligned.
When the jres projections were obtained without tilting these data, the multiplicity of the
peaks remains, but the separation is not in pc 1 as might be expected from the larger variable
span of multiplets, which should be less susceptible to peak shift influences. Hence, it should
be appreciated that added to the multiplicity collapse, the reduced density of signals due to T2-
editing, the sine-bell processing and the projection step could all cause the jres projection data
to be inherently more variable than the 1D and cpmg spectra.
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Table 3.4: Orthogonal partial least squares discriminant analysis (opls-da) models were made with 1 predictive
component for the different processed data sets. Data were mean-centred and scaled to unit variance. The mean
sensitivity of the prediction for the two classes is displayed; the values marked with an asterisk are the maximum
obtained (evaluated up to 5 orthogonal components, oc), and for these instances, no perfect separation was
achieved. The q2y values are given for the model with no orthogonal components. The values were calculated
with 100 Monte Carlo class-balanced cross-validation rounds, where 75% of the data were used to calculate the
model.
UNALIGNED
Tilt Symmetrisation Projection Sensitivity 0 oc Sensitivity 1 oc q2y 0 oc
yes no skyline 0.96 1 0.7352
yes no sum 0.9925 1 0.7495
yes yes skyline 0.9575 0.9925* 0.7057
yes yes sum 0.9950 1 0.7424
no no skyline 0.9500 0.9875* 0.7002
no no sum 0.9600 1 0.7137
1D 1 1 0.8830
cpmg 1 1 0.8984
ALIGNED
Tilt Symmetrisation Projection Sensitivity 0 oc Sensitivity 1 oc q2y 0 oc
yes no skyline 1 1 0.7621
yes no sum 1 1 0.8093
yes yes skyline 1 1 0.7945
yes yes sum 1 1 0.7818
no no skyline 1 1 0.7895
no no sum 1 1 0.7443
1D 1 1 0.9194
cpmg 1 1 0.9355
Orthogonal partial least squares discriminant analysis (opls-da, see §2.3.5) of the urinary jres
projection data before and after alignment confirmed the findings from pca: before alignment
orthogonal components are necessary to achieve optimal models in terms of the mean sensitivity
of class prediction (see equation 2.18), whereas after alignment no orthogonal components are
necessary, see table 3.4. Evaluation of the loadings confirmed the dispersive components are
modelled as orthogonal variation. From this table, it is also clear that the goodness of prediction
for the first component, q2y, is higher for the aligned models. Interestingly, opls-da models of
the plasma data actually show better prediction performance for the unaligned spectra than for
the aligned spectra, which is possibly caused by the creation of minor artefacts with the current
alignment protocol, and the high quality of the original data.
In conclusion, the data type (multiplets or singlets) and processing (skyline or sum projection,
usage of tilt and symmetrisation) will greatly influence the resultant pattern recognition model.
However, the variation induced by a combined effect of peak shifts and peak width differences,
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can be addressed with an adequate alignment approach.116,117,137–139 Alignment can cause some
minor artefacts, see e.g. figure 3.4 and for plasma data, alignment is less necessary: opls models
showed good separation on unaligned data and pca model scores and loadings were not largely
improved with alignment either. Therefore, it is not clear if the advantages of alignment outweigh
the disadvantages for the analysis of plasma data.
3.4.5 Improved STOCSY results by use of aligned JRES projections
Information retrieval from correlation analyses such as statistical total correlation spectroscopy
(stocsy)67 is also improved after peak alignment. stocsy plots corresponding to the data shown
in figure 3.4 are shown in figure 3.6, in which peak height represents the covariance of the variable
with the class dummy vector and the colour represents the correlation with this vector. The severity
Figure 3.6: stocsy plots based on urine 800 MHz 1H jres symmetrised skyline projections obtained before and
after peak alignment, as shown in figure 3.4. The correlation (colour, r2) and covariance (peak height) of the
jres projections with respect to a class dummy vector are displayed; peaks pointing upward covary positively
with the toxic insult. Upon alignment, correlations are more pronounced and peaks lose the dispersive shape
that is characteristic of unaligned data, improving interpretability. Strong J-coupling spectral artefacts are seen
in the original spectra between the signals of galactosamine resonances at δ ∼3.8 and are also visible here.
Legend: dma, dimethylamine; 2-og, 2-oxoglutarate; and α/βG, α/β-galactosamine.
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of the toxic insult, and inter-individual differences in response,31,140 cause a broad concentration
range for certain metabolites in the different samples, increasing the reliability of the obtained
correlation coefficients. Spectral alignment removes the dispersive shapes in the stocsy plot
and reveals correlations that were previously unobserved, for example those of the galactosamine
resonances.
3.4.6 STORSY analysis of JRES projections
STORSY analysis of glucuronidation time-series
The proposed storsy method (see §3.3.6) was evaluated in a straightforward data set: the regres-
sion slopes were calculated for the different molecular species present in a sample displaying acyl
glucuronide intra-molecular transacetylation reactions.88 Many carboxylate drugs are metabolised
to ester glucuronides by conjugation with glucuronic acid. These 1–β–O–acyl glucuronides (e.g.
see figure 3.7) can be reactive and can isomerise to the 2–,3– and 4–O–acyl forms with mutaro-
tation to the corresponding α isomers; the 1–α isomer is formed by a back reaction from the 2–α
isomer. All isomers can also hydrolyse to free aglycone and glucuronic acid. Reactions of various
aglycones have been studied including the glucuronides of (R)– and (S )–α-methyl phenylacetate
acid.88,146,147 In this data set, the internal acyl migration reactions of 1–β–O–acyl glucuronide
were monitored by nmr acquisitions at regular intervals, resulting in spectra with different concen-
trations of the isomers as a function of time. A scheme illustrating the rearrangement and various
nmr assignments can be found in Johnson et al.88
nmr spectra are acquired as the spontaneous reactions proceed, to monitor the changing pro-
portions of the substances present in the sample. The results of storsy on this data set are
presented in table 3.5, where it is observed that the regression slopes between the H1’ of the
1–β–isomer (see figure 3.7) and several intra-molecular protons are not in correspondence with
Figure 3.7: Structure of the 1–β–O–acyl glucuronide of (S)-α-methyl phenylacetic acid, the H1’ atom that is
used to calculate regressions and correlations is coloured pink.
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Table 3.5: The regression coefficients (b) and correlation coefficients (Corr.) with the H1’ resonance (*) of
1–β–O–acyl glucuronide, shown in figure 3.7.
SYMMETRISED UNSYMMETRISED
Atom 1H Proton Corr. Slope Slope Corr. Slope Slope
(ppm) ratio y = bx y = bx+ a y = bx y = bx+ a
H1’ * 5.576 1 1.0000 1.00 1.00 1.0000 1.00 1.00
H5 1.540 3 0.9997 2.27 2.53 0.9998 2.30 2.40
H2’ 3.494 1 0.9998 0.71 0.72 0.9997 0.74 0.75
H4’ 3.503 1 0.9997 0.59 0.59 0.9997 0.60 0.60
H3’ 3.588 1 0.9999 0.75 0.74 1.0000 0.76 0.77
H5’ 3.811 1 0.9999 0.87 0.86 1.0000 0.91 0.91
H4 4.001 1 0.9995 0.29 0.29 0.9995 0.28 0.28
H3 7.383 2 0.9976 0.37 0.40 0.9980 0.41 0.43
H1 7.416 1 0.9991 0.33 0.38 0.9980 0.36 0.42
H2 7.450 2 0.9985 0.41 0.47 0.9984 0.41 0.47
the chemical structure (‘proton ratio’). This is notable, because the correlations are highly
significant (for H3, r = 0.9976, p  10−15). Moreover, the assignment of resonances is un-
ambiguous, as the other anomers have negative correlations to the 1–β–isomer and the spec-
tra have been assigned previously with the use of two-dimensional nmr and correlation tech-
niques.88 When using orthogonal least squares regression (orthogonal linear regression func-
tion, http://www.mathworks.com/matlabcentral/fileexchange/16800), which takes into ac-
count the equivalent measurement error for the ‘x’ and ‘y’ variables, the values remain almost
unchanged. As an example, the orthogonal regression with intercept from H1’ to H3, the lowest
correlation, and therefore most likely to improve with this approach, gives 0.399 for the sym-
metrised and 0.430 for the unsymmetrised case, whereas the theoretical value of the ‘proton ratio’
is 2 (see table 3.5). This suggests that due to T2-editing and various other processing steps in jres
spectra, the usual stoichiometric area ratios are not observed, which was confirmed by evaluation
of peak integrals.
STORSY in the galactosamine toxicity study
A demonstration of the regression between jres projection signal intensities of the same molecule
across a series of samples is shown in figure 3.8. storsy was used to calculate the peak ratios
between the CH and CH3 peaks from lactate in the galactosamine toxicity study, and a useful
degree of variation between the samples is observed. Unfortunately, the computed ratios of either
the peak height (used for correlation analyses such as stocsy) or the peak integral (traditionally
used for quantitation) of the jres sum projections are incorrect. Despite the high correlations,
due to the linear relationship between peak signals being maintained, the value of the regression
slope for the lactate signals is at least 4.6 for both peak height and peak integral, as opposed to
the theoretical value of 3. Similar discrepancies were observed for other molecules investigated.
67
Figure 3.8: Regression slope with (blue) and without (pink) intercept, and the correlation coefficient (r) for the
peak height (A) and peak area (B) data as calculated for the lactate peak in jres spectra of plasma, processed
without symmetrisation and using a sum projection. Although the regression is highly significant, there is a large
discrepancy between the expected slope of 3 and the calculated slopes ranging between 4.6 and 5. Pearson’s
correlation values (r) for the skyline projections without symmetrisation were 0.977 for peak height and 0.973
for peak area.
It should be noted that both the peak area and the peak height did not agree with the molecular
stoichiometry, indicating that the quantitation is also absent for traditional approaches which would
employ peak area.
Feasibility of STORSY
In conclusion, the reproducibility of jres spectra is high, as is demonstrated by consistently
high correlation values, but the sum projections of these jres data are non-quantitative. This
phenomenon is explained by a combination of factors, including differential relaxation effects: the T2
and T1 relaxation time constants are not the same for different protons in a given molecule.148 Peak
quantitation is further compromised by processing using absolute value mode, which is inherently
non-quantitative, and the use of sine-bell apodisation to create better-resolved peaks with smaller
dispersive tails, which can differentially affect the peak intensity from peaks of different linewidth.
The lack of quantitation of jres data has been discussed previously: some signal intensities were
found to be decreased whilst others increased, and this was explained by the different T2 relaxation
time constants.122 Composite window functions have been proposed for optimal data processing
that claim to provide accurate quantitation;136 in general the quantitation is heavily dependent on
the processing parameters.135,149
Although the applied processing procedure is non-quantitative, a high correlation was displayed
between intra-molecular protons of sum projections, validating the use of stocsy for jres sum
projections.67,88,115 These correlations were also maintained in skyline projections, because a
given molecule has consistent peak multiplicities and relative intensities for different samples. Semi-
quantitative (relative) changes in metabolite concentrations have also been achieved by others using
binned jres projection spectra,128 and recently a line shape fitting strategy to aid quantitative
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analysis of metabolites was proposed.135
The severe disturbances in the measured peak ratios indicate that there are some major lim-
itations that need to be overcome in order to acquire spectra with a quality suitable for storsy
analysis. The requirements for an nmr experiment that can provide high quantitation accuracy
include minimal relaxation-editing, and the removal of peak overlap and ideally multiplicity.
Alternative methods of obtaining jres spectra include the usage of Zangger–Sterk pulse se-
quence elements150 that encode the second dimension spatially rather than with time, resulting in
quantitative spectra with absorption mode line shapes.151,152 The quantitative jres spectroscopy
method suggested by Pell et al.151 has been investigated and it was found that the observed s/n
is prohibitively low for use with currently available technology for metabolic profiling studies in
biofluids. In addition, the involved pulse power optimisation is not appropriate for high-throughput
applications.
3.4.7 Over-representation of metabolite peaks in NMR spectroscopy
In many nmr-based metabonomic studies, the spectra show prominent peaks from drugs, toxins
and their metabolites. These can have undue weight in multivariate statistical models and the
identification and means of down-weighting such peaks have been demonstrated previously using
stocsy type approaches.153 In addition, many of these substances give rise to multiple, often
highly J -coupled, signals. This situation is also encountered here, where galactosamine and its
metabolites, as well as endogenous compounds such as glucose, have many resonances that are in
turn extensively coupled, and thus can be considered to be ‘over-represented’ in the nmr spectrum
with respect to the number of variables that correspond to a metabolite. This has a major influence
on variance-modelling approaches such as pca, which could be dominated by these resonances,
and makes the identification of other, possibly more discriminatory, markers more difficult. jres
projections could mitigate this problem, as the number of data points representing a given peak is
markedly reduced upon the collapse of multiplets.
The spectral information content in the various types of 1D 1H nmr representations is evaluated
by estimating the overall similarities between the different spectral data types through computing
Pearson’s correlation coefficient between every pair of spectra. The results are plotted in figure 3.9,
where each ‘pixel’ represents the correlation between two individual spectra; black lines separate
different blocks representing six discrete data sets, related to the type of pulse sequence (1D, cpmg
and jres) and treatment class (galactosamine-treated and control). These figures allow for a direct
comparison between the complete spectral information (not focused on peaks but also including
baseline regions, although higher intensity peaks will have a greater leverage effect than smaller
baseline peaks) of the different nmr experiments for the two biofluid matrices.
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Figure 3.9: Heat maps showing Pearson’s correlation coefficient (r) between the 1D, cpmg and skyline projected
jres nmr spectra for urine and plasma, before and after recursive segment-wise peak alignment.116 The solid
black lines separate the galactosamine dosed (‘D’) and control (‘C’) groups and the different experiment types
(‘1D’, ‘cpmg’, ‘jres’).
It is apparent from figure 3.9 that spectral alignment of urine nmr data greatly improved the
overall clustering with experiment and class subtypes. Dose-related clustering patterns are highly
disturbed for 1D and cpmg data and almost absent from jres data before alignment, confirming
the necessity for peak alignment; similar results were obtained for sum projected spectra. The
correlation patterns for plasma demonstrate clear differences between the different experiments: 1D
and cpmg plasma data are more similar to each other than to the jres projections. As expected,
the jres projections are slightly more correlated to the cpmg data than the conventional 1D
spectra, which can be explained by the known T2 relaxation editing in both pulse sequences.
The aligned urinary nmr data in figure 3.9 show that the 1D experiments from the control
group have a higher correlation to the cpmg spectra of the control group than to the dosed 1D
data. This is not unexpected, as for urine the difference between a cpmg and 1D spectrum is
small due to the limited number of molecules edited out by the cpmg, since urine is predominantly
comprised of low molecular weight compounds. Moreover, urine from the dosed group contains
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high levels of galactosamine and its metabolites (with high multiplicity and therefore containing
many variables), which are absent from the control spectra, in addition to the toxicity-induced
alteration of endogenous components. Ultimately, the differences in biochemical content of urine
for the dosed and control samples in this study are much larger than the spectral differences
between these pulse sequences. If the differences between the groups were more subtle, this would
not necessarily have been the case.
The correlations between the dosed and control groups for urinary spectra are higher for the
jres projections than for the 1D and cpmg spectra. This can be explained by the smaller number
of variables that are changed following the toxic insult and this in turn is due to the collapse
of the multiplets, leaving the jres projections from the two classes more alike. This indicates a
higher representation of xenobiotic-related peaks in 1D and cpmg urinary spectra of galactosamine-
treated animals. Similarly, the jres spectra of control urine have a lower correlation coefficient
with dosed 1D and cpmg spectra (figure 3.9, dotted blocks), compared to dosed jres spectra with
either control or dosed 1D and cpmg spectra (figure 3.9, dashed block). Naturally, the difference is
smaller when the jres spectra were also from dosed samples, or when the 1D and cpmg are control
spectra as well. Thus the toxin-related metabolites can be regarded as ‘over-represented’ in the
1D and cpmg data and the effective 1H broadband decoupling as achieved through projection of
jres data reduces this effect. This over-representation of multiplets in 1D and cpmg spectra is
comparable to the over-representation of protein envelope signals in pca models based on plasma
nmr data scaled to unit variance.44
An example of over-representation of glucose is seen in figure 3.10, where the variables repre-
senting glucose are coloured for a 1D spectrum and a jres projection. The ‘over-representation’ is
not completely remedied by the multiplet collapse. For example, glucose has more resonances than
most other metabolites even when collapsed into jres projections (12 chemically shifted protons
for the α and β anomers). From a biological point of view, there is no reason why metabolites
with more (non-equivalent) protons should be allowed to dominate any pattern recognition model:
the over-representation is caused by molecular structure and not by biological importance. Peak
or curve fitting (e.g. possible with commercial software), factor analysis, curve resolution154 and
stocsy-e153 might be able to compress signals in a jres projection further into one variable per
metabolite, i.e. deconvoluting the constituting metabolites into the pure spectral profiles, to obtain
relative concentrations across a sample series, which can then be subjected to unbiased multivariate
analysis.
When projecting the jres data without tilting, the multiplicity is retained. It was found that
the untilted jres projections were still dissimilar from the 1D and the cpmg data in the correlation
maps. This indicates that it is not only the multiplicity that caused these data to be inherently
different, but also the nature of the jres experiment with the different degree of T2-editing and
data processing applied such as usage of absolute value mode and sine-bell apodisation.
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Figure 3.10: An illustration of the fraction of variables that is representing the highly-split multiplets of the
glucose resonances in a 1D spectrum and a jres projection. The over-representation is more pronounced for
the glucose peaks in a 1D spectrum, than in a jres projection.
The patterns that were observed in figure 3.9 were not found when the data were scaled to
unit variance prior to analysis, or if the more robust Spearman rank correlation was used. This
is because there are a few large peaks that are the main cause of the correlation coefficients, as
they exert a ‘leverage effect’ (where a few high values profoundly influence the regression and
correlation coefficients); the same effect will also occur with methods such as pca and pls, and
can be partially remedied by scaling of the variables. Therefore, this figure is not only a clear
example of the over-representation of signals, but in addition it emphasises the need to reduce the
influence of high-intensity peaks, for example through the use of robust methods or by employing
appropriate scaling.
Normalisation of JRES spectra
The previously reported bias in total area normalisation associated with toxic insults,80 should
theoretically decrease when using jres projections, due to the reduction in presence of high-
concentration exogenous and endogenous signals contributing to the total spectral area.
Probabilistic quotient normalisation is based on the assumption that less than 50% of the
data points change across different spectra,82 but this requirement may not be fulfilled in jres
spectra. In the jres urine projections, for example, the majority of variables correspond to noise
regions that may be less representative of the sample concentration (in jres projections, ∼60%
of the spectrum is ‘noise’ as opposed to ∼10% for 1D; to calculate the percentage of data points
comprising noise in the spectra, 10 times the standard deviation of the noise over the region δ 0.2–
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0.5 in jres spectra and δ 9.8–10.0 in 1D spectra was used as a cut-off value). These considerations
demonstrate that the choice of ‘best’ normalisation method is complicated; however because the
probabilistic quotient normalisation is the more robust option, this was performed.
3.4.8 Complementarity of 1D and CPMG spectra and JRES projections
It might be thought that the information content of a cpmg nmr spectrum from a biofluid sam-
ple may essentially be obtained from acquisition of a jres spectrum combined with a standard
pulse-and-acquire ‘1D’ experiment. The main virtue of cpmg, T2-editing, is also obtained in the
jres experiment, with the added advantage that jres spectra provide projections that are easier to
interpret in heavily overlapped regions, especially when combined with the scalar coupling informa-
tion available in the 2D data. A potential disadvantage of the jres experiment is more pronounced
T2-editing than with the cpmg experiment since conventional sine-bell apodisation minimises the
contribution of rapidly relaxing protons even further. As a result, increased information extraction
is obtained in highly overlapped spectral regions, for example around δ 3.0–4.0 (see the assignments
in figure 3.3) at the expense of information density for rapidly relaxing species.
Because it is unnecessary to acquire a large number of increments (as zero filling and linear
prediction155 can be of help), it is possible to acquire good-quality jres spectra of typical biofluid
samples very quickly, in a period of less than 5 minutes.156 There are multiple approaches for fast
jres data acquisition: one is based on a reduction of the number of increments and transients in
the traditional jres experiment,156 whereas other methods encode the second dimension spatially
rather than through time, reducing data acquisition times, albeit at the cost of sensitivity.150–152,157
The sensitivity of jres data is only slightly lower than the sensitivity of 1D spectra acquired
over the same amount of time,158 and can be increased further through the use of cryoprobes.
Therefore time is not prohibitive to supplement or substitute acquisition of cpmg spectra with
jres spectra, even though more scans could be required. Moreover, it has been shown that the
cpmg experiment can be reliably approximated from mathematical manipulation of 1D data.159
Given the above, jres nmr spectroscopy is found to be advantageous and complementary to the
more usual one-dimensional nmr methods for routine use in metabonomic research, as previously
suggested.123,128 An additional benefit is that jres spectra, in contrast to 1D and cpmg spectra,
have the same appearance at different observation frequencies when spectra are displayed on the
ppm scale, and thus data can be more easily compared across different spectrometers. This allows
for rapid comparative analysis of spectral data sets from multiple field instruments and will simplify
generation of universal spectral databases.134 Thus, jres nmr spectra can be extremely useful as
part of the metabonomic nmr toolbox.115,134
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3.4.9 An example of information recovery using JRES spectroscopy
As illustrated in figure 3.11 with data from the galactosamine toxicity study, the reduced overlap
of biofluid spectral peaks in jres spectra not only aids model interpretation, but can also resolve
previously unidentified correlations; that is, the reduction in peak congestion resolves overlapped
multiplets, thereby allowing previously concealed peaks to be recovered.128 The jres projections
of the CH3 peak of alanine (in plasma, δ 1.47) and creatinine (in urine, δ 3.05) show improved
intra-molecular correlations; the correlation with the alanine CH peak at δ 3.77 and the creatinine
CH2 peak at δ 4.06, respectively, are more pronounced, see figure 3.11. The plasma region was
previously crowded with amino acid and glucose signals, whilst the creatinine signals in urine were
overlapped with galactosamine resonances. The individual resonances are completely resolved
upon jres projection (despite the imperfect alignment of peaks in this region for urine jres
projections) and hence a more reliable stocsy plot is obtained, demonstrating improved intra-
molecular correlations. This high correlation was not observed in the untilted jres projections,
which demonstrates that the obtained correlation is indeed uncovered by the reduced overlap due
to effective broadband decoupling. Notably, this is achieved despite a lower s/n for the presented
jres spectra (see table 3.1). These findings are particularly relevant to the study of endogenous
changes when the conventional 1D spectra are heavily obscured by peaks from the administered
toxin and/or its metabolites.
Figure 3.11: stocsy plots represent the correlation (r2) and covariance, using colour and height, respectively.
(A, B) The stocsy driven from the alanine CH3 peak at δ 1.47 shows improved correlation with the alanine
α–CH signal for the jres spectra of plasma, because the overlap with glucose signals is reduced. (C, D) stocsy
driven from the creatinine CH3 δ 3.05 peak shows good correlation to its CH2 signal in urine, demonstrating
that this intra-molecular correlation is only present in jres projections, where the overlap with galactosamine
resonances is removed.
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Similarly, in figure 3.12 the improved identification of biomarker metabolites when using jres
projections compared to 1D and cpmg spectra in the galactosamine toxicity study is demonstrated
through a stocsy plot related to class (note that some correlations are not optimal because the
creatinine δ 4.06 and H2 β-galactosamine δ 3.14 resonances are not aligned perfectly in the jres
projection). The correlation patterns identify the same biomarkers for response to the galac-
tosamine toxic insult in the 1D, cpmg and jres spectra, but the reduced overlap in the jres
projections (and the availability of splitting patterns in the 2D spectrum) significantly aids in a
complete and unambiguous assignment of all the individual metabolic resonances, contrary to pre-
vious results where the region δ 3.4–4.2 had to be simply labelled ‘galactosamine’.140 It should also
be noted that the 2-oxoglutarate peaks display a much higher correlation in the jres projection
and therefore this metabolite is unveiled as a potential biomarker.
Figure 3.12: Correlations of the spectral data points (colour, r2) with a dummy variable representing the
control or galactosamine-treated class, projected onto the covariance spectrum with the dummy variable for
the different aligned spectral nmr types of urine: (A) 1D, (B) cpmg, (C) jres symmetrised skyline projection.
The interpretation of highly overlapped signals, for example in the region of δ 3.0–4.0, is greatly improved
for jres, resulting in improved biomarker identification. Legend: dma, dimethylamine; 2-og, 2-oxoglutarate;
α/βG, α/β-galactosamine.
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3.5 Conclusions
The most important advantage of jres nmr spectroscopy over 1D and cpmg nmr spectroscopy
is the reduction in peak overlap, which aids biomarker identification and data interpretation in
‘congested’ spectral areas. The usefulness of full-resolution jres projections was evaluated, and
ways to realise the potential of the technique for metabonomic studies have been specified, partic-
ularly with respect to processing and spectral alignment of the data. The chosen galactosamine
toxicity data set is particularly suitable, as many previously identified differentiating biomarkers
of galactosamine toxicity represent complex multiplets and thus a considerable effect resulting
from the collapse of signals in the jres spectral projections was observed. Due to the inherently
non-quantitative nature of the standard jres spectrum, there is no need to use the stoichiometry-
conserving sum projection, and thus the skyline projection is often preferred, as this gives an
increased s/n and is still highly reproducible. Correlations of interest retrieved with stocsy are
conserved or improved compared to conventional one-dimensional experiments for both projection
methods, whilst regression slopes obtained using storsy are unreliable in the current experimental
system. The effective peak span widths decrease upon projection compared to highly split multi-
plets, and thus pattern recognition and correlation methods require alignment of the full-resolution
jres spectral projections. The subsequently reduced peak overlap in projected jres spectra can
improve the quality and interpretation of multivariate models and statistical correlation analyses,
and will enhance biomarker identification and reduce the differential degree of over-representation
of molecules. Hence, judicious acquisition of jres data and application of alignment can improve
the interpretation of pattern recognition models and increase the information content extractable
from nmr-based metabonomic studies, resulting in enhanced biomarker identification.
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Chapter 4
Simulated annealing optimised
K-OPLS in metabonomics
4.1 Aims and objectives
In the previous chapter, the choice of nmr experiment, peak alignment and subsequent use of linear
multivariate projection methods, such as principal component analysis and orthogonal partial least
squares (opls), which find use in modelling of spectroscopic data, were discussed. However, when
the relationship between the descriptor variables and the response is non-linear, conventional linear
prediction models will perform sub-optimally. In this chapter, the focus is shifted to evaluate the
mathematical non-linear predictive modelling of spectroscopic data with kernel-based orthogonal
partial least squares (k-opls), and its characteristics are illustrated with three separate metabon-
omic data sets: a study on the liver toxin galactosamine, a study of the nephrotoxin mercuric
chloride and a study of Trypanosoma brucei brucei parasite infection. This work, for which the
accepted publication is included in appendix D, was done by means of the following steps:
1. Demonstrating that the optimisation of the parameter σ of the Gaussian kernel transforma-
tion performed in k-opls can be done effectively and in a user-friendly manner by means of
simulated annealing;
2. Implementation of the simulated annealing optimisation and calculation of prediction per-
formance metrics (auc and q2y) using a nested cross-validation approach;
3. Comparing the predictive ability of non-linear k-opls and its linear equivalent opls;
4. Evaluating model interpretation enabled by the separate modelling of predictive and orthog-
onal variation and accompanying score plots;
5. Development of methods to approximate and visualise which variables play a main role in
the non-linear model based on ‘pseudo-samples’.
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4.2 Introduction
Multivariate projection methods such as partial least squares (pls)87 and the related orthogonal
pls (opls, see §2.3.5)93 are frequently applied for modelling of spectroscopic biological data, as
they provide predictive and interpretable models.23,55,64 The opls algorithm enables separate
modelling of Y-predictive (response-related) and systematic Y-orthogonal (response-orthogonal)
variation in data, ‘structured noise’.92–95,160 Thus, opls is beneficial in terms of model interpre-
tation compared to pls, and has been successfully employed in metabonomics.56 The concept
of Y-orthogonal variation can be understood as systematic effects that are needed to characterise
the system but are unrelated to the question at hand, i.e. the model predictions. For instance,
when aiming to classify a group of responders versus non-responders to a particular treatment,
the structured noise could be composed of inter-sample differences that are needed to describe
variability of the system but are not useful for separating responders from non-responders.
Most of the commonly used multivariate prediction models in metabonomics assume a linear
relationship between the X (descriptor) and Y (response) variables. However, many biological
systems display non-linear characteristics in response to a perturbation. Under such conditions,
non-linear methods are expected to provide improved models, which is particularly important in
predictive applications such as disease diagnostics,161 assessment of toxicity142 and characterisation
of variable response of individuals to drugs in personalised healthcare.33,34
A particular class of non-linear models are kernel-based models,162 with an early chemometric
application in the form of radial basis functions–pls.163,164 Other examples of kernel-based mod-
els include support vector machines (svm),165–167 kernel-based partial least squares (kpls168,169)
and kernel-based least squares regression.170 Kernel-opls (k-opls) is the non-linear extension
of the opls model, a commonly used multivariate model in metabonomic studies.55,56 In con-
trast to separate (linear) orthogonal signal correction (osc) followed by kpls modelling,171 or
kernel-osc followed by kpls modelling,172 k-opls provides an integrated orthogonal signal cor-
rection property that allows for separate modelling of predictive and Y-orthogonal variation in the
feature space, removing drawbacks associated with multi-step solutions, such as separate (k)osc
and (k)pls steps.93 Although the k-opls method does not necessarily provide improved pre-
diction performance compared to other kernel-based models,162 k-opls facilitates an improved
model interpretation compared to alternative models, which can aid quality control and further
understanding of the model and data.
Kernel-based models require an optimisation of the kernel-function parameter, which may be
challenging for the non-specialist, as the kernel parameter is often a continuous parameter with
an undefined upper limit that may have multiple local optima. The optimisation step is essential
to produce a model with a good predictive performance.171,173,174 Here, an automated procedure
is implemented for optimisation of the kernel parameter based on simulated annealing (sa), a
stochastic optimisation method,175,176 which greatly simplifies the use of k-opls, as suggested by
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Bylesjo¨ et al.57 This optimisation has been incorporated into the freely available k-opls software
package for both r and matlab (http://sourceforge.net/projects/kopls/).
The main objective in this study is to evaluate if non-linear prediction models provide an
advantage compared to linear alternatives in two common application areas of metabonomics:
toxicology and disease diagnostics. Using the non-linear sa-k-opls method, the possibility for
improved prediction performance in comparison to the linear opls model is demonstrated for
three separate spectral nmr metabonomic data sets. In particular, the focus is on problems where
prediction is of paramount importance, and it is also shown how structured Y-orthogonal variation
can be interpreted to gain further insight into the data. To further increase model transparency,
the influence of variation of each variable in the k-opls model is approximated.
4.3 Methods
4.3.1 Kernel-OPLS
The k-opls algorithm is a kernel reformulation of the opls algorithm, described in §2.3.5, utilising
the computationally efficient ‘kernel-trick’, allowing the elements of the kernel Gram matrix K
[n× n] to be treated as dot-products in the higher-dimensional feature space F to which the data
are (non-linearly) mapped. k-opls57,58 has a set of predictive latent variables represented by the
predictive scores matrix Tp [n×ap], where ap is the number of predictive components, and a set of
Y-orthogonal latent variables represented by the scores matrix To [n×ao], where ao is the number
of extracted orthogonal components, in analogy to the opls model.
The kernel-trick is common among all kernel-based pattern recognition methods, and is compu-
tationally efficient since no explicit transformation of the data is needed. Estimating a kernel-based
model is a two-step procedure. First, K is calculated using a suitable kernel function, see equation
4.1, where xi and xj represent rows i and j in X. This circumvents the explicit mapping of the
descriptor data to the (higher dimensional) feature space, and facilitates modelling of non-linear
variation.
Ki,j = k(xi, xj) (4.1)
Then, k-opls is used to establish a regression or discriminant analysis model of the, potentially
non-linear, relationship between the descriptor data, now represented by the kernel-matrix, K, and
the response variable(s), Y .
4.3.2 Kernel function optimisation
The are many kernel functions available to construct a kernel matrix K; here the commonly used
Gaussian kernel function is employed, see equation 4.2.
k(xi, xj) = exp(
−||xi − xj||
2σ2
) (4.2)
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This kernel function has a tuning parameter related to the size of the Gaussian kernel (σ). The
value of the kernel parameter greatly influences the predictive performance of the resulting model
(see the black line in figure 4.1, showing the predictive ability as a function of the kernel parameter),
emphasising the importance of optimisation of this parameter.
To find a good parameter value for the kernel function, grid search or gradient minimisation
could be applied,166,173 but these approaches may be computationally and labour intensive or
inefficient, can get trapped in local minima and are also dependent on the selected grid range
and resolution. An exhaustive search over all possible values is not computationally tractable due
to the continuous nature of the parameter. There is a multitude of global optimisation methods
available, such as simplex-based methods177 and genetic algorithms,178,179 previously reported in
the context of svm applications. In this work, it is demonstrated how simulated annealing (sa)
can be used to automatically optimise the kernel parameter178,180 in the k-opls model in order
to achieve good prediction performance in a user-friendly manner, but other approaches could
also have been applicable to this optimisation problem. The goal is not to compare different
optimisation methods, but to provide and demonstrate an automated and easy-to-use procedure.
4.3.3 Simulated annealing
In analogy with thermodynamic principles,181 where an infinitely slowly cooled ‘sample’ will occupy
the lowest energy state, simulated annealing enables stochastic sampling of the kernel parameter
space as a function of the decreasing ‘temperature’.175 The temperature influences the probability
of temporarily moving to sub-optimal parameter values in order to overcome local minima, and
with decreasing temperature the search range of the kernel parameter is slowly narrowed down
(see the bars in figure 4.1).
The pseudo-code for the sa algorithm is provided in table 4.1 and algorithm 1 (also see Corana
et al.176 for further details). In line 1 of the sa algorithm, the kernel parameter x is initialised.
Subsequently, and until convergence, the prediction performance is evaluated and a new kernel
parameter is proposed in the area surrounding the previous value, based on the step size v. If
the prediction performance, determined by cross-validation (see §4.3.4), of the evaluated value is
improved, the proposed parameter value will always be accepted, otherwise, the proposed param-
eter value is accepted with a probability related to the current temperature T , according to the
Metropolis criterion (line 14).181 High temperatures have a higher probability of accepting kernel
parameter states that result in sub-optimal prediction performance, enabling adequate sampling
of the parameter space and avoiding local minima. The sa algorithm is designed to maintain an
acceptance rate of around 50% of the proposed kernel parameter values, and the step size is se-
quentially updated to accommodate this (line 25 in algorithm 1). As the temperature is gradually
decreased (line 29), the chance of accepting high-energy values, i.e. kernel parameter values that
result in worse predictive ability, decreases until a defined convergence criterion (line 7) is fulfilled.
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Figure 4.1: The optimisation of a Gaussian kernel parameter σ with simulated annealing is performed by
minimising 1−q2y (left hand axis). The predictive ability for the sampled σ values is plotted in black, here for an
exemplar run of the mercuric chloride high dose regression data set, see §4.4.2, and the presence of local minima
is clear. Subsequent ‘optimal’ points (i.e. a value that is a new minimum when it was evaluated) are connected
with the red line. A number of values for the kernel parameter σ are sampled, the spread of which becomes
smaller as the temperature (right hand axis) decreases. The bars indicate the region in which kernel parameters
were evaluated for a given temperature T . The temperature cooling rate rT was 0.7 for demonstration purposes,
for all sa-k-opls results rT = 0.1 was used.
Here, results are presented from sa-k-opls using a Gaussian kernel function, however, the sim-
ulated annealing approach is widely applicable, and can be used to optimise other kernel functions
with a continuous parameter. The kernel parameter σ in the Gaussian kernel function defined in
equation 4.2 is optimised for values > 0. There are a number of parameter settings, that were im-
plemented as defaults in the available code, that could influence the simulated annealing procedure.
These values were optimised heuristically, based on literature recommendations176 and time and
convergence considerations. Although it may seem counter-intuitive to set more than one parame-
ter in order to optimise the one kernel parameter setting, the default simulated annealing settings
appear robust and typically provide good convergence, whereas the predictive performance as a
function of the kernel parameter is a complex, non-trivial optimisation problem as is illustrated in
figure 4.1.
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Algorithm 1 The algorithm used for optimisation of the kernel parameter based on simulated
annealing, see also Corana et al.176
1: x(0) ∼ U(0, 1) {Initialise kernel parameter x}
2: v = x(0) {Initialise step size v}
3: R(0) = f(x(0)) {Calculate performance metric R}
4: Ropt = R(0) {Initialise performance metric R(opt)}
5: h = 0
6: i = 0
7: while (RT(h) − Ropt >  & max{RT(l∈{h−N :h}) − RT(h)} > ) do
8: for j = 1 to NT do
9: Naccepted = 0
10: for k = 1 to NS do
11: xprop = xi +U(−1, 1)× v {Propose new kernel parameter}
12: Rprop = f(xprop) {Evaluate performance at proposal}
13: α ∼ U(0, 1)
14: if α < min{exp(R(i)−Rprop)/T , 1} then
15: x(i+1) = xprop {Accept and save current state}
16: R(i+1) = Rprop {Save current performance}
17: if R(i+1) < Ropt then
18: xopt = x(i+1) {Save if best state so far}
19: Ropt = R(i+1) {Save the optimal performance}
20: end if
21: Naccepted = Naccepted + 1
22: i = i+ 1
23: end if
24: end for
25: Update v:
v =

v
1+
Naccepted
NS
− 0.6
0.2
 if Naccepted > 0.6NS
v1+ 0.4−
Naccepted
NS
0.2

if Naccepted < 0.4NS
v otherwise
26: end for
27: RT(h) = R(i) {Save last accepted value before temperature update}
28: h = h+ 1
29: T = rT × T {Update temperature T}
30: x(i) = xopt
31: R(i) = Ropt
32: end while
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Table 4.1: List of symbols and variables used in simulated annealing (algorithm 1) and default values.
Symbol Description and default
 Convergence criterion precision (scalar), default 0.01
f(x) Function returning the performance metric R at x
* Discriminant analysis: 1-auc
* Regression analysis: (1-q2y)
Naccepted Number of accepted points since last step size update (integer)
N Number of temperature rounds in convergence check (integer), default 2
NS Number of iterations before step size update (integer), default 5
NT Number of iterations before temperature update (integer), default 5
R(i) Response performance value, corresponding to x(i) (vector)
Ropt Current optimal performance value, corresponding to xopt (scalar)
RT(h) h
th performance value before temperature update (vector)
rT Temperature decay rate (scalar), default 0.1
T Temperature (scalar), default starting value 0.1
U(a,b) Uniform random number ∈ [a,b] (scalar)
v Step size (scalar)
x(i) i
th accepted kernel parameter value (vector)
xopt Current optimal kernel parameter value (scalar)
4.3.4 Nested cross-validation
A nested cross-validation procedure182,183 was used to evaluate prediction performance during
optimisation of the kernel parameter, and the optimisation was performed separately for models
with different numbers of Y-orthogonal components, see §4.3.5. In each ‘outer cross-validation
loop’, the data were split into a training set and a test set, and the kernel parameter was optimised
in the ‘inner cross-validation loop’ (using only the training data from the outer cross-validation
loop, see figure 4.2 A). The prediction performance was then evaluated using the test set from the
outer cross-validation loop. Thus, the outer loop test set is never used for model optimisation, but
only for evaluation of overall prediction performance. This nested cross-validation procedure (see
also §2.3.6) is repeated for n outer cross-validation rounds, and figure 4.2 B provides a schematic
overview of the procedure.
The predictive ability of regression models was evaluated using the ‘goodness of prediction’
measure q2y (see equation 2.17), and discriminant analysis models were characterised by the mean
sensitivity (see equation 2.18) and the area under the receiver operating characteristic curve (auc,
see equation 2.19). For the presented results, Monte Carlo cross-validation (mccv, see §2.3.6)
was used for regression problems and the class-balanced mccv approach (mccvb) for discriminant
analysis, with 10 and 100 repetitions in the inner and outer cross-validation loop, respectively, and
75% of the data were used in the training set for both the inner and the outer cross-validation
loop. Identical training and test sets were used to generate sa-k-opls and opls models in order
to achieve a fair comparison. The score plots and reported kernel parameter values (σ, see table
4.2) were generated based on a kernel-optimisation and k-opls model using the full data set, as
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Figure 4.2: (A) The nested cross-validation procedure minimises the risk of model over-fitting and overestimating
the prediction performance while optimising the kernel parameter. In this procedure, n optimal kernel parameters
are determined, where n is the number of repetitions of the ‘outer’ cross-validation (cvo) round. The kernel
parameter for each cvo training set is optimised using simulated annealing in the ‘inner’ cross-validation loop
cvi , while the cvo test set is used to evaluate the prediction performance. (B) This schematic demonstrates
that the simulated annealing step is performed in each inner cross-validation loop (step 1) to find the kernel
parameter (step 2) which is used to predict the cvo test set (step 3). The full procedure is repeated n times
(step 4) to generate the cross-validated estimate of performance.
this model would be the one that could be used for prediction of additional data (an example of
external validation is shown in figure 4.9). The convergence plots shown in figure 4.3 demonstrate
that the prediction performances stabilise within the 100 outer cross-validation rounds to provide
reliable estimates of q2y and auc.
4.3.5 Number of Y-orthogonal components
The number of Y-orthogonal components for the opls and sa-k-opls models presented was chosen
by evaluating results for models calculated with 0 to 10 orthogonal components (oc); all models
required the use of 1 predictive component (because Y was a single vector or a two-class dummy
matrix). The kernel parameter is optimised separately for each number of calculated components
in the model (e.g. with 2 oc, the kernel parameter will be slightly different than with 1 oc).
The final number of orthogonal components was determined as follows: additional components
were included if q2y increased by more than 1% per component for regression analysis, and in
discriminant analysis the number of components corresponding to the maximum auc was chosen.
Table 4.2 lists the final number of components used for each data set. The optimal number of
components is determined separately for sa-k-opls and opls models, as the models are different
in nature.
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Figure 4.3: The prediction results of the 100 outer cross-validation rounds are shown for both the opls and sa-
k-opls models in the top panels for the five data sets presented in this work. The cumulative mean (solid line)
and median (thin line) for one to 100 cross-validation rounds are shown in the middle panels. This demonstrates
the convergence of the q2y predictive values for regression studies: ‘HgCl2 high dose’ (B), ‘HgCl2 both doses’
(C) and ‘TBB infection time’ (E); and stabilisation of the auc measure for the discriminant analysis studies:
‘Galactosamine’ (A) and ‘TBB classification’ (D). The prediction performance appears to be converged for all
data sets, as the means appear consistent after 100 cross-validation rounds. The cumulative standard deviation
(std, solid line) and median absolute deviation (mad, thin line) are shown in the bottom panels.
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A toy example
The glucuronide data set (see §3.4.6 and figures 2.10 and 2.11) will be used to demonstrate the
use of sa-k-opls in non-linear spectral modelling. This data set consists of nmr spectra acquired
at regular intervals as the transacetylation and isomerisation reactions of 1–β–O–acyl glucuronide
proceed. The time after solvation of the glucuronide is predicted based on the binned nmr spectral
data (δ 0.01 resolution) of the evolving mixture using 100 outer and 10 inner mccv rounds (75%
of the data was used in the mccv). The results are shown in figure 4.4 and it was found that
the predictive performance improved significantly compared to the linear model: the p-value of a
t-test based on the 100 cross-validation q2y values in sa-k-opls versus the opls q
2
y results (both
with 4 orthogonal components) is  10−15. The prediction is improved, because compounds that
are neither starting nor final components will show a non-linear behaviour as a function of time,
as their concentration initially increases and then decreases.
Figure 4.4: sa-k-opls predictions of time (colour-coded) in the glucuronide data set were improved compared
to the already high-quality linear opls model.
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4.3.6 Software implementation
The updated K-OPLS software (version 1.1.1)57 is freely available at http://sourceforge.net/
projects/kopls/. Implementations are provided for matlab and r, and are compatible with
Windows, Mac OS X and Linux operating systems and include functionality for nested cross-
validation and kernel parameter optimisation using simulated annealing and grid search. All results
presented here were obtained using matlab (R2008a, The Mathworks, MA, USA).
4.3.7 Visualisation of K-OPLS variable importance
A method recently presented to infer variable importance in svm184 was altered to visualise the
important variables for k-opls discriminant analysis models. Three different approaches were
undertaken, all based on the evaluation of variations in an individual variable represented by a
‘pseudo-matrix’. There are m pseudo-matrices, one for each variable, and each pseudo-matrix
consists of 20 pseudo-samples (so that the matrix dimensions are [20 ×m]). The intensity of all
variables in the pseudo-matrix was set to zero, except the variable under investigation, of which the
value was incremented from the minimum to the maximum value of that variable in the original
data matrix (here, this data matrix had been scaled to unit variance). Thus, a pseudo-matrix
Xps consists of zeros [20×m] with the column of the selected variable represented by 20 values of
increasing intensity.
• PCA of the kernel-transformed data
The kernel matrix of the spectral data with the optimum parameter σ in the k-opls model is
centred (Kc [n× n]) after subtracting variability described by the response-orthogonal com-
ponents, and a pca model is calculated. The score plots of this pca model are subjectively
evaluated to find a combination of two pcs for which the classes show the best separa-
tion. Then, each pseudo-matrix is subjected to the same kernel-transformation, including
the orthogonal signal subtraction, as the original spectral data. Each kernel pseudo-matrix
is subsequently centred (Kcps [20 × n]) and projected into the previously constructed pca
model, which results in 20 score values for each of the pseudo-matrices. In the score plot of
the two selected pcs that showed a separation of the classes, the pseudo-matrix scores are
connected to form the trajectory of the variable in the non-linear score space. Trajectories in
the direction of discrimination between the classes are expected to have higher importance
in the model.184
• PLS of the kernel-transformed data
A pls model with one predictive component is calculated based on the kernel transformed
spectral data Kc. Each kernel pseudo-matrix Kcps is projected into the pls model to give 20
predictive score values for each of the pseudo-matrices; variables that cause a large change
in the predictive component are more important.
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• K-OPLS prediction of pseudo-samples
The scores of Xps are predicted by a previously-built k-opls model. The maximum difference
between the predictive scores for the 20 pseudo-samples is calculated, and this range of the
predictive scores for each variable is used as a measure of variable importance.
4.4 Data sets
4.4.1 Galactosamine toxicity
The galactosamine toxicity data set comprises 1H nmr urinary spectra from rats treated with
galactosamine hydrochloride (n = 40, 500 mg/kg). Galactosamine is a model hepatotoxin that has
been shown to induce a highly variable pathological response in a given cohort of rats: it is common
that a proportion of animals show no adverse effects (non-responders) and responders display varied
severities of hepatic necrosis.140 Independent histopathological and clinical chemistry analyses were
used to determine the degree of response to galactosamine (galN). Urine samples were obtained at
8 and 16 hours collection intervals representing -48 to -40 (8 hr), -40 to -24 (16 hr), -24 to -16 (8 hr)
and -16 to 0 (16 hr) hours before dosing (samples courtesy of the COMET–2 project), as described
previously in Coen et al.140 For this data set, the goal was the classification of non-responders
(n = 10) versus responders (n = 30) from the pre-dose urinary 1H nmr spectra (samples acquired
at 40, 24, 16 and 0 hours before dosing), and this was performed using discriminant analysis with
sa-k-opls.
4.4.2 Mercuric chloride toxicity
Rats were administered mercuric chloride, and full details are given in Lindon et al.142 Mercuric
chloride and its possible metabolic derivatives are nmr-invisible, and thus all observed spectral
changes can be attributed to endogenous metabolites. Doses were given at two levels (n = 10 ‘low’
dose, 0.5 mg/kg, and n = 10 ‘high’ dose, 2.0 mg/kg) and urinary samples were obtained at time
points before (0 hr) and after dosing (8, 24, 48, 72, 96, 120, 144 and 168 hr post-dose) and 1H
nmr spectra were acquired. Half of the animals at each dose level were sacrificed at 24 hours after
dosing, the other animals were sacrificed at 168 hours. The time-course (9 time points) is modelled
with sa-k-opls regression.
4.4.3 Trypanosoma brucei brucei parasitic infection
To evaluate the effect of T. brucei brucei parasite infection in mice, plasma samples were collected
from an infected group (n = 12), and a control group (n = 12) of animals. Animals in both groups
provided samples (108 in total) at a series of time points pre- and post-infection (-2, 1, 7, 14,
21, 28 and 33 days after infection), as described by Wang et al.185 The presence of infection was
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established using discriminant analysis of pre-infection and control animals versus infected animals.
This was followed by a regression analysis, on the infected animals only (64 samples), to predict
the time after infection.
4.4.4 Data processing
Proton (1H) nmr spectra were acquired as previously detailed.140,142,185 As is standard, spectra
were imported into matlab (R2008a, The Mathworks, MA, USA) with δ 0.0005 resolution. Spec-
tral regions, excluding the water resonance for all spectra and the urea peak for urine samples,
were uniformly binned with δ 0.01 resolution, where a summed spectral intensity is calculated for
each bin. For plasma nmr spectra the spectral regions δ 0.00–4.60 and δ 5.10–10.00 were used and
for urine nmr spectra, this was δ 0.60–4.70, δ 5.05–5.50 and δ 6.25–10.00. Data quality control
was performed by identifying and removing outliers from an initial investigation with principal
component analysis. Samples were only omitted if they occupied an extreme value in score space
and have an identified technical of biological reason, for example poor water peak suppression or
lower than acceptable s/n. The resulting spectra were subsequently normalised with probabilistic
quotient normalisation,82 and variables were mean-centred and scaled to unit variance. The data
set sizes and sa-k-opls model details can be found in table 4.2.
4.5 Results and discussion
4.5.1 Prediction performance and optimisation of the kernel parameter
A summary of prediction performances, auc for discriminant analysis and q2y for regression models,
and optimised Gaussian kernel parameter (σ) values for each data set can be found in table 4.2.
Detailed results for each data set are presented in the following sections. For the current data set
type, scaling and size, the kernel parameters had comparable orders of magnitude, but this cannot
be assumed in general (it is possibly related to the similar nmr spectroscopy acquisition procedures
and data processing), and therefore these values should not be used as a future guideline. The
scaling of the data will have a large influence on both the chosen kernel parameter as well as the
q2y metric; therefore, a kernel parameter found optimal for mean-centred data is most likely not
appropriate for data scaled to unit variance, and the predictive ability of models built on differently
scaled data sets may also differ.
It should be noted that simulated annealing is a stochastic optimisation method, and therefore
the end result of every optimisation will vary slightly. To ensure that the prediction performance
estimates were reliable for comparison, and not unduly effected by random variability relating
to the cross-validation procedure, the convergence of the prediction performance metrics during
cross-validation was monitored, see figure 4.3.
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Table 4.2: Details of the evaluated data sets: the prediction of responders in galactosamine toxicity (GalN), the
prediction of time after intoxication with mercuric chloride (HgCl2) for a ‘high dose’ level and two dose levels
and the classification of infection with T. brucei brucei parasite (TBB) and the time after infection with TBB
were modelled (using discriminant analysis (da) or regression (re) models). The Gaussian kernel parameter
(σ) of the full model is shown. The prediction performance is given in terms of auc for discriminant analysis
and q2y for regression models. The number of orthogonal components (#oc) is indicated for both opls and
sa-k-opls models.
Data set Biofluid Model Size Response σ prediction #oc
type type [n× k] variable performance
GalN urine da 159×830 2 classes 20.06 opls 0.834 5
-responders sa-k-opls 0.876 3
HgCl2 urine re 60×830 9 time points 21.62 opls 0.615 4
-high dose sa-k-opls 0.666 4
HgCl2 urine re 123×830 9 time points 24.28 opls 0.584 4
-two doses sa-k-opls 0.660 3
TBB plasma da 108×950 2 classes 20.29 opls 0.956 2
-classification sa-k-opls 0.972 1
TBB plasma re 64×950 6 time points 22.66 opls 0.640 3
-time sa-k-opls 0.676 3
The prediction results are shown in figure 4.5, where the prediction improvement of sa-k-opls
over its linear equivalent opls is visible for all models. For certain metabonomic applications,
predictive performance is of paramount importance, such as in toxicology and disease diagnostics.
Although linear models often provide a basic level of prediction performance for multivariate data
sets, in the presence of substantial non-linear variability in data, non-linear models are expected
to provide improved predictions compared to linear models. This is explained by the potential
ability of a more flexible non-linear model to incorporate additional predictive information if the
predictor and response variables are related non-linearly. The aggregation of information across
many weakly associated descriptor variables, linearly and non-linearly related to Y , also contributes
to an improved, and potentially also more robust, prediction model. For the data sets analysed
here, it was observed that predictions by sa-k-opls were better than, or equivalent to, the linear
opls model. However, the additional assumption of linearity in the opls model may result in
better prediction performance under certain specific conditions, for example if the problem is truly
linear and the available training data are very limited in the number of observations.
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Figure 4.5: The differences of the prediction performance results for sa-k-opls and opls models were evaluated
using 100 outer cross-validation rounds (mean and the standard error of the mean, representing the variability
in the 100 cross-validation results, are indicated as bars with error bars). Regression analysis results from
the mercuric chloride (HgCl2) data sets and the T. brucei brucei (TBB time) time after infection data were
evaluated with q2y. Discriminant analysis results are presented with both the mean sensitivity and the area under
the receiver operating characteristic curve (auc), for the separation of infected versus uninfected samples from
the T. brucei brucei infection study (TBB class.) and for classification of non-responders versus responders in
the galactosamine toxicity data set (GalN resp.).
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4.5.2 Prediction of non-responders in the galactosamine toxicity study
Galactosamine has been widely used as a toxin to model hepatitis, although numerous studies
have identified significant variability in response to this hepatotoxin.140 In drug discovery, the
ability to prospectively identify and account for non-responders would greatly reduce the num-
ber of patients needed in clinical trials.186 Attempts have been made to predict non-responders
from their urinary metabolic profiles prior to,33,34,187 or soon after dosing188 in pharmacometabo-
nomics. Non-responders (n = 40) and responders (n = 119) to galactosamine, as determined by
histopathological and clinical chemistry markers of necrosis, were classified from the baseline (i.e.
pre-dose) urinary 1H nmr spectra using sa-k-opls discriminant analysis.
The discrimination between the responder (circles) and non-responder (squares) classes is clear
in figure 4.6, and an interesting, initially unexpected source of variation is visible on the orthogonal
component, which could be associated with the collection period (urine was collected from -48 to
-40 hr and -24 to -16 hr, whereas two other fractions represented collections from -40 to -24 hr
Figure 4.6: A score plot of the predictive and first orthogonal component of the galactosamine toxicity data
set shows a clear discrimination in the predictive component (x-axis) between responders and non-responders
(circles and squares, respectively). The first orthogonal component (y-axis) shows a trend related to diurnal
variation, as inferred from the urine collection time-period (either -48 to -40 hr and -24 to -16 hr: 8 hours (day)
collection; and -40 to -24 hr and -16 to 0 hr: 16 hours (night) collection).
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and -16 to 0 hr). It is visible that the 16 hours (night) collections have lower values on the first
orthogonal component (oc 1), and the 8 hours (day) collections appear to have a higher value on
oc 1. The orthogonal variance is therefore likely to reflect diurnal variation, which has been shown
to exert a subtle impact on metabolite profiles of urine.94,189
An increased prediction performance is observed with respect to the linear opls model: the
mean sensitivity increased from 0.75 to 0.79, and the auc from 0.84 to 0.88, using 5 and 3 orthogonal
components for opls and sa-k-opls, respectively, see figure 4.5. The roc curve of sa-k-opls is
constantly higher than the opls roc curve, see figure 4.7, indicating the overall high performance
of the non-linear approach for different specificity and sensitivity choices.
Figure 4.7: The receiver operating characteristic curves for the galactosamine toxicity study.
The difference between k-opls and kpls is analogous to the difference between opls and pls:
k-opls provides a separate set of predictive and Y-orthogonal model components, a property that
caused opls to gain great attention for analysis of metabonomic data.56 For comparison, the
equivalent kpls model was made using the same kernel parameter σ = 20.06 and 4 predictive
components (equal to the 1 predictive and 3 orthogonal components in sa-k-opls); the kpls code
was provided by Dr. R. Rosipal (Medical University of Vienna, AUT). The score plots from this
model are shown in figure 4.8, and do not allow this clear observation and separation of the diurnal
effects as orthogonal variation; moreover the separation between the two classes is not solely on the
first component, as was the case for sa-k-opls. This demonstrates one of the unique features of
k-opls compared to other kernel-based methods: the ability to capture and interpret non-linear
structured variation in a data set that is unrelated to the response variable (Y). Y-orthogonal
variation may be interpreted as multivariate latent variables that describe unspecified covariate
variation, for example unknown batch effects, animal variability or drift in analytical instruments
over time. Interpretation of orthogonal variation thus provides additional means for quality control
and understanding of data and model. For this data set, similar diurnal orthogonal variation is
observed in the opls model, which had a lower predictive ability, see figure 4.8.
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Figure 4.8: Score plots of a kpls model of the galactosamine toxicity study, using the same kernel parameter
and the number of components as the sa-k-opls model. The score plot for the predictive and first orthogonal
component of the opls model is also shown.
External validation
Prediction performances reported here were calculated by nested cross-validation, which reduces
the risk of over-fitting when optimising the kernel parameter.182 If obtainable, an external test set
should ideally be used to evaluate prediction performance, however the nested cross-validation is
expected to give an unbiased estimate of the predictive ability if no external test data are available.
An example of the prediction performance of sa-k-opls on an external data set was generated
by splitting the galactosamine toxicity data set into a modelling and an (external) validation set.
Thus, the nested cross-validation was used to create a model based on 120 observations, and the
39 removed samples from the validation set were predicted using this model. Also in this instance,
the prediction improved for sa-k-opls compared to opls, see figure 4.9. Of course, it would be
preferred to validate the model with an external test set that was acquired on a different occasion,
to fully test the robustness of the method, but these data are not always available.
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Figure 4.9: The classification results of non-responders versus responders in the galactosamine toxicity data set
were evaluated using a model solely built on 75% of the data (n = 120), the ‘Training data’. The results are
presented for both the mean sensitivity and the auc. The opls model was based on 5 oc, which gave the
maximum auc for the training data (calculated with nested cross-validation), and for sa-k-opls 2 oc were
used. The mean and standard error of the mean of the 100 outer cross-validation rounds are shown, representing
the variability in prediction performance of the training data set. Results for the ‘External validation data’, the
remaining 25% (n = 39), indicate large improvements for both mean sensitivity and auc for the sa-k-opls
model compared to the linear modelling equivalent, opls.
4.5.3 Time-course modelling of mercuric chloride toxicity
Mercuric chloride is a well-studied nephrotoxin targeting the proximal tubules of the kidney.190,191
A single dose induces a reversible lesion demonstrating a clear dynamic profile of metabolic con-
sequences progressing to maximum insult and then recovery. Urinary 1H nmr data were used to
predict the time after dosage with mercuric chloride (high dose level). This is of relevance for
toxicology, because a good delineation of the time-course describing the onset, evolution and re-
gression of a toxic lesion is of value for comparison with the gold standard histopathology approach,
to identify fast and slow responding animals, and for selecting the most appropriate sampling times
for other assays such as transcriptomics.192 The prediction of time after dosing is improved using
the non-linear kernel method compared to linear modelling: q2y is 0.67 compared to 0.61 (4 orthog-
onal components for both opls and sa-k-opls), see figure 4.5. Interpretation of the orthogonal
component reveals inter-animal variation in response: figure 4.10 A shows that animal 28 exhibits
a different response compared to the other animals, and animal 29 also diverges from the other
animals at later time points.
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Figure 4.10: (A) A score plot of the prediction of time after dosage with a high dose of mercuric chloride based
on metabolic changes was used to delineate the onset and regression of a toxic lesion. The predictive score
component (x-axis) describes variability related to the Y variable (time), while the orthogonal score component
(y-axis) captures some systematic metabolic changes occurring at predominantly 24–48 hours after dosing.
Interestingly, animal 28 (squares) and later animal 29 (diamonds) diverge from the behaviour of the other
animals over time. (B) A score plot of the prediction of time after dosage with ‘low’ and ‘high’ doses of
mercuric chloride. The orthogonal score component (y-axis) captures systematic metabolic differences between
the low and the high dose group. Animal 28 and later animal 29, which diverge from the behaviour of the other
high dose samples over time, appear to recover in a path similar to low dose samples.
Figure 4.11: A principal component analysis of serum clinical chemistry data acquired at 24 and 168 hours
post-dose (mean-centred and scaled to unit variance) of the animals in the mercuric chloride toxicity study
demonstrates that the high dose animals cluster separately from the low dose animals, except the data acquired
from animal 28, and the later time point of animal 29; these findings are in agreement with the results in the
orthogonal component of the sa-k-opls models.
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A regression model was also constructed where data from the low and high dose levels of mer-
curic chloride were combined. Thus, this model is focussed on the common time-related metabolic
response across toxin dose-levels, allowing prediction of the time from dosing, in analogy with
clinical situations where the dose level and exposure time may be unknown. Also for this model,
the prediction performance increased for sa-k-opls compared to opls (see figure 4.5, q2y is 0.66
compared to 0.58). Moreover, the aberrant observations for the two animals 28 and 29 in the high
dose group discussed above now cluster with the low dose animals in the score plot, see figure 4.10
B, indicating that they show a less severe response to the toxin.
Figure 4.12: Score plots for kpls and opls models for the two mercuric chloride data sets, the colour-coding
is identical to figure 4.10. (A) The score plots of the kpls model for the high dose mercuric chloride toxicity
study, using the same kernel parameter and number of components as the sa-k-opls model. (B) Score plots
of the kpls model on the mercuric chloride ‘both’ doses data set, using the kernel parameter and number
of components that were used for the sa-k-opls model. (C) A score plot showing the predictive and first
orthogonal component of the opls model for the high dose mercuric chloride data set. (D) A score plot
showing the predictive and first orthogonal component of the opls model based on the combined low and high
dose mercuric chloride data set.
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The trends found for animal 28 and 29 of the high dose group were confirmed independently in
the serum clinical chemistry data, where at 24 and 168 hours after dosing animal 28 showed lower
levels of typical markers such as creatinine, gamma-glutamyl transpeptidase, urea nitrogen and
phosphate than the rest of the high dose group, and similar effects were observed for animal 29 at
168 hours after dosing. The disparate metabolic behaviour of the identified ‘outlier’ animals is also
clear from a pca model created on the clinical chemistry data measured in serum, see figure 4.11.
It should be noted that the spectra were based on urinary samples, so both biofluids demonstrate
the altered metabolism of the animals. Thus, these animals were correctly identified as having a
different response, based on the orthogonal variation in the sa-k-opls score plot, without prior
knowledge or consultation of the metadata.
This example confirms that sa-k-opls not only improves the predictive ability for these two
data sets compared to opls, but moreover, unlike other non-linear kernel-based methods, provides
a visual interpretation of the variation in the data set, in terms of predictive variation as well
as structured Y-orthogonal variation. The orthogonal variation information is not observed for
the corresponding kpls models, see figure 4.12 A and B where the score plots are shown for the
high dose (5 components) and both doses (4 components) data sets (using σ = 21.62 and 24.28,
respectively). Interestingly, a clear interpretation of the orthogonal variation was not possible in
the equivalent opls models, see figure 4.12 C and D.
4.5.4 Classification of T. brucei brucei parasitic infection
In a third exemplar data set, the 1H nmr data of plasma samples from a T. brucei brucei parasitic
infection (African sleeping sickness) in a murine model were evaluated.185 Spectra were acquired
from plasma samples of mice before and at various stages during the infection and similarly from
control animals. Data from infected animals formed the ‘infected group’; the ‘uninfected group’
consisted of the combined pre-infection and control animal data. The discrimination between the
infected and uninfected groups resembles the situation in a clinical setting, where it is crucial to es-
tablish the occurrence of infection, irrespective of the time elapsed after initial infection. Improved
classification accuracy between infected and uninfected individuals with sa-k-opls was observed
compared to linear modelling, see figure 4.5 and table 4.2, with an increased mean sensitivity (sa-
k-opls: 0.92 with 1 oc, opls: 0.88 with 2 oc), as well as a larger auc (0.97 compared to 0.96).
The roc curves for these two models intersect, see figure 4.13, and thus there is a small region of
specificity and sensitivity where opls would perform better than sa-k-opls.
In figure 4.14 A, it is apparent that the early time point of infection (day 1) is more difficult to
discriminate from the uninfected spectra than the later time points (this was also observed for the
opls and kpls models, see figure 4.15 A and B), which can be expected from the development of
a parasitic infection.
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Figure 4.13: The receiver operating characteristic curves for the African sleeping sickness (TBB) classification.
4.5.5 Prediction of T. brucei brucei parasitic infection time-course
The status of the T. brucei brucei infection in terms of the time after contraction is highly relevant
as the nature of therapeutic intervention and the prognosis for recovery are greatly dependent on
the event of blood-brain barrier crossing of the parasite that occurs in this infection. As with
the mercuric chloride toxicity data set, a metabolic trajectory reflecting the progression of the
infection can be characterised using spectral profiling.185 To stage the infection time point, the
time after infection was modelled non-linearly as a regression, and prediction results are displayed
in figure 4.14 B; the corresponding opls and kpls models are shown in figure 4.15 C and D. It was
found that the prediction was improved for the sa-k-opls model compared to the results from the
linear opls model: q2y increased from 0.64 in opls to 0.68 in sa-k-opls, both with 3 orthogonal
components, see also figure 4.5 and table 4.2.
Figure 4.14: (A) The classification of samples into two groups representing presence and absence of a T. brucei
brucei parasitic infection using non-linear modelling is visible on the predictive component (x-axis). (B) The
predicted versus actual time points are plotted for the regression with sa-k-opls to model the time after
infection with the T. brucei brucei parasite.
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Figure 4.15: (A) The score plots of kpls and (B) opls models for the classification of T. brucei brucei infection
data. (C) The score plots of kpls and (D) opls models for the prediction of time after infection with T. brucei
brucei.
4.5.6 Visualisation of variable importance in K-OPLS models
In contrast to linear methods, there are no model loadings accessible for interpretation of variables
in the case of kernel-based methods, due to the usage of the kernel trick. The non-linear mapping
to the high-dimensional feature space removes the direct relation between model scores and load-
ings. This may be a disadvantage of kernel-based non-linear modelling but the importance of this
potential disadvantage will depend on the application. For example it could be a problem in stud-
ies where biomarker identification was the main goal, but in studies where maximum predictive
performance is imperative, for example in toxicology and disease diagnostics using multivariate
biomarker panels, the improved predictive ability is a major advantage.
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Evaluation of kernel-transformed pseudo-samples in a PCA biplot
As the visualisation and interpretation of important variables could greatly aid biological under-
standing, an attempt is made to approximate the variable importance for the TBB classification
model. The sensitivity of a model to variations in a selected variable is analysed by means of
a ‘pseudo-matrix’ Xps, representing the effect of the variation of one variable, see §4.3.7. This
method was recently introduced to achieve a similar purpose in svm modelling, and is based on
the concept of biplots, where loadings and scores of a pca model are simultaneously displayed; it
is proposed that the change of a score value as a function of variation of a variable is a measure
of the variable importance. This property has been proven for linear models,184,193,194 and it is
postulated that the same approach also gives a measure of variable importance for non-linear mod-
els. The visualisation of this pca-based variable importance metric is discussed here for k-opls
models, and two similar metrics of variable importance are introduced.
The scores of a pca model on X, shown in figure 4.16 A, do not discriminate between the infected
and uninfected groups on pc 1 and 2. When a pca model is calculated based on the mean-centred
kernel-transformed descriptor data, the two classes still show a large degree of overlap, see figure
4.16 B. However, the scores of a pca model from the mean-centred kernel-transformed spectral
data matrix after orthogonal signal correction (Kc) separate the infected and uninfected classes
more effectively, as is indicated with the dotted line in figure 4.16 C. Interestingly, the majority
of the samples that are misclassified are from time point 1, which was also observed for the opls,
kpls and k-opls models.
The importance of the different variables in this pca model of the kernel-transformed data
is subsequently evaluated with a kernel-transformed pseudo-matrix Kcps, consisting of pseudo-
samples, to represent the variation of one variable as described in §4.3.7. The scores of Kcps in
the pca model are calculated, and connected to form a trace. This process is repeated for each
variable (which is represented by its own pseudo-matrix), and the resulting score trajectories are
interpreted in a similar manner as loadings in a linear model. The score trajectories are shown in
figure 4.16 D, where each line corresponds to a series of connected pca scores for one variable. The
colouring is related to the variable importance, which was determined by the range of the projection
of the score trajectory on the (solid) class-separating line that was determined in figure 4.16 C: the
maximum distance between projections of the twenty pseudo-samples in each pseudo-matrix on
the discriminant line determines the variable importance. Thus, variables with a larger component
on the solid line (which is mostly in the direction of pc 2), are shown in red and are considered
most responsible for the visible score patterns and class separation in figure 4.16 C.184,193
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Figure 4.16: (A) Scores from a pca model of the descriptor data scaled to unit variance X (for colour-
coding of symbols, see figure 4.14). (B) Scores from a pca model of the mean-centred kernel matrix before
orthogonal signal correction. (C) Scores from a pca model of mean-centred kernel matrix after orthogonal
signal correction Kc. A separating plane between the infected and uninfected samples is indicated with the
dotted line (calculated with linear discriminant analysis, classify in the MATLAB statistics toolbox). The vector
orthogonal to this discriminant axis is shown as a solid line. (D) The pseudo-sample trajectories for each variable
are colour-coded according to the variation in the direction of separation (black line): the most ‘important’
variables are represented as red lines and are visualised in a spectral form in figure 4.17 A.
Evaluation of three pseudo-sample based variable importance metrics
The pca biplot method was extended with two other approaches to form a set of three related
variable importance metrics, all based on this concept of ‘pseudo-matrix’ scores, that were used to
evaluate the variables in the TBB classification model:
• Two pcs showing discrimination between the groups in a pca model of Kc are found. The
scores of Kcps in this pca model are evaluated to find the variables showing the largest
variance in the direction of group separation, see figure 4.16 and 4.17 A. This is based on the
property of pca that loadings and scores can be superimposed in a biplot.184,193,194 The
kernel matrix that was used is based on the kernel parameter and the number of orthogonal
components of the original sa-k-opls model.
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• To make a predictive model, rather than an unsupervised model, pls is used to predict the
two classes based on Kc. Subsequently, the score values of Kcps are predicted by this pls
model. The scores on the predictive component are used to evaluate the ‘sensitivity’ of this
model to variations in the respective variable, see figure 4.17 B. As the kernel matrix was
already corrected for orthogonal variation and it is a two-class problem, only 1 predictive
component and no orthogonal components were used.
• The score values of the pseudo-matrix Xps are predicted from the k-opls model, established
in §4.5.4, to give an indication of the effect of changes in a variable to the score value on the
predictive component, see figure 4.17 C. This variable importance metric makes use of the
fact that k-opls provides score values, unlike svm, for which the non-linear biplot model
was necessary.184 However, there is no theoretical ground to assume that variables found
important by this metric are related to the model predictions in a similar way as loadings
are for linear models, since the effect of the kernel transformation is not well-defined.
For the pca-approach, a linear discriminant analysis is performed to find the direction of
separation between the two classes. The range of the projections of the pseudo-samples for each
variable on the discriminating line (the solid line in figure 4.16 D) is used to evaluate variable
importance. The discriminating plane of the pca-based approach is not always in the first pcs: for
the galactosamine toxicity model, the best separating plane was a linear combination of pc 20 and
21. For the galactosamine model, a clear effect of diurnal variation on the pca model was noticed,
which confirms that the kernel-transformed matrix after orthogonal signal correction should be
used. For the pls and k-opls models, the range of the scores on the predictive component was
used to evaluate variable importance.
A spectral representation of the different metrics is shown in figure 4.17, where the mean
spectrum is colour-coded with variable importance. It should be noted that these approximations
are not true loadings, and are unable to take interactions between variables into account. The
resulting values can be viewed as an indication of the ‘sensitivity’ of the model scores to changes in
a variable. The absolute values of the loadings (P = XTTp/Tp
TTp) of the opls model are included
in figure 4.17 D for comparison. Note that the sign of the loadings from the opls model would
give an indication of the up- or down-regulation of a metabolite, whereas the kernel method allows
the modelling of non-linear patterns that have no clear directionality (see e.g. the parabolic shape
of some of the score trajectories in figure 4.16 D), and thus only provides an unsigned importance
metric.
From figure 4.17, it is clear that the three related pseudo-sample approaches give very similar
results in terms of variable importance. This could be the result of the similar nature of the
three methods, which all project the pseudo-samples in a non-linear model, using the same kernel-
transformation. There are only minimal differences between the variable importances of the linear
and non-linear approaches, including the slightly increased importance of variables in the opls
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Figure 4.17: A colour-coding representing the importance of the variables is projected on the mean spectrum of
TBB study samples; the colour-coding for all plots ranges from blue (unimportant) to red (most important). (A)
The variable importance is based on the range of projections of the pca score trajectories of the pseudo-samples
on the discriminating axis shown in figure 4.16 D. (B) A colour-coding representing the change in predictive
score value of the pseudo-data based on a pls model of the kernel-transformed data. (C) A colour-coding
representing the change in the score on the predictive component when predicting the pseudo-samples with
the previously generated k-opls model, see §4.5.4. (D) The loadings of the equivalent opls model (with two
orthogonal components, see §4.5.4) from the original, i.e. not kernel-transformed, spectral data.
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model in the range δ 6.8–8.8 compared to the non-linear models, and vice versa around δ 1.90, δ
2.43 and δ 2.91. Although the pseudo-sample approach needs to be further validated, a comparison
of the linear and non-linear models confirms that signals important in linear models typically remain
useful in non-linear modelling with k-opls.
The approach of pseudo-samples to determine important variables in non-linear models is not
restricted to k-opls discriminant analysis and svm: once it is verified to be an accurate measure
of variable importance, the method could also find use in other non-linear projection models such
as kpls, and it could be extended to aid the interpretation of regression models.184 The pseudo-
samples were created in the range of the original variable, which is expected to have a large effect
on the projection trajectories if the data would not have been scaled to unit variance. In this
situation, it could be worthwhile to normalise the trajectories in order to correct for the overall
size of the trajectory.
Summarising, three different approaches to indicate variable importance for this non-linear
model based on pseudo-matrices are suggested, and they show large correspondence with each other
and the loadings of opls, indicating that this could be a viable way to increase the transparency
of sa-k-opls models.
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4.6 Conclusions
Currently, predictive modelling in metabonomic studies is almost exclusively performed using linear
methods. Here, it is demonstrated that a non-linear kernel-based model can provide valuable
prediction performance improvements compared to the linear model in three typical metabonomic
data sets. The kernel-based opls model (k-opls) was used in this study, which is analogous
in its model structure to the commonly used linear opls model. It was found that the non-
linear (k-opls) prediction performance is better than or equal to the linear opls model. k-opls
provides added value compared to alternative kernel-based models by enabling separate modelling
of predictive and Y-orthogonal model components, facilitating improved model interpretation and
providing a means for quality control. The introduced variable importance approximations could
potentially provide additional biological interpretation of non-linear models.
A complicating factor for non-expert users in the application of kernel-based models can be
the optimisation of the kernel function parameter. It was demonstrated how simulated annealing
can be applied successfully to automate optimisation of the kernel parameter, providing a user-
friendly procedure based on nested cross-validation. Thus, it was shown that sa-k-opls provides
a flexible framework for non-linear classification and regression modelling and it is anticipated that
the method can also be employed successfully in studies with data collected by other analytical
methods and for modelling of other -omics data types, as well as high-dimensional and potentially
non-linear data in general.
These results should facilitate increased utilisation of non-linear prediction models in metabolic
profiling studies, especially in application areas such as disease diagnostics and toxicology, where
prediction performance is of utmost importance. The sa-k-opls algorithm applied here is available
in the k-opls software packages for r and matlab, including cross-validation procedures, kernel-
optimisation and calculation of prediction performance metrics.
106
Chapter 5
Multivariate analysis of mass
spectrometry imaging data
5.1 Aims and objectives
The previous chapters described methods for processing and modelling of nmr spectral data that
summarise global profiles of tissues or biofluids. An exciting new development with great potential
for metabonomic studies, is the acquisition of localised molecular spectra with mass spectrometry
imaging (msi). An msi data set consists of a series of mass spectra obtained from various sequential
locations forming a grid. Thus, the data can be interpreted as a full mass spectrum at a given
spatial point (pixel), or as a map of a given substance level over a two-dimensional set of pixels. In
terms of modelling, the previous chapters already explored the modelling of spectral data, and the
msi data additionally required to take the image information into account. Therefore, sophisticated
approaches are needed and the following steps are discussed in this chapter to address different
aspects of msi data, in order to extract the maximum amount of useful information from the
acquired hyper-spectral data:
1. Develop and evaluate various approaches to processing msi data;
2. Implement and discuss a correlation-based measure of spectral similarity of different pixels;
3. Perform principal component analysis and evaluate the distribution of pixels in the score
plots and the mass spectrometry image;
4. Compare the distribution of pixels on self-organising maps with the localisation of these
pixels in the image;
5. Visualise the global and local structure of the data in a few dimensions using non-linear
dimensionality reduction based on manifold learning techniques.
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5.2 Introduction
Mass spectrometry imaging (msi) provides localised spectroscopic information about the contents of
a sample, e.g. a tissue slice, across a grid, see §2.2.2.51,76–78,195,196 It reports a spatial biochemical
topology with high molecular specificity, providing an ex vivo view of tissue. msi can be exploited
to find tissue biomarkers or characteristic metabolic profiles of sample regions. For example,
classification based on msi spectral data is suggested as a method to obtain a digital staining.197
msi has been used to study proteins,77,198–204 lipids,205 metabolites206,207 and drugs,208,209 and
has been performed on a large number of sample types, including plants,207 bacterial colonies,210
drug-treated tissue,209,211 rat brain, and human surgical specimens,77,212 including human cancer-
ous tissue in breast204,213 and ovarian cancer.201 Even whole animals have been imaged as part of
a drug study.208
msi data combine spatial resolution and spectroscopy; characteristic of this type of data is a
high dimensionality (see table 5.1) and complexity, especially for biological samples. maldi is a soft
ionisation technique, and therefore there is little fragmentation, however a large number of adducts
can be formed. Variable tissue height and differential ionisation patterns further complicate the
obtained spectra. Data are typically evaluated with standard msi analysis tools and software, such
as biomap,214,215 ClinProTools216 and others.217,218
Analysis of single images (i.e. one m/z value) is most commonly employed,77,208–210,213 and
univariate analysis of selected peaks can be performed.212 The complexity of human biology and
disease, however, is unlikely to be captured with this approach. Single or manually obtained
biomarkers are probably not robust, as a plethora of different mechanisms will lead to subtle
variations in observed molecular concentrations. Some work has addressed the multivariate nature
of the mass spectrometry data in matrix-assisted laser desorption/ionisation (maldi) msi data sets,
for example, principal component analysis (pca) has been performed on selected msi pixels201,219
or the complete sample.205,220–223 pca can also be used to compare anatomical regions of different
animals224 and to align images of multiple msi data sets from one sample in a mosaic.225 pca has
further been employed to compress the data prior to clustering203,226 or to perform discriminant
analysis of regions of interest.219,226 Classification of msi data can also be performed with k-nearest
neighbour methods,202 partial least squares,227 support vector machines,166,202,204,212,220 neural
networks,204 random forests197 and hierarchical clustering.198,203,204
Multivariate techniques have also been suggested and employed for other types of msi data,
for example generated by secondary ion mass spectrometry (sims).218,228,229 pca followed by a
varimax rotation to yield physically realistic spectral loadings and increase image contrast was
useful in an analysis of tof-sims imaging data, but at the cost of chemical specificity.229,230 An
alternative was suggested through the use of probabilistic latent semantic analysis,231 which also
produces non-negative components.
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Often, msi is applied to analyse high molecular weight species, but the approach can be ex-
tended to metabolite data,206,207 and it is expected to be advantageous compared to ‘classical’
metabonomic mass spectrometry through the combination of relatively high sensitivity with lo-
calised metabolic information. One problem is that the applied matrix in maldi imaging causes
peaks that interfere with the spectral profile. This is one of the challenges that is addressed and
discussed in this thesis. Moreover, there has been little research that has taken the multivariate
nature as well as the image nature of the msi data into account. Therefore, the focus is on visu-
alisation rather than classification, and the full data set is used rather than a small selection of
sample regions and single m/z values. Intuitive and straightforward approaches for analysis, that
retain the link between data modelling and biological interpretation by cross-referencing between
the spectral data and the image, are explored in this work. The methods are demonstrated with a
formalin fixed sagittal rat brain section, with spatial resolution 100 µm× 100 µm and from which
mass spectra were acquired in the range m/z = 50–1000.
5.3 Materials and methods
The sample preparation and histology and msi data acquisition were all performed by Claire Carter,
University of Birmingham.
5.3.1 Materials
Alpha-cyano-4-hydroxy cinnamic acid (αchca) and trifluoracetic acid (tfa) were purchased from
Sigma-Aldrich (Dorset, UK). 10% neutral buffered formalin (nbf) was supplied by the Histology
Department of the Medical School at the Royal Hallamshire Hospital (Sheffield, UK). Methanol
was purchased from Fisher Scientific (Loughborough, UK). Whole control rat brains were supplied
by Covance (Harrogate, UK). A TM Sprayer (automated matrix deposition system) was supplied
by Leap Technologies (North Carolina, USA).
5.3.2 Tissue preparation for MALDI MSI of phospholipids
A whole rat brain was removed from the -80 ◦C freezer and allowed to thaw at room temperature.
Once thawed, the brain was placed in 10% nbf and fixed for 48–72 hr. Fixed brains were bisected
and half of each was mounted onto a cryostat chuck, using water-ice slush. 12 µm serial sections
of each brain were thaw mounted onto stainless steel maldi target plates for mass spectrometry
and glass slides for histology. Tissue samples were coated in 5 mg/mL αchca matrix material,
prepared in 80% methanol (0.1% tfa) using the Leap TM sprayer. Plates were sprayed at 150 ◦C,
10 psi, a flow rate of 0.25 mL/min with a stage velocity of 500 mm/min. Each target insert was
sprayed with 8 cycles.
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5.3.3 Mass spectrometry imaging
All experiments were carried out on a QqTOF (Qstar Elite) mass spectrometer (Applied Biosys-
tems, Foster City, USA), operated in positive ion reflectron mode. Instrument parameters had
been previously optimised for the analysis of glycerophosphatidylcholines from rat brain. The
Nd:YAG (355 nm) laser was operated at 20% available power (2.1 µJ) with a repetition rate of 500
Hz. The target plate stepping distance was set to 100 µm for both the x and y dimension using
the imaging acquisition software. Data were acquired using the ‘dynamic pixel’ setting, which
involves the laser being moved within the 100 µm2 pixel area and resultant data being summed to
give an accumulated mass spectrum over one second for each pixel area. The resulting data were
converted from .wiff data format to ‘analyst’ files with the wiff-to-analyse script (supplied by MDS
Analytical Technologies, Ontario, CAN), and the data were imported into biomap image software,
available from www.maldi-msi.org.
Mass peaks were identified based on published literature values for maldi msi and were con-
firmed by fragmentation studies observing the head group. Molecules were named according to the
lipid maps nomenclature: PC is glycerophosphatidylcholine, SM is sphingomyelin, and the number
of carbon atoms in the lipid chain is indicated followed by a colon and the number of double bonds;
examples are [PC 34:1] and [SM 20:0].
5.3.4 Histology
For histological evaluation of tissue architecture, the adjacent serial section was stained with haema-
toxylin and eosin. A histology image of the stained sagittal rat brain section with several anatomical
regions labelled is shown in figure 5.1.
Figure 5.1: A stained histology image from the rat brain, anatomical regions are indicated. CB: cerebellum; CC:
corpus callosum; CTX: cerebral cortex; HP: hippocampus; HY: hypothalamus; M: medulla; MD: mid brain; OC:
optic chiasm; P: pons; PG: pituitary gland; S: septum; TH: thalamus. Note that this image is rotated through
180◦ with respect to the other figures in this chapter.
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5.4 Processing of MSI data
Here, the processing of the acquired msi data from the formalin-fixed sample of rat brain tissue is
described. The data were stored in a biomap-generated file, which is a software program frequently
used to analyse the msi data.214,215 Although biomap allows for various forms of image analysis
and manipulation (region of interest analysis, segmentation, clipping, histogram display etc.), it
is based on an image approach, where one m/z value is evaluated at a time. This implies that
> 1000 images have to be analysed if one wants to thoroughly evaluate the data set, which is
not only very time- and labour-intensive, but also highly likely to miss relations between different
m/z values, because the multivariate aspect of the data is ignored. To process the data and
perform multivariate analysis, the data were imported into matlab using the readanalyze function
(available from http://www.mathworks.com/matlabcentral/fileexchange/3760).
The requirement of processing msi data has been emphasised previously,232,233 and the aim
of this work is to discuss the necessary data processing steps. The processed data can then be
analysed by various multivariate approaches, described in §5.5.
5.4.1 Binning, alignment and baseline correction
msi data have an extremely high information density and the analysis of these imaging data is
in its infancy. Binning, taking the sum of all signals over a range, may not be ideal for certain
types of data (see chapter 3). However, the data were already binned to ∆m/z = 0.2 width when
imported into the biomap software. The use of unbinned data is not further pursued here for two
reasons: the difficulty in obtaining the full-resolution spectra, and the increased data set size and
concomitant increase in memory and computational burden. This is at the cost of identification
of single molecules, as it is not unlikely that different molecular species are together contributing
to the observed intensity of a bin, i.e. different signals can overlap within the bin width of ∆m/z
= 0.2. The effects of binning can be re-evaluated at a later stage combined with the possible
development of a data alignment algorithm, if necessary.
Calibration of msi data can be necessary when large m/z ranges are acquired212 or the spectral
resolution of the m/z bins is very high, but was not necessary for the current data set. From
evaluation of the plotted spectral data, it was decided that baseline correction and alignment
of the binned data are not necessary: a flat baseline was observed and it appeared that peak
misalignment was not present, as isotope patterns were consistent and did not shift across the
different pixels.
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5.4.2 Unfolding of the data: from 3D to 2D
The msi data can be thought of as an array, see figure 2.7 B1, either of various mass spectra at
the different spatial positions (figure 2.7 B4), or as images for various m/z values (figure 2.7 B3).
However, image analysis of single m/z values or the analysis of individual mass spectral profiles
are univariate approaches, and in this chapter a different route is taken: the application of various
multivariate approaches allows a thorough, unbiased overview of the data, taking the multivariate
and collinear nature of the data into account (see also §2.3.2).
The two directional dimensions of the msi data were ‘collapsed’ to form a large matrix where
each row is the mass spectrum at a given x,y position and each column one m/z variable, see
figure 2.7 B2. The nature of the msi data is very similar in the x and y directions of the original
data tensor, as both are identifiers of location, and therefore the unfolding step seems appropriate.
Unfolding increases the speed of computations (e.g. compare parallel factor analysis (parafac)
and pca)229 and reduces the complexity of the resulting models.79 Therefore, data analysis with
multi-way methods, that would analyse the data tensor shown in figure 2.7 B1, is not further
explored and the unfolded matrix [20535 × 4751] is used. The information of the x,y location of
each spectrum is retained and used to reconstruct images.
5.4.3 Peak selection
Peak selection has been shown to be integral to obtain useful multivariate models of msi data212
and here it is confirmed that peak selection is useful: it decreases the number of non-informative
variables, and it reduces the data size and calculation times. Peak selection is not trivial because
spectral information and quality varies between the pixels, so an easy definition that can be used
to reject noisy variables is not directly available. A number of approaches have been evaluated,
and here, two methods are applied consecutively, and both fulfil two important criteria. Firstly, a
thorough selection of peaks is achieved, where only a small fraction of the original number of vari-
ables is retained. Secondly, the approaches were pragmatic and relatively intuitive to understand
and calculate.
Approach A for peak selection: correlation with matrix peaks
Preliminary analysis of the data set demonstrated that some peaks are more prominent in the
region surrounding the tissue sample than on the sample itself, and these therefore probably arise
from the applied matrix solution used in maldi. These peaks, although possibly informative, do
not directly convey information on endogenous metabolites. Hence, as a first approach, it was
decided to remove these peaks. One such peak at m/z = 172.0 is from the αchca matrix solution
([M - H2O + H]
+, m/z = 172.04, C10H6NO2). The correlation of each m/z variable with this
selected matrix peak m/z = 172.0 across all pixels was evaluated, because it is anticipated that
peaks with a negative correlation with the matrix peaks are more prominent on the tissue than in
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Figure 5.2: (A) The 10 peaks that were selected to represent the main matrix peaks (those with maximum
covariance with m/z = 172.0) are shown in red. The y-axis is the mean intensity, calculated across all 20535
pixels for the 4751 variables. (B) The selection of those peaks of which the summed correlation with the 10
selected matrix peaks is negative is shown in orange (1224 variables, approach A). (C) Peaks from the selection
in B that fulfilled the second criterion, based on the variance explained in a pca model, are shown in green (564
variables, approach B).
the region outside the tissue, and correspond to interesting variables. Conversely, peaks correlating
positively with a matrix peak are more likely to be related to the matrix and other experimental
settings, than endogenous metabolic variation. To correct for any chance correlations, 10 prominent
matrix peaks were used, selected by calculating the covariance of each m/z value with the peak
at m/z = 172.0. These 10 peaks displaying the highest covariance with the selected matrix peak
are indicated in figure 5.2 A, where covariance was used rather than correlation in order to select
high-intensity peaks only and to avoid selection of isotopes instead of different matrix molecules.
The correlations for each variable in the data set (4751 in total) with each of the 10 matrix
peaks were calculated and summed; only those peaks with a negative sum of the 10 correlations
were retained, shown in orange in figures 5.2 and 5.3. It is clear from examples in the different
correlation regions, shown in figure 5.3, that positive correlations indeed correspond to variables
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Figure 5.3: The correlations of each variable with 10 selected matrix peaks, see figure 5.2 A, were summed,
and the summed correlations were sorted. Note that the x-axis is arranged according to decreasing correlation
with the matrix peaks, which is plotted on the y-axis, and does not to relate to the individual m/z values.
Only peaks with a negative summed correlation are retained (coloured orange). Images of 3 selected variables
demonstrate that positive correlations correspond to higher intensity outside the sample (m/z = 650.2), low
correlations often correspond to non-informative peaks (m/z = 207.6), and large negative correlations show
clear relevance to the biological tissue (m/z = 761.6).
with a higher signal intensity outside the tissue region than within the tissue, and are therefore
unlikely to be biologically relevant (e.g. m/z = 650.2). Peaks with a low correlation, e.g. m/z =
207.6, are mostly representing noisy variables, and peaks with a negative overall correlation, e.g.
m/z = 761.6, display a clear structure and distribution in the sample.
Approach B for peak selection: variance explained in PCA on the image
It is clear that the peak selection made with approach A, which was based on correlation with the
matrix, could be improved, since noisy variables were still included (e.g. see m/z = 207.6 in figure
5.3). Although many multivariate approaches are able to cope with noisy variables, the model
strength decreases with a large number of non-informative variables. For univariate methods, the
effects of noise can be even more problematic. Therefore, it was proposed to identify the variables
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in the selection of approach A that lack any relation to anatomy, and are likely to be noise. This
was achieved using a pca-based decomposition of each m/z image: the intensity values of the pixels
for the selected m/z are represented in a matrix, where rows correspond to different y-locations and
columns to the x-position in the sample. The variance explained in the first principal component
of the pca model (with only mean-centring) was used as an indicator of image-related intensity
distribution of the variable. If the intensity differences are randomly distributed, the variance
explained in the pca model will be low, e.g. for m/z = 989.6, see figure 5.4. On the other hand,
if there is any structure in the image, more variance is modelled with pca, as is shown for m/z =
873.6 in figure 5.4.
To select a pragmatic and user-friendly cut-off, an h-index was used as an appropriate heuristic,
and calculated as the sum of all explained variances divided by the number of original variables
(1224). Variables that have explained variances in pc 1 higher than this h-index of 24.3% were
retained and coloured green in figure 5.4. The expansions in figure 5.2 show that the variables
selected with approach A but not retained in approach B are mostly corresponding to variables
that have a lower mean intensity. However, this pca-based approach avoids removing low-intensity,
informative ions; or retaining artefactual high-intensity, noisy ions. A similar approach would be
the investigation of structure in the image using an entropy-based criterion.
Figure 5.4: The variance explained for the first principal component of a pca-based decomposition of the image
for each variable (mean-centred) is plotted. Note that the x-axis corresponds to variables that were sorted
with decreasing variance explained, and does not correspond to the m/z values. Variables with lower levels of
explained variance contain less biological and anatomical relevance (compare m/z = 873.6 and m/z = 989.6).
An h-index of 24.3% was used as a cut-off for variable selection: only variables with a higher percentage of
variance explained were selected and coloured green.
The m/z images and values of the deleted variables verified that not many informative peaks
were removed with approach B: if any signal was found at all, the related main isotopes were still
selected, so information regarding the parent ion was not lost. Thus, a potential loss of information
is not problematic, since there is a lot of redundancy in the data. Even if 10% of the potentially
informative peaks were removed, it is unlikely that this would result in the disappearance of
characteristic molecular fingerprints. Moreover, there are clear computational and interpretative
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advantages for smaller and cleaner data.
It should be noted that a very similar variable selection resulted if the images were rotated
through 90◦ (swapping the columns and rows for the pca, i.e. a matrix transpose). If for any
future sample, anatomical structures are expected to be directional, e.g. more horizontally or
vertically oriented, this information should be used in the decision of transposing the data matrix
before pca-based variable selection. Columns with only 0 were removed prior to pca calculations.
Mean-centring of the data prior to pca-decomposition is necessary as it removes the overall mean,
which would otherwise be the main contributor to the variance in the first principal component.
Unit variance scaling was not performed, as this would give equal weight to all columns, which
could negatively affect the selection of small anatomical features and emphasise noise in the data.
A high level of explained variance would also be obtained for m/z images that are high in the
surrounding and low in the sample region. Therefore, the variable selection with approach A has
to precede peak selection with approach B.
5.4.4 Pixel selection
After peak selection with approaches A and B, it was decided to only discard those pixels that
clearly do not arise from sample regions, although certain studies only retain a few selected spec-
tra.212 A fast method to select the sample pixels was found based on the total ion count (tic)
ratios of the informative peaks versus all original variables. The tic is the sum of the intensity
values for a pixel, and was calculated for all original 4751 variables, and the data set after variable
selection with approaches A and B (564 variables). As can be seen from figure 5.5 A, the ratio
of both tics shows two classes of pixels (the colour-coding refers to the threshold that was used
to select the pixels shown in figure 5.5 C). A plot of log10(
TIC564
TIC4751
), as shown in figure 5.5 B,
demonstrates that a higher tic from selected variables compared to the total tic corresponds to
sample pixels. This can be explained by the relative increase of informative peaks in the sample
region, compared to mostly peaks from matrix variables in the surrounding region.
Application of the manually chosen threshold log10(
TIC564
TIC4751
) = −0.5 results in the selection of
the pixels coloured green in figure 5.5 A, and figure 5.5 C is obtained. Some discontinuities in the
selected pixels are clear, but these are not problematic for data analysis (see also §5.4.7). The data
set sizes of the data after unfolding, peak and pixel selection steps can be evaluated in table 5.1; the
consecutive processing steps achieve a reduction of data set size, which decreases computational
cost and increases model quality.
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Figure 5.5: (A) Pixels from the sample were selected based on the ratio of the total ion count (tic) from the
564 selected variables to the tic from all 4751 variables. (B) An image coloured with log10(
TIC564
TIC4751
) illustrates
that a relatively high value of tic564 versus tic4751 corresponds to pixels from the sample. (C) A threshold
of log10(
TIC564
TIC4751
) = −0.5 results in the selection of the green-coloured pixels (the points coloured green in A).
5.4.5 Normalisation
Normalisation is the procedure whereby a correction is made for an experimental bias that would
result in higher (or lower) signal intensities in some pixels than in others, for example as a result of
uneven maldi matrix coating or altered ionisation efficiency. Thus, the correction should address
analytical and technical variation, rather than biological variation, and is widely known to be
necessary for analysis of msi data, especially to correct for differences in matrix solution coverage.
msi spectra are frequently normalised to total ion count (tic), which is the sum of all signal
intensities.197,201,203,204,219,224 Normalisation can also be performed with respect to a matrix
peak.207 Other commonly used methods of normalisation in mass spectrometry and their influence
on the identification of biomarkers in a non-image setting have been described,234,235 and in §2.3.1
various normalisation approaches for nmr data are discussed. Here, four normalisation methods
are evaluated:
• A reference molecule of which the concentration is constant throughout the sample could
be used to normalise the pixels. One variable that showed a fair degree of homogeneity,
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and no distribution clearly related to anatomical regions (which would be of biological origin
rather than analytical, and it is only the latter that needs to be corrected), is m/z = 749.6,
see figure 5.6 A. Note that figure 5.6 A displays the peak intensities after pixel selection,
however the complete image of this variable showed that the concentration is much lower in
the surrounding region than in the sample region, implying this is a genuine biological signal.
Usage of such a reference molecule is based on the assumption that there exists a molecule that
would have an identical concentration in each pixel. This assumption seems unrealistic: even
cell membrane components, such as certain phospholipids, will not be uniformly abundant
as membrane composition, cell sizes and packing density can vary.
• Normalisation to the TIC of ‘matrix-positively correlated peaks’ is a correction for
uneven matrix coating, which is performed by the dividing by the sum of all variables that
were deleted with approach A for peak selection, see §5.4.3. This normalisation factor is
displayed in figure 5.6 B, where it is observed that edges have overall higher tic values.
Normalisation to matrix peaks is based on the assumption that more analyte is measured if
there is more matrix signal present, as it is the matrix that co-crystallises with the analytes.
However, it commonly occurs that the matrix crystallises without analyte, or that different
analytes are distributed unevenly within the crystals,76,236 which causes this normalisation
method to be inappropriate.
• Normalisation to the TIC of all (original) data, the division by the sum of all 4751
variables in this study, is another normalisation option, see figure 5.6 C. Although this is
a commonly used normalisation method, no rationale for using this normalisation method
was found in the literature. The problems observed for normalisation to matrix peaks are
persistent in this approach: high matrix concentration without co-crystallised analyte, crystal
inhomogeneity and differential ionisation efficiency will negatively affect the accuracy of this
normalisation.
• Normalisation to the TIC of ‘informative peaks’, the division by the sum of the 564
peaks after variable selection (see figure 5.2 C), is displayed in figure 5.6 D. Here, the rationale
is that biological constituents might have varying concentrations in different regions, but these
will largely average out: the concentration of molecule A might be higher in tissue part 1
than 2, but that of molecule B might show a reverse pattern.
In figure 5.6, the factor by which each pixel would be divided is shown for the different normal-
isation methods, and it is clear that the different approaches will give drastically different results.
Interestingly, a ‘halo’ effect is seen in figure 5.6 B and C, where a higher tic is observed around
the edge of the sample.
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Figure 5.6: Four methods for normalisation of msi data are evaluated and the factor by which each individual
pixel would be divided is shown on a colour scale. (A) The intensity values of a ‘uniformly distributed’ reference
peak (e.g. m/z = 749.6). (B) The tic from the matrix-related peaks (i.e. all 3527 peaks that were deleted in
§5.4.3). (C) The tic from all data (4751 variables), this is the most commonly performed normalisation. (D)
The tic from the 564 selected, ‘informative’ variables; the normalisation approach proposed here.
The differential co-crystallisation efficacy of the matrix is confirmed in figure 5.7 A, which
invalidates the normalisation to the tic of matrix-positively correlated peaks and the normalisation
to the tic of all (original) data. In this figure, a direct correlation between the tic from the 564
‘informative peaks’ and the tic from all 4751 variables, including the matrix peaks, is observed
for the majority of points, but a cloud of points above the diagonal indicates the discrepancy
between the two measures. A similar tic from informative peaks, but different tic from all peaks
was observed for the two indicated pixels, shown in the image of figure 5.7 B. To evaluate the
nature of the tic differences, the ratio between the peak intensities of the two pixels (
Iblue
Igreen
) was
calculated for the ‘informative’ variables (564 selected peaks), ‘all’ variables (4751 original peaks),
and the ‘matrix’ variables (3527 peaks that correlated with matrix signal). Histograms of these
peak intensity ratios are visible in figure 5.7 C, where only the lower 90% quantile is shown for
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Figure 5.7: (A) The tic from the ‘informative peaks’ (the sum of 564 variables) versus the tic from all peaks
(4751 variables) is plotted. A correlation between the two values is found for a large proportion of the sample
pixels. However, some pixels show a relatively large tic from all peaks compared to the tic from informative
peaks. Two points with a similar tic from informative peaks but different tic from all peaks were selected.
(B) The pixels that were selected in A are shown in the image, the blue circle demonstrates a higher tic from
all data than the pixel highlighted with the green circle. (C) Histograms of the peak intensity ratios
Iblue
Igreen
, for
only the informative peaks (left), all data (middle), or the matrix peaks (the m/z values that were not-orange
in figure 5.3, right). Only the 90% lower quantile is plotted for clarity and the median of the ratios is indicated
in red. The peak intensity ratios were calculated based on the variables that were non-zero in both pixels: 556
(from 564) for the informative peaks, 2325 (from 4751) for all data, and 1329 (from 3527) for the matrix peaks.
clarity, and the median is indicated in red. The histograms illustrate that the ‘informative’ peaks
vary little between the two pixels, and this was confirmed by inspection of the spectral data. Thus,
normalisation to the tic of 4751 variables or the tic of matrix peaks could possibly create a
non-existing difference between the two pixels.
The normalisation based on informative peaks seems most robust to differential matrix co-
crystallisation effects, matrix inhomogeneity and inconsistent ionisation efficiency. However, if
two pixels had similar compositional profiles but with a two-fold concentration difference (i.e.
the measured content is two-fold diluted between the two pixels), the result is that these profiles
would be identical after normalisation to the tic of informative peaks. It is deemed unlikely that
120
this phenomenon would be the result of a biological effect, if it would occur it is most likely of
analytical nature, for example as a result of matrix crystallisation without analyte, and therefore
correction would be beneficial, rather than problematic. Nevertheless, it should be noted that
different biological complexity, e.g. across different tissues, would negatively skew normalisation to
tic of informative peaks, as well as normalisation to the tic of all peaks.
Probabilistic quotient normalisation (pqn),82 discussed in §2.3.1, is frequently used to normalise
nmr data. The use of pqn in msi data normalisation was deemed inappropriate due to the potential
lack of ‘common variables’ in mass spectra from different anatomical regions. This is prohibitive
for the application of pqn, which is based on the assumption that less than 50% of the variables
change across the different spectra. If a large number of variables are not shared between two
tissue regions, this would affect pqn a lot more than tic; tic normalisation, on the other hand,
would suffer from the presence of some high intensity peaks in one region that are not present
in other regions. Thus, normalisation based on tic is more robust than pqn in terms of variable
molecular composition, but potentially less accurate, as occurrence of high-intensity peaks could
skew the normalisation.
5.4.6 Data transformation
The correlation between the mean and standard deviation of the peak intensity indicated that for
this msi data set, the variance increases with peak intensity: the Spearman correlation between
the mean and standard deviation of the 564 variables is 0.9726. To stabilise the variance, the
data were transformed as follows: xnew = log10(1 + x). The transformation should be performed
prior to smoothing (discussed in §5.4.7), since variance-stabilised data will improve smoothing
results. Logarithmic scaling increases the importance of lower intensity but structurally informative
variables in subsequent modelling steps.232 Other transformations of maldi msi data have been
suggested, including power, root or threshold transformation;222 however, choosing from the large
number of possible transformation functions and settings might be troublesome for an inexperienced
user.
5.4.7 Smoothing
A smoothing step was performed, based on the convolution of each m/z image with a smoothing
window, see figure 5.8, to reduce the effects of noise on the image. This procedure is performed
for each variable: a separately smoothed image results for each m/z. Smoothing of sims msi data
with a Markov random field has been reported in a study of tumour xenografts.197
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Here, a Gaussian function was used to calculate the smoothing window, see equation 5.1, where
x and y are the coordinates of the pixel in the window, and xc and yc are the coordinates of the
window centre, which is located at the pixel that is being smoothed, see figure 5.8 B.
C(x,y) =
1√
2piσ2
exp(−
(x− xc)
2 + (y− yc)
2
2σ2
) if |x− xc| <
l
2
and |y− yc| <
l
2
(5.1)
The two parameters σ and l are the width of the Gaussian and the length of the convolution
window, respectively, and C is the resulting convolution window, see figure 5.8 A. In this figure,
four window functions are shown with σ = 1 or 2, and l = 7 or 15. The edges of the larger
convolution windows have negligible contributions to the smoothed result due to the fast decay of
the Gaussian with the chosen σ values.
The current implementation of the convolution results in the ‘removal’ of edges: only those
pixels completely surrounded by selected pixels (see figure 5.5) in the applied convolution window
are retained, see figure 5.8 C. This can be exploited to remove the edge regions which may suffer
from artefacts, as indicated by high tic levels seen in figure 5.6 B and C, and resolves the discon-
tinuities in the pixel selection (see §5.4.4). Comparison of the top and bottom rows in figure 5.8
C shows that the effect of l on the image is small, so the main decision factor for the width l is
edge removal. The width was chosen as l = 7 here, which decreases the sample width by removing
approximately 4 pixels around the edges (see table 5.1 for the final data set size). In cases where
smoothing is not necessary, a convolution window with the identity transformation was used to
remove edge pixels.
Figure 5.8: (A) Gaussian window functions with σ = 1 or 2, and l = 7 or 15. (B) An exemplar m/z image
before smoothing. Each pixel is replaced with the smoothed value based on the convolution window, centred
on the pixel (indicated with a circle); windows of width l = 7 and 15 are drawn. (C) The result of convolution
of the image in B with each of the window functions shown in A. The settings σ = 1; l = 7 were used for this
data set (top left figure).
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The choice of σ is based on visual inspection of the smoothed results for a variety of m/z
images, and was chosen to be σ = 1. This is a balance between higher σ levels removing too much
of the local variation, possibly ‘over-smoothing’ and blurring the image (compare the left and right
images of figure 5.8 C), and lower values of σ performing minimal smoothing, which results in highly
pixelated images. It should be appreciated that the matrix crystal size and sample preparation
can influence the necessity and optimal settings for smoothing. The effective pixel size or spatial
resolution is reduced by application of smoothing, but is likely still comparable to or better than
the ‘experimental spatial resolution’, which includes losses of spatial integrity as a result of sample
preparation.51
Smoothing enhances the spectral quality of pixels, for example, noise spikes are down-weighted
and poor pixel quality is improved. Moreover, smoothing enhances the data set with local informa-
tion; modelling on smoothed data therefore effectively incorporates a local component. It would
be interesting to evaluate the results of a ‘smart smoothing’ procedure, where a quality criterion
for each pixel is used in the smoothing weighting to obtain a high-quality data set. This crite-
rion could for example be based on information from the tic ratio discussed in figure 5.5, where
lesser quality pixels would be down-weighted in order to avoid artefactual signals. It should be
noted that edge-preserving smoothing methods could be used to improve the image sharpness,237
but evaluation of different smoothing methods is outside the scope of this work, and sufficient
smoothing results were obtained using the straightforward Gaussian window.
Table 5.1: The data set sizes after the various processing steps, including peak selection, pixel selection and
smoothing.
Description Data set size
raw data 4751× 111× 185
unfolded data 20535× 4751
peak selection A 20535× 1224
peak selection B 20535× 564
pixel selection 13324× 564
smoothing 11439× 564
5.4.8 Centring and scaling
The log transformation that was performed in §5.4.6 stabilises the variance, and hence the need
for data scaling is greatly reduced. Mean-centring of the data was performed, and subtracts the
average intensity for each m/z variable.
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5.4.9 Overview and generalisation of this approach
The steps described in the previous sections are summarised in figure 5.9, where the following
methods are shown:
1. Peak selection is based on anti-correlation of biologically relevant peaks with the peaks
from the applied matrix; this selects only those variables that are more intense in the sample
region than outside the tissue section. Subsequently, peaks that do not represent (anatomical)
structure are removed, based on the variance explained in a pca model of each m/z image.
2. Pixel selection uses the ratio of tic from all peaks (including the matrix peaks) to the tic
from the selected peaks.
3. Normalisation divides signal intensities by the tic of the selected variables for each pixel.
1. PEAK SELECTION
correlation with 
matrix peaks
explained 
variance in PCA
2. PIXEL SELECTION
3. NORMALISATION
TIC of selected 
peaks
4. TRANSFORMATION
log10 
transformation
5. SMOOTHING
Smoothing with 
Gaussian 
(s = 1, width =7)
6. CENTRING AND SCALING
mean-centring
log10
TICselected peaks
TICall peaks
>-0.5
Figure 5.9: A flowchart showing the 6 main steps executed in the processing of the rat brain msi data set,
including peak and pixel selection, normalisation, data transformation, smoothing and centring. Note that all
steps should be executed consecutively, changing the order for any of these steps can have a large effect on the
resulting data set.
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4. Transformation is performed by a (1+log10(x)) operation on all data.
5. Smoothing using a Gaussian window function of width l = 7, and a smoothing parameter
σ = 1 results in noise reduction and removes sample edges.
6. Centring and scaling was performed by mean-centring the variables, no scaling was per-
formed.
The heuristic approach that was taken to process the msi data may appear ad hoc. However,
a systematic evaluation of all possible processing steps is difficult, firstly because there are many
combinatorial options for all the processing steps (so an experimental design could prove useful),
but most importantly there is no objective evaluation criterion: there is no clear metric that could
be used to assess which of the different processing options is better. Therefore the pragmatic
processing choices were based on rational arguments, such as pareto-efficiency for the h-index as
a cut-off, and visual inspection. The order of the different processing steps is important: it is
necessary to identify informative peaks in order to perform the pixel selection and normalisation
steps, log-transformation has to be performed prior to smoothing, etc. One could argue that peak
selection is not absolutely necessary, as some modelling methods are relatively insensitive to the
presence of noisy variables. However, the memory and time requirements of modelling the msi
data are considerable, and a reduction in data set size makes the calculations significantly faster
and the models easier to interpret.
The processing of msi data of a different nature can use the flowchart shown in figure 5.9 as a
guideline, but may require fine-tuning and tailoring of e.g. the pixel and peak selection steps. The
data of a sample that was ‘fresh’, rather than formalin-fixed, could without further amendments
be analysed with the presented processing and multivariate analysis tools, some resultant image
visualisations are shown in appendix A.
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5.5 Multivariate analysis of MSI data
The processing of the msi data, as described above, resulted in a data set of 11439 pixels × 564
m/z variables. Various methods can be used to evaluate these processed msi data; here the use of
correlation analyses and multivariate modelling with pca are discussed, and connections between
the image and the latent space of pca are investigated. Subsequently, non-linear modelling with
self-organising maps is introduced for the analysis of msi data, where the distribution of pixels
over these maps is visualised. Finally, data modelling with two examples of manifold learning
techniques is reported and a critical comparison between msi data and in vivo magnetic resonance
spectroscopy data is made.
5.5.1 Correlation analyses of MSI data
Modified correlation coefficient for higher contrast in pixels similarity
To demonstrate similarity in spectral profile of a pixel with the remainder of the sample, correlations
(r) are calculated between the pixel of interest and all other pixels. The result of this pixel
correlation is shown in the top of figure 5.10 for a pixel in the hippocampus: grey and white
matter areas show up as highly correlated and anti-correlated, respectively. Here, it is proposed to
employ enhanced correlations to get a clearer contrast of the different levels of correlation between
pixels, an approach previously used in the evaluation of pharmaceutical tablets.238 This is done by
scaling the correlations between 0 to 1, representing the lowest and highest correlation, respectively,
according to equation 5.2.
rscaled =
r−min(r)
max(r) −min(r)
(5.2)
Subsequently, an ‘enhanced correlation’ renh is obtained via equation 5.3, where α is a parameter
governing the discrimination power: a value close to 0 implies high discrimination power, a value
of α close to 1 will give a correlation profile similar to the original correlation coefficients.238
renh =
rscaled −min(rscaled)
max(rscaled) + α− rscaled
(5.3)
This approach can be viewed as a non-linear transformation of the colour scale of the images, and
will therefore not uncover new information, but enhance the contrast in the correlation figures.
The correlation enhancement was implemented for both Pearson and Spearman correlations,
and the result is visible in figure 5.10. The top row shows the Pearson (left) and Spearman (right)
correlations with the selected pixel, and a large number of correlated pixels are observed. The
smaller plots indicate the evolution of the observed correlation profiles with increasing levels of α,
where α = 1 is almost equivalent to the normal correlation profiles, highlighting all grey matter, and
lower levels of α accentuate the hippocampus. This is exactly the use of correlation enhancement:
small differences in correlation patterns are emphasised, to allow more differentiation between
otherwise highly correlated regions. Notably, the Pearson and Spearman correlation patterns are
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Figure 5.10: The Pearson (left) and Spearman (right) correlations of image pixels with a selected pixel (centre
of white circle in the hippocampus). The smaller maps show images of the enhanced correlations for different
levels of α, see equations 5.2 and 5.3, for both the Pearson and Spearman correlation data.
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very similar, but Spearman correlations need a higher α value to achieve the same pattern, e.g.
compare α = 0.2 for Pearson with α = 0.5 for the Spearman correlation.
Figure 5.11 A shows the frequency histogram of the Pearson correlations from the pixel selected
in figure 5.10 before correlation enhancement. The correlation was enhanced with α = 0.01 to create
the histogram shown in figure 5.11 B, and an expansion is shown in figure 5.11 C. It is clear that
the number of highly positively correlated peaks is greatly reduced after correlation enhancement,
in correspondence with the analogous image for α = 0.01 in figure 5.10.
correlation
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Figure 5.11: (A) Frequency histogram showing the distribution of Pearson correlation values before correlation
enhancement (for the pixel selected in figure 5.10). (B) The frequency histogram after correlation enhancement
with α = 0.01. (C) An expansion of the histogram in B shows that the number of highly correlated peaks is
greatly reduced compared to A.
STOCSY and the quality of MSI data
Correlation analysis of msi data has previously shown the ability to relate different m/z values
based on co-localisation, and it was found that results of correlation analysis are greatly dependent
on data processing steps, such as smoothing, baseline subtraction and normalisation.239 The
use of statistical total correlation spectroscopy (stocsy, see §2.3.7) to relate different molecular
compounds was briefly evaluated for this msi data set, as similar spatial distributions of isotopes
and fragments could help identification of unknowns. However, there are a number of effects that
hinder the successful application of stocsy. Firstly, maldi is a soft ionisation approach and
therefore there will not be many fragments, whereas e.g. in gc-ms there will be many fragments
and in nmr there are often a number of resonances from one molecule. Additionally, adducts
are formed in the ionisation step, for example the cationisation of the analyte with alkali metal
ions such as potassium and sodium, dimerisation and other interactions with the maldi matrix
solution. The formation of adducts is known to vary in different parts of the tissue, and this will
negatively affect correlation approaches: if more sodium than potassium adduct is formed in one
part of the tissue, and more potassium than sodium adduct in a second part, these peaks will show
a low or even negative correlation. Studies have found that the distributions of metal adduct forms
are different: the hippocampus had nearly twice as much potassium adduct of m/z = 734 as the
protonated form, while the corpus callosum had nearly equal amounts.240 It could be an option to
128
identify molecules by performing stocsy only on the pixels of a selected anatomical region (with
comparable adduct formation), rather than on the complete image.
Matrix choice and application method are crucial determinants of the information obtained
from the sample, in terms of measured (desorbed) metabolites as well as in terms of quantitation
and reproducibility.206,213 Spectral quality is additionally influenced by suppression effects, which
is that certain desorbed species can preferentially become ionised, and therefore appear to be at
higher abundance in the spectrum; this process is at the cost of species that have lower ionisation
efficiency and therefore appear to have lower relative abundances than the true sample composition.
Suppression effects can differ between tissue types and analyte classes,226 which can cause serious
artefacts when comparing regions and tissues in a quantitative manner. Thus, maldi imaging data
should be treated as semi-quantitative, or qualitative, especially because the variable pixel quality
can skew the distributions of peak intensity.
5.5.2 Principal component analysis of MSI data
Although it has been stated that msi data acquired with sims could be more suitable for mul-
tivariate analysis than maldi data due to the presence of correlating fragments in sims,51 the
following work aims to demonstrate that multivariate methods are very useful in the analysis of
maldi imaging data.
Multivariate versus univariate analysis
Principal component analysis (pca) of the msi data, processed as described in §5.4, with 564
variables and 11439 pixels and mean-centred, is able to identify a number of features, see figure
5.12. In this figure, the scores of the pca model on a given pc axis are used to colour-code the
image, so a red pixel corresponds to a high value on that pc. These images show that pc 1 models
the overall difference between the grey and white matter, and subsequent pcs show substructures,
such as the hippocampus and the cerebellum, that are blue in pc 3.
The loadings of the pca model can be visualised by ‘back-projection’,90 as is shown in figure
5.13. In this figure, the colour is the absolute value of the loading, and thus red peaks are most
important for this component. The sign of the loading is combined with the unscaled data to present
the height of the peaks. The example shown in figure 5.13 is for pc 1, and can similarly be calculated
for all subsequent components. The peak at m/z = 835.6 was assigned as a sphingomyelin ([SM
24:1 + Na]), the peak at m/z = 788.6 as a phosphatidylcholine ([PC 36:1 + H]) and m/z = 810.6
as [PC 36:1 + Na]; these compounds are higher in the areas coloured red for pc 1 in figure 5.12,
such as the corpus callosum, medulla and the white matter in the cerebellum. In contrast, m/z
= 782.4, which could be from [PC 34:1 + Na], m/z = 756.4 and m/z = 697.4 are higher in the
areas coloured blue for pc 1 in figure 5.12, including the cerebral cortex, hippocampus and the
cerebellar grey matter.
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Figure 5.12: Images colour-coded with the scores of the pixels on the different principal components (pc 1 to
6, the respective variance explained is indicated). The pca model was built on the mean-centred data set after
processing (11439 pixels × 564 variables), and the scores on the pcs are ‘refolded’ to the image to aid visual
interpretation.
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Figure 5.13: The absolute values of the loading for the first pc are used as a colour-coding; peaks coloured red
can be considered important variables. The sign of the loading is combined with the data without mean-centring
to form the peak height and direction and create a mass spectral appearance. Peaks pointing up have a higher
intensity in the pixels with high scores on pc 1, whereas negative bars correspond to pixels with low scores on
pc 1.
A different way of representing the scores is based on red–green–blue (rgb) encoding, where
each colour corresponds to the scores on one of the principal components. An example is shown
in figure 5.14 A, where pc 1 (red), pc 2 (green) and pc 3 (blue) can be summarised in one image,
(compare with figure 5.12). This differentiates e.g. the corpus callosum and the white matter and
cortex of the cerebellum. The same can be done for any combination of principal components,
e.g. the rgb image based on pcs 4, 5 and 6 is shown in figure 5.14 B, where the hippocampus,
thalamus and septum are visible. Comparison of these two figures with the histology image (figure
5.1) shows an advantage of the modelled msi data in terms of differentiating anatomical parts.
Figure 5.14: The scores on three different principal components can be summarised in one image using red,
green and blue encoding for the different pcs. (A) The combined image of pc 1 (red), pc 2 (green) and pc 3
(blue). (B) The rgb encoded image of pc 4 (red), pc 5 (green) and pc 6 (blue).
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Multivariate analysis241 of the high-dimensional msi data is preferred to univariate analysis.
As an example, two m/z images are shown in figure 5.15: m/z = 810.6 [PC 36:1 + Na], which
had the highest loading on pc 1, and the variable with the highest average intensity, m/z = 760.4
[PC 34:1 + H]. As expected, there is some similarity between these images and pc 1 and pc 2
(inverted), respectively, but the clarity of the images differ (compare with figure 5.12). Moreover,
the choice of these two values is biased: 2 from the 564 variables were selected manually, whereas
pca is an unbiased method to create an overview of the data. To find specific structures, it would
be necessary to evaluate each individual m/z variable. Thus, manual variable selection is likely to
overlook interesting substructures or over-interpret artefacts.
Figure 5.15: Images of the variable with the highest loading on pc 1 (m/z = 810.6, left) and the highest
average value in the image (m/z = 760.4, right).
Score space versus image space
Evaluation of pca results is not limited to mapping back the scores of a principal component in
the image: the score plot itself can be used to evaluate clustering of certain image pixels.242,243
The identified outliers, classes or trends can then be mapped back onto the image, similar to a
mask, where only the selected pixels are presented. Examples of this are given in figure 5.16 A–C,
where two clusters of pixels in the score plot of pc 1 versus pc 5 are coloured, and these pixels
correspond to the outer right side of the image: the top (pink) and bottom (turquoise) regions.
This separation in the score plot could be the result of the different composition of these two
regions in the cerebral cortex, but because pca models the variation in the spectral data, it is not
possible to differentiate between biologically interesting variation and analytical artefacts. The
only thing that is certain is that the measured signal differs between these two regions. Thus, the
fact that separate clusters are detected can indicate both analytical variation as well as biological
variation and can therefore be used in data quality control. One example of an analytical artefact
would be the observation of a raster-effect, which could happen because the msi data are currently
acquired in a grid: artefact modelling would allow the diagnosis of sample degradation over time.
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Ideally, the spectra should be measured in a random order, but with the current technology this
would result in a great increase in measurement time or incomplete coverage of the image.
A score plot of pc 8 versus pc 9, see figure 5.16 D–F, has a distinct separate cluster (yellow) cor-
responding to the anatomical structure of the hippocampus; the cluster coloured blue corresponds
to pixels in the region around the pons and pituitary gland.
Figure 5.16: (A) The scores of pc 1 versus pc 5, two clusters in the score space are selected. (B, C) The
position of the selected pixels from the score space in the image is visualised, where a grey scale and colour
scale, both based on pc 1, are used to indicate the unselected and selected pixels, respectively. (D) The scores
of pc 8 versus pc 9, the yellow and blue clusters are selected. (E, F) The positions of the selected pixels from
the score space are visualised, where the grey scale and colour scale are based on the scores on pc 8. (G)
The loadings of the two clusters in A are shown as turquoise and pink bars. The loadings are calculated as
the weighted linear combination of both pc axes, pc 1 and 5, based on the median position of each cluster,
indicated with crosses in A. An exemplar expansion of these composite loadings is shown. (H) The loadings
can also be visualised with a biplot, where the scores (black) and loadings (green, cyan and blue) of pc 8 and
9 are superimposed. Variables increased in the hippocampus (yellow cluster in D) are shown in blue, negative
loadings are shown in cyan, and the corresponding m/z values are listed in table 5.2.
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Interpretation of the variables important for the clusters in the pca score plots is possible
using the median of the selected pixel clusters in the score space region (indicated with crosses).
The linear combination of both principal component loadings was calculated, and visualised in
the barplot of figure 5.16 G for the clusters indicated in figure 5.16 A. An alternative option is
to create a biplot, see figure 5.16 H, which superimposes the scores (black) and loadings (green,
cyan and blue).194 The loadings were multiplied by 0.1 to match the range of the scores, and
loadings that are in the same region as the hippocampal cluster (yellow in D) are coloured blue.
Therefore, the yellow pixels are characterised by higher levels of the blue and lower levels of the
cyan loadings; the m/z values are listed in table 5.2. The example shown in figure 5.16 D and
E is an excellent illustration of the use of multivariate approaches in the analysis of msi data:
the score and image space visualisations identify patterns in the data of biological relevance with
accompanying characteristic m/z profiles.
Table 5.2: The selected variables indicated as blue and cyan loadings in figure 5.16 H, representative for the
yellow cluster of the hippocampus in figure 5.16 D, are given in terms of m/z value; tentative assignments of
some of the isotopes are shown where known.
Blue m/z Assignment Cyan m/z Assignment
264.2 725.4 SM 16:0+Na
363.2 769.4 SM 18:0+K
459.2 784.4
496.2 784.6 PC 34:0+Na
518.2 785.4
599.4 797.4
694.4 828.4
734.6 PC 32:0+H 828.6 PC 38:6+Na
735.6 829.4
745.4 856.4
753.4 SM 18:0+Na 856.6 PC 40:6+Na
754.4 PC 32:1+Na
761.4
776.6
783.4
804.4
804.6 PC 36:4+Na
805.4
805.6
809.6
820.4 PC 36:4+K
832.4 PC 38:4+Na
833.4
833.6
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Figure 5.17: The sum of squared residuals of each pixel in the pca model is plotted in the image. Sums of
squared residuals for each variable are calculated and plotted on the right hand side.
Finally, one can also evaluate the residuals of the pca model (E, see equation 2.10), by cal-
culating the sum of squares of the distances from the data to the model. An example of the
residuals from the mean-centred pca model after calculating nine components is shown in figure
5.17. It is clear that after nine components, unmodelled structural variation is still present, as
some structures are highlighted red when the residues are plotted. The choice for nine components
is arbitrary, used for illustration purposes; the variance explained for each subsequent component
is smaller than 0.4%. The sum of squares for the residuals of each variable was also plotted, and
some of the highest residuals are annotated in figure 5.17. It is clear that investigation of these
residuals is necessary when an exhaustive pca analysis is performed, as some features might still
be latent in the data and can be discovered with this approach.
5.5.3 Analysis of MSI data with self-organising maps
This section introduces the use of self-organising maps (soms) in msi data analysis. The non-
linear approach as enabled by som has not been previously used for the analysis of msi data.
Classification with support vector machines (svm) allows for modelling non-linearities and has
been applied to msi data,166,202,204,212,220 but does not have the localised modelling, visualisation
and interpretation possibilities that som has. The som is a type of artificial neural network that
maps high-dimensional data to a two (or three) dimensional space, as described in §2.3.8. A som
map is self-organised, which means that neighbouring units are more similar to each other than
further removed units. Data analysis with som is versatile and effective for three main reasons: 1) it
allows for non-linear mapping of the data, unlike e.g. pca which is based on a linear decomposition
of the variance, 2) soms are unsupervised and therefore not biased by prior assumptions and 3)
the resulting maps present an overview of the data with clear visualisations.
All models were made with the SOM toolbox for MATLAB,109 and in-house written scripts were
developed in conjunction for visualisation improvement. One disadvantage of som is that the
choice of the size, shape and dimensionality of the map is not straightforward. In this study, the
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default settings of the som package and the batch implementation were used.109 The reduced
number of variables (564 instead of the original 4751) aids the calculation of the som, firstly in
terms of speed and secondly by improving the quality of the map.
Pixel distribution across a small SOM
The visualisation capabilities of soms are demonstrated in figure 5.18 for a map of ten units (or
neurons). Each pixel is mapped onto the most similar neuron, and a small number of neurons
generates a clustering-like result, where many pixels are mapped on each neuron. The size of the
hexagon in figure 5.18 A is indicative of the number of pixels mapped onto a unit (the hit map,
see §2.3.8).109,110 The pixels that were mapped onto each unit in figure 5.18 A can be coloured
correspondingly in the image, as shown in figure 5.18 B. A clear spatial clustering pattern is the
result, where different anatomical structures are mapped onto different units.
The similarity between neighbouring units is shown in figure 5.18 C: a unit similar to its
neighbour will have a short distance and a black colour. From figure 5.18 C it is clear that there
are two clusters: the top units (1, 6, 2 and 7) versus the bottom units (4, 9, 5 and 10), which
are separated by units 3 and 8. The distances shown in figure 5.18 C can also be visualised in
the image, see figure 5.18 D. In this figure, lighter blue corresponds to pixels that were mapped
onto units that are dissimilar from other units (e.g. units 3 and 8). This aids in the identification
of pixels in connective tissue, such as between the pink (unit 10) and light blue (unit 6) coloured
pixels of the cerebral cortex and corpus callosum, respectively, shown in figure 5.18 B.
A gradient colour-coding of the units can also be employed, see figure 5.18 E: units more to the
right have a green component in them, and from top to bottom, a larger red component is added
(hence appearing from dark red for unit 1 to bright red for unit 5). The combination of green
and red results via additive colour mixing in the yellow colour for unit 10 etc. The pixels can be
coloured correspondingly in the image, as shown in figure 5.18 F. This gradient colour-coding does
justice to the self-organising character of the som, as it retains the relation to the organisation
created by mapping. For example, the colour-coding by som of the image pixels changes from red
via yellow to green between the cerebral cortex region and the corpus callosum. The compositional
difference between the white and grey matter in the cerebellum is also more evident in figure 5.18
F than in figure 5.18 B.
The blue encoding shown in figure 5.18 D representing the dissimilarity of units can be added
to the mapping shown in figure 5.18 F, the result of which is shown in figure 5.18 G. For example,
the tissue between the grey and white matter of the cerebellum has a large blue component and is
coloured purple in figure 5.18 G, confirming that the two neighbouring tissues are very different.
This method adds distance information to the self-organisation colouring, but the current encoding
does not improve the differentiation of two neighbouring neurons that are highly dissimilar from
each other, as they could both have a large blue component. One solution would be to use
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Figure 5.18: Visualisation of a self-organising map consisting of 10 units based on the mean-centred msi data
(564 variables, 11439 pixels), see figure 2.14 for an explanation of som visualisation. (A) A colour-coding for
each unit is provided, and the hexagon size of each unit corresponds to the number of pixels mapped onto each
unit. (B) The pixels that were mapped in A can be shown in the original image with the same colour-coding.
(C) A distance map shows how similar each unit is to its neighbours, blue units have weight vectors dissimilar
from their surroundings. (D) The pixels can be colour-coded in the image based on the distance map shown in
C. (E) An alternative encoding of the units uses red and green values for y and x map-coordinates, respectively.
(F) The image pixels are coloured with the encoding shown in E, to retain the localised aspect of the som. (G)
The blue component shown in D is overlaid with the map displayed in F.
a distance-based gradient for the colour-coding of the axes shown in E, where rather than the
current linear scheme for red and green components, the distance information is included to map
the organisation as well as the dissimilarity between neighbouring neurons.
The clusters identified in figure 5.18 can also be displayed individually, as is shown in figure
5.19. Here, a pca-based colour-coding in grey is used to visualise anatomical structures, and the
pixels belonging to the displayed unit are shown in colour (using the same colour-scheme as in
figure 5.18 A). This figure illustrates that white matter pixels are mapped in the upper region of
the som, and grey matter pixels in the bottom part. A similar visualisation could use digital image
data of histological staining (if available), rather than pca-based colour gradients.
137
Figure 5.19: The clusters established in figure 5.18 are shown individually as coloured onto a grey map, all
colour gradients are based on the scores on pc 1.
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The clustering pattern and distance map of a som based on the msi data scaled to unit variance
are shown in figure 5.20 A and B: the results are quite similar to the mean-centred figures, indicating
that the effect of scaling after log-transformation is small for this analysis. The distribution between
clusters 5 and 10, and 1 and 6 is shifted, but since these neighbouring units are similar to each
other, the effect on interpretation is minor.
Figure 5.20: Visualisation of the distribution of pixels across the 10 units of a self-organising map (left) and the
corresponding distance map (right). (A, B) A som based on the data set described in figure 5.18 after scaling
to unit variance. (C, D) A som calculated from the scores of a pca model with 3 components based on the
mean-centred data. (E, F) Results of a som based on a single variable (m/z = 756.4).
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soms were also calculated based on ‘compressed’ data, namely the scores from pca models with
3, 7 and 12 components (bending points when the explained variance is plotted), with 91.05%,
97.39% and 99.10% variance explained, respectively. The results based on 7 and 12 components
were very similar to the results of the original data, as can be expected from the high percentage
of variance retained after this compression. The results of a som based on 3 components is shown
in figure 5.20 C and D. The orientation of the som map is reversed along the y-axis with respect
to figure 5.18, interchanging e.g. unit 5 (dark green) and 10 (pink). Irrespective of colour, some
clustering structures are retained, e.g. in the cerebral cortex and corpus callosum (the bottom
right), whereas the pons and medulla regions (top left) are different.
The advantage of multivariate analysis over univariate analysis is demonstrated with a som
based on m/z = 756.4, which is the variable with the maximum sum of the absolute intensities
of the som weights. The results are summarised in figure 5.20 E and F, where only two main
structures can be discerned (unit 5 in green versus unit 7 in blue), and most of the fine-structure
that was found in the other maps has disappeared. Notably, this map is based on the most highly
weighted variable, so the som results of other variables could be even less clear; moreover, the
individual analysis of each of the 564 variables with som maps would be very cumbersome.
SOM weight vectors
The interpretation of the variables responsible for the observed distribution in the som map is
crucial for biological investigations. This is enabled by plotting the weight vectors of each unit,
as shown in figure 5.21 A. Alternatively, the original data can be used, where the median of the
intensities of all pixels mapped onto a unit is calculated for each variable, shown in figure 5.21 B.
Small differences are observed when comparing the median intensities and the weight vectors, e.g.
for m/z = 782.4, 788.4 and 788.6. Finally, it is possible to investigate whether the som weight
values of an m/z value correspond to a certain unit:45,114 the correlation of the (ten) weight
values for a variable with each individual unit is determined, by calculating the correlation with
a ‘dummy variable’. This dummy variable is a vector which is set to 0 for all units, except the
unit of interest, which is set to 1 (similar to the dummy matrix in pls-da). Only those variables
which correlate with p < 0.05 are presented in figure 5.21 C. The correlation threshold for this
p-value was empirically determined by calculating the correlations of 100000 normally distributed
random draws representing ‘fake variables’ with the dummy variable, see also §2.3.6 on validation
methods. These results were not corrected for multiple testing, and hence no firm conclusions
should be drawn from figure 5.21 C, but the approach is useful for obtaining a quick overview of
the potentially interesting variables in the different regions of the map.
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Figure 5.21: (A) The contribution of each variable to the weight vectors of the som is shown, colour-coded per
unit. (B) The median intensity of each variable across all pixels that were mapped onto a unit can be used to
indicate variable importance, again colour-coded per unit. (C) Bars are shown for those variables of the weight
vector that correlate (p < 0.05) with a specific unit. For clarity, only the region m/z = 780–790 is shown.
RGB colour-coding of larger SOMs
The map size in the previous examples was manually set to be 10 units large, to allow an easy
interpretation of the individual clusters. However, soms can also be used for overview purposes,
rather than the semi-segmentation that was discussed above. As an example, a som was made
using the setting mapsize=small in the toolbox developed by Vesanto et al.,109 where a heuristic
rule determines the optimum map size, creating a map of 133 units [19 × 7], see figure 5.22. The
rgb encoding discussed for the map in figure 5.18 is now preferable to the standard colour map
coding, compare figure 5.22 E and F. Previously established anatomical patterns such as the corpus
callosum are not observed clearly with the default colour map for a large number of units, as the
133 unique colours are not individually distinguishable, and additionally do not convey information
on the location of the unit, losing the self-organised information (see figure 5.22 E).
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In contrast, when the rgb encoding is used, based on the y and x location of the units and the
distance map, as discussed previously, figure 5.22 F is obtained. This image with rgb encoding is
more homogeneous and interpretable than the previous colouring, which is the result of the rgb
encoding conserving local organisation structure of the som.
Finally, it is possible to increase the dimensionality of the som map. Although this is not
widely used, the three-dimensional maps allow for interpretable visualisation when combined with
the rgb image encoding. For example, a map of size [6 × 9 × 3] was calculated and the rgb
encoding (6 red, 9 green and 3 blue levels) is visualised by showing each individual colour in figure
5.23 A, and the overlay is shown in figure 5.23 B. Again, rgb encoding is highly preferred over
Figure 5.22: Visualisation of a self-organising map [19×7] based on the mean-centred msi data (564 variables).
(A) A unique colour for each unit is assigned using a standard colour map; the size of the hexagons corresponds
to the number of pixels mapped onto each unit. (B) The distance map shows how dissimilar each unit is
from its neighbours, a separate cluster in the top right hand corner is indicated by the blue colouring. (C)
Visualisation using a gradient colouring, with red and green values for y and x map-coordinates, respectively.
(D) The gradient encoding from C is combined with the blue distance encoding shown in B. (E) The pixels
can be mapped into the original image with the colour-coding used in A. (F) The pixels were coloured based
on the colour-coding shown in D, retaining the relation to the organisation of the map (red and green) and the
distances (blue).
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encoding each neuron with the standard colour map, as is clear from a comparison of figure 5.23
C and D: the standard encoding (27 unique colours) of a [3 × 3 × 3] som map in figure 5.23 C
does not remotely give the clear anatomical information and sense of (dis)similarity of structure
as the same map with rgb encoding shown in figure 5.23 D, e.g. in terms of the similarity between
the substructures in the hippocampus and the cerebral cortex. Thus, this novel rgb encoding of
msi pixels in soms has clear advantages for interpretation, and as shown in figure 5.21, the weight
vectors can be used to interpret the responsible m/z values. The inclusion of the distance map, as
was possible with the blue-level in 2D som maps, should be feasible using opacity or other visual
tools,221 but was not further explored in this work since the current som software does not return
distance maps for three-dimensional map grids.
Figure 5.23: Visualisation of a three-dimensional som. (A) The individual colour components for a 6 (red) ×
9 (green) × 3 (blue) map. (B) rgb coloured result for a som map of size [6 × 9 × 3]. (C) The result of a
[3× 3× 3] 3D som map where each unit is assigned an individual standard colour, similar to e.g. figure 5.22 A.
(D) rgb coloured result of the [3× 3× 3] som map shown in C.
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5.5.4 Evaluation of MSI data with manifold learning
Manifold learning approaches attempt to embed high-dimensional data in a new low-dimensional
space.244–249 From this definition, pca and som can be seen as special subclasses of the versatile
manifold learning approach. Manifold learning methods are typically well-suited for data visualisa-
tion and investigation of non-linear structure and classes in the data, but are difficult to interpret
in terms of responsible variables, or explained variance of the data.
ISOMAP: isometric feature mapping
One commonly used manifold learning approach is isometric feature mapping or isomap.245 It
solves the dimensionality reduction problem using geodesic metrics, curve-based distances, to visu-
alise the underlying non-linear global geometry. isomap firstly defines which points are neighbours,
either within a fixed radius, or with a nearest-neighbour approach. This neighbourhood informa-
tion is combined in a graph, where only neighbouring points are connected and the edge length
depends on the distance between the two neighbours. Subsequently the shortest path for any two
points through this graph is calculated. Finally, a multidimensional scaling is performed on the
matrix of graph distances, to embed the data in a Euclidean space that preserves the manifold’s
geometry. isomap will find the globally optimal solution of the convex, well-determined embed-
ding problem, and shows a low-dimensional Euclidean representation of a high-dimensional data
set based on geodesic distances.245
The result of isomap analysis of the msi data set (suggested by Dr. L. Pizarro, Imperial College
London, UK) is shown in figure 5.24 A (based on k = 12 nearest neighbours, the default setting,
to calculate the graph). Anatomical regions of interest such as the cerebellum, hippocampus
and optical chiasm can clearly be discerned in this 2D visualisation with rgb encoding for the
three calculated isomap axes. The number of components calculated for the isomap models was
based on a maximum likelihood estimation of the dimensionality as implemented in the MATLAB
toolbox for dimensionality reduction, which was used to calculate all models (obtained from http://
homepage.tudelft.nl/19j49/home.html).244 The result of isomap on the unsmoothed msi data
is shown in figure 5.24 B, which gives a more noisy, but sharper, better resolved picture. The black
dots are the data points that were not embedded in the manifold learning: if the neighbourhood
graph is not fully connected, only the largest connected component of the neighbourhood graph is
embedded in the last step of isomap.
The location of pixels on the isomap axes can also be plotted (similar to a score plot in pca),
and an example is shown in figure 5.24 C for the first two calculated isomap components of the
smoothed data. The pixels selected in figure 5.24 C can be evaluated in image-form, as is shown
in figure 5.24 D. The pixel clusters correspond to high degree with anatomical structures such as
the cerebral and cerebellar cortex, corpus callosum and hippocampus. A great similarity between
pixels of anatomical units is observed, even though isomap is unsupervised and no information
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Figure 5.24: (A) The results of isomap are visualised with rgb encoding of the location of pixels on the three
isomap axes. (B) Results of isomap on the data without smoothing, 26 dimensions were calculated but only
the first three dimensions are used in this visualisation. Not all pixels could be embedded for this data set, and
the non-embedded data appear as black pixels on the image. (C) A plot showing the position of each pixel
on the first two isomap axes for the smoothed data set. (D) Images showing the pixels corresponding to the
selections coloured in C. (E) The results of isomap where images are used as variables and the m/z values are
the observations, shown as points. (F) Images of the highlighted m/z from E show related distributions if they
had comparable isomap coordinates, i.e. similar images are typically mapped close together.
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about the origin of the pixels is included (the mapping is only based on the mass spectra). This
clustering is unlikely to be an analytical artefact: although a bias could arise because neighbouring
pixels are acquired close in time, this would only be observed in one direction, so a line-shaped
pattern would be found rather than the clear biological structures observed here.
Finally, instead of using the mass spectra as variables, one can consider the images to be the
variables, and the distribution of m/z values in a low dimensional embedding can be evaluated.
The result of this approach is shown in figure 5.24 E, where a set of 9 m/z values was randomly
selected. The distribution profiles of these m/z are shown in figure 5.24 F, and distributions are
more similar for variables with comparable isomap coordinates. The swapping of variables and
observations can also be done in pca and other approaches; in general the transposed data matrix
will give additional information for most data analysis approaches.221
t-SNE: t-distributed stochastic neighbour embedding
The recently introduced technique known as t-distributed stochastic neighbour embedding (t-sne)
is another manifold learning method.247,248 This dimensionality reduction algorithm (available in
the MATLAB toolbox for dimensionality reduction244) is particularly valuable for the visualisation of
high-dimensional data sets, as it creates a map that reveals structure at many different scales. This
is for example useful for analysis of high-dimensional data that lie on several different, but related,
low-dimensional manifolds. t-sne parametrises the non-linear mapping between the original data
and the latent space with a feed-forward neural network and is unsupervised.247,248
The results of the t-sne visualisations on the msi data are shown in figure 5.25, for both two
and three calculated axes and on both smoothed and unsmoothed data. In these figures, different
regions corresponding to anatomical features are well-defined; especially for the unsmoothed data.
Interestingly, the hippocampus appears as two separate clusters in the smoothed data, but as one
cluster for the unsmoothed data. It is also worth noting that the hippocampus is more dissimilar
from the cerebral cortex in the t-sne image than for the isomap results in figure 5.24 A and B.
This is likely to be the result of the preservation of both global and local structure with t-sne,
resulting in tighter and more dispersed sets of clusters.248 This results in a contrasting colouring
for the different anatomical regions such as the pons, pituitary gland, hippocampus, and thalamus,
in addition to the global differences between the white and grey matter of the cerebellum and the
difference between the corpus callosum and the cerebral cortex that were also modelled with other
multivariate approaches.
The t-sne results can also be plotted as positions on the manifold axes, which is done in figure
5.26 A. In this figure, it is clear that t-sne mapping results in well-defined clusters. Some of these
clusters have been selected and the corresponding pixels in the image are coloured, see figure 5.25
B. The anatomical relevance is even more pronounced than for the isomap results, and different
regions of the cerebellum are easily distinguished, which was not obtained with e.g. pca. This is
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Figure 5.25: The results of t-sne with two (top) or three (bottom) calculated axes. An encoding with red and
green (and blue for the third axes) corresponding to the position of the pixels in the t-sne map was used. (A,C)
t-sne results for the mean-centred data set, with all previously discussed processing steps. (B,D) t-sne results
for the data set without smoothing but with mean-centring.
a most promising result, and it is intriguing that t-sne, an unsupervised approach, is able to find
this level of anatomical detail.
When using the images as variables in the t-sne model, figure 5.26 C is obtained; a group of
7 variables was arbitrarily selected and their distribution profiles are shown in figure 5.26 D. The
clustering of similar spatial distributions for these examples is less defined than with isomap as
was shown in figure 5.24 F. The calculation of isomap and t-sne models for the ‘normal’ matrix
[11439×564] is quite computer-intensive (∼5–8 hr), but when using the 564 images as observations
[564× 11439], the calculation is performed within a minute.
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Figure 5.26: The results of t-sne for the smoothed data set, based on two t-sne components, using either the
mass spectra as variables (top) or the images as variables (bottom). (A) The scatter plot of t-sne results based
on the spectral data shows clear clustering patterns. Several clusters are selected and their points coloured. (B)
The pixels contained in the selections in A correspond to defined anatomical features, showing that clustering
in t-sne space corresponds to meaningful results in the image space. (C) Results of t-sne using the images as
variables. The m/z are now the observations, and a cluster of 7 m/z values is indicated in red. (D) Distribution
maps of the m/z selected in C.
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5.5.5 Comparison of histology and multivariate modelling of MSI data
For completeness, figure 5.27 displays the histological image shown in figure 5.1 and the rgb en-
coded images for the pca, som and t-sne multivariate models, which are rotated to allow easy
comparison. This figure clearly demonstrates the interpretational advantages of the ‘digital stain-
ing’ allowed by multivariate modelling of msi data compared to traditional histology images. The
anatomical regions can be distinguished to various degrees with the different modelling methods,
where pca models major features, whereas som and t-sne additionally model local and non-linear
variations. It is clear that the choice of modelling method will influence the results and visualisa-
tion, and it should be remembered that the msi data have additional molecular information which
is not available in histological data, and less accessible when using the manifold learning methods.
C D
BA
Figure 5.27: Anatomical differentiation as allowed by histological and digital image staining. (A) The histology
image. (B) The rgb-encoded pca model of the msi data. (C) The colouring as achieved with a 3D som map.
(D) The results of t-sne modelling.
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5.5.6 MSI versus magnetic resonance spectroscopy imaging
This chapter has focussed on the analysis of mass spectrometry data, whereas the other chapters
were based on magnetic resonance data. There is an equivalent of ms imaging in the magnetic
resonance world, known as magnetic resonance spectroscopy imaging (mrsi) or chemical shift
imaging. Commonly, only a few pre-selected volume elements (voxels) in different anatomical
regions are acquired in mrsi. If, however, a full grid is acquired, the similarity between mrsi and
msi data is clear: they both entail the acquisition of analytical, localised data, creating a hyper-
spectral imaging data set. However, the typical s/n for a given voxel size is a lot larger for the msi
data than for the mrsi data.
The lower s/n of mrsi data is caused by a combination of factors, including: magnetic field
inhomogeneity, limited field strength and movement of the sample. To obtain a good s/n, a
typical voxel size in mrsi is 2 cm × 2 cm × 2 cm while for msi the used pixel size was 100
µm × 100 µm. An additional complicating factor for high-field mrsi machines is that tuning
and matching of the probe is sometimes done manually, which can be very difficult in long-bore
machines. Consequently, consistent spectral quality is rarely obtained, and only a limited number
of signals are observed. The number of observable peaks and the s/n of msi data greatly exceeds
the current mrsi experimental results.
As an example of the s/n of mrsi spectra, figure 5.28 shows the in vivo 1H mrsi spectrum of a
rat brain, acquired at 11 T (470 MHz 1H), which is a very high field for in vivo studies. However,
even at this field strength, only a limited number of high-concentration metabolites are visible,
some of which would not qualify above the s/n threshold in an in vitro nmr experiment, e.g. see
figure 2.3, and the s/n is clearly a lot lower than for msi spectra, as shown in figure 2.6.
Another main difference between the two methods is that mrsi data can be acquired in vivo,
whereas msi data are acquired ex vivo. Naturally, the information content is of most biological
relevance if obtained in vivo, rather than ex vivo: msi can only reliably analyse stable metabolites.
Figure 5.28: Exemplar in vivo 1H magnetic resonance spectrum acquired from a rat brain at 11 T (spectrum
acquired in collaboration with the amris facility at the University of Florida, FL, USA). Tentative assignments
of the peaks are shown. Legend: PCr, phosphocreatine; Cr, creatine; Glx, glutamine and glutamate; Tau,
taurine; Cho, choline; NAA, N-acetylaspartate.
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The acquisition of mrsi data is limited in time, as studies on living objects can typically not
last over 0.5–1 hr. msi acquisitions typically take hours and because the sample is in vacuum, a
change in sample composition and metabolic degradation can occur during the acquisition time;
moreover, lipids are known to ‘migrate’ from the sample. Thus, the main, obvious advantage of
mrsi is that the technique is non-invasive and operates in vivo, while msi is based on surgical
specimens such as tissue slices and is destructive for the sample. This destructiveness limits the
ability to perform repeat experiments for msi, the closest possibility is to use neighbouring cryo-
sectioned slices. Replicate experiments in mrsi can also be troublesome, as different positioning,
experimental set-up (e.g. shimming) and metabolic status of the subject will influence the spectra.
Both imaging approaches have been mostly applied to problems of relatively limited difficulty,
such as classification of different cancer types, or diagnosis of healthy and diseased patients. There
is a lot of scope for improvement, on the instrumental and data acquisition side, as well as in terms
of appropriate and sophisticated data analysis that takes the multivariate and image nature of
these data sets into account.
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5.6 Conclusions
This work suggests some solutions for a number of initial bottlenecks in the analysis of maldi msi
data, such as an intuitive method for peak and pixel selection. The normalisation method choice
is non-trivial, especially as no background was found in the literature, even though there seems
to be a consensus to use the overall total ion count, and an alternative, robust normalisation is
suggested to mitigate artefacts from differential co-crystallisation of the analyte with the matrix.
The proposed work-flow, with simple and pragmatic processing steps, is not theoretically limited
to any type of tissue and can be tailored for different types of msi data.
Quantitative approaches cannot easily be used for msi data analysis due to the nature of the
data: not all molecules are ionised and desorbed to the same extent during the maldi process, due
to dependencies on the matrix composition, differences in co-crystallisation and different proton
affinities, causing intense signals to suppress others. Univariate analysis of images or selected
spectral profiles is likely to miss interesting aspects of the data or to over-interpret artefacts,
and instead a non-targeted approach was taken to visualise the data set effectively and to obtain
characteristic profiles.
The suggested methods, such the modified correlation coefficient for enhanced contrast, the
score-space and image-space visualisation of pca results, and the rgb encoded visualisation of
pixel distributions in soms were all newly introduced to the analysis of msi data. Manifold learning
analyses of msi data showed remarkable clustering in relation to anatomy, and resulted in high-
quality visualisation of the data, that was clearly different in character from the pca and som-based
visualisations.
These various results show that rather than analysis of single m/z values, a multivariate ap-
proach should be preferred, as it is less biased, more robust and incredibly versatile. The main
virtue of the presented approaches is that the link between mass spectra and images is always re-
tained, greatly aiding the interpretation of the resulting models. The various rgb-encoded images
show a very sharp anatomical relevance, more pronounced than individual m/z images, and are
an exceptional improvement compared to the traditional histology image.
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Chapter 6
Discussion and future work
6.1 Discussion
The aim of this project was to develop and implement chemometric approaches for metabonomics
to achieve improved data interpretation, visualisation and predictive modelling. This is based on
an appropriate choice of spectroscopic method, data processing and modelling approaches and
would give researchers the ability to extract more information from their samples. One example is
the acquisition of J -resolved nmr spectral profiles to reduce the frequently occurring peak overlap,
which can result in more interpretable data and models, especially if full-resolution projections are
used. In addition, optimal predictive ability for non-linear data and improved model transparency
are enabled with a user-friendly implementation of sa-k-opls, which is demonstrated for meta-
bonomic nmr data sets. Another example of increased information extraction is the analysis of
tissue with msi instead of using tissue extracts or magic-angle spinning based nmr techniques, to
provide localised molecular information. If the tissue is inhomogeneous, for instance a small or
heterogeneous tumour sample, the investigation will greatly benefit from an imaging approach, as
this provides separate biochemical profiles for the different locations, rather than an average or
‘diluted’ spectral profile. Here, several aspects of the presented work are discussed in the context
of current analytical and chemometric methodologies, biological interpretation, and applications
and implications in other research.
6.1.1 Analytical methodologies
Current data acquisition and analysis tools have been extended by the approaches discussed in this
thesis, and figure 1.4 illustrates the various spectroscopic methods, data processing and modelling
steps that were addressed.
For example, although jres spectroscopy has been used in the past,122,128 the evaluation of
projections was based on binned data, whereas in this work full-resolution spectra were evaluated.
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A comparison of full-resolution jres projections and 1D spectra based on multivariate models
and correlation-based techniques showed improved interpretation through reduced peak overlap,
and demonstrated that peak alignment was a necessary processing step. Knowledge about these
evaluated processing and modelling aspects of jres data should improve the quality of future
jres data and models. This work has highlighted the advantages of additional dimensions in nmr
spectra, and it is expected that the development of both conventional and fast methods in multi-
dimensional nmr spectroscopy will profit from the observations stated here; examples include the
need for aligning data, and the ability to appreciate and exploit the dispersion across the extra
dimension(s).
Typically, the s/n of jres projections is lower than for 1D nmr experiments, and T2-editing
also reduces the intensity of fast-relaxing metabolites in jres spectra. Strong coupling artefacts
can occur, although these are not common for structurally-simple metabolites. Thus, the severity
of peak overlap will be a determining factor in deciding on the usefulness of jres in the analysis of
a sample set. For example, certain correlations retrieved with stocsy will be improved by reduced
peak overlap, but a decrease in correlation as a result of lower signal intensity and s/n can also
result. Generally, jres can be considered as complementary to the conventional 1D and cpmg
techniques.
Spectroscopic developments, such as the move from in vitro mass spectrometry to imaging,
will further our understanding of the biological specimen under study: the localised information
obtained with the imaging approach would not have been available with traditional in vitro ap-
proaches. Moreover, it is also expected that in vivo magnetic resonance approaches will benefit
from the chemometric and image analysis tools presented in this thesis.
6.1.2 Chemometric methodologies
Chemometrics will have to cope with increasingly large and complex data sets in the near future.
It is especially in these cases that non-linear modelling such as with sa-k-opls can be essential
rather than simply beneficial. Time-course studies become more feasible with technical advances
and reduced experimental costs (also for other -omics), and complex experimental designs are being
used. A hallmark example of increased complexity is the shift from ‘simple’ toxicity classification
studies to complicated, multifaceted studies of personalised medicine and disease prevention.
The modelling of msi data is currently often limited to pca or analysis of selected pixels, and
this thesis presents a new set of modelling tools and develops and carefully evaluates a rationalised
data processing scheme. The application of multivariate methods to the information-dense msi data
provides visualisations where pixels cluster in relation to anatomical features. This is a significant
improvement compared to manual evaluation of the individual m/z images, where prior knowledge
is necessary. The non-linear visualisation of the msi data using soms and the developed colour-
coding that retains the localised information characteristic of the som, presented in this thesis, have
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not been reported before. Other methods for msi data segmentation can be used,203,237,250 but
the great virtue of the presented methods is their ability to account for both the multivariate and
the image nature of the data. The expected rapid expansion of the field of msi should increase the
appreciation of the need for multivariate analysis of these data. More generally, there is a need for
methods to study large, multi-way data sets. For example, over the past years many researchers
have gained access to various -omics platforms, and thus there is a strong drive to integrate
these data and perform ‘true systems biology’: combining e.g. transcriptomic, metabonomic and
proteomic data.251 The use of chemometric methods by wet-lab research groups and clinicians is
greatly dependent on the ease of use and interpretability of the modelling methods, especially in
terms of visualisation, which was provided with the suggested msi data analysis approaches that
retain the link with the image during multivariate modelling.
Finally, the new implementation and interpretation of sa-k-opls has been described. It was
shown how sa-k-opls can give insight into the data with score plots, and is able to differentiate
predictive and orthogonal variation, which is not possible with other kernel-based methods such
as kpls168,169 and svm,165–167 although they may give comparable prediction performance. The
performance of sa-k-opls is always at least equivalent to the linear model; that is, the predictive
ability of sa-k-opls is unlikely to be outperformed by opls, and improved predictive performance
was demonstrated for various data sets. The interpretation of relevant variables in a non-linear
model based on pseudo-samples, which was recently introduced in the analysis of svm models184
and was adapted for the k-opls models, has helped to open up the ‘black box’ that normally
surrounds kernel-based models. Although the developments presented for k-opls are more in-
cremental than the contributions to the relatively untapped field of msi data analysis, they are
extremely useful: the automated optimisation and nested cross-validation make sa-k-opls more
user-friendly and provide reliable predictive ability estimates, whilst the interpretation of orthog-
onal variation increases model transparency. Moreover, clear examples of non-linear modelling in
metabonomic studies have been provided, including applications to pharmacometabonomics (pre-
diction of drug responsiveness prior to dosing), toxicological time-course studies, and parasitic
infection predictions.
6.1.3 Potential application areas
The methods developed here are not limited to the data for which they were presented. sa-k-opls
was demonstrated for metabolic spectral data of biofluids, and is anticipated to be equally useful
for analysis of other types of nmr data and ms spectra, and other high-dimensional data sets
such as from genetics, transcriptomics and proteomics. It should be noted that the number of
variables that were used in the sa-k-opls modelling was quite low (∼900 bins), but bigger data
sets (e.g. with higher resolution) could be analysed at the cost of increased computational time.
Using data sets with a higher resolution could result in models with improved predictive ability,
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and would also increase the ease of interpretation of the variable importance approximations, as
peak overlap within bins would be reduced. All kernel-based methods need optimisation of the
kernel parameter, and thus simulated annealing could also be applied to these problems, where it
is strongly suggested that a nested cross-validation is used to prevent over-fitting.
Acquisition of msi data can be targeted to study all sorts of molecular classes in addition
to lipids, such as proteins,77,201 metabolites206,207 and drugs.208,209 The data processing can
provisionally be used for other data sets, provided that the acquisition is done in a similar manner,
e.g. with the characteristic that there is more matrix signal from pixels outside the sample than
from within the sample. As an example, msi data from a fresh tissue sample (which is different
from the formalin-fixed tissue that was presented in chapter 5) were processed and modelled with
the tools described in this thesis, and the results are shown in appendix A. Any type of correctly
processed msi data can be subjected to the multivariate modelling techniques, and it is anticipated
that these methods will be of great use in the analysis of msi data from different classes of molecules.
The hyper-spectral data analysis demonstrated with pca, som and manifold learning could
also be applied to data obtained with other analytical techniques such as magnetic resonance
spectroscopy imaging. Interestingly, manifold learning is well-known in the study of images, but it
has been illustrated here that it can also be very informative in the study of spectral data, especially
for large data sets. The application of manifold learning approaches to other metabolic profiling
data could be useful. As manifold learning techniques are especially beneficial for the analysis
of data sets with a large number of samples, they could be employed to evaluate the metabolic
profiles resulting from the administration of different toxins (such as the COMET consortia data).
Another virtue of manifold learning is the simultaneous non-linear modelling of both local and
global variation, which could for example be used in the evaluation of individual differences, in the
context of personalised medicine.
6.1.4 Biological interpretation
Knowledge generation is facilitated by high data quality and model transparency. Improved detec-
tion and identification of biomarkers as allowed with the reduced overlap in jres projections will
enhance our understanding of biochemistry e.g. in toxicology and diabetes models, where carbo-
hydrate signals dominate the spectra. Improvements from jres arise firstly because the weight of
dominating molecules in modelling is reduced, and secondly because signals previously overlapped
or covered can be unveiled, for example the amino acid resonances in the range δ 3.7–4.0.
The ability to investigate orthogonal variation with score plots, and to approximate the im-
portance of the variables in the sa-k-opls models, aids in the interpretation of these powerful
predictive models. This was illustrated in the pharmacometabonomic study on galactosamine re-
sponsiveness, where diurnal variation was initially unknown and later discovered as the source of
orthogonal variation. Knowledge of this confounding effect can aid future experimental design and
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quality control. For example, one could model the samples from the two collection times separately,
or future studies can collect samples at only one time during the day.
The improved interpretation of msi data with the suggested processing and modelling ap-
proaches consists of various contributions, starting with an increased understanding of the contri-
bution from the maldi matrix solution to the acquired spectra. As an example, ∼20 main matrix
peaks would typically be identified by researchers and removed prior to analysis, but in this study
3527 peaks were found to be correlated with the matrix distribution patterns. Another example is
that the different normalisation methods highlight tic effects at the edge of the biological sample;
this information should be used during quality control, as this widely observed halo effect is detri-
mental for image interpretation because it compromises the reliability of peak intensity. Then, the
advantages of multivariate modelling of msi data compared to univariate approaches have been
emphasised, and pca and som provide a basis for biochemical interpretation based on loadings and
variable weights. Ionisation patterns and adduct formation can further contribute to anatomical
differentiation,240 and can provide clues about matrix effects and quantitation as well as potential
information on salt concentrations, provided the underlying physical phenomena are understood.
Translational research, i.e. studies providing results and models which could eventually be used
in the clinic by non-specialists, requires biological models to use fewer parameters and reduce
the number of user intervention steps. An example of increased user-friendliness is predictive
modelling with sa-k-opls, where the automated optimisation of the kernel parameter and the
nested cross-validation allow the usage of this method by a wider target audience. This thesis
illustrated the use of sa-k-opls in a clinical setting through a murine model of a T. Brucei Brucei
parasitic infection, where the diagnosis and time of blood–brain barrier crossing must be accurately
predicted for optimal treatment outcome.
The processing of msi data could potentially be developed as a push-button technique, and
unsupervised multivariate models can easily be made with minimal user input. This removes the
need for either manual investigation of every single m/z image or prior knowledge of anatomy and
biochemical composition in the analysis of tissue based on msi data. A clear illustration is the (un-
supervised) t-sne manifold learning method, that could identify many anatomical (sub)structures,
which is not easily achieved with traditional simple staining methods.
6.1.5 Extensions to real-time use
Instantaneous data modelling is not directly feasible with the current implementation for some of
the methods, as several hours can be required to calculate the sa-k-opls and manifold learning
models. sa-k-opls is a computationally intensive method, specifically because of its use of nested
cross-validation and optimisation steps. Although the calculation time is longer than conventional
linear models, the advantage of non-linear modelling is that it gives improved predictive ability.
Similarly, the msi data sets are very large, which causes a computational and memory burden, but
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the msi data are much more informative than unlocalised ms data. With a parallel implementation
of algorithms, and with the progression of electronics to faster machines with bigger memory, the
modelling can be speeded up significantly and thus these computational considerations are not an
insurmountable problem.
Importantly, the modelling step is still many orders of magnitude faster than the data acquisi-
tion. In fact, real-time data acquisition might pose a problem, since, for example, the acquisition
of msi data can take hours. There are several tricks to decrease the msi experimental time, which
include a reduction of the dimensions of the sampled region and the use of a smaller spatial and
spectral resolution; more sophisticated solutions include the use of faster lasers and better analy-
sers.252 The acquisition of jres nmr data takes about twenty minutes per spectrum, which can be
reduced by limiting the number of increments and scans.156 Different pulse sequences have been
suggested to collect data even faster, and thus this method might be feasible for use in a real-time
setting.150–152,157
The slowest step in data analysis is often the identification of peaks, both in nmr and ms
experiments. This is part of the scientific process, and is used to obtain biological information (in
addition to the predictions and visualisation that can be achieved real-time, as discussed above).
Tentative peak assignments and hypotheses about ongoing biological processes need to be validated
and investigated in further, targeted studies, but are not necessarily involved in the decision-
making steps that need to be real-time. Once a developed chemometric model is well-validated
and biochemically understood, it can be used in a real-time situation, provided that the new
analytical data can be acquired quickly and reliably, as prediction of new data points using an
existing model is fast.
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6.2 Future work
One of the main features of this work is the use of multivariate projection methods to overcome
the collinearity and noise present in spectral data sets. However, one avenue that is at the moment
under-explored, is the increase in model accuracy if a data table of deconvoluted molecular concen-
trations is used instead of the spectra; such a table would consist of an entry for each metabolite
and the measured concentration in each of the samples. This would completely overcome the over-
representation problem that is partially addressed by using jres spectral projections, and can
additionally be used to remove confounding exogenous signals. There are a number of approaches
that could be investigated to achieve this, for example the use of multivariate curve resolution61,154
combined with a reference library, although the full deconvolution of the spectra of unknown peaks
would be difficult. An alternative approach is iterative spectral editing based on correlations.153
The peak alignment of jres projections proved essential for the urinary data sets, but less
pronounced improvements were observed for plasma, as peak shifts are relatively small in that
biofluid. One could argue that, because the used alignment procedure is not fully artefact-free (see
figure 3.4), alignment of plasma data is optional. However, a preferable option is to develop a more
sophisticated approach to aligning the spectral data. Namely, although the exact chemical shift
may vary, the same compound in different samples should exhibit identical J -coupling patterns
and relatively stable J -coupling constants,253 and this information is available in the 2D spectra.
Incorporation of this information in the alignment algorithm is expected to greatly reduce or
remove the occurrence of artefacts (based on a remark from F. Geier, Imperial College London,
UK).
There is a wealth of multi-dimensional nmr techniques available, with jres being the main 2D
technique that has commonly been applied in metabolite profiling settings. Other methods have
been used, but mostly on a pre-selected sample with the goal of peak identification. It is often
not feasible to perform 2D nmr experiments on all samples, because it takes longer to acquire
2D data than 1D data, as a second axis needs to be encoded. The J -coupling as a second axis
requires relatively few increments compared to encoding the chemical shifts of a second nucleus
such as 1H, 13C or 15N, and thus jres is a relatively fast multi-dimensional technique. However,
the advent of fast multi-dimensional nmr methods, which are based on the encoding of one axis
with location in the sample rather than with a time increment, would decrease the experimental
time.150–152,157 In the following years, pulse sequences and hyper-polarisation methods should be
developed further to achieve a good s/n and reproducibility for these fast methods, which would
be complemented by the trend of increasing magnetic field strength for nmr machines. One point
that needs to be addressed is the optimisation of pulse lengths and other experimental parameters:
at the moment the time necessary to set up a 1D experiment is very short, as identical settings
can be used for a series of similar samples. It would be practical if fast 2D methods also require
minimal experimental set-up, as otherwise they would not be as time-effective as intended. 2D nmr
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spectra can be analysed with chemometric methods,119,254–257 and it seems worthwhile to focus
pattern recognition and other modelling efforts on multi-dimensional nmr spectra acquired with
fast methods. It is also worth investigating the use of peak detection in the 2D spectra followed
by the calculation of peak intensity. When these values are used as variables, the information on
both axes is retained, which was not the case in the current jres analyses, where projections were
taken and coupling information was discarded during modelling. Finally, the inclusion of multi-
dimensional spectral data could improve the performance of (semi-)automated peak assignment
algorithms.
To fully automate sa-k-opls, the number of orthogonal components, and if necessary the
number of predictive components, should be optimised within the simulated annealing process. To
optimise the kernel parameter in sa-k-opls faster, it could be useful to tune the parameters of
the simulated annealing approach and to evaluate if the shape of predictive ability as a function of
σ is informative (see figure 4.1). Alternatively, other optimisation approaches that provide a good
solution in a shorter amount of time can be investigated. One method would be to use a logarithmic
series of kernel parameters,173,258 as it is a more reasonable option than trial and error172 or the
linear grid-search that is commonly employed.162,259 Although this deterministic search would be
faster than simulated annealing, it might also be less precise and prone to miss the global optimum.
Further research should evaluate whether the decreased modelling time is outweighed by possibly
poorer prediction performance. Whichever method is used, it should always be implemented with
a nested cross-validation in order to provide reliable predictive performance metrics.
The importance of variables in the non-linear models, which is available as a loading for linear
models, was approximated by the use of pseudo-samples.184,193 This approach needs to be further
validated and contrasted with other methods, such as those that could accommodate interactions
between variables. Examples of alternative methods include the calculation of the correlation
between the input data and the kernel matrix260 and feature selection, for example based on boot-
strapping and resampling approaches.261,262 An important factor to consider in this respect is
calculation time: if a bootstrapped model would need full calculation of the kernel parameter with
simulated annealing and nested cross-validation, then this approach would be more computation-
ally expensive than the conceptually simple pseudo-data approach that was used here. Extension
of the variable importance approximations to multi-class and regression problems appears straight-
forward, and would be useful to investigate.
The processing and analysis of msi data is expected to be increasingly important in the future,
as this method becomes more commonly used. The realisation that not all the information that
is present in the data is extracted by the majority of researchers is an issue that future research
should urgently address; for example through the development of accessible and understandable
methods and by collating the different approaches in an easy-to-use toolbox. A difficulty that
can arise is the lack of compatibility between certain data set sizes and current computing power:
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faster processors with more memory and smarter algorithms to perform the processing steps and
calculate the models are necessary.
There is a wide range of methods that have not yet been applied but are potentially very
useful for analysis of msi data, in terms of processing as well as data modelling. In terms of data
processing, it was proposed to develop a ‘smart’ smoothing step (see §5.4.7), where the quality of
each pixel is weighted in the smoothing procedure to obtain the highest-quality data set possible,
which for example can deal with noisy pixels and pixels near the edge of the sample; edge-preserving
smoothing is another interesting research avenue.237 A multivariate approach that could be added
to the suggested set of modelling tools is opls-da, which has already been applied to an ft-ir
hyper-spectral image data set.263 Predictive methods such as pls can be used in conjunction with
histology264 and the orthogonal variation in opls, which is currently often ignored, could be used
to understand sampling, experimental and data processing features and artefacts. Another option,
although possibly highly computationally intensive, is the use of robust methods that are able to
deal with inferior pixel quality and noisy spectral components. The assessment of various methods
requires good evaluation criteria, and extra data sets to test the reproducibility, reliability and
generalisation of the results. It is also necessary to obtain expert input on the resolved anatomical
structures and interesting m/z values to evaluate the visualisation and modelling.
Manifold learning approaches such as isomap and t-sne showed promising results for the vi-
sualisation of msi data, and these methods will need to be further explored and validated. At the
moment, the main disadvantage of these non-linear methods is the lack of a variable importance
metric: manifold learning techniques have no clear equivalent to the ‘loading’ that is calculated
in pca or to the ‘weights’ in som. This information is important for biological understanding,
as it would provide a measure of the contribution of individual peaks to the separation of classes
or visualisation. There are, however, some approximations that can be suggested, such as taking
a representative profile of a cluster in the t-sne plot, or performing pca on a pre-selected set of
pixels identified with the manifold learning method. Future work should be aimed at labelling
those variables that formed the basis of the visualisation as important, in order to aid biological
interpretation.
It was shown that manifold learning techniques could be used to study mass peaks, since
related m/z values cluster in groups (see figure 5.24 E and F and figure 5.26 C and D). Other
methods such as pca and som can also be used in this manner, where the m/z values are used as
observations and the images are used as variables, in order to find clustering patterns of related
peaks. This approach can aid in the assignment of peaks, and the tentative identity can then be
further validated with e.g. the use of tandem mass spectrometry.
The data presented were extracted from a biomap-generated file, with a resolution of ∆m/z
= 0.2. Future research should evaluate whether the use of full-resolution data, which is likely to
need peak alignment and additional processing steps, would instead provide an increased amount of
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knowledge. Advancements in technology are likely to increase m/z resolution and spatial resolution
further and some imaging instruments incorporate an ion mobility separation step prior to the mass
measurements, increasing dispersion and aiding peak identification. This further increases the
dimensionality and size of the data, and thus also increases the need for appropriate multivariate
modelling and efficient computational techniques, such as the storage of data as sparse matrices.229
As an example, manifold learning techniques have proven to be extremely powerful unsupervised
visualisation tools, but since these methods take a few hours to calculate one model, algorithmic
improvements might be required.
With the advent of high-throughput, automated imaging ms,265 and the possibility of three-
dimensional imaging,250 more samples will be available. This will necessitate the co-registration
of the different tissue slices and the development of methods that can analyse multiple images.
Additionally, it will be necessary to address the experimental and analytical reproducibility, such as
variable adduct formation. Other developments in msi include imaging on (sub)cellular-resolution
level;199 analysis of these data with extremely high resolution will greatly increase current biological
knowledge, provided appropriate data analysis is performed.
Overall, the challenge is to clearly demonstrate the advantages, reliability and reproducibility of
msi compared to histology as the gold standard. This thesis shows how multivariate approaches can
extract a wealth of information from the vast msi data set. In fact, it would be very interesting
to compare and integrate the results of msi with histology or other imaging modalities, such
as fluorescence methods or in vivo magnetic resonance (see §5.5.6).266 A drawback of msi is
that obtaining a sample is an invasive procedure, and thus the combination of msi with a non-
invasive approach such as magnetic resonance imaging or mrsi could have a synergistic effect,
where the simultaneous interpretation of both data sets could enhance the understanding of each
individual method. Another exciting application is the ‘intelligent knife’, which analyses the mass
spectra of the tissue-originated gaseous ions generated with surgical methods employing thermal
ablation;267,268 the integration of these surgical data from different tissues with the equivalent msi
spectra, analysed with tools based on the work presented here, has a great potential for healthcare.
162
6.3 Conclusions
The work in this thesis has shown how the development and application of analytical spectroscopic
methods, data processing and chemometric modelling tools can allow a researcher to extract a
maximum amount of information from a provided set of samples. Firstly, the use of J -resolved
1H nmr spectroscopy for improved biomarker identification was exemplified with a galactosamine
toxicity study. The advantages of reducing peak overlap and over-representation of signals and the
analysis of jres spectra with multivariate projection techniques and correlation approaches were
demonstrated. The use of jres spectral data in metabolic profiling is advantageous, due to the
ability to quickly generate 2D spectral data that increase peak dispersion and provide J -coupling
information. Secondly, simulated annealing optimised kernel-based orthogonal partial least squares
was used to perform predictive modelling in metabolic profiling data sets. The interpretation of or-
thogonal components and approximation of variable importance increases the transparency of this
kernel-based modelling approach. The user-friendly implementation with nested cross-validation
should allow this non-linear predictive modelling method to become attractive for researchers, not
only in the field of metabonomics, but also in the wider research community. Finally, the pro-
cessing and multivariate analysis of mass spectrometry imaging data demonstrated how this vast
spectral data set can be analysed to provide a large amount of information. The visualisation
and modelling of these hyper-spectral data were done by accounting for both the multivariate and
the imaging nature of the method. The presented approaches will allow researchers to generate
an unbiased and meaningful overview of these data, and to interpret the corresponding biological
variables: both the anatomy of the image and the corresponding m/z peaks.
Overall, the metabonomic toolbox has been expanded with various spectroscopic, data pro-
cessing and modelling methods, which aim to increase the information content and facilitate the
interpretation of the data. Therefore, this work is expected to further biological understanding,
drug development and healthcare.
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Appendix A
Analysis of MSI data from fresh
tissue
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Figure A.1: The results of multivariate analysis of the msi data set [14531 × 643] from the fresh brain tissue
sample, processed using the same approach and settings as the formalin-fixed sample discussed in chapter 5.
A pca model was calculated, and the first three components are mapped with rgb colouring (see also figure
5.14). Additionally, a 3D [3× 3× 3] som map was calculated and the x, y and z locations of the map encoded
with rgb, compare with figure 5.23. The results of manifold learning with isomap are also shown (the data set
was too big to perform t-sne); the first three manifold axes are encoded with rgb colouring, similar to figure
5.24 A.
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Figure A.2: The results of multivariate analysis of the msi data set [12641 × 643] from the fresh brain tissue
sample, processed with a smoothing window of size 13 (to remove a large number of edge pixels and create a
smaller data set). A pca model was calculated, and the first three components are mapped with rgb colouring
(see figure 5.14). Additionally, a 3D [3× 3× 3] som map was created and the x, y and z locations on the map
are displayed with rgb encoding, compare with figure 5.23. The results of isomap are also shown; the three
calculated isomap coordinates for each pixel are encoded with rgb colouring, similar to figure 5.24 A. Finally,
the visualisation based on t-sne embedding, using three rgb encoded axes, as was done in figure 5.25 C, is
also displayed.
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Figure A.3: The results of multivariate analysis of the msi data set [12641 × 643] from the fresh brain tissue
sample, processed without smoothing using the same pixels as in figure A.2. A pca model was calculated, and
the first three components are displayed with rgb colouring. Also shown are the results of a 3D [3× 3× 3] som
map, where the x, y and z locations were mapped with rgb encoding. The results of isomap are displayed,
where the first three of the 53 calculated isomap axes are encoded with rgb colouring. Finally, the results of
t-sne with three rgb colour-coded axes are shown.
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Evaluation of Full-Resolution J-Resolved 1H NMR
Projections of Biofluids for Metabonomics
Information Retrieval and Biomarker Identification
Judith M. Fonville, Anthony D. Maher,† Muireann Coen, Elaine Holmes, John C. Lindon, and
Jeremy K. Nicholson*
Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London,
Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, United Kingdom
Spectroscopic profiling of biological samples is an integral
part of metabolically driven top-down systems biology and
can be used for identifying biomarkers of toxicity and
disease. However, optimal biomarker information recov-
ery and resonance assignment still pose significant chal-
lenges in NMR-based complex mixture analysis. The
reduced signal overlap as achieved when projecting two-
dimensional (2D) J-resolved (JRES) NMR spectra can be
exploited to mitigate this problem and, here, full-resolu-
tion 1H JRES projections have been evaluated as a tool
for metabolic screening and biomarker identification.
We show that the recoverable information content in
JRES projections is intrinsically different from that
in the conventional one-dimensional (1D) and Carr-
Purcell-Meiboom-Gill (CPMG) spectra, because of
the combined result of reduction of the over-repre-
sentation of highly split multiplet peaks and relax-
ation editing. Principal component and correlation
analyses of full-resolution JRES spectral data dem-
onstrated that peak alignment is necessary. The
application of statistical total correlation spectros-
copy (STOCSY) to JRES projections improved the
identification of previously overlapped small mol-
ecule resonances in JRES 1H NMR spectra, com-
pared to conventional 1D and CPMG spectra. These
approaches are demonstrated using a galactosamine-
induced hepatotoxicity study in rats and show that
JRES projections have a useful and complementary
role to standard one-dimensional experiments in
complex mixture analysis for improved biomarker
identification.
Metabolic profiling is a versatile tool for investigating biological
functions at the cell and systems levels and, thus, inter alia for
studying disease and other pathological processes.1-6 Biofluids,
such as plasma and urine, are easily collected and contain a wealth
of metabolic information, which can be captured using analytical
techniques such as mass spectrometry and nuclear magnetic
resonance (NMR) spectroscopy.7 NMR is a nondestructive
technique requiring minimal sample preparation, and, although
the sensitivity is lower than mass spectrometry, a great number
of diverse metabolite signals can be observed, especially at high
magnetic field strengths.8,9 The natural abundance of hydrogen
in biological materials and the inherently high NMR sensitivity
of the proton makes 1H an obvious choice for generating
metabolic fingerprints.10 Computational pattern recognition
methods can then be applied to evaluate and discriminate
different classes of samples, e.g., control versus disease, based
on multivariate spectral inputs.11,12
Challenges associated with 1H NMR-based metabolic profil-
ing include the considerable peak overlap in biofluid spectra
and chemical shift variation for some peaks, and this often
inhibits complete interpretation of the spectra and accompany-
ing pattern recognition models.13-15 One specific problem for
NMR spectroscopy is that many metabolites give rise to a
considerable number of spin-coupled multiplets over a range of
chemical shifts. This spectral overlap has two consequences:
impaired peak dispersion and over-representation of the metabolite
in any statistical classification exercise.
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One method of reducing peak overlap is to disperse signals
into a second dimension. J-resolved (JRES) NMR spectroscopy16
is one of the simplest two-dimensional (2D) NMR experiments
where data can be rapidly obtained. This can be more efficient
than physical separation of the compounds (for example, using a
chromatography step before NMR analysis17) or the use of lower-
sensitivity 2D NMR experiments (such as homonuclear and
heteronuclear correlation spectroscopy18). The JRES experiment
is formed of an array of spin-echo pulse elements, in which an
incremented delay period is used to define a second frequency
dimension. After suitable data processing,10 the chemical shift and
J-coupling information are resolved on two orthogonal axes,
thereby increasing signal dispersion, while the resonance intensi-
ties are edited based on the proton T2 relaxation times. The 2D
JRES spectrum can be projected onto the chemical shift
axis,19,20 effectively yielding a 1H broadband decoupled proton
spectrum consisting exclusively of “singlets”, which can then
be subjected to pattern recognition analysis. Potentially, this
approach can reduce the over-representation problem encoun-
tered in biological samples.
The value of JRES NMR spectra in metabolic profiling studies
of biofluids was demonstrated almost two decades ago,21-24 and,
since then, JRES spectra have been routinely acquired,10,25-27
including, inter alia, studies of human urine,21 plasma,8,22 and
cerebrospinal fluid.23 JRES NMR spectroscopy has been utilized
in diverse studies of the components of plants,28 fish,29 and beer,30
as well as in kinetic drug metabolism studies,31 with magic angle
spinning NMR data of tissues32 and even in vivo.33 The most
readily apparent advantages of JRES NMR spectroscopy stem from
improved dispersion, through reduced peak congestion, and T2-
editing, which attenuates broad macromolecular signals. JRES
has proven to be particularly useful in metabolic profiling
studies,21,27 because many of the nuclear spin systems of such
small molecules exhibit first-order NMR spectra; hence, artifactual
peaks associated with second-order effects are rare. However,
there are limitations caused by the nonstandard line-shape and
T2-editing in JRES NMR spectra, in terms of metabolite
quantitation.34
Improved spectral clustering of data in principal component
analysis (PCA) models built from JRES data versus conventional
one-dimensional (1D) spectra has been reported.26 However, to
date, most studies to evaluate JRES spectra have used binned data
based on a low-resolution representation of the peak intensities
rather than full-resolution spectral data.26-29,32 The limitations of
binning spectral data on data interpretation and information
recovery are well-documented.35,36 The main reason for binning
data is to minimize the effects of chemical shift variability;
however, the development of alignment algorithms for NMR data
have lessened the need for this compromise.14,15,37,38 Other studies
have investigated the effect of JRES NMR data acquisition
parameters applied to metabonomics.10,39
Here, we comprehensively re-evaluate the JRES NMR experi-
ment, together with the use of full-resolution one-dimensional
projections, because it is anticipated that the increased level of
apparent resolution will aid biomarker identification, especially
for complicated, highly overlapped spectral regions. We consider
the processing steps required for the routine and robust use of
JRES NMR spectra in metabonomics, including peak alignment
and the use of full-resolution data. We assess qualitative and
quantitative aspects, in conjunction with correlation spectroscopy
approaches, and consider the degree of information recovery,
compared to conventionally acquired 1D and Carr-Purcell-
Meiboom-Gill (CPMG) 1H NMR spectra. As an exemplar where
NMR peak over-representation is acute, we have used spectra
acquired from plasma and urine samples from a galactosamine
toxicity study in rats.40 These contain compounds that are
spectrally high-represented with respect to the presence of
many multiplets arising from exogenous and endogenous
metabolites, thus obscuring a considerable portion of the
spectral range.
MATERIALS AND METHODS
Sample Preparation. Samples were collected and analyzed
previously as part of the COMET-2 project41,42 and were stored
at-80 °C. Rats were administered a 10 mL/kg vehicle (0.9% saline,
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n ) 8) or galN (galactosamine hydrochloride dissolved in 0.9%
saline to give a free base concentration of 41.5 mg/mL, n ) 8).40
Urine specimens were collected for 24 h after administration and
plasma was obtained upon sacrifice, 24 h after administration, as
described previously.40 Urine samples were thawed, vortexed, and
allowed to stand for 10 min prior to mixing aliquots (400 µL) with
phosphate buffer (200 µL, 0.2 M containing 10% deuterium oxide
(D2O), 3 mM TSP (3-(trimethylsilyl)-[2,2,3,3-2H4]-propionic acid
sodium salt) and 3 mM sodium azide) and centrifuged at 13 000
rpm for 10 min. Samples (550 µL) were placed in NMR tubes
with an outer diameter of 5 mm. Stored plasma samples,
previously prepared and placed in NMR tubes with an outer
diameter of 5 mm,40 were thawed and used for analysis.
1H NMR Spectroscopy. Proton NMR spectra were acquired
on a Bruker Avance-800 spectrometer operating at a 1H frequency
of 800.32 MHz and a temperature of 27 °C. D2O provided a
field frequency lock and TSP provided a chemical shift
reference for the urine samples. Urine and plasma 1D 1H NMR
spectra were acquired with water peak presaturation using the
pulse sequence (d1-90x-4 µs-90x-tm-90x-acquire FID). For
each sample, 64 transients were collected into 64k data points
using a spectral width of 16 025 Hz, with a relaxation delay
(d1) of 2 s, an acquisition time of 2.04 s, and a mixing time (tm)
of 100 ms. The water resonance was selectively irradiated
during d1 and tm. CPMG 1H NMR spectra of urine and plasma,
acquired with the pulse sequence (d1-90x-[τ-180y-τ]n-
acquire FID), with a spin-spin relaxation delay of 2nτ ) 102.4
ms (τ ) 0.4 ms, n ) 128) were collected with 64 transients
and a d1 of 2 s into 64k data points with a spectral width of
16 025 Hz and an acquisition time of 2.04 s. The water peak
was irradiated during delay d1. The 2D JRES urine and plasma
1H NMR spectra were acquired with the pulse sequence
(d1-90y-τ-180-τ-acquire FID, with suppression of the water
resonance during d1) into 64k data points in F2 with a d1 of 2 s
and 8 transients using 32 increments of τ; the spectral widths
in F2 and F1 were 16 025 and 50 Hz, respectively.
Data Processing. A line broadening function of 1 Hz and one
level of zero filling were applied to all 1D and CPMG spectra prior
to Fourier transformation (FT). Automated phase and baseline
correction and referencing to TSP (δ ) 0.000) or R-glucose (δ )
5.233) resonances for urine and plasma, respectively, were
performed using in-house software (NMRproc v0.3; Drs. T. M. D.
Ebbels and H. C. Keun, private communication43-45). JRES data
were zero filled to 128k data points in F2, and up to 256 increments
in F1. Apodization of the JRES data was performed using an
unshifted sine-bell function in both dimensions prior to FT. As is
necessary, the absolute value spectra were calculated. Data were
tilted, symmetrized with respect to the horizontal through the
center of F1, and skyline- or sum-projected as indicated. The JRES
projections were referenced and baseline-corrected as above. All
spectra were imported to Matlab (R2008a, The Mathworks, Inc.,
Natick, MA) and data were interpolated to form a vector running
from δ -1.0 to δ 10.0, in steps of 0.00025. This maintains the
resolution of the spectral data while allowing for increased
accuracy in chemical shift referencing. Following removal of the
TSP, water, and urea regions, the data between δ 0.1-4.5 and δ
6.0-10.0 were used for further analysis (resulting in 44 001 data
points per spectrum) and subjected to probabilistic quotient
normalization.46 There were six datasets in total: urine and plasma
data for each of the three NMR experiments (1D, CPMG, and
JRES). To investigate the effect of peak alignment, recursive
segment-wise peak alignment14 was performed, where the refer-
ence spectrum for each set of 16 samples (8 galactosamine-treated,
8 controls) was chosen to be the one with maximum correlation
with the other spectra.
Signal-to-Noise Ratio and Line Width Analyses. The signal-
to-noise ratios for different processing options of the JRES
projections were calculated as the mean ratio across the 16
samples of a given peak maximum, with respect to the standard
deviation of noise (δ 0.2-0.5 for JRES, δ 9.8-10.0 for CPMG).
The signal-to-noise ratio was calculated for the alanine methyl
signal at δ 1.47 and the lactate methyl signal at δ 1.33, in both
urine and plasma, and the TSP singlet at δ 0.00 and the succinate
singlet at δ 2.41 in urine; for the CPMG spectra, the highest value
of the lactate and alanine doublet signals was used. Note that the
term noise is not absolutely correct in JRES spectra, because it is
not truly random, having no negative components in the absolute
value mode, prior to any baseline correction. The line widths of
the JRES projections were approximated as the median of the full
width at half height for the lactate methyl singlet and the alanine
methyl singlet in plasma and urine, in addition to the TSP and
succinate singlets in urine.
Statistical and Chemometric Analyses. The Pearson’s cor-
relation coefficient (r) was calculated between spectra to estimate
the (dis)similarity between different samples. Principal component
analysis47 (PCA) models were generated using mean-centered
spectral data before and after alignment. Axes of separation were
determined based on the direction of differentiation between the
scores of the two groups. Statistical TOtal Correlation Spectros-
copY48 (STOCSY) plots display the Pearson correlation (color)
and covariance (height) of all spectral data points with a variable
of interest, typically either a peak of interest, e.g., the alanine CH3
resonance (for doublets, the high-frequency peak was used),
the creatinine CH3 resonance at δ 3.05, or a dummy vector
representing the class (encoded as 0 ) control, 1 ) dosed).
Orthogonal partial least squares49 models were constructed
with in-house software on unit-variance scaled and mean-
centered data, with a dummy vector as above to represent the
two classes.
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RESULTS AND DISCUSSION
Projection and Symmetrization of JRES Spectra. JRES
spectra may be projected in the chemical shift dimension after
tilting the 2D spectrum, to effectively produce a homonuclear
decoupled 1D proton spectrum. The effect of this “collapse” of
multiplets is demonstrated in Figure 1: for example, the multiple,
highly overlapped glucose resonances can now be unambiguously
assigned in the full JRES spectrum from their chemical shift and
coupling pattern information. As is well-known, two types of
projection can be routinely employed:19,20 the sum projection,
summing all signals along F1, and the skyline projection, retaining
the highest signal along F1. Generally, the skyline projection
results in signals with a better signal-to-noise ratio (S/N).39 This
is illustrated in Figure 1, where a representative “control” 2D
spectrum and associated projections are shown, scaled to equiva-
lent noise levels. In Table 1, the mean S/N is displayed for the
various processing methods as applied to both urine and plasma
spectral peaks, demonstrating that, in all cases, the S/N is better
for skyline than sum projections. Because most increments of the
JRES spectrum do not contain signal, the commonly observed S/N
increase with the square root of summed increments is not
achieved.39 Naturally, this S/N advantage of skyline projection is
more pronounced for singlets than multiplets. For example, in
Figure 1, the H5 -glucose resonance at δ 3.464 (ddd) shows
similar sum and skyline projection peak intensities after scaling
to constant noise levels. Most applications of JRES projections in
metabonomics have used the skyline projection, with only a few
exceptions.25,42 Although the S/N is lower for all of the JRES
projections, compared to the CPMG results with the current
acquisition parameters (Table 1), this can be remedied by
adjustment of the spectral acquisition parameters such as an
increased number of scans or increments. We show (vide infra)
that the disadvantage of the lower overall signal-to-noise ratio of
Figure 1. Example of a symmetrized 2D JRES 1H NMR spectrum acquired at 800 MHz from plasma of a control rat in the galactosamine study
(see the Materials and Methods section for details). Sum (blue) and skyline (red) projections without symmetrization are shown, scaled to
identical noise levels (measured at δ 0.2-0.5). For comparison, the conventional 1D 1H NMR spectrum is shown (black). The use of increased
dispersion of the JRES experiment and the incorporation of multiplicity information in peak identification is demonstrated with assignment of glc
(which denotes glucose). Some minor peaks remain unassigned.
Table 1. Mean Signal-to-Noise Ratios (S/N) and Full Width Half Height Line Widths of Various Spectral Data Typesa
spectral data urinary alanine plasma alanine urinary lactate plasma lactate urinary succinate urinary TSP
Mean Signal-to-Noise Ratios (S/N)
CPMG spectrum 0.616 × 103 1.27 × 103 1.35 × 103 4.92 × 103 5.38 × 103 20.0 × 103
JRES skyline projection 0.262 × 103 0.485 × 103 0.702 × 103 2.32 × 103 5.86 × 103 21.8 × 103
JRES sum projection 0.077 × 103 0.141 × 102 0.218 × 103 0.639 × 103 0.728 × 103 2.80 × 103
Full Width Half Height Line Widths (Hz)
JRES skyline projection 1.4 2.0 1.6 1.7 1.4 1.4
JRES sum projection 1.4 1.8 1.4 1.8 1.3 1.2
a S/N results for CPMG NMR spectra are based on values from the highest peaks in the listed doublet. The standard 1D NMR spectrum values
are not given, because the peak height and noise measurements for plasma are confounded, because of the presence of macromolecular signals.
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JRES spectra is outweighed by a drastically improved apparent
resolution due to reduced peak overlap in the projections.
The full widths of specified peaks at half height are also given in
Table 1, and these show little difference between symmetrized skyline
and sum JRES projection peaks. In addition, symmetrization of the
JRES data results in narrower peaks of subsequent projections, which
is a phenomenon that is directly related to the symmetrization
procedure. Without symmetrization, sum projections resulted in
broader peaks than skyline projections and this is in agreement with
the superior resolution of skyline projections found previously (data
not shown).20 All further results presented are based on symmetrized
spectra.
Necessity of Spectral Alignment of Full-Resolution JRES
Projections for Statistical Analysis. Using the unsupervised
statistical method of principal component analysis (PCA), it was clear
(see Figure 2 and Table 2) that the discrimination of galactosamine
treated and control groups for urine JRES projections in the first
principal component (PC) is conditional on proper peak alignment.14
Alignment significantly improved the PCA model, with a much
higher proportion of the variance explained in PC1 (76.4% versus
33.2%) and biological separation on the basis of toxicity being
Figure 2. (A, B) Principal component analysis (PCA) scores for the skyline-projected JRES urine spectra before and after alignment,14 mean-
centered; for galactosamine-dosed animals (solid squares) and vehicle-dosed controls (solid circles). PC: principal component and associated
percentage of explained variance. (C, D) The corresponding PCA loadings displayed for the region δ 2.0-4.5 clearly demonstrate the
disappearance of dispersive shapes upon peak alignment for, e.g., taurine (1), dimethylamine (2), succinate (3), citrate (4), 2-oxoglutarate (5)
and creatinine (6), while resonances of galactosamine (7) become a dominant source of variance in the first two PCs.
Table 2. Principal Component Analysis Results before
and after Spectral Peak Alignmenta
% Variation explained
PC1 PC2
PC showing
group
separation
unaligned spectra
skyline JRES projection 33 17 3
sum JRES projection 31 23 1
aligned spectra
skyline JRES projection 76 7 1
sum JRES projection 82 7 1
a Principal component analysis (PCA) was based on mean-centered
urine NMR data before and after recursive segment-wise peak alignment.14
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promoted to higher principal components (compare Figures 2A
and 2B).
It is not only important to align the data to create improved
models, but, in addition, the interpretation of the data is greatly
increased upon alignment.14 Before alignment, the resultant
dispersive line shape of the loadings due to peak position
variability makes it ambiguous, with regard to whether a certain
peak is actually contributing positively or negatively to a PCA
loading. Peak positional variation was indicated14 for virtually all
resonances, e.g., taurine, dimethylamine, succinate, citrate, and
2-oxoglutarate (see Figure 2C). The galactosamine resonances
are unaligned to such a high degree that these variables do not
contribute significantly to the variance modeled in the first
principal components (PCs), much in contrast to the aligned
model (see Figure 2D). For plasma data (not shown), the
difference in separation of the two classes upon alignment is
minimal, but the improvement in loading interpretation remains,
similar to that observed in Figure 2.
Urinary 1H NMR spectra show more peak positional varia-
tions than plasma spectra, and this is caused by, for example,
greater variability in pH, metal, and ion concentrations. The
parameters for each PCA urine model are given in Table 2,
where the skyline projections of the JRES data did not separate
in PC1 before alignment, but in PC3 (Figure 2). In contrast, the
sum projection did separate in PC1, possibly because highly split
multiplets, for example, from the galactosamine multiplet peaks,
manifest higher intensity and hence greater importance in the
sum projection than the corresponding peak in the skyline
projection.
JRES data are more sensitive to misalignment effects, com-
pared to 1D and CPMG spectra, because the reduction in
“chemical shift bandwidth” for each resonance (multiplets are
collapsed into singlets) causes small variations in chemical shift
to manifest as marked misalignments in JRES projections.
Therefore, the data type and the applied processing parameters
(e.g., skyline or sum projection, symmetrization) will greatly
influence the resultant pattern recognition model. However, this
variation, induced by a combined effect of peak shifts and peak
width differences, can be completely removed using an adequate
alignment approach.14,15,36-38
Improvement of STOCSY Analyses by Use of Aligned
JRES Projections. Information retrieval from correlation analyses
such as STOCSY (statistical total correlation spectroscopy48) is
also improved after peak alignment. Figures 3A and 3B shows
JRES projections from 1H NMR spectra of urine from the dosed
and control groups before and after alignment, with expansions
demonstrating the substantial improvement by alignment. The
corresponding STOCSY plots for these data are shown in
Figures 3C and 3D, in which the peak height represents the
covariance of the variable with the class dummy-vector and the
color represents the correlation with this vector. The severity of
the toxic insult, and interindividual differences40,50 in response,
cause a broad concentration range for a given metabolite in the
different samples, increasing the reliability of the obtained cor-
relation coefficients. Spectral alignment removes the dispersive
shapes in the STOCSY plot and clearly reveals correlations that
were previously unobserved (for example, those between the
galactosamine resonances).
Orthogonal partial least squares models of the urinary JRES
projection data before and after alignment confirmed the findings
from PCA: before alignment, one orthogonal component is
necessary to achieve optimal models in terms of the goodness of
prediction (Q2) and the sensitivity and specificity of class
prediction, whereas after alignment, no orthogonal components
are necessary and, thus, standard partial least squares models
would suffice (data not shown).
Previous analyses of JRES data of metabolite mixtures did not
suffer from peak alignment artifacts because binned integral data
were used.26-29,32 However, it should be appreciated that peak
alignment is preferable over binning, because multiple signals may
become concatenated or individual signals may split in the latter
procedure. Moreover, the use of bins precludes the direct interpreta-
tion of multivariate models.14,15 Previously,26-29 some major peak
shifts had to be taken into account by combining multiple bins,
indicating that even binning itself may not compensate for major peak
shifts.
Alignment proved to be uncomplicated for the singlets in JRES
projections (in Figure 3, most peaks are well-aligned) and possibly
other algorithms will give equally good results. A similar situation
occurs in the alignment of 13C NMR spectra,36 where peak shift
correction is more straightforward than for overlapping 1H
NMR spectra that exhibit complicated multiplet resonances.
Investigation of the Inclusion of Stoichiometric Informa-
tion into STOCSY Analyses. Peak intensities in JRES sum
projections from different protons in the same molecule should, in
principle, be related to the number of protons contributing to each
peak. However, the situation is complicated by the probability of the
various NMR resonances having different T2-values. Whether this
proportionality can be use for improved correlation analysis has
been investigated using a regression of two signal intensities from
the same molecule across a series of samples (Statistical Total
Regression Spectroscopy, STORSY, full details are given in the
Supporting Information). This could hypothetically help with the
assignment of unidentified molecules and aid the differentiation
between intramolecular and intermolecular correlations. Interpreta-
tion of STORSY data would only be trivial for spectra without
multiplicity patterns, such as JRES projections. The computed
intensity ratios were determined to not be consistent with the
theoretical values (see Figure S-1 in the Supporting Information),
because of the protons having different T2-values,21 together with
the nature and processing of the JRES experiment. Despite this,
a high correlation was displayed between intramolecular protons,
validating the use of STOCSY for JRES sum projections. These
correlations were also maintained in skyline projections where a
given molecule has consistent peak multiplicities and relative
intensities across different samples. Semiquantitative (relative)
changes in metabolite concentrations have also been achieved
by others using binned projections of JRES projection spectra,27
and, recently, a line-shape fitting strategy was proposed.34
Effects of Over-Representation of Metabolite Peaks in
NMR Spectroscopy on Statistical Analysis. In many NMR-
based metabonomics studies, the spectra show prominent peaks
from drugs, toxins, and their metabolites. These can have undue
weight in multivariate statistical models and the identification and
(50) Coen, M.; Want, E. J.; Clayton, T. A.; Rhode, C. M.; Hong, Y. S.; Keun,
H. C.; Cantor, G. H.; Metz, A. L.; Robertson, D. G.; Reily, M. D.; Holmes,
E.; Lindon, J. C.; Nicholson, J. K. J. Proteome Res. 2009, 8, 5175.
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means of down-weighting of such peaks has been demonstrated
previously using STOCSY-type approaches.51 In addition, many
of these substances give multiple, and often highly J-coupled
multiplets. This situation is also encountered for some endogenous
species (such as glucose), and, here, it is shown that the use of
JRES projections can mitigate this problem.
Figure 3. (A, B) 800 MHz 1H JRES skyline projections of urine samples from the galactosamine toxicity study before and after alignment.14
Spectra from dosed animals are colored red and those from control rat spectra are colored blue; expansions are shown for δ 2.67-2.74
and δ 3.42-3.48. Asterisks (*) denote that the creatinine δ 4.06 and H2 -galactosamine δ 3.14 resonances are not aligned perfectly. (C,
D) STOCSY plots based on urine 800 MHz 1H JRES skyline projections obtained before and after alignment. The correlation (color, r2)
and covariance (peak height) of the JRES projections, with respect to a class dummy vector, are displayed; peaks pointing upward co-
vary positively with the toxic insult (see the Materials and Methods section). Upon alignment, correlations are more pronounced and
peaks lose the dispersive shape that is characteristic of unaligned data, greatly improving interpretability. Strong-coupling artifacts occur
between the signals of galactosamine resonances at δ ∼3.8. (Legend: DMA, dimethylamine; 2-OG, 2-oxoglutarate; and R/G,
R/-galactosamine.)
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The spectral information content in the various types of 1D
1H NMR representations is elucidated as a prior step. To
evaluate this, the overall similarities between the different
spectral data types were estimated by computing the Pearson’s
correlation coefficient between every pair of spectra. The
results are plotted in Figure 4, where each “pixel” represents
the correlation between two individual spectra; black lines separate
different blocks representing six discrete datasets, related to the
type of pulse sequence (1D, CPMG, and JRES) and analyzed
separately by class (galactosamine-treated and control). These
figures allow for a direct comparison between the complete
spectral information (not focused on peaks but also including
baseline regions) of the different NMR experiments for the two
biofluid matrices.
It is apparent from Figure 4 that spectral alignment of urine
data greatly improved the overall clustering with experiment and
class subtypes. Dose-related clustering patterns are highly dis-
turbed for 1D and CPMG data and are almost absent from JRES
data before alignment, confirming the necessity for peak align-
ment. The correlation patterns for plasma demonstrate clear
differences between the different experiments: 1D and CPMG
plasma data are more similar to each other than to the JRES
projections. As expected, the JRES projections are slightly more
correlated to the CPMG data than the conventional 1D spectra,
which can be explained by the known T2 relaxation editing in
both pulse sequences.
The correlation coefficient between the dosed and control
groups for urinary spectra is higher for the JRES projections than
for the 1D and CPMG spectra. This can be explained by the
smaller number of variables that are changed following the toxic
insult and this, in turn, is due to the collapse of the multiplets,
leaving the JRES projections from the two classes more alike. This
indicates a higher representation of xenobiotic-related peaks in
1D and CPMG urinary spectra of galactosamine-treated animals.
Similarly, the control JRES spectra of urine have a lower correla-
tion coefficient with dosed 1D and CPMG spectra (see Figure 4,
dotted blocks), compared to dosed JRES spectra with either
control or dosed 1D and CPMG spectra (Figure 4, dashed block).
Thus, the toxin-related metabolites can be regarded as “over-
represented” in the 1D and CPMG data, and the effective 1H
broadband decoupling, as achieved through projection of JRES
data, reduces this effect. This over-representation of multiplets
in 1D and CPMG spectra is comparable to the over-representa-
tion of protein envelope signals in unit-variance scaled PCA
Figure 4. Heat maps showing the Pearson’s correlation coefficients (r) between the 1D, CPMG, and skyline-projected JRES NMR spectra for
urine and plasma, before and after recursive segment-wise peak alignment.14 Black lines indicate the clustering of the galactosamine-dosed
(denoted by the prefix “D”) and control (denoted by the prefix “C”) groups and the separation of the different experiment types (denoted by the
suffixes “1D”, “CPMG”, and “JRES”). Similar results were obtained for sum-projected data (results not shown).
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models based on plasma NMR data.52 The previously reported
bias in total area normalization associated with toxin insults,35
should theoretically decrease when using JRES projections,
because of the reduction in the presence of high-concentration
exogenous and endogenous signals that contribute to the total
spectral area.
The “over-representation” is not completely remedied by the
multiplet collapse. For example, glucose has inherently more
resonances than other metabolites, even when collapsed into JRES
projections. From a biological point of view, there is no reason
why metabolites with more (nonequivalent) protons should be
allowed to dominate any pattern recognition model, as is the case
for variance-based techniques. Factor analysis, curve resolution,53
and STOCSY-E51 might be able to compress signals in a JRES
projection further into one variable per metabolite, i.e., deconvo-
luting the constituting metabolites into the pure spectral profiles,
to obtain relative concentrations across a sample series, which
can then be subjected to multivariate analysis.
Complementarity of 1D, CPMG, and JRES Projections.
It might be thought that the information content of a CPMG NMR
spectrum from a biofluid sample may essentially be obtained from
acquisition of a JRES spectrum combined with a standard pulse-
and-acquire “1D” experiment. The main virtue of CPMG, T2-
editing, is also obtained in the JRES experiment, with the added
advantage that JRES spectra provide projections that are easier
to interpret in heavily overlapped regions, especially when
combined with the scalar coupling information available in the
2D data. A potential disadvantage of the JRES experiment is
more-pronounced T2-editing than with the CPMG experiment,
because conventional sine-bell apodization minimizes the
contribution of rapidly relaxing protons even further. As a
result, increased information extraction is obtained in highly
overlapped spectral regions, for example, in the range of δ
3.0-4.0 (see assignments in Figure 1) at the expense of
information density for rapidly relaxing species.
Because it is unnecessary to acquire a large number of
increments (as zero filling and linear prediction54 can be helpful),
it is possible to acquire good-quality JRES spectra of typical
biofluids samples very quickly, in a period of <5 min.55 There are
multiple approaches for fast JRES data acquisition: one is based
on reduction of the number of increments and transients in the
traditional JRES experiment,55 whereas other methods encode the
second dimension spatially rather than through time, reducing
data acquisition times, although at the cost of sensitivity.56-59
The sensitivity of JRES data is only slightly lower than 1D
spectra acquired over the same amount of time60 and can be
increased further through the use of cryoprobes. Therefore, time
is not prohibitive to supplement or substitute acquisition of CPMG
spectra with JRES spectra, even though more scans could be
required. Given that we have shown that the CPMG experiment
can be reliably approximated from mathematical manipulation of
1D data,61 its substitution may be more efficient in high-
throughput studies.
Given the above, JRES NMR spectroscopy is observed to be
advantageous and, thus, complementary to the more-usual 1D
NMR methods for routine use in metabonomic research, as
previously suggested.21,27 An additional benefit is that JRES
spectra, in contrast to 1D and CPMG spectra, all have the same
appearance at different observation frequencies when spectra are
displayed on the ppm scale and, thus, data can be more easily
compared across different spectrometers. This allows for rapid
comparative analysis of spectral datasets from multiple field
instruments and will simplify generation of universal spectral
databases. Thus, JRES NMR spectra can be extremely useful as
a part of the metabonomics NMR toolbox.
An Example of Information Recovery Using JRES Spec-
troscopy. As illustrated in Figure 5, the reduced overlap of
biofluid spectral peaks in JRES spectra not only aids model
interpretation, but also can resolve previously unidentified cor-
relations; that is, the reduction in peak congestion resolves
overlapped multiplets, thereby allowing previously concealed
peaks to be recovered.27 The JRES projections of the CH3 peak
of alanine (in plasma, δ 1.47) and creatinine (in urine, δ 3.05)
allow improved correlation with the other peaks in the same
molecules, i.e., the alanine CH peak at δ 3.77 and the creatinine
CH2 peak at δ 4.06, respectively. The plasma region was
previously crowded with amino acid and glucose signals, while
the creatinine signals in urine were overlapped with galac-
tosamine resonances. The individual resonances are completely
resolved upon JRES projection (despite the imperfect alignment
of peaks in this region for urine JRES projections) and, hence,
a more-reliable STOCSY plot is obtained, demonstrating
improved intramolecular correlations. Notably, this is achieved
despite a lower S/N ratio for the presented JRES spectra (see
Table 1). These findings are particularly relevant when the
conventional 1D spectra are heavily obscured by peaks from the
administered toxin and/or its metabolites.
Similarly, in Figure 6, we demonstrate the improved identifica-
tion of biomarker metabolites when using JRES projections,
compared to 1D and CPMG spectra through a correlation/
covariance plot with class (note that some correlations are not
optimal, because the creatinine δ 4.06 and H2 -galactosamine δ
3.14 resonances are not aligned perfectly in the JRES projection).
The correlation patterns identify the same biomarkers for response
to the galactosamine toxic insult in the 1D, CPMG, and JRES
spectra, but the reduced overlap in the projections (and availability
of splitting patterns in the 2D spectrum) significantly aids in
complete and unambiguous assignment of all individual metabolic
resonances;40 we also note that the 2-oxoglutarate peaks display
a much higher correlation, and, therefore, this metabolite is clearly
unveiled as a biomarker in the JRES projection.
CONCLUSION
The most important advantage of J-resolved (JRES) nuclear
magnetic resonance (NMR) spectroscopy over conventional one-
(51) Sands, C. J.; Coen, M.; Maher, A. D.; Ebbels, T. M. D.; Holmes, E.; Lindon,
J. C.; Nicholson, J. K. Anal. Chem. 2009, 81, 6458.
(52) Maher, A. D.; Cloarec, O.; Patki, P.; Craggs, M.; Holmes, E.; Lindon, J. C.;
Nicholson, J. K. Anal. Chem. 2009, 81, 288.
(53) Richards, S. E.; Wang, Y.; Lawler, D.; Kochhar, S.; Holmes, E.; Lindon,
J. C.; Nicholson, J. K. Anal. Chem. 2008, 80, 4876.
(54) Nuzillard, J. M. J. Magn. Reson., Ser. A 1996, 118, 132.
(55) Giraudeau, P.; Guignard, N.; Hillion, E.; Baguet, E.; Akoka, S. J. Pharm.
Biomed. Anal. 2007, 43, 1243.
(56) Zangger, K.; Sterk, H. J. Magn. Reson. 1997, 124, 486.
(57) Pell, A. J.; Edden, R. A. E.; Keeler, J. Magn. Reson. Chem. 2007, 45, 296.
(58) Pell, A. J.; Keeler, J. J. Magn. Reson. 2007, 189, 293.
(59) Giraudeau, P.; Remaud, G. S.; Akoka, S. Anal. Chem. 2009, 81, 479.
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dimensional (1D) and Carr-Purcell-Meiboom-Gill (CPMG)
NMR spectroscopy is the reduction in peak overlap, which aids
biomarker identification and data interpretation in “congested”
spectral areas. We have evaluated the usefulness of full-resolution
JRES projections and demonstrated means to realize the potential
of the technique for metabonomic studies, specifically in terms
of processing and spectral alignment of the data. The skyline
projection is often preferred over the sum projection, because this
gives an increased signal-to-noise ratio and is still highly reproduc-
ible: correlations of interest retrieved with statistical total correla-
tion spectroscopy (STOCSY) are conserved or improved. The
effective peak span widths decrease for singlet projections versus
highly split multiplets, and thus pattern recognition and correlation
methods require alignment of the full-resolution JRES spectral
projections. The subsequently reduced peak overlap in projected
JRES spectra can improve the quality and interpretation of
multivariate models and statistical correlation analyses, and it will
enhance biomarker identification and reduce the differential
degree of over-representation of molecules. Hence, judicious
application of JRES data and alignment can improve the interpreta-
tion of pattern recognition models and increase the information
content extractable from NMR-based metabonomic studies, result-
ing in enhanced biomarker identification.
(60) Aue, W. P.; Bachmann, P.; Wokaun, A.; Ernst, R. R. J. Magn. Reson. 1978,
29, 523.
(61) Maher, A. D.; Crockford, D.; Toft, H.; Malmodin, D.; Faber, J. H.; McCarthy,
M. I.; Barrett, A.; Allen, M.; Walker, M.; Holmes, E.; Lindon, J. C.; Nicholson,
J. K. Anal. Chem. 2008, 80, 7354.
Figure 5. STOCSY plots driven from (A, B, C) the CH3 alanine peak at δ 1.47 for the various plasma datasets as shown and (D, E, F) the
creatinine CH3 peak at δ 3.05 in the urine datasets. The color and height represent the correlation (r2) and covariance, respectively. ((A, D) 1D
spectra; (B, E) CPMG spectra; and (C, F) JRES skyline projections.)
Figure 6. Correlations of the spectral data points (color, r2) with a dummy variable representing the control or galactosamine-treated class,
projected onto the covariance spectrum with the dummy variable for the different aligned spectral NMR types of urine: (A) 1D, (B) CPMG, (C)
JRES skyline projection. The interpretation of highly overlapped signals, for example, in the region of 3-4 ppm, is greatly improved for JRES,
resulting in improved biomarker identification.
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The evolution of partial least squares models
and related chemometric approaches in
metabonomics and metabolic phenotyping
Judith M. Fonvillea, Selena E. Richardsa, Richard H. Bartona, Claire
L. Boulangea, Timothy M. D. Ebbelsa, Jeremy K. Nicholsona, Elaine Holmesa
and Marc-Emmanuel Dumasa*
Metabonomics is a key element in systems biology, and with current analytical methods, generates vast amounts of
quantitative or qualitative metabolic data. Understanding of the global function of the living organism can be
achieved by integration of ‘omics’ approaches including metabonomics, genomics, transcriptomics and proteomics,
increasing the complexity of the full data sets. Multivariate statistical approaches are well suited to extract the
characterizing metabolic information associated with each level of dynamic process. In this review, we discuss
techniques that have evolved from principal component analysis and partial least squares (PLS) methods with a focus
on improved interpretation and modeling with respect to biomarker recovery and data visualization in the context of
metabonomic applications. Visualization is of paramount importance to investigate complex metabolic signatures,
the power and potential of which is illustrated with key papers. Recent improvements based on the removal of
orthogonal variation are discussed in terms of interpretation enhancement, and are supported by relevant
applications. Flexibility of PLS methods in general and of O-PLS in particular allows implementation of derivative
methods such as O2-PLS, O-PLS-variance components, nonlinear methods, and batch modeling to improve analysis of
complex data sets, which facilitates extraction of information related to subtle biological processes. These approaches
can be used to address issues present in complex multi-factorial data sets. Thus, we highlight the key advantages and
limitations of the different latent variable applications for top-down systems biology and assess the differences
between the methods available. Copyright  2010 John Wiley & Sons, Ltd.
Keywords: metabonomics; multivariate; partial least squares; O-PLS; systems biology
1. INTRODUCTION
Metabonomics [1–6] was originally defined as ‘the quantitative
measurement of the dynamic multi-parametric metabolic
response of living systems to pathophysiological stimuli or
genetic modification’ [1]. In the same era, metabolomics was
defined in plant biology and microbiology as ‘the systematic
study of the metabolic complement of the cell’ [2], but has since
broadened to encompass a wider characterization of metabolic
responses, and often the two terms are used interchangeably.
The concept of metabonomics arose from pioneering work
[3] on the application of nuclear magnetic resonance (NMR)
spectroscopy to study the metabolic composition of biofluids,
cells and tissues and was aimed at the augmentation and
complementation of the information provided by measuring the
genetic, and later proteomic, responses to xenobiotic exposure.
Genomics, proteomics, and metabonomics [4]/metabolomics
[5] now form a core part of the fundamental systems biology
framework [7], and are required for an understanding of the
integrated function of the living organism [8,9], with each ‘-omic’
platform generating large amounts of data.
To investigate the complex metabolic consequences of, for
example, disease processes, toxic reactions or genetic manipula-
tions, information-rich analytical approaches are required. Several
methods in addition to NMR can produce metabolic signatures of
biomaterials, including mass spectrometry (MS) [10], and optical
spectroscopic techniques such as Raman, Fourier transform
infrared (FTIR), near infrared (NIR) and ultraviolet–visible (UV–Vis)
spectroscopies. Simplification of the mass spectra can be
obtained by coupling MS to a separation technology such as
gas chromatography (GC/MS) or high-performance liquid
chromatography (HPLC/MS) [11]. NMR and MS are currently
the most frequently used techniques for metabolic profiling [12],
and the characteristic differences in their nature mean that they
often provide complementary information for the analytical
scientist. The obtained spectra of biofluids such as plasma and
urine, or of tissues and tissue extracts, provide metabolic patterns
corresponding to the metabolic status of the organism as a
function of genetic, environmental or toxicological influence.
(wileyonlinelibrary.com) DOI: 10.1002/cem.1359
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Ongoing analytical developments include development of
cryogenic probes and increases in magnetic field strength for
NMR as well as mass resolution for MS. The enhanced sensitivity
and resolution gained by these developments increases the
capability for biomarker detection, at the expense of increased
spectral complexity. Spectral complexity was traditionally
addressed by peak picking or by binning signals across the
spectra in order to generate a smaller or more manageable data
set. For NMR spectra typically 250 buckets of 0.04 ppm resolution
would be generated [13,14]. With increased computational
capacity, this procedure has largely been replaced by importing
full resolution spectra (e.g. 32k data points) [15]. For this reason,
the analyses are performed using the full data set rather than a
peak-picked selection, which increases data dimensionality. This
full spectral import can increase the information recovered, for
example potential biomarkers, from the statistical modeling per-
formed on the data. Similarly, mass resolution has now increased
up to 10 000 for time-of-flight analyzers and up to 100 000 for
Fourier-transform MS analyzers, which ensures access to accurate
mass measurements and peak lists with 1000–5000 peaks.
The analysis of these data sets is now possible with the constant
improvement of computing capabilities of both software and
hardware for personal workstations. Additionally, increased
throughput of samples and the move toward increased cross-
platform integration have further increased the complexity and size
of data sets and present a considerable challenge to the analyst.
In order to accommodate the enormity of the data, chemometric
methods are often employed to extract the specific metabolic
information characterizing each group or dynamic process, in order
to form or confirm hypotheses associated with the expression of a
metabolic profile. In this review the most commonly used latent
variable methods for the extraction of statistically characterized
metabolic phenotypes are discussed in semi-chronological order
(Figure 1 and Textbox); we especially emphasize the improvement
in interpretability of spectral data made possible through the use of
orthogonal partial least squares (O-PLS) [16].
2. LATENT VARIABLE METHODS IN
METABONOMICS
2.1. Univariate versus multivariate approaches
The application of the multivariate advantage to biological
studies produces weighted combinations of the original variables
(forming the latent variables) that delineate groupings, which
are often not visible via any classical univariate analytical
approach. Only multivariate methods can really take into account
the relations between variables: multi-variable patterns can be
significant, even if the individual variables are not. For example,
classes of metabolically differentiated groups may only be
evident using multivariate approaches. In an early paper on
classification of brain tumors [17] it was noted that ‘. . .when these
data are subjected to pattern recognition analyses, the possibility
will be open for an objective differential diagnosis. . . based solely on
differences in. . . biochemical composition’, thus emphasizing the
need for unbiased approaches in biochemical studies. Although
initially, spectral analysis of metabolic profiles was performed
visually [18,19] it was soon recognized that pattern recognition
(PR) methods had great potential for metabonomic studies [20].
The multivariate approach [21] results in an unbiased overview of
the data set, as facilitated through the representation with latent
variables. In such cases as NMR, latent variables may be visually
presented in pseudo-spectral form as will be discussed later, a
great aid to the experienced spectroscopist [15].
Two commonly used multivariate methods are principal
component analysis (PCA [22], unsupervised) and partial least
squares regression (PLS [23], supervised). In these models, a
multivariate latent variable is constructed from the input
(X matrix, e.g. spectral variables). Latent variables, as opposed
to observed variables, are derived from modeling using the
original variables. This latent vector maximizes total variance (in
PCA), or the covariance between the X and response (Y) matrices,
in PLS.
Figure 1. A timeline displaying the order of development of PLS and subsequent or related approaches with exemplar applications in metabonomic
analyses. The applications listed here are discussed throughout the text and relate to typical examples, not the timeline.
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The early use of multivariate analysis in the medical precursor
work [17] was followed by the application of these techniques
in metabonomic research [6,13,20,24]. An exemplar employment
of PR methods in a metabonomics context was the classification
and interrogation of the 1H NMR urinalysis data in a variety of
experimental toxicity states in the rat [20]. PR reduced the
potentially enormous spectroscopic data to a few interpretable
latent variables and provided a means of classifying toxicological
data.
Multivariate projection approaches are advantageous for a
reliable and flexible analysis of NMR and MS data as they reduce
the dimensionality of the data to improve data visualization and
interpretation. This allows handling of the multicollinearity and
information redundancy issues commonly observed in spectral
data sets: the spectral signature of a given metabolite may
contain multiple signals, for example isotopologues, fragments,
and adducts in MS and multiplets in NMR. Often, the number of
variables is much larger than the number of observations, which
is problematic for classical linear regression methods. All of these
issues are appropriately addressed through the use of latent
variable methods.
2.2. Principal component analysis
Early PR methods employed in metabonomics included non-
linear mapping, hierarchical cluster analysis (HCA), and PCA
[13,14,20,24,25]. Based on 1H NMR urine spectra, HCA and PCA
methods were found to give reliable clustering of renal proximal
tubular toxins based on similarity of mechanism of toxicity. PCA is
suited as a data representation because the decomposition
retains a high proportion of the variance in the original data set.
Many early metabonomic studies employing PCA were
toxicity studies that involved large toxin-induced metabolic
perturbations, which appeared in the first few principal
components, and often displayed the separation of the different
study groups on the first component. Clustering of liver, kidney,
and testicular toxins could, for example, be obtained through
such unsupervised PR methods applied to spectral biofluid data.
Moreover, direct visualization of the prominent metabolic
changes is possible by plotting the loadings of the PCA model
[13,14,20,24,25].
2.3. PCA-based classification
Group classification and membership prediction was initially
performed using unsupervised or ‘semi-supervised’ PCA-based
approaches. The generated PCA model can be used to project
new data and determine membership on the basis of scores
projection. The PCA-based method called soft independent
modeling of class analogy (SIMCA) [26] is based on class
groupings: independent PCA models are generated for each of
the given classes in a data set and new samples are projected
onto each independent model; new sample membership is then
assigned by proximity to the sub-models. Often, complementary
information such as the unmodeled variance for a sample is
incorporated into a Cooman’s plot, showing the proximity to
the PCA scores confidence interval space (Hotelling’s T2) that
provides a visual classification method for the two-class case.
One of the earliest applications of the SIMCA modeling approach
in metabolic profiling can be traced back to 1981, when Wold
and co-workers [17] used GC/MS to study human cancer cells.
Subsequently, applications in metabonomic toxicity, clinical
pathologies, and molecular parasitology have been developed
[27,28]. A disadvantage of SIMCA for data visualization is the
presence of several different sub-models, rather than one overall
model with clear-cut interpretation of the loadings. This is the
main drawback in using SIMCA for metabonomic applications, as
it is hard to ascertain what variables separate the classes.
Alternative procedures providing this information include the use
of density distributions on the latent variable [29] or the use of
discriminant analysis (DA) version of PLS (PLS-DA).
Historical background of PLS methods
The origins of PCA itself lie as far back as Cauchy and his eigenanalysis (ca. 1829), but PCA was made explicit by Pearson [122], 1901,
for application in biometric studies, and later used by Hotelling in the 1930s [123,124] before being employed in econometrics by
HermannWold. PLS shares some central features of PCA in that it is a ‘variance harvesting’ approach for the analysis of large data sets.
It is neither appropriate nor possible here to provide a detailed history and evolution of PCA and subsequent PLS methods, but for
those wanting more historical details on PLS, the review by Geladi [125] from 1988 on the history and nature of PLS modeling is
recommended, as is the textbook by Eriksson et al. [38]. In outline, the PLSmethod was described by Horst in 1961 [125,126], working
in the area of psychometrics, although Horst also claimed that the PLS principle was already understood by Hotelling [127] as early as
1936 in his original article on canonical analysis. Subsequently, many PLS applications in the field of econometrics were pioneered by
HermannWold [125], including the path PLS approach as well as the NIPALS algorithm, developed together with his son SvanteWold,
and in fact it was the NIPALS algorithm fromwhich the name ‘partial least squares’ was drawn [38]. Officially S. Wold places the ‘public
delivery’ date of PLS as being 1977 [125] although the NIPALS procedure was published in 1969 in the context of PLS path modeling
[128]. It is interesting to note that while econometrics made significant developments in various issues for large matrix analysis, the
more recent concept of orthogonal variance filtration was introduced in the context of chemical analysis. Methods filtering out the
variation orthogonal to the response vectors led to the development of OSC in 1998, implemented using NIPALS, andwhich was later
integrated with the PLS algorithm, giving O-PLS in 2002. Although the principle of canonical analysis was introduced very early on by
Hotelling [127], the development of alternative algorithms such as NIPALS [129], and SIMPLS [130] greatly improved computational
speed, efficiency, and stability of subsequent PLS algorithms. The computational ease with which PLS can be implemented and the
advent of computer numerical methods have powerfully assisted the expansion of real-world application of PLS in diverse fields that
require the analysis of large, complex measurement matrices, such as biometry, process analysis, chemo-informatics, bio-informatics,
psychometrics, and econometrics.
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2.4. Partial least squares
Unlike PCA, PLS regression is directed by a response data set Y
to derive the components from the descriptor data set X that best
describe the specified Y structure, as it maximizes the covariance
expressing the common structure between X and Y [23,30,31].
PLS is sometimes subdivided into regression analysis and
discriminant analysis (PLS-DA). In classification or DA, samples
are allocated into the appropriate discrete classes, which are
represented by using so-called ‘dummy’ variables (Booleans).
PLS and supervised approaches, in general, are often applied
to tackle more subtle problems in metabonomics, in which large
arrays of data require an approach that permits relationships
buried in a background of other large and multiplexed effects
to be uncovered within these data. For example in biological
systems (e.g., environmental, nutritional, or epidemiological
studies) it is often the case that several metabolic contributions
control the composition of the same biosample and the main
source of variation may not address the biological question; not
all influences are relevant to the biological variation of interest
and these should be disregarded or down-weighted during
analysis. For example human urine can display large differences
between individuals [32], and different metabolic phenotypes
have been suggested [33], which can complicate studies of
more subtle effects such as physiological challenges, the effect of
probiotics and prebiotics, and nutritional status. A noteworthy
application of PLS involved the introduction and validation of
the pharmaco-metabonomics concept, in which the individual
response to a toxic insult can be predicted prior to a drug
treatment [34,35]. Such developments in the pursuit of
personalized healthcare were direct consequences of careful
and efficient application of PLS modeling. The main virtue of
latent variable projection methods such as PLS is the
transparency of the models with respect to scores (with possible
sub-groupings), and weight vectors, which allow metabolic
interpretation. This is more difficult with ‘black box’methods such
as support vector machines and other classifiers that need
dimensionality reduction prior to nonlinear classification.
2.5. Validation
One of the main advantages of PLS is the predictive ability of
the obtained models. However, without caution, any supervised
modeling is prone to overfitting. Ideally, the availability of a
second, independent data set would allow for validation of
the calculated PLS models. Alternatively, there are a number of
methods to perform cross-validation based on the data that
are used for modeling. These include methods that leave
either one or a fraction of the samples out (such as n-fold
cross-validation), but preference should be given to the use of
resampling techniques, such as Monte Carlo cross-validation
[36] and bootstrapping [37]. The use of cross-validation
gives the possibility to calculate model statistics such as R2
(proportion of explained variance) and Q2 (proportion of
predicted variance), as well as the sensitivity, specificity, and
the receiver operating characteristic (ROC) [38]. The use of
cross-validation also results in predictions from the left-out
samples and one can advantageously use these cross-validated
scores plots to get more realistic information on the predictivity
and quality of the model.
Interestingly, the number of components is often determined
based on the Q2 value, but as the Q2 is later used to report the
predictive ability, some degree of ‘overfitting’ could result. Nested
cross-validation is an approach to give a more unbiased
optimization of the number of components while still reporting
valid prediction results [39], and a randomization test has been
suggested [40].
One sophisticated validation approach is to use computer-
intensive model re-sampling under the null hypothesis: a
population of models is generated by random permutations of
the Y data (i.e., the correspondence between metabolic data X
and class data Y is no longer valid) [41]. By evaluating the
prediction performance of these ‘random’ models in comparison
to the original model, the value of the predictive measures can be
interpreted. This pragmatic approach enables the validation of
the obtained prediction, resulting in increased confidence in the
results obtained with this supervised approach.
3. ORTHOGONAL PARTIAL LEAST
SQUARES FOR BIOMARKER RECOVERY IN
METABONOMICS
3.1. From orthogonal signal correction to orthogonal
partial least squares
A relatively recent development in ‘PLS evolution’ was the
introduction of the concept of orthogonal filtration, which is the
removal of variance orthogonal to the variation of interest. This
concept of orthogonal ‘noise’ [42] was developed on the basis of
non-equivalence between the number of dimensions computed
by PLS and the rank of the covariance matrix YTX. The operation
deflates the information orthogonal to Y from the X and can
be seen as a filter aimed at cleaning the X of the information
unrelated to Y, such as that caused by run order, temperature
drift, or batch effects. Another interpretation is that this is
equivalent to giving a different weight to the variables from X.
This makes orthogonal signal correction (OSC) a method for
quantitative multivariate filtration, contrary to variable selection,
which assigns a binary weight to the variables (preserved or
rejected variable). Thus, the OSC filter enables variable filtration,
without losing the spectral structure of the loadings, and
consequently facilitates interpretation through identification
of the metabolites which are the basis of the discrimination.
Metabonomic applications of OSC to minimize confounding
physical and biochemical variation with subsequent PLS
modeling became popular in the early 2000s with successes in
such areas as cardiovascular disease diagnosis [43,44].
Originally, OSC was applied as a separate step in a data
processing sequence, and, as such, was troublesome regarding
validation and detection of overfitting [42]. Also, the proportions
of the predictive and orthogonal variance in a data set were
not easily ascertained. The use of OSC and PLS led quite naturally
to their integration within a single-procedure decomposition,
O-PLS, developed and refined by Trygg and Wold [16]. O-PLS
performs a regression with orthogonal filtration of X on a
vector Y. This resolved the validation difficulties of OSC-PLS and
continued to make a powerful addition to the repertoire of
applied PLS methods because the variance in a data set can
be split by O-PLS into predictive and orthogonal variance. The
basis of an orthogonal component can be characterized by
the structure and content of this latent variable, which may
suggest or determine the basis of this spurious variance, such as
temperature drift [44]. The ‘structured noise’ described in the
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orthogonal components can, if not filtered, decrease the
interpretability of the resulting model, such as classical PLS
models. Importantly, in O-PLS these components add an extra
dimension in which the data can be interpreted: both predictive
and orthogonal components display highly relevant information
from the data set. Removal of orthogonal ‘structured noise’ from
the data is very similar to assessing between-group variance and
within-group variance, as indicated for MS-basedmetabolite data
of wild type and transgenic poplar trees [45]. The orthogonal
(non-predictive) scores and loadings can be used to interpret
sub-group structures within the data: applications have included
orthogonal filtration of diurnal variation from a data set, or the
removal of gender effects across a study [46].
O-PLS allows an enhanced focus on variation of interest (such
as disease state, diet, strain or genotype), while minimizing other
variation, which can be of, for example, biological or analytical
source. In the DA version of O-PLS, O-PLS-DA [47], the maximum
separation between class samples Y (n dummy variables for n
classes) is explained using the input data X, by decomposing
the covariance matrix (YTX) into n 1 predictive components
and a sufficient number of orthogonal components, to be
determined by, for example, cross-validation. Subsequently,
the model coefficients locate the variables associated with a
specific class encoded in Y. This is of key importance for
applications in metabolic profiling, as the basis of class separation
is the biological information sought after. The possibility of
direct interpretation of predictive and orthogonal components in
relation with the experimental design (and other external
variables such as sample run order) represents a great advantage
in terms of simplicity and interpretability.
3.2. O-PLS and metabonomics
The use of PLS regression and DA in metabonomics has become
standard over the past 15 years [48,49] (Figure 2). Moreover, the
use of O-PLS, combined with increased data set resolution, has
recently set new standards in metabonomic research; it appears
that metabolic research is one of the main disciplines to have
applied O-PLS, as demonstrated by the number of citations found
for the original O-PLS article by Trygg and Wold [16]: an ‘ISI Web
of Science1’ search (11 February 2010) demonstrated that 92 out
of 204 quotations contained the key ‘metabo*’. Interestingly, the
only ‘psych* and O*PLS’ result was in fact from a metabolic study
on the effect of stress stimuli on individuals [50].
The main reason for the success of O-PLS in metabonomics is
that the interpretation of the model (even for a single response)
is obtainable from just the first component, rather than an
evaluation of many or all PLS components [51], and is easier than
interpretation of the coefficients of a PLS model as this will
also involve coefficients related to the Y-orthogonal variation.
The possibility of direct interpretation of the relation between
scores and loadings clearly simplifies interpretation of O-PLS-
DA models (Figure 3). The typical data set used to exemplify this
effect shown in Figure 3 was obtained from a nutri-genomic
experimental design study of four different groups (22),
consisting of two different genotypes (genetics and variation
of interest) and two different nutritional statuses (diet and
‘orthogonal noise’). The direct separation of the scores in relation
to the genetic background is possible with O-PLS-DA, whereas
the PLS-DA model suffered from imperfect separation caused by
variance due to the different diets. The ‘realignment’ of the scores
Figure 2. A bar chart representing the results of an ISI web of Science1 search (11 February 2010), displaying the usage of multivariate methods in
different areas of research. These do not include all applications of the methods, but serve to demonstrate to what extend the methods are used in
different fields.
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results in the possibility to directly focus on the first latent
variable, as the loadings change correspondingly between
PLS and O-PLS, by maximizing the relation of the predictive
component of X and Y. The predictive ability of O-PLS models is
inherited from PLS models, which enables building efficient and
pragmatic predictive models. The incorporation of the OSC filter
within the PLS algorithm enabled a straightforward validation
and thus decreased the risk of undetected overfitting of the
data when using O-PLS. The validation approaches discussed
above are, without change, fully applicable to O-PLS models, and
cautious modeling is always warranted to prevent over-
interpretation of resultant models.
O-PLS became one of the most popular chemometric
approaches in metabonomics following the development of
an intuitive display of model coefficients. To represent the
loadings of a unit variance scaled model with a spectral app-
earance, Cloarec et al. [15] introduced the concept of ‘back-
scaling’. Here, the loadings are multiplied by the standard
deviation of the corresponding variable, creating a pseudo-
spectrum with a covariance-based appearance; subsequently the
scaled O-PLS weights can be mapped onto this pseudo-spectrum
using a color scale, resulting in a spectral appearance color-coded
by O-PLS weights (Figure 4). Because the covariance in the
backscaled plot is roughly proportional to the mean signal level,
it appears like a normal spectrum, while the information from
the loadings is retained. In fact, this representation of data can
be implemented for any latent variable method, such as mean-
centered and unit variance scaled PCA models [52]. A related
approach is the S-plot [45], which plots the correlation versus
the covariance for each variable, and thus contains the same
information as backscaled loadings. However, one main
disadvantage is that the S-plot does not display the information
in a spectral shape, and hence there is a need to backtrack
to determine the important variables in the spectrum, thus
removing the easy visual spectroscopic interpretation is
removed. Also, S-plots get cluttered when plotting full-resolution
spectral variables. An additional advantage of the spectral
presentation of loadings is the prevention of false interpretation
of individual variables that appear important by chance, through
interpretation of correlation patterns of the whole spectral peak.
The current implementation and visualization for O-PLS
allows reliable multivariate models to be built, with intuitively
interpretable loadings with a spectral appearance. This allows
non-expert users to evaluate the results of O-PLS models, which
is one of the key reasons for its success. Examples of applications
of O-PLS as a generic method targeting between-group variance
(in classification problems) include metabonomic parasitology
[53–55], nutritional metabonomics [56,57], the genetics of meta-
bolic profiles [56,58], metabonomic toxicology, cancer metabo-
nomics [59,60], and molecular epidemiology [61,62]. For example
the discrimination between protein sources (meat and veg-
etables) in a large epidemiological study was validated through
the application of O-PLS-DA [63]. In the area of genetical
metabolomics [58,64], genomic variability and metabolic profiles
are integrated, typically using a quantitative trait locus mapping.
Recent developments introduced the concept of the metabo-
lome-wide association study (MWAS) [65,66], where environ-
mental and genomic influences are related, for example, through
multivariate modeling, to phenotypic variations and disease risk
factors in the general population.
In an O-PLS framework, if the data in X (and Y) are mean
centered and scaled to unit variance, then the weight vectors of
an O-PLS model on these data are directly related and scalable to
the correlation between X and Y [51,66]. As a consequence, O-PLS
can be instinctively described as a bridge between PLS modeling
on the one hand, and univariate modeling on the other hand,
as both approaches can be used to derive linear correlation
coefficients. This property of O-PLS coefficients has been used in
several applications, such as the computation of O-PLS-derived
variance components for full factorial experimental designs with
several factors (see section on O-PLS Variance Component
Figure 3. A benchmark for latent variable methods, using the data set
presented by Dumas et al. [56]. The data set is constituted of mean-
centered NMR spectra (n¼ 273) with a typical nutrigenomic 2 2 design:
2 strains (genetic background effect: Balb/c and 129S6 strains) and 2 diets
[environmental effect: high fat diet (HFD) and carbohydrate diet (CHD)].
Unsupervised PCA shows that the two diet groups have very different
variance structures, which overwhelms the genetic background
(A). PLS-DA to discriminate the two strains (a two-class problem) results
in an efficient segregation of the genetic background, but due to the
presence of strong diet-related within-group variance (i.e. orthogonal
noise), the scores plot shows a weak genetic discrimination on T1 and a
significant dietary effect on T2 (B). The use of orthogonal filtering in
O-PLS-DA provides a clear-cut discrimination on Tpred, and examination of
Torth,1 shows a strong within-group variance associated with the effect of
diet (C).
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models below) [64,67], or the use of univariate testing procedures
to assess the significance of correlations of potential biomarkers
identified by O-PLS modeling [68]. For interpretation of the latent
variable in terms of original variables, it is important to know
which parts are statistically reliable. Multiple testing correction
for interpreting importance of individual variables in these
situations is required, although there is currently no widely used
objective criterion (e.g. p-value) for selecting significant variables
from O-PLS models. Since multivariate modeling does not
prevent inclusion of noisy variables in the latent variable, it is
recommended to be cautious about false discoveries when
considering validation of individual markers.
4. PLS-DERIVATIVE AND
COMPLEMENTARY APPROACHES IN
METABONOMICS
The expectations of systems biologists include the computational
integration of, for example genetic, transcriptomic, proteomic,
Figure 4. Reconstruction of a backscaled loading from a correlation spectrum obtained from the unit-variance scaled loading (top) and a covariance
spectrum obtained from the mean-centered model (middle) to form a combined backscaled loading plot with correlation represented with a heatmap
(C). The backscaled plots work nicely because covariance (like variance) is roughly proportional to the mean signal level; consequently, this covariance
plot looks like a normal NMR spectrum.
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and metabonomic data to give a holistic picture of the system,
which is not available by other methods. This should ultimately
enable a more fundamental understanding of biology. Moreover,
themodeling of time-sequence systems biology as well as a more
complete classification of the range of metabolic processes found
in higher animals and how they may interact to determine
the outcome of a disease process [69] or drug interaction [35] is
required. In this section, some extensions of the PLS approach are
discussed as examples, namely for the integration of different
descriptor data sets, the analysis of dynamic biological processes,
and the incorporation of nonlinear and probabilistic PLS
approaches.
4.1. Use of O2-PLS for integration of multiple data sets
From a systems biology perspective, the integration of different
data sets can serve to validate complex biological hypotheses
and give a more complete insight into the response of an
organism to induced perturbations. Rather than combining
results from analysis of different biological data matrices post hoc
[70] (sometimes known as conceptual level of data integration
[71]), the prior integration of different ‘omics’ data sets has been
achieved through the development of the sophisticated O2-PLS
[72,73] method. Here, both the response and predictor matrices
are iteratively orthogonalized and thus filtered for variation in X,
which is maximally uncorrelated to Y (and vice versa) before
two-way modeling is carried out (Figure 5). This retains the
multivariate advantage: cross-platform latent variables of the
various ‘omics’ data sets are maintained in the final modeling.
Multivariate model-based data integration, achieved
through O2-PLS, has been demonstrated through the combined
modeling of transcript and metabolite data [74], metabolic and
proteomic data [75], and metabolic NMR data combined with
denaturing gradient gel electrophoresis-derived microbiome
information [76]. A series of O2-PLS models was used to integrate
transcript, protein, and metabolite data [77], thus increasing
the capability for a holistic systems interpretation of biological
data, although the need for sequential modeling is sub-optimal
and a method to integrate all data sets simultaneously would
be preferable. O2-PLS advances the integration of data from
different analytical platforms, resulting in a synergistic effect in
which the joint variation is highly informative, while the obtained
orthogonal components display systematic variation that is unique
to each data set. Compared to standard PLS, the predictions are
identical, but the interpretation is greatly improved because
the predictive latent vector contains the variation that is maximally
related to the response. This simplification of the model inter-
pretation makes it particularly suitable for top-down systems
biology approaches.
4.2. O-PLS variance component models
Molecular epidemiology data sets and nutri-genomic exper-
iments typically include several factors (genetics, diet, age and
disease risk factors), which can be tested in a single experimental
design. Variance components (VC) can be easily accessed
using O-PLS-based multiple regressions on the design factors
included in the data set. O-PLS-VC models correspond to an
O-PLS regression model on a Ymatrix constituted by full factorial
experimental design (orthogonal by construction). The corre-
lation coefficients between each variable and each design factor,
derived from the model coefficients, are then squared, giving
the proportion of variance. As a consequence, O-PLS-VC enables
parallel quantification and visualization of the proportion of
variance contributed by each design factor. VC could be accessed
at the variable level from any PLS model, but only the O-PLS-VC
can simultaneously provide variance components and the O-PLS
scores. Thus the interpretation of the scores will relate directly to
the design factors because the variation not related to the
experimental design will have been removed by the orthogonal
components (Figure 6). Blaise et al. [64] performed O-PLS-VC on a
full factorial 24 experimental design to validate high-resolution
magic angle spinning NMR spectroscopy in a functional
genomics analysis of silent mutations in the model organism
Caenorhabditis elegans. In a variance component model, it is
possible to decipher the proportion of variance associated with
each factor, for each input variable [64,67]. It is then possible to
identify which part of the metabolome is associated with which
factor, and assign the variance to the ‘influences’ incorporated in
the experimental design. With such a strategy, the genetic and
Figure 5. Integration of data analysis results can be performed at the conceptual level, where the conclusions from data set X and data set Y were
merged (A). Alternatively, the data can be analyzed simultaneously with O2-PLS (B), where the complementary information of both data sets is modeled
in the predictive components (PRED), together with the data set specific variation in the orthogonal components (ORTH) and the residual non-systematic
variation (RES).
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biological variations of interest were shown to be one order
of magnitude stronger than the potentially confounding
technological variations linked to experimental protocol and
instrumental irreproducibilities [64].
4.3. Correlation studies
Many approaches use correlation structure in the data in
metabolic profiling. One method that is widely used, primarily
to aid metabolite assignments, is statistical total correlation
spectroscopy (STOCSY [78]), which is based on the correlation
patterns emerging across a series of spectra. Although this
method is not multivariate, it is often used in conjunction
with PLS as it is a powerful tool for biomarker identification
and structural elucidation. STOCSY is based on multicollinearity
between spectral peaks arising from the same compound
across a series of samples: the relative peak intensities of a
given molecule remain constant. Other approaches resulting
from methodological extensions of STOCSY include combining
NMR and MS on the same sample set to facilitate structural
assignment, which leads to Statistical HeterospectroscopY (SHY
[79]). Visualization of STOCSY often involves producing pseudo-
spectra with a spectral appearance, on which the correlation
coefficient is then projected as a color. The peak-like displays are,
for example, generated from sample or mean spectra (Figure 7),
or by using the covariance between the X and Ydata to generate
a pseudo-spectral representation. Alternatively, STOCSY can
be displayed in a 2D fashion, similar to the representation in
multi-dimensional NMR spectroscopy [78,80].
STOCSY has proven useful for biomarker identification,
especially in metabonomic studies, because the need for time-
consuming two-dimensional experiments or separation techniques
before spectral analysis is reduced. Moreover, in NMR, STOCSY
actually provides a larger and more complete number of corre-
lations than traditional pulse sequence approaches because
these are limited by bond connectivities and distances. Exemplar
studies using STOCSY included evaluation of analgesic usage
in a large epidemiological study [81] and the study of drug
metabolism kinetics [82]. The correlation-based approach of
STOCSY highlights not only signals from the same molecule,
but also other highly-correlated signals that can, for example,
be pathway-based, for example connectivities in relation to
metabolic effects of a renal toxin [75]. Direct metabolite
interaction can also be identified, an example being where
epidemiological plasma samples treated with EDTA were
analyzed using STOCSY to detect chelation-based interactions
with Ca-binding proteins within these samples [83].
4.4. Hierarchical methods
Hierarchical-PCA (H-PCA) or -PLS [84,85] can be used to simplify
interpretations in applications involving megavariate data sets.
In such a situation, plots and lists of loadings, weights and
Figure 6. An O-PLS-derived variance components analysis applied to
the data set described by Dumas et al. [56]. The data set is constituted of
NMR spectra (n¼ 273) with a typical nutrigenomic 2 2 design: 2 strains
(genetic background effect) and 2 diets (environmental effect). This
experimental design is retrieved in the scores plot (A). It is possible to
derive variance proportions (r2) from O-PLS loadings (B) because the
O-PLS models are related to data covariance. The colored area under the
curve summarizes the amount of variance explained by each factor, for
each NMR variable. The white area up to 100% corresponds to the residual
of the O-PLS model (orthogonal components and model residual).
Figure 7. Statistical total correlation spectroscopy (STOCSY) plot per-
formed on the data set described by Dumas et al. [56]. The unknown
resonance at 7.83 ppm was used to generate a correlation profile across
the NMR spectrum. Other peaks with strong correlations confirm the
assignment of hippurate.
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coefficients tend to become cluttered and the results are often
difficult to overview. Instead of reducing the number of variables,
a better alternative is to divide the variables into conceptually
meaningful blocks of variables and apply H-PCA. In H-PCA each
block of input data is modeled separately by a projectionmethod,
which accounts for the variation within each individual block.
The block scores are then used as ‘super variables’ on a higher
modeling level where a new multivariate model estimates the
structure of the blocks, that is of the super variables. In this way
H-PCA operates on two levels: on the lower levels the relationship
between the variables in the same block is modeled by block
models; on the higher levels the relationship between the blocks
is modeled. In order to avoid overfitting, validation should be
performed on both steps together, rather than for the individual
steps only. When a valid model is generated, this provides two
levels of interpretation: the top-level projection should display
the entire data set, perhaps revealing the presence of clusters (i.e.
overview of the data), while lower-level projections display
block-specific structure (i.e. detail of the data), which might not
be apparent in the higher-level projections. Hierarchical PCA can
be easily extended to hierarchical PLS or O-PLS by adding a Y
(response/discriminant) matrix for the application of PLS or O-PLS
on either the lower or upper level [86]. H-PLS has been used for
the visualization of multi-compartmental transgenomic meta-
bolic interactions to study perturbations triggered by symbiotic
microbiota; thus, the systems-level effects of microbial-host
interactions could be integrated [87]. Similarly, clinical chemistry
and expression data were integrated with metabolite data for
toxicological class separation [88], allowing for the correlation of
biological properties of the different types, improving interpret-
ation of both data sources.
4.5. Multiway PLS
Multiway PLS (N-PLS [89]) is an extension of the ordinary
regression model PLS to the case where the data array consists
of more than two modes. For three-way PLS, a trilinear
decomposition of the data cube X is completed. The trilinear
constraint assumes that the signal intensity is, for example, a
linear combination of time intervals, variables, and animals or
individuals. The advantage of using N-PLS in metabonomics
scenarios is the use of fewer parameters, which increases
interpretability, and the models are more robust against the
influence of noise in the data. Recently, the use of N-PLS for the
quantification of lipoprotein fractions obtained by 2D diffusion-
edited NMR spectra has been evaluated [90]. Longitudinal
microbial metabolic data have beenmodeled [91] with N-PLS and
parallel factor analysis (PARAFAC [92], a three-way PCA), to
account for the multi-mode nature of the data. Another method
of three-way PCA is through the Tucker3 model, which was used
to study toxicity-related metabolic perturbations by providing
interpretable time profiles [93]. An unsupervised multi-way
approach provided by PARAFAC allowed the multivariate modeling
of different compartments to make metabolic correlations
between different organs [94], although direct interpretation
of multi-way models can be complicated. Similarly, the effect of a
genetic mutation on metabolic profiles of maize kernels was
investigated [95] with N-PLS-DA: the different metabolic profiles
as well as time responses could be evaluated from the model.
Multilevel studies were also able to extract effects from a
human nutritional intervention study [96], where data sets are
typically affected by large amount of study-unrelated variation,
and therefore profit from a multilevel design and supervised data
analysis. However, due to trilinearity constraints (requiring signal
robustness in several dimensions) and complexity of interpret-
ation, such approaches have not been widely used. Alternatively,
an approach that exploits the paired data structure, for example
in human nutritional cross-over designs, has been suggested
to improve the power of resulting multivariate models [97].
It remains to be seen to what extent novel methods such as
paired data analysis become widely used in the metabolic
profiling community.
4.6. Batch modeling
Analogous to industrial batch processes, biological processes are
dynamic, such as the progressive metabolic influence of a toxic
substance, aging, etc. The trajectories of metabolic profiles from
such ‘batch’ studies contain information about the properties of
the final state and how the biological perturbation affects
the intermediate biological states. The main purpose of batch
process monitoring is to detect and identify deviation from
normal behavior. This can be accomplished using PLS [98,99]
to find the relation between the dependent variables (e.g.
spectroscopic variables) and dynamic independent variable such
as time. The dependent variables are measured at a number of
distinct time intervals throughout the process. Similar data will
be collected on a number of individual objects (constituting a
batch). The average scores trajectory for each component from
a single PLS time regression is displayed with upper and lower
limits (based on standard deviations) to indicate the normal
dynamic trajectory for a batch. The control chart can be used for
detecting deviations from normality. Batch modeling has been
applied to monitor and interpret time dependent toxicological
responses in metabonomics NMR studies with favorable results
[100–102], as well as the time-dependent growth response of the
poplar tree [103].
A different way to deal with time-series data in metabolic
profiling, which retains the advantages of O-PLS, is piecewise
multivariate modeling [104], demonstrated for modeling and
prediction of the time response of HgCl2 intoxication. This
method allows the modeling of nonlinear affects, but is less
applicable if the metabolic differences between two subsequent
time points are small, for example when the frequency of
sampling is high.
4.7. Nonlinear PLS methods
There are a number of nonlinear methods available for modeling
metabonomic data [71], including nonlinear mapping, neural
networks, genetic algorithms, etc. The complete description of
these is beyond the scope of this review, and we focus on a
method that is more closely related to PLS (kernel O-PLS), and
self-organizing maps (SOMs), which with its simplicity and
transparency provides easy interpretation of complex data sets.
4.8. Kernel methods
The aforementioned methods are all based on the assumption
that the relation between descriptor and response variables is
linear, which is not necessarily correct for all data, particularly
biological data. Although the (linear) PLS model has the ability to
model mild nonlinearities, in instances where the nonlinear
relationship between the descriptor variables and the response
variables is substantial, the accuracy and predictive performance
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of themodel will degrade or it may fail entirely. A general solution
for modeling nonlinear data is provided by kernel-based methods,
such as the kernel-PLS (KPLS [105,106]) model. In this approach,
a kernel, which expresses the ‘core’ nature of the proposed
nonlinearity, is introduced into the modeling and the regression
is then matched to this structure. The choice of the value of the
kernel parameter has great influence on the final results.
A limited number of applications of KPLS to metabonomic
data sets have been found so far [107–109]. After the
development of KPLS, the addition of an OSC filter prior to
KPLS was suggested [110], and kernel-based OSC algorithms
have also been published [111]. A kernel-based implementation
of the O-PLS model has recently been developed (K-O-PLS
[108,112]), enabling the separate modeling of Y-predictive and
Y-orthogonal components in the feature space. This approach
has been shown to result in improved predictions for a metabolic
profiling data set [108], as well as improved model interpretation
when Y-orthogonal variation is present [108,112]. For example
metabolic data from aspen trees, acquired by magic angle
spinning NMR, demonstrated different properties between
mutant and wild-type genetics, with orthogonal variation and
nonlinearities that were efficiently modeled with the K-O-PLS
approach. Improved predictive abilities and interpretation of
orthogonal variation can be expected with use of an appropriate
kernel.
4.9. Self-organizing maps
Traditional PR methods such as PCA and PLS explicitly assume
that the data behave linearly, and only perform well if the data do
not contain outliers. Self-organizing maps (SOMs), developed by
Kohonen, provide an elegant mapping technique for examining
the structure of high-dimensional nonlinear data sets [113,114].
Such a Kohonen map incorporates in an unsupervised way
the topology present in the data; usually a two-dimensional,
topographical plane is sufficient to elucidate most specific
features characterizing the nature of the high-dimensional data.
The SOMs can be prone to overfitting, acting as a ‘memory’ of the
data, and hence a rigorous (external) validation as well as a
large number of samples is advisable. The created map is used
to visualize and interpret the data and to link the metabolic
profiles to the underlying factors, for example, environmental,
physiological, or gut microbial. SOMs have been used to study
transcriptome and metabolome data in plant metabolism [115],
and to evaluate human blood plasma 1H NMR lipoprotein lipid
profiles [116] and were recently used to study subtle metabolic
changes in diabetics to evaluate the different clinical phenotypes,
vascular complications, and mortality [117]. A demonstration of
the application of SOM to the analysis of human saliva samples
analyzed by NMR spectroscopy demonstrated the effectiveness
of the approach in the study of an oral healthcare product [118].
Additionally, there is a plethora of supervised versions of the SOM
[113,119,120], including SOM-PLS [121], although the latter has
not yet been applied in metabonomic studies.
5. CONCLUSION
PLS and its derivative methods, in particular O-PLS, enable
the efficient analysis of metabolic profiles and the generation of
biological hypotheses at the metabolite, gene, and protein level.
PLS and O-PLS methods are now playing a critical role in
statistical integration of systems biology data and predictive
modeling in personalized healthcare. The use of PLS and derived
methods for model data reduction will become increasingly
relevant to handling the current explosion of the size of analytical
data sets obtained from any biological system. A progressive
move was observed from PCA to PLS, and then via OSC followed
by PLS and then on to O-PLS (and O2-PLS) as part of meta-
bonomic ongoing evolution, together with their appropriate
linked DA methods. In this review, we have illustrated how
developments in PLS modeling in metabolic profiling are
driven both by fundamental methodological improvement in
the chemometrics community and by new challenges posed by
applications in the systems biology arena.
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a b s t r a c t
Linear multivariate projection methods are frequently applied for predictive modeling of spectroscopic
data inmetabonomic studies. TheOPLSmethod is a commonly used computational procedure for charac-
terizing spectralmetabonomicdata, largelydue to its favorablemodel interpretationpropertiesproviding
separate descriptions of predictive variation and response-orthogonal structured noise. However, when
the relationship between descriptor variables and the response is non-linear, conventional linear mod-
els will perform sub-optimally. In this study we have evaluated to what extent a non-linear model,
kernel-based orthogonal projections to latent structures (K-OPLS), can provide enhanced predictive per-
formance compared to the linear OPLS model. Just like its linear counterpart, K-OPLS provides separate
model components for predictive variation and response-orthogonal structured noise. The improved
model interpretation by this separate modeling is a property unique to K-OPLS in comparison to other
kernel-based models. Simulated annealing (SA) was used for effective and automated optimization of the
kernel-function parameter in K-OPLS (SA-K-OPLS).
Our results reveal that the non-linear K-OPLS model provides improved prediction performance in
three separate metabonomic data sets compared to the linear OPLS model. We also demonstrate how
response-orthogonal K-OPLS components provide valuable biological interpretation of model and data.
The metabonomic data sets were acquired using proton Nuclear Magnetic Resonance (NMR) spec-
troscopy, and include a study of the liver toxin galactosamine, a study of the nephrotoxin mercuric
chloride and a study of Trypanosoma brucei brucei infection. Automated and user-friendly procedures for
the kernel-optimization have been incorporated into version 1.1.1 of the freely available K-OPLS software
package for both R and Matlab to enable easy application of K-OPLS for non-linear prediction modeling.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
Multivariate projection methods are frequently applied for
modeling of spectroscopic biological data [1–3]. This category
of methods provides predictive and interpretable multivariate
models well suited for handling the multi-colinearity of vari-
ables encountered in spectral data and in other high-dimensional
‘-omics’ data, where the number of observations is much smaller
∗ Corresponding author. Tel.: +44 0 1865 285363; fax: +44 0 1865 272595.
E-mail addresses: j.fonville07@imperial.ac.uk (J.M. Fonville),
max.bylesjo@almacgroup.com (M. Bylesjö), m.coen@imperial.ac.uk (M. Coen),
j.nicholson@imperial.ac.uk (J.K. Nicholson), elaine.holmes@imperial.ac.uk
(E. Holmes), j.lindon@imperial.ac.uk (J.C. Lindon), rantalai@stats.ox.ac.uk
(M. Rantalainen).
than the number of variables. Two commonly used multivariate
prediction models are partial least squares (PLS) [4] and the related
orthogonal PLS (OPLS) [5–7]. The OPLS algorithm enables sepa-
rate modeling of Y-predictive (response-related) and systematic
Y-orthogonal (response-orthogonal) variation in data, “structured
noise” [5,8–11], providing beneﬁts in terms of model interpreta-
tion compared to PLS. The concept of Y-orthogonal variation can
be thought of as systematic effects that are needed to character-
ize the system but are unrelated to the question at hand, i.e. the
model predictions. For instance, when aiming to classify a group
of responders versus non-responders to a particular treatment, the
structured noise could be composed of inter-sample differences
that are needed to describe variability of the system but are not
useful for separating responders from non-responders.
OPLS has been successfully employed in metabonomics [12]
and the related ﬁeld of metabolomics, branches of systems
0003-2670/$ – see front matter © 2011 Elsevier B.V. All rights reserved.
doi:10.1016/j.aca.2011.04.016
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biology studying themetabolic responses under various conditions
and perturbations [13–15]. For metabolic proﬁling of biological
samples, analyticalmethods such asmass spectrometry andproton
(1H) nuclear magnetic resonance (NMR) spectroscopy are com-
monly employed [16].Metabonomics has successfully beenapplied
in a number of areas including toxicology [17,18], biomarker and
drug discovery [19,20], personalized medicine [21,22], nutrition
[23,24] and parasitology research [25–27].
Most of the commonly used multivariate prediction models in
metabonomics assume a linear relationship between the descrip-
tor and Y (response) variables. However, many biological systems
display non-linear characteristics in response to a perturbation.
Under such conditions, non-linearmethods are expected toprovide
improved models, which is particularly important in predictive
applications such as disease diagnostics [28], assessment of toxi-
city [29] and characterization of variable response of individuals to
drugs in personalized healthcare [22].
A particular class of non-linear models are kernel-based mod-
els [30], with an early chemometric application in the form of
radial basis functions – PLS [31,32]. Other examples of kernel-based
models include support vector machines [33–35], kernel-based
partial least squares (KPLS [36,37]) and kernel-based least squares
regression [38]. Kernel-OPLS (K-OPLS) [39–42] is the non-linear
extension of the OPLS model, a commonly used multivariate model
in metabonomic studies [1,12]. In contrast to separate (linear)
orthogonal signal correction (OSC) followed by KPLS modeling
[43], or kernel-OSC followed by KPLS modeling [44], K-OPLS pro-
vides an integrated orthogonal signal correction property that
allows for separate modeling of predictive and Y-orthogonal vari-
ation in the feature space, removing drawbacks associated with
multi-step solutions, such as separate (K)OSC and (K)PLS steps
[5].
Kernel-based models require an optimization of the kernel-
function parameter, which may be challenging for the non-
specialist, as the kernel parameter is a continuous parameter
with an undeﬁned upper limit that may have multiple local
optima. The optimization step is essential to produce a model
with optimal predictive performance [41,43,45]. Here we have
implemented an automated procedure for optimization of the
kernel parameter based on simulated annealing (SA), a stochas-
tic optimization method [46,47], which greatly simpliﬁes the
use of K-OPLS. This optimization step has been incorporated
into the freely available K-OPLS package for both R and Matlab
(http://sourceforge.net/projects/kopls/).
Our main objective in this study is to evaluate if non-linear
prediction models provide an advantage compared to linear
alternatives in two common application areas of metabonomics:
toxicology and disease diagnostics. Using the non-linear SA-K-
OPLS method, we demonstrate how prediction performance can
be improved in comparison to the linear OPLS model for three
separate spectral NMR metabonomic data sets. We focus in par-
ticular on problems where prediction is of paramount importance,
and we also show how structured Y-orthogonal variation can be
interpreted to gain further insight into the data.
2. Methods
2.1. Notation
Let X be the matrix of descriptor variables of dimensionality
[N× k] for N observations and k variables and Y be the matrix of
response variables of dimensionality [N×m] for m variables in Y.
In the case of classiﬁcation, Y consists of ones and zeros forming a
design matrix indicating the class of each observation; the matrix
transpose is indicated as T.
2.2. Orthogonal projections to latent structures (OPLS)
TheOPLSalgorithm[5]decomposes thedescriptordatamatrixX
into a set of predictive (response-related) and a set of Y-orthogonal
(response-orthogonal) latent variables. Let Tp [N×Ap] and To
[N×Ao] represent the predictive and Y-orthogonal score matri-
ces respectively, with Ap predictive components and Ao orthogonal
components (latent variables). Pp [k×Ap] and Po [k×Ao] are the
corresponding loading matrices. The OPLS model of X is outlined in
Eq. (1), where E [N× k] is the residual matrix.
X = TpPTp + ToPTo + E (1)
2.3. Kernel-OPLS
The K-OPLS algorithm is a kernel reformulation of the OPLS
algorithm, utilizing the computationally efﬁcient ‘kernel-trick’,
allowing the elements of the kernel Gram matrix K [N×N] to be
treated as dot-products in the higher-dimensional feature space F
to which the data are (non-linearly) mapped [48]. K-OPLS [39,40]
has a set of Y-predictive latent variables represented by the pre-
dictive scores matrix Tp [N×Ap] and a set of Y-orthogonal latent
variables represented by the scores matrix To [N×Ao], in anal-
ogy to the OPLS model. The kernel-trick is common among all
kernel-based pattern recognition methods, and is computationally
efﬁcient since no explicit transformation of the data is needed. Esti-
mating a kernel-based model is a two-step procedure. First, K is
calculated using a suitable kernel function k(·,·), circumventing the
explicit mapping of the descriptor data to the (higher dimensional)
feature space to facilitate modeling of non-linear variation, see Eq.
(2), where xi and xj represent rows i and j in X.
Ki,j = k(xi,xj) (2)
Second, K-OPLS is used to establish a regression or discriminant
analysis model of the, potentially non-linear, relationship between
the descriptor data, now represented by the kernel-matrix, K, and
the response variable(s), Y.
2.4. Kernel function optimization
The kernel matrix (K) is required to be positive semi-deﬁnite,
and there aremanykernel functions available fulﬁlling this require-
ment [49], here we focus on the commonly used Gaussian kernel
function (Eq. (3)).
k(x,y) = e
−||x−y||2
22 (3)
This kernel functionhas a tuningparameter related to the sizeof the
Gaussian kernel (). The choice of kernel parameter greatly inﬂu-
ences the predictive performance of the resulting model (see the
gray points in Fig. 1A, showing the predictive ability as a function
of the kernel parameter), emphasizing the importance of optimiza-
tion of this parameter. An exhaustive search over all possible values
is not computationally tractable due to the continuous nature of
the parameter. It is common to apply a grid search strategy to ﬁnd
a reasonable parameter value [41], but this approach does not nec-
essarily provide an optimal value as it may ﬁnd local minima and
is also dependent on the selected grid range and resolution. Here,
we use simulated annealing (SA) [50,51] to automatically optimize
the kernel parameter in the K-OPLS model in order to achieve good
prediction performance.
2.5. Simulated annealing
In analogy with thermodynamic principles [52], where an
inﬁnitely slowly cooled ‘sample’ will occupy the lowest energy
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Fig. 1. Optimization of a Gaussian kernel parameter with simulated annealing. (A) The optimization with simulated annealing of the kernel parameter  is performed by
minimizing (1 − Q2Y ), which is plotted for all evaluated points in gray, here for an exemplar run of the mercuric chloride high dose regression data set. Subsequent ‘optimal’
points (i.e. a value that is a new minimum when it was evaluated) are connected with the dashed line. (B) The sampled values for the kernel parameter  are indicated as
points for each temperature, the spread of which becomes smaller as the temperature decreases. The bars indicate the region in which kernel parameters were evaluated
for a given temperature T. The temperature cooling rate rT was 0.7 for demonstration purposes, for all SA-K-OPLS results rT =0.1 was used.
state, simulated annealing enables stochastic sampling of the ker-
nel parameter space as a function of the decreasing ‘temperature’
[46]. The temperature inﬂuences the probability of temporarily
moving to sub-optimal parameter values in order to overcome local
minima, and with decreasing temperature the search range of the
kernel parameter is slowly narrowed down (see the bars in Fig. 1B).
The pseudo code for the SA algorithm is provided in Supplementary
data 1 (also see Corana et al. [47] for further details). Here, we
present results from SA-K-OPLS using a Gaussian kernel function,
however, the simulated annealing approach is general and appli-
cable to other kernel functions with a continuous parameter to
optimize. The kernel parameter () in the Gaussian kernel function
deﬁned in Eq. (3) is optimized for values >0.
2.6. Evaluation of models
2.6.1. Performance metrics
Prediction performance of regression models is evaluated using
theQ2Y metric, commonly referred to as the ‘goodness of prediction’,
which is inversely proportional to the generalization error (Eq. (4)).
Q2Y = 1 −
∑
(Yˆcv − Y)
2∑
(Ymean − Y)2
(4)
Here, Yˆcv is the vector (or matrix) of predicted values for Y from
cross-validation and the summation is over all elements of Y. In
discriminant analysis, classmembership is determined by the deci-
sion function fmax (Yˆcv,i), returning the class label (or class index) for
which Yˆcv,i has the highest value; Yˆcv,i is a vector of the predicted
values for each class for observation i. Prediction performance of
discriminant analysis models was evaluated by two different met-
rics. The ‘mean sensitivity’ is calculated across all k classes with
Eq. (5), where TPi (the number of true positives, i.e. number of
detected cases for class i) is divided by the total number of cases for
class i, calculated as the sum of the number of false negatives (FNi)
and true positives. A mean sensitivity equal to one implies perfect
discrimination between the classes.
mean sensitivity =
∑k
i=1TPi/(TPi + FNi)
k
(5)
In the special case of two classes, an alternative performance met-
ric for discriminant analysis models is the area under the receiver
operating characteristic curve (AUC), which was calculated using
a standard trapezoid approximation [53]. AUC is interpreted as
the probability that the model will rank a random true positive
observation higher than a random true negative observation and is
related to the non-parametric Wilcoxon rank sum test as well as
the Mann–Whitney U test. An AUC value of 1 corresponds to per-
fect classiﬁcation, a value of 0.5 indicates randomperformance. The
AUC metric has favorable properties in classiﬁcation scenarios as it
is independent of the class frequencies and does not depend on a
cut-off point between the classes used for dichotomization.
2.6.2. Nested cross-validation
A nested cross-validation procedure [54,55] was used to eval-
uate prediction performance during optimization of the kernel
parameter, and the optimization was performed separately for
models with different numbers of Y-orthogonal components (see
Section 2.7). In each ‘outer cross-validation loop’, the data were
split into a training set and a test set, and the kernel parameter
was optimized in the ‘inner cross-validation loop’ (using only the
training data from the outer cross-validation loop). The prediction
performance was then evaluated using the test set from the outer
cross-validation loop. Thus, the outer loop test set is never used for
model optimization, but only for evaluation of overall prediction
performance. This nested cross-validation procedure is repeated
for n outer cross-validation rounds, and Fig. 2 provides a schematic
overview of the procedure. For evaluating the prediction in regres-
sion, the Q2Y metric was used. In discriminant analysis, the mean
sensitivity and the area under the receiver operating characteris-
tic curve (AUC, for two classes) were evaluated. For the presented
results, we used Monte Carlo cross-validation (‘mccv’) for regres-
sion problems and the class-balanced mccv approach (‘mccvb’) for
discriminant analysis, with 10 and 100 repetitions in the inner and
outer loop, respectively and 75% of the data in the training and
25% in the test set for both the inner and the outer loop. Identical
training and test sets were used to generate SA-K-OPLS and OPLS
models in order to achieve a fair comparison. The score plots and
reportedkernelparameter values (, Table1)weregeneratedbased
on a kernel-optimization and K-OPLS model using the full data set,
as this model would be the one that could be used for prediction
of (future) new data (see Supplementary data 2 for an example
of external validation). The convergence plots (see Supplementary
data 3) demonstrate that the prediction performances stabilize
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Fig. 2. Nested cross-validation. The nested cross-validation procedure minimizes the risk for model over-ﬁtting and overestimating the prediction performance while
optimizing the kernel parameter. In this procedure, n optimal kernel parameters are determined, where n is the number of groups in the ‘outer’ cross-validation (CVo) round.
The kernel parameter for each CVo training set is optimized using simulated annealing using the ‘inner’ cross-validation loop CVi , while the CVo test set is used to evaluate
the prediction performance. In results presented here, n=100 outer cross-validation rounds and m=10 inner cross-validation rounds were calculated using mccv and mccvb
cross-validation.
within the 100 outer cross-validation rounds to provide reliable
estimates of mean prediction performance.
2.7. Number of Y-orthogonal components
The number of components for the OPLS and SA-K-OPLS models
presented was chosen by evaluating results for models calculated
with 0 up to 10 orthogonal components (OC); all models required
the use of 1 predictive component (becauseYwas a single vector or
a two-classdummymatrix). Thekernelparameter isoptimizedsep-
arately for eachnumberof calculated components in themodel (e.g.
with2OC, thekernelparameterwill be slightlydifferent thanwith1
OC). The ﬁnal number of orthogonal components was determined
as follows: additional components were included if Q2Y increased
by more than 1% per component for regression analysis, and in dis-
criminant analysis thenumber of components corresponding to the
maximumAUCwas chosen. Table 1 lists theﬁnal numberof compo-
nents used for each data set. The optimal number of components is
determined separately for SA-K-OPLS and the linear OPLS models,
as the models are different in nature.
2.8. Software implementation
The simulated annealing K-OPLS method is available
as a software package, which can be downloaded from
http://sourceforge.net/projects/kopls/ and is freely provided
under a GPL v2 license. The updated K-OPLS [40] software (version
1.1.1) is available for Matlab and R on Windows, Mac OS X and
Linux operating systems and includes functionality for nested
cross-validation and kernel parameter optimization using simu-
lated annealing and grid search. All results presented here were
obtained using Matlab (The Mathworks, Natick, MA, USA).
3. Data sets
3.1. Galactosamine toxicity
The galactosamine toxicity data set comprises 1H NMR urinary
spectra from animals treated with galactosamine hydrochloride
(n=40, 500mgkg−1). Galactosamine has been shown to induce a
highly variable pathological response in a given cohort of rats (Ref.
[56] and within): it is common that a proportion of animals show
no adverse effects (non-responders) and responders display varied
severities of hepatic necrosis. Independent histopathological and
clinical chemistry analyses were used to determine the degree of
response to galactosamine. Urine samples were obtained at 8 and
16h collection intervals representing −48 to −40 (8h), −40 to −24
(16h), −24 to −16 (8h) and −16 to 0 (16h)h before dosing (sam-
ples courtesy of the COMET-2 project), as described previously in
Coen et al. [56]. For this data set, the goal was the classiﬁcation of
non-responders (n=10) versus responders (n=30) from the pre-
dose urinary 1H NMR spectra (acquired at −40, −24, −16 and 0h
before dosing), and this was performed using discriminant analysis
with SA-K-OPLS.
Table 1
Details of the evaluated data sets.
Data set Bioﬂuid type Model type Size [N× k] Response variable  Prediction performance #OC
GalN – resp. Urine DA 159×830 2 classes 20.06 OPLS 0.834 5
SA-K-OPLS 0.876 3
HgCl2 – high dose Urine RE 60×830 9 time points 21.62 OPLS 0.615 4
SA-K-OPLS 0.666 4
HgCl2 – two doses Urine RE 123×830 9 time points 24.28 OPLS 0.584 4
SA-K-OPLS 0.660 3
TBB – class. Plasma DA 108×950 2 classes 20.29 OPLS 0.956 2
SA-K-OPLS 0.972 1
TBB – time Plasma RE 64×950 6 time points 22.66 OPLS 0.640 3
SA-K-OPLS 0.676 3
The prediction of responders in galactosamine toxicity (GalN), the prediction of time after intoxication with mercuric chloride (HgCl2) for a ‘high dose’ level and two dose
levels and the classiﬁcation of infection with T. brucei brucei parasite (TBB) and the time after infection with TBB were modeled (using discriminant analysis (DA) or regression
(RE) models). The Gaussian kernel parameter () of the full model is shown; this value is greatly dependent on data set and scaling, and should therefore not be used as a
guideline. The prediction performance is given in terms of AUC for discriminant analysis and Q2Y for regression. The number of orthogonal components (#OC) is indicated for
both models.
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3.2. Mercuric chloride toxicity
Animals were administered mercuric chloride, full details are
given in Lindon et al. [29]. Mercuric chloride and its possible
metabolic derivatives are NMR-invisible, and thus all observed
changes can be attributed to endogenous metabolites. Doses were
given at two levels (n=10 ‘low’ dose, 0.5mgkg−1, and n=10 ‘high’
dose, 2.0mgkg−1) and urinary samples were obtained at time
points before (0h) and after dosing (8, 24, 48, 72, 96, 120, 144 and
168h post-dose) and 1H NMR spectra were measured. Half of the
animals at each dose level were sacriﬁced at 24h after dosing, the
other animals were sacriﬁced at 168h. The time course (9 time
points) is modeled with SA-K-OPLS regression.
3.3. Trypanosoma brucei brucei parasitic infection
To evaluate the effect of T. brucei brucei parasite infection
in mice, plasma samples were collected from an infected group
(n=12), and a control group (n=12) of animals. Animals in both
groups provided samples (108 in total) at a series of time points
pre- and post infection (−2, 1, 7, 14, 21, 28 and 33 days after infec-
tion), as describedbyWanget al. [25]. Thepresence of infectionwas
establishedusingdiscriminant analysis of pre-infection and control
animals versus infected animals. This was followed by a regression
analysis, on the infected animals only (64 samples), to predict the
time after infection.
3.4. Data processing
Proton (1H) NMR spectra were acquired as previously detailed
[25,29,56]. As is standard, spectra were imported with ı 0.0005
resolution. Spectral regions, excluding the water resonance for all
spectra and theureapeak for urine samples,wereuniformly binned
with ı 0.01 resolution, where a summed spectral intensity is cal-
culated for each bin. For plasma NMR spectra we used the spectral
regions ı 0.00–4.60 and 5.10–10.00 and for urine NMR spectra, this
was ı 0.60–4.70, 5.05–5.50 and 6.25–10.00. Data quality control
was performed by identifying and removing outliers from an ini-
tial investigationwith principal component analysis. Sampleswere
only omitted if they occupied an extreme value in score space, for
example for technical reasons such as poor water peak suppres-
sion and lower than acceptable signal-to-noise ratio. The resulting
spectra were subsequently normalized with probabilistic quotient
normalization [57], and variables were mean-centered and scaled
to unit variance. The data set sizes and SA-K-OPLS model details
can be found in Table 1.
4. Results
4.1. Prediction performance and optimization of the kernel
parameter
A summary of prediction performances and optimized Gaus-
sian kernel parameter () values for each data set can be found
in Table 1. See Supplementary data 3 for ﬁgures displaying the
convergence of the prediction performance metrics during cross-
validation. Detailed results for each data set are presented in the
following sections.
4.2. Prediction of non-responders in galactosamine toxicity
Galactosamine has been widely used as a hepatotoxin to model
hepatitis, although numerous studies have identiﬁed signiﬁcant
variability in response to the toxin [56]. In drug discovery, the abil-
ity to prospectively identify and account for non-responderswould
greatly reduce the number of patients needed in clinical trials [58].
Attemptshavebeenmade topredictnon-responders fromtheiruri-
nary metabolic proﬁles prior to [22,59], or soon after dosing [60] in
pharmacometabonomics.
Non-responders (n=40) and responders (n=119) to galac-
tosamine, as determined by histopathological and clinical chem-
istry markers of necrosis, were classiﬁed from the baseline (i.e.
pre-dose) urinary 1H NMR spectra using SA-K-OPLS discriminant
analysis. An increased prediction performance was observed with
respect to the linear OPLS model: the mean sensitivity increased
from 0.75 to 0.79, and the AUC from 0.84 to 0.88, using 5 and 3
orthogonal components for OPLS and SA-K-OPLS, respectively, see
also Fig. 3. The ROC curves for OPLS and SA-K-OPLS are shown in
Supplementary data 4.
This data set was also used to evaluate the prediction perfor-
mance of SA-K-OPLS on an (external) test data set, generated by
splitting the data into a modeling and an (external) validation set.
Thus the nested cross-validation was used to create a model based
on 120 observations, and the 39 removed samples from the vali-
dation set were predicted using this model. Also in this instance,
the prediction improved for SA-K-OPLS compared to OPLS, further
details and results can be found in Supplementary data 2. The dis-
crimination between the classes is clear in Fig. 4, and an interesting,
initially unexpected source of variation is visible, which could be
associatedwith the collectionperiod (urinewas collected from−48
to−40hand−24 to−16h,whereas twoother fractions represented
collections from −40 to −24 and −16 to 0h). It is visible that the
16h (night) collections have lower values on the ﬁrst orthogonal
component (OC 1), and the 8h (day) collections appear to have a
higher value on OC 1. The orthogonal variance is therefore likely to
reﬂect diurnal variation, which has been shown to exert a subtle
impact on metabolite proﬁles of urine and other bioﬂuids [61]. The
score plots of KPLS (using the same kernel parameter and number
of components as SA-K-OPLS), shown in Supplementary data 5A, do
not allow this observation and separation of orthogonal variation.
This demonstrates one of the unique features of K-OPLS compared
to other kernel-based methods: the ability to capture and inter-
pret non-linear structured variation in a data set that is not related
to the response variable (Y) to provide further interpretation and
understanding of model and data. The score plots of OPLS models
based on this data set are shown in Supplementary data 6A.
4.3. Time-course modeling of mercuric chloride toxicity
Mercuric chloride is a well-studied nephrotoxin targeting the
proximal tubules [62,63]. A single dose induces a reversible lesion
demonstrating a clear dynamic proﬁle of metabolic sequelae. Uri-
nary 1H NMR data were used to evaluate the prediction of time
after dosage with mercuric chloride (high dose level). This is of
relevance for toxicological studies, because a good delineation of
the time course describing the onset, evolution and regression of
a toxic lesion is of value for comparison with the gold standard
histopathology approach, to identify fast and slow responding ani-
mals, and for selecting the most appropriate sampling times for
other assays such as transcriptomics [64]. The prediction of time
after intoxication was improved using kernel methods compared
to linear OPLS: Q2Y is 0.67 compared to 0.61 (4 orthogonal compo-
nents for both OPLS and SA-K-OPLS), see Fig. 3. Interpretation of
the orthogonal component also revealed inter-animal variation in
response: Fig. 5A shows that animal 28exhibits a different response
compared to the other animals, and animal 29 also diverges from
the other animals at later time points. Thiswas conﬁrmed indepen-
dently in the serum clinical chemistry data, where at 24 and 168h
after dosing animal 28 showed lower levels of typical markers such
as creatinine, gamma-glutamyl transpeptidase, urea nitrogen and
phosphate than the rest of the high dose group, and similar effects
were observed for animal 29 at 168h after dosing. Thus, these
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Fig. 3. Bar graph of prediction performance. The difference of the prediction performance results for SA-K-OPLS and OPLS models was evaluated using 100 outer cross-
validation rounds (mean and the standard error of the mean, representing the variability in the 100 cross-validation results, are indicated as bars with error bars). Regression
analysis results (mercuric chloride (HgCl2) data sets, and the T. brucei brucei (TBB) time after infection data) were evaluated with Q2Y . Discriminant analysis results are
presented with both the mean sensitivity and the area under the receiver operating characteristic curve (AUC), for classiﬁcation of non-responders versus responders in the
galactosamine toxicity data set (GalN resp.) and the separation of infected versus non-infected samples from the T. brucei brucei infection study (TBB class). The prediction
improvement of SA-K-OPLS over its linear equivalent OPLS is visible for all these models.
animals were correctly identiﬁed as having a different outcome,
without prior knowledge or consultation of the metadata.
A regression model was also constructed where data from the
low and high dose levels of mercuric chloride were combined.
Thus, this model is focused on the common time-related metabolic
response across toxin dose-levels, allowing prediction of the time
fromdosing, in analogywith clinical situationswhere thedose level
and time after exposure may not be known. Also for this model, the
predictionperformance increased for SA-K-OPLS compared toOPLS
(see Fig. 3, Q2Y is 0.66 compared to 0.58). Moreover, the two aber-
rant animals 28 and 29 in the high dose group discussed above now
cluster with the low dose animals in the score plot (see Fig. 5B),
Fig. 4. Score plot showing discriminant analysis of non-responders and responders to the toxin galactosamine. A score plot of the predictive and ﬁrst orthogonal component
of the galactosamine toxicity data set shows a clear discrimination in the predictive component (x-axis) between responders and non-responders (circles and squares,
respectively). The ﬁrst orthogonal component (y-axis) shows a trend related to diurnal variation (dark versus light periods) with respect to the urine collection time period
(either −48 to −40 and −24 to −16h: 8h (day) collection; and −40 to −24 and −16 to 0: 16h (night) collection).
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Fig. 5. Score plot of mercuric chloride regression model. (A) A score plot of the prediction of time after dosage with a high dose of mercuric chloride based on metabolic
changes was used to delineate the onset and regression of a toxic lesion. The predictive score component (x-axis) describes variability related to the Y variable (time), while
the orthogonal score component (y-axis) captures some systematic metabolic changes occurring at predominantly 24–48h after dosing. Interestingly, animal 28 (squares)
and later animal 29 (diamond) diverge from the behavior of the other animals over time. (B) A score plot of the prediction of time after dosage with ‘low’ and ‘high’ doses of
mercuric chloride. The orthogonal score component (y-axis) captures some systematic metabolic changes occurring predominantly for the high dose group. Animal 28 and
later animal 29, which diverge from the behavior of the other high dose samples over time, appear to recover in a path similar to low dose samples.
indicating that they show a less severe response to the toxin, in
agreement with the histology results. This example therefore con-
ﬁrmed that SA-K-OPLS not only improved the predictive ability of
the data set compared to OPLS, but moreover, unlike other non-
linear kernel-based methods, provided a visual interpretation of
the variation in the data set, related to the predictive variation as
well as structured Y-orthogonal variation, which was not observed
for the corresponding KPLS models (see Supplementary data 5B
and C), and OPLS models (Supplementary data 6B and C). The two
presented toxicology data sets clearly demonstrate the value of
using non-linear methods in these metabonomic studies, and in
particular the value of K-OPLS for improved model interpretation.
4.4. Classiﬁcation of T. brucei brucei parasitic infection
Here,we evaluated the 1HNMRdata of plasma samples froma T.
brucei brucei parasitic infection (African sleeping sickness) in mice
[25]. Spectra were acquired from the animals before and at vari-
ous stages during the infection and similarly from control animals.
Data from infected animals formed the ‘infected group’; the ‘unin-
fected group’ consisted of the combined pre-infection and control
animal data. The discrimination between the infected and unin-
fected groups resembles the situation in a clinical setting, where
it is crucial to establish the occurrence of infection, irrespective
of the time elapsed after initial infection. Improved classiﬁcation
accuracy between ‘infected’ and ‘uninfected’ individuals with SA-
K-OPLS was observed compared to linear modeling, see Fig. 3 and
Table 1, with an increased mean sensitivity (SA-K-OPLS: 0.92 with
1 OC, OPLS: 0.88 with 2 OC), as well as a larger AUC (0.97 com-
pared to 0.96), the ROC curves are plotted in Supplementary data
4. In the K-OPLS score plot (Fig. 6A), it is visible that the early time
point of infection (day 1) is more difﬁcult to discriminate from the
uninfected spectra than later time points, which can be expected
fromthedevelopmentof aparasitic infection, seenext section.KPLS
and OPLS score plots are shown in Supplementary data 5D and 6D,
respectively.
4.5. Prediction of T. brucei brucei parasitic infection time-course
The status of the T. brucei brucei infection in terms of the time
after initial infection is highly relevant as the nature of therapeutic
intervention and the prognosis for recovery are greatly dependent
on the event of blood–brain barrier crossing of the parasite that
occurs in this infection. As with the mercuric chloride toxicity data
set, a metabolic trajectory reﬂecting the progression of the infec-
tion can be characterized using spectral proﬁling [25]. To stage the
infection time point, the time after infection was modeled non-
linearly as a regression against time, as displayed in Fig. 6B; the
corresponding OPLS and KPLS models are shown in Supplementary
data 5E and 6E. It was found that the prediction was improved for
the SA-K-OPLS model compared to the results from the linear OPLS
model: Q2Y increased from 0.64 in OPLS to 0.68 in SA-K-OPLS, both
with 3 orthogonal components, see also Fig. 3 and Table 1.
5. Discussion
For certain metabonomic applications, predictive performance
is of paramount importance, such as in toxicology studies and dis-
ease diagnostics. Although linearmodels often provide a basic level
of prediction performance for multivariate data sets, in the pres-
ence of substantial non-linear variability in data, non-linearmodels
are expected to provide improved predictions compared to lin-
ear models. This might be explained by the potential ability of a
moreﬂexible non-linearmodel to incorporate additional predictive
information if the predictor and response variables are related non-
linearly, but also by the aggregation of information across many
weakly associated descriptor variables, linearly and non-linearly
related toY, which contributes to an improved, and potentially also
more robust, prediction model.
Prediction performances reported here were calculated by
nested cross-validation,which reduces the riskof over-ﬁttingwhen
optimizing the kernel parameter [54]. If obtainable, an external test
set should ideallybeused toevaluatepredictionperformance, how-
ever the nested cross-validation is expected to give an unbiased
estimate of predictive ability if no external test data are avail-
able. We note that simulated annealing is a stochastic optimization
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Fig. 6. Results of classiﬁcation and regression modeling of T. brucei brucei infection. (A) The classiﬁcation of samples into two groups representing presence and absence of a
T. brucei brucei parasitic infection is improved with non-linear modeling compared to linear models (see also Fig. 3). (B) The predicted versus actual time points are plotted
for the regression with SA-K-OPLS of time after infection with the T. brucei brucei parasite. The prediction performance Q2Y is increased compared to OPLS from 0.64 to 0.68.
method, and therefore the end result of every optimization will
vary slightly. To ensure that the prediction performance estimates
were reliable for comparison, and not unduly effected by random
variability relating to the cross-validation procedure, we moni-
tored the convergence of the 100 cross-validation rounds, seen in
Supplementary data 3. For the data sets analyzedhere,weobserved
that predictions by SA-K-OPLS were better than, or equivalent to,
the linear OPLS model. However, the additional assumption of
linearity in the OPLS model may result in better prediction perfor-
manceunder certain speciﬁc conditions, for example if the problem
is truly linear and the available training data are very limited in the
number of observations.
Although the K-OPLS method does not necessarily provide
improved prediction performance compared to other kernel-based
models [30], K-OPLS facilitates an improved model interpretation
compared to alternative models, which can aid quality control and
further understanding of the model and data (see Supplementary
data 5). The difference between K-OPLS and KPLS is analogous
to the difference between OPLS and PLS: SA-K-OPLS provides a
separate set of predictive and Y-orthogonal model components, a
property that caused OPLS to gain great attention for analysis of
metabonomic data [12].Y-orthogonal variationmay be interpreted
as multivariate latent variables that describe unknown covariate
variation, for example unknown batch effects, animal variability or
drift in analytical instruments over time, thus providing additional
means forquality control andunderstandingofdata. The scoreplots
presented in Figs. 4 and 5 clearly demonstrate the interpretation
of Y-orthogonal model components, in addition to the strength of
prediction using a non-linear modeling approach.
To ﬁnd a good parameter value for the kernel function, grid
search or gradientminimization could be applied [35,41], but these
approaches may be computationally and labor intensive or inefﬁ-
cient and can get trapped in local minima. There is a multitude
of global optimization methods available, such as simplex-based
methods [65] and genetic algorithms [51,66], previously reported
in the context of support vector machine applications. We have
demonstrated how simulated annealing can be used to achieve
good optimization performance in a user-friendly manner, but
other approaches could also have been applicable to this opti-
mization problem. We note that the kernel parameters for the
different analyzed data sets had comparable magnitude (Table 1).
This cannot, however, be assumed in general and is possibly related
to the fact that these data sets were all acquired by comparable
1H NMR spectroscopy procedures and pre-processed in a highly
similar manner. Our goal here was not to compare different opti-
mization methods, but to provide and demonstrate an automated
and easy-to-use procedure. Grid search optimization has also been
implemented as an option in the K-OPLS software package.
In contrast to linearmethods, there arenomodel loadings acces-
sible for interpretation for kernel-based methods, due to the usage
of the kernel trick. This may be a disadvantage of the kernel-based
non-linear modeling, depending on the application, and there-
fore the method is particularly suited to studies where maximum
predictive performance is imperative, for example in toxicology
applications and disease diagnostics using multivariate biomarker
panels.
We have demonstrated that SA-K-OPLS can provide an
improved prediction performance compared to the linear OPLS
method in the context of 1HNMRspectral data sets of twobioﬂuids:
blood plasma and urine. The presented method is expected to be
applicable to other data sets, not restricted to analytical method or
study type. SA-K-OPLS is especially appropriate to be used for pre-
dictivemodeling if the data showpresence of non-linear variability
and could potentially contain systematic Y-orthogonal variation.
6. Conclusions
Predictivemodeling inmetabonomic studies is currently almost
exclusively performed using linear methods. We demonstrate here
that a non-linear kernel-based model can provide valuable predic-
tion performance improvements compared to the linear model in
three typical metabonomic data sets. The kernel-based OPLS (K-
OPLS)modelwas used in this study,which is analogous in itsmodel
structure to the commonly used linear OPLS model. We found that
the non-linear (K-OPLS) prediction performance is better than or
equal to the linear model (OPLS). K-OPLS provides added value
compared to alternative kernel-based models by enabling separate
modeling of predictive and Y-orthogonal model components, facil-
itating improved model interpretation and providing a means of
quality control.
A complicating factor for non-expert users in the application of
kernel-based models can be the optimization of the kernel func-
tion parameter. We demonstrated how simulated annealing can
be applied successfully to automate optimization of the kernel
parameter, providing a user-friendly procedure based on nested
cross-validation. Thus, SA-K-OPLS has been shown to provide a
ﬂexible framework for non-linear classiﬁcation and regression
modeling and we anticipate that the method can also be employed
successfully in studies with data collected by other analytical
methods and for modeling of other ‘-omics’ data types, as well
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as high-dimensional and potentially non-linear data in general
[39,41].
We hope that our results will facilitate increased utilization
of non-linear prediction models in metabolic proﬁling studies,
especially in application areas such as disease diagnostics and tox-
icology, where prediction performance is of utmost importance.
The K-OPLS procedures applied here are available in the K-OPLS
software packages for R andMatlab, including cross-validationpro-
cedures, kernel-optimization and prediction performance metrics.
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The explosion of -omics technologies in the characterization and prediction of deﬁned physiological or
pathological states necessitates a parallel development in data integration and visualization tools in order to
display and interpret vast amounts of data in an efﬁcient manner. Here we summarize some of the key
achievements in this area and compare the strengths and limitations of each method with respect to their
use in representing biological processes in a systems biology environment.
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1. Introduction
Metabonomics is a metabolism driven top-down systems biology
approach for detecting, identifying, analyzing and cataloguing time-
related metabolic changes in complex organisms that have been
subjected to a biological challenge [1]. The approach is deﬁned as “the
quantitative measurement of the dynamic multiparametric metabolic
response of living systems to pathophysiological stimuli or genetic
modiﬁcation” [1]. This concept arose mainly from the work on the
application of nuclear magnetic resonance (NMR) spectroscopy to
study the metabolic composition of bioﬂuids, cells and tissues. A
parallel approach, metabolomics arose in the late 1990s, mainly from
plant and microbial sciences and originally from the study of in vitro
cellular systems [2]. Historically, metabolomics was deﬁned on the
basis of analytical rather than biological criteria, referring to the total
sum of measurable metabolites within a cell or tissue type. In general
metabolomic experiments require comprehensive analysis in which
all the metabolites of a biological system are identiﬁed and quantiﬁed,
whereas metabonomic experiments require the identiﬁcation and
characterization of the metabolic response to biological stimuli. The
analytical methods and multivariate statistical approaches used for
cells, plants, and animals are now highly convergent and for the
purpose of this review we will refer to the combined ﬁeld as
metabonomics [3,4]. Powerful analytical strategies, in combination
with advanced multivariate statistical tools, are required to provide
maximum relevant information and knowledge about the complex
biological system to enable the detection and identiﬁcation of
endogenous and exogenous metabolites responsible for mediating
the phenotypic expression of altered metabolism resulting from a
biological challenge [5,6]. Genomics, proteomics, metabonomics form
the fundamental systems biology framework and can give an
integrated understanding of the cellular functions in living organisms.
In these -omics ﬁelds of study vast amounts of quantitative or semi-
quantitative data are derived covering a variety of levels of
biomolecular organization. One of the expectations of the systems
biologist is that these datasets can be integrated to give a holistic
picture of the state of the system, e.g. development, ageing, health or
disease that provides insights that enable a more fundamental
understanding of biology to be obtained via understanding network
connections of interactions at the molecular level [7–14].
In this review we discuss the various efforts that have been made
to integrate information from different -omics datasets. Although
there are multiple ways to classify levels of data integration, we
recognize three main levels of integration [15]: conceptual integra-
tion, the integrative interpretation of results from multiple experi-
ments; statistical integration, the simultaneous multivariate analysis
of data from multiple sources; and model-based integration, the
construction of predictive functional networks or models from
multiple experimental components. Here, we focus on the recent
developments and applications at the statistical level of data
integration for metabonomic applications. The advantages and
disadvantages of the statistical methodologies for each application
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are discussed, initially for statistical integration strategies using
different analytical techniques for the same biological sample.
This is followed by the integration of metabolic data from different
biological samples taken from the same comprehensive metabolic
studies. These include, for example, analysis of various tissues, tissue
extracts and bioﬂuids, in what has been termed ‘integrative
metabonomic’ investigations. In the second section of the review we
discuss the ‘holy grail’ of systems biology, that is the intelligent
integration of data from different -omic studies at different levels
of molecular biology, such as transcriptomics, proteomics and
metabonomics, such that the data accurately reﬂect the biology of
the whole organism, and we present and review where this has
been achieved at the level of interpretation and data construction.
Finally the complexities of modeling biological systems are discussed,
and methods for achieving full systems biology integration are
proposed.
1.1. Overview of current analytical technology used in metabolic
proﬁling
Bio-analytically, nuclear magnetic resonance (NMR) spectroscopy
and mass spectrometry (MS) are the most powerful and widely used
spectroscopic techniques for both untargeted and targeted metabolic
proﬁling, which is the compositional analysis of lowmolecular weight
species in complex biological samples. The metabolic proﬁles can be
used for two purposes: either to characterize the metabolome of an
organism or to identify metabolites or ‘candidate’ biomarkers
(whose identity may or may not be known) that are associated with
a particular biological state in bioﬂuids and tissue samples [8,16–22].
1H NMR spectroscopy has several advantages for measuring metab-
olite levels including minimal sample preparation, data acquisition
typically takes only a fewminutes per sample and so high-throughput
and automated analysis is possible. Furthermore, it is non-destructive
and cost effective. Undoubtedly the largest disadvantage of NMR
spectroscopy is its poor sensitivity in comparison to MS techniques,
which limits the number of observable molecular species. However,
the high degree of connectivity within metabolic networks can
somewhat reduce the problem of comparatively low sensitivity, as
changes in low concentration (invisible or latent to NMR spectrosco-
py) metabolites may lead to indirect changes in higher concentrations
(visible to NMR spectroscopy) metabolites. Additionally, NMR
spectroscopy has been repeatedly shown to be highly reproducible
with very low coefﬁcients of variation in metabolic studies [23,24].
Alternatively, MS-based metabonomics offers quantitative analyses
with high selectivity and sensitivity. Combination with a separation
technique such as gas chromatography/MS (GC/MS) [25–27], high
performance liquid chromatography/MS (HPLC/MS) [28–30] and
capillary electrophoresis/MS (CE/MS) [31–33] reduces the complexity
of the mass spectra due to metabolite separation in a time dimension,
reduces ion suppression, can provide isobar separation, i.e. the
differentiation between molecules with similar nominal mass and
different molecular formula, and delivers additional information on
the physico-chemical properties of the metabolites. However, mass
spectrometry-based techniques usually requires a sample preparation
step, which can cause metabolite losses, and based on the sample
introduction system and depending on the ionization technique used,
speciﬁc metabolite classes may be discriminated or metabolites
differentially ionized. The largest disadvantage of MS in comparison
with NMR spectroscopy is its lower reproducibility. Nevertheless,
both NMR spectroscopy and MS provide complementary informa-
tion to the analytical scientist. Other spectroscopic methods that
can produce metabolic signatures of biomaterials include optical
spectroscopic techniques such as Raman [34,35], Fourier transform
infrared (FTIR) [36,37], near infrared (NIR) [38] and ultraviolet–
visible (UV–VIS) [39] spectroscopy, for a more comprehensive review
see reference [3].
1.2. Properties of the various biological samples used in metabolic
proﬁling
The various physiological properties of mammalian bioﬂuids
have been reviewed in relation to spectroscopic information recovery
[177,178]. The spectroscopic measurement of bioﬂuids or tissues
provides information on chemical structure, quantitative composi-
tion, metabolic pathway relationships as well as latent information on
the status of the organism as a function of the genetic background,
environment or gene–environment interaction [40]. Each bioﬂuid
yields a characteristic spectroscopic ﬁngerprint in which the spectral
intensity distribution is determined by the relative concentration of
the solutes, and in some cases by their intermolecular interactions, an
example of an 800 MHz 1H NMR spectrum of untreated human urine
is given in Fig. 1. Although metabolite concentrations can vary
dramatically between individuals and betweenmetabolites in a single
individual, signiﬁcant differences between groups can be optimized
through appropriate scaling of the data [41]. Most mammalian
metabonomic analyses are performed on plasma, serum and urine
because they are easily collected and reﬂect instantaneously sampled
states in dynamic equilibrium with multiple cells and tissues of the
body and have traditionally been used for prognosis or diagnosis of
many diseases. Other bioﬂuids used for metabolic proﬁling include,
saliva [42], amniotic ﬂuid [43,44], cerebral spinal ﬂuid [45,46], breast
milk, synovial ﬂuid, seminal plasma [47], gastric, bile and digestive
ﬂuids. Biological tissue samples used for metabolic proﬁling include
liver [48–50], kidney [51,52], feces [53–55], white adipose tissue
(WAT) [56] and brown adipose tissue (BAT). Tissues are ideal for
biomarker discovery because they are under tight homeostatic
regulation and can provide highly consistent organ speciﬁc metabolic
measurements between individuals leading to a precise metabolic
characterization of groups or dynamic processes. The difﬁculty of
using tissue samples are that sample acquisition is invasive and
samples generally require more preparation steps in comparison to
bioﬂuids prior to analysis. The metabolic information provided by
bioﬂuids and tissues can be used to characterize multicompartmental
consummate events such as toxicity and disease [57,58], thus giving a
more complete description of the mechanistic consequences than can
be obtained from one ﬂuid or tissue alone. There are a large variety of
samples used for plant metabolomics and include leaves, roots, sap,
fruits, stalks, tubers, ﬂowers, derived materials (e.g., oil, wine, resins),
reﬂected in the wide number of reported studies in this ﬁeld [59–62]
as well as cells in microbial metabolomics [63], metabonomic analysis
of nematodes [64,65] and non-model organism [66], etc.
1.3. Chemometric analysis of spectral data
A limiting factor in understanding the biochemical information
from both spectral proﬁles of tissues and bioﬂuids is their complexity;
high resolution spectra of bioﬂuids may contain several thousand
peaks from potentially 100s or 1000s of metabolites (Fig. 1). Therefore
multivariate statistical chemometric techniques are required to
reduce the dimensionality of the data in order to extract the deﬁning
metabolic information associated with each group or dynamic
process. Multivariate statistical methods include unsupervised pat-
tern recognition methods such as principal component analysis (PCA)
[67–69] that reveals patterns, trends and outliers in these data, via an
orthogonal decomposition. Self modeling curve resolution (SMCR)
[70–73] resolves the underlying metabolic signatures (spectrotypes)
and their relative contributions which are associated with, for
example, dynamic biological processes, such as aging, via linear
decomposition followed by alternating least-squares reﬁnement.
Supervised pattern recognition methods, such as partial least-squares
(PLS) regression [74], try to maximize the joint covariance structure
between a measurement matrix, X and a second matrix, Y containing
response, compositional or class identiﬁcation information, with the
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goal of identifying biomarkers that are associated with particular
classes or responses. The implementation of ﬁltration methods such
as orthogonal signal correction (OSC-PLS) [75–78] can provide a
means of removing extraneous variation in the data set when the level
of complexity is high and thus ﬁltration steps are often incorporated
into the multivariate methods, using for example orthogonal partial
least-squares methods OPLS [79] and O2PLS [80]. Other commonly
employed methods include neural networks [81,82], kernel methods
[83–85] or probabilistic approaches [86,87], which offer comparable
or even superior classiﬁcation potential but do not provide transpar-
ency in terms of the discriminating signals.
2. Methods for organizing -omics data prior to data integration
For simultaneous analysis of data derived from multiple sources,
e.g. NMR spectroscopy andMS, multiple NMR nuclei (1H, 13C, 19F, 31P),
multiple biological samples (urine, liver), or -omics experiments
(DGGE, NMR spectroscopy) can be arranged in different directions
[88]. In typical metabonomic applications, rows in the data matrix
represent mixture spectra recorded for each participant in the
study nð Þ, columns represent measurements on multiple variables,
i.e. chemical shift, mass to charge ratio, etc. mð Þ, and the third
dimension, sometimes called tubes, represent the multiple experi-
ments, i.e. different analytical spectroscopic measurements, different
NMR nuclei, different biological samples, different -omics experi-
ments, or different time points (time-series or batch analysis) [89] etc.
Multiple datasets with at least one order in common can be arranged
in three different directions: along the row space nð Þ, along the
column space mð Þ, or along the tube space qð Þ. The three procedures
give a row-wise augmented matrix Xr n × mqð Þ, a column-wise
augmented matrix Xc nq × mð Þ, and a tube-wise augmented matrix
Xt q × nmð Þ respectively.
There are several multivariate statistical tools available for the co-
analysis of multiple data sets using either (a) multiblock/multiset
model, applied to either the individual block data or the two-way
matrices; Xr n × mqð Þ or Xc nq × mð Þ and (b) three-way methods
applied to the three-waymatrix X n×m×qð Þ, when the length of at least
two dimensions are common, see reference [90] for extensive reviews
of three-way multiway analysis methods. In this review various
multivariate statistical approaches applied and developed for the
simultaneous analysis of metabonomics and multi -omics datasets
and the statistical analysis of the signal amplitude co-variation are
discussed.
2.1. Integration of data from different spectroscopic platforms:
inter-platform integration
One of the most useful recent advances in data modeling is the
statistical integration of molecular proﬁles of the same sample using
different spectroscopic platforms. This enables molecular biomarker
identiﬁcation and information recovery on metabolic pathway
connectivities by the examination of different levels of metabolic
information from the statistical integration of analytical platform–
platform variation. Various multivariate methods for inter-platform
integration have been proposed. These methods range from extrac-
tion of simple correlations to trilinear projection-based approaches.
Selected examples of currently applied integration methods are given
below.
A correlation-based multiblock hierarchical PCA (HPCA) [91,92]
has been used for the simultaneous analysis of 1H NMR spectroscopy
combined with gas chromatography-electrospray ionization time-of-
ﬂight MS (1H NMR spectroscopy and GC-EI-TOF-MS) for the global
compositional analysis of melon fruit ﬂesh extracts [62]. Appropriate
scaling of the data is required to ensure the variation from one
platform does not dominate or mask the variation from a second
Fig. 1. 800 MHz 1H NMR spectrum of untreated human urine. The 1H NMR spectrum was recorded on a Bruker Avance II 800 NMR spectrometer (Bruker, Germany), operating at
800.00 MHz for 1H. A standard one dimensional 1H NMR spectrum with water peak presaturation was acquired using the pulse sequence (RD-90-t1-90-tm-90-acq), where RD is a
relaxation delay and 90 represents 90° high power pulses. Here, the inter-pulse delay t1 was 3 μs and the mixing time tm was 100 ms. A weak irradiation ﬁeld was applied at the
water resonance frequency during both the mixing time and the recycle delay. A total of 1024 scans were collected into 64 k data points with a spectral width of 16,025 Hz and
relaxation delay of 3 s. The acquisition time was 2.045 s and the total pulse recycle time was 5.2 s. 1H NMR spectra were corrected for phase and baseline distortion using Topspin 2.0
(Bruker). The spectra were referenced to the chemical shift of 3-(trimethylsilyl)-2,2,3,3-tetradeuteropropionic acid (TSP) resonance at 0.00 ppm.
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platform. HPCA and hierarchical PLS (HPLS) have been applied for the
analysis of LC/MS and NMR spectroscopy for the classiﬁcation of rats
dosed with citalopram (positive control for phospholipidosis). In this
study several different variable and block scaling methods were
assessed. Variable scaling methods included division by the mean,
unit variance scaling, Pareto scaling, variance scaling and vast scaling.
Block scaling methods included those that ensured each block (LC/MS
or NMR spectroscopy) was scaled to give equal mean intensity or each
block was scaled to give equal sum of standard deviation. The
optimization of the different scaling was performed by cross-
validation. In this application the optimal block-scaling method for
the row-wise augmented data was scaling each block to give equal
sums of standard deviation [93]. A more generalized framework for
the evaluation of sequential multiblock methods, found that consen-
sus PCA (CPCA) [94], (which ensures that both blocks are considered
equal by weighting each block prior to the PCA decomposition of the
row augmented data) was superior in a separate evaluation [94].
Application of CPCA (using blocks weights equal to the square root of
sum of squares) and comparison with canonical correlation analysis
(CCA) [95] for the integration of microbial metabolomics datasets
(GC/MS and LC/MS) from Pseudomonas putida S12 and Escherichia coli
found CPCA focused on the direction describing the largest source of
variance (i.e. the identiﬁcation of the large common effects possibly
associated with relations hips between metabolome and the speciﬁed
metabolites) whilst CCA identiﬁed trends between the two datasets
that were strongly correlated (i.e. possibly biochemically related
metabolite associations) [96]. In a similarly designed experiment
using LC/MS and GC/MS the proportion of the overlapping sources of
variance from both datasets was quantiﬁed using CPCA, validated
against the matrix correlation coefﬁcient, (the RV-coefﬁcient) [97].
The RV-coefﬁcient was modiﬁed in a subsequent study to circumvent
problems of high dimensional data [98]. Multiple factor analysis
(MFA) [99,100], a similar method to CPCA, in which each block is
weighted to the square root of the ﬁrst eigenvalue derived from PCA of
each block [99,100] rather than the square root of the sum of squares,
followed by PCA decomposition of the row augmented matrix, has
been applied for the co-analysis of 1H–13C Heteronuclear Multiple
Bond Connectivity NMR spectroscopy (1H–13C HMBC NMR spectros-
copy) and Pyrolysis Metastable Atom Bombardment Time-of-Flight
MS (Py-MAB-TOF-MS) to perform metabolic ﬁngerprinting on cattle
treated with anabolic steroids [101]. The advantage of the MFA
weighting procedure is it accounts for dominant scaling effects.
Furthermore, Van Deun et al. [102], in a separate study showed
simultaneous component analysis (SCA) methods such as MFA, were
largely dependent upon the pre-processing, weighting [102] and
noise structure [103].
Three-way analysis methods that have been used for the full
integrative modeling of multiple platform data include parallel factor
analysis (PARAFAC) [104]. The requirement and hence limitation of
the PARAFAC model is that the data, must be approximately low rank
and trilinear to provide physically meaningful loadings (e.g. pure
spectra) which limits the application of PARAFAC models to
metabonomics spectrosocpic datasets which are generally rank-
deﬁcient, containing high numbers of metabolites which are both
biologically and statistically correlated and have overlapped spectro-
scopic peaks. Tucker decomposition [105–107], a generalized PCA on
multiway data, has the same capabilities of PCA i.e. to compress
variation, extract features and explore data. In addition to these
capabilities, the presence of the core array in the Tucker decompo-
sition allows for interpretation of the interaction between the
different components, describing the variation between the samples,
measurement on multiple variables and experiments. Furthermore,
the three-way structure of the original data may allow for more direct
interpretation of features common to the data [108,109]. Dyrby et al.
[110] showed how a traditional dose–response experiment could be
properly explored using Tucker3 models and PARAFAC was used for
similar data [111]. Idborg et al. [112] exempliﬁed the use of PARAFAC
and N-way partial least squares (NPLS) [113] in handling metabolite
screening using liquid chromatography/electrospray ionization MS
(LC/EI-MS). Lipoprotein characterization using 2D diffusion-edited
NMR spectroscopy was analyzed with PARAFAC providing chemically
meaningful spectra [114]. Visualization of important variables in each
mode (samples, measurement on multiple variables and experi-
ments) can sometimes be difﬁcult with these models (i.e. NPLS,
Tucker and PARAFAC). An analogy to the two-way correlation loading
plot to assess variable signiﬁcance was considered by Lorho et al.
[115], and a generalization to the multiway case was developed using
congruence loadings and applied to a metabonomics experiment
using 2D diffusion-edited NMR spectroscopy [115]. ANOVA-simulta-
neous component analysis (ASCA) [116] has been developed to
increase the interpretability of a multivariate dataset in terms of the
experimental design (i.e. providing a more direct answer to the
experimental question at hand) and extended to themultiway case by
combining ASCA with PARAFAC (PARAFASCA) [117]. This approach
was used to study the time-effect of hydrazine toxicity in the urinary
composition of rats evaluated by 1H NMR spectroscopy.
Structural and biological connectivity between metabolites mea-
sured on multiple spectroscopic platforms have been achieved using
correlation-based approaches, such as Statistical TOtal Correlation
SpectroscopY (STOCSY [118]), which was primarily designed to aid
peak assignments in NMR spectroscopic metabonomic studies. The
Fig. 2. Two-dimensional HET-STOCSY correlation plots derived from 31P-{1H} and 1H
CPMGMAS NMR spectra of (A) jejunal and duodenal tissues (considered to be identical
anatomically) and (B) transverse colon [125].
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assumption underlying the STOSCY approach is that spectral peaks
arising from the same compound across a series of samples are
multicollinear, i.e. the relative signal intensities of a given molecule
are constant. Thus the correlation of two non-overlapped peaks arising
from the same compound throughout the array is high, whereas
unrelated compoundswill generally showa lowcorrelationunless there
is a biological linkage producing correlation. The ease with which
STOCSY can be implemented resulted in valuable applications, including
studies on analgesic usage in a large epidemiological study [119],
pathway connectivities in relation to a renal toxin [120] and drug
metabolism kinetics [121]. Both structural and novel toxicological
connectivities between xenobiotic and endogenous metabolite signals
were detected in the rat [122]. It should be noted, though, that basis for
an observed correlation, is far from unambiguously decided, and a
comparison of metabolite concentrations across various experimental
conditions is suggested to evaluate and identify invariant features of
metabolic proﬁles [123]. Integrative analysis using HET-STOCSY
(heteronuclear statistical total correlation spectroscopy) based on
STOCSY principles, can be performed across a set of samples by using
twoNMR spectroscopic data sets of different nuclei, for example 1H and
31P [124,125], Fig. 2, or 19F and 1H [126], outcomes of the analysis,
contribute to conﬁrmation of structural elucidation or pathway
elucidation determined from other single platform analyses allowing
an integrated overview of biological response to physiological or
pathological stimuli.
The correlations between two different matrices derived from the
sample set, e.g. arising from two analytical platforms, can be
calculated. The ﬁrst implementation demonstrated was the integra-
tion of 1H NMR spectroscopy and MS data, and resulted in the
successful demonstration of Statistical HeterospectroscopY (SHY)
[127,128]. As most analytical platforms contain highly complemen-
tary information, the cross-correlation of spectral parameters has a
synergistic effect with increased information extraction, as bidirec-
tional multivariate correlations between identiﬁed and unidentiﬁed
signals can lead to mutually increased information content and
signiﬁcantly improved interpretability. The approach is not limited to
these two platforms, and other examples include the integration of
NMR spectroscopy and capillary electrophoresis [129]. Thus the
statistical integration of molecular proﬁles of the same sample using
different spectroscopic platforms enables molecular biomarker
identiﬁcation, information recovery on metabolic pathway and
connectivities by the examination of different levels of the analytical
platform–platform correlation matrices. A summary of published
inter-platform statistical integration methods is given in Table 1.
2.2. Inter-sample type integration: integrative metabonomics
Integrative metabonomics [8,130] can be used to describe changes
in metabolic chemistry in different body compartments that are
caused by exposure to a biological intervention. Such timed proﬁles in
multiple compartments are themselves characteristic of particular
types and mechanisms and the statistical integration of multiple
tissue samples can reveal metabolic information associated with e.g.
the Cori cycle between muscle and liver or insight about renal
clearance or retention from the co-analysis of plasma and urine, thus
giving a more complete description of the mechanistic consequences
than can be obtained from one ﬂuid or tissue alone. There are many
more examples of conceptual integrative metabonomics methods
than statistical integration for different sample types. Typically,
conceptual integrative models are constructed on each bioﬂuid and
(or) tissue using either unsupervised or supervised pattern recogni-
tion methods such as PCA, PLS-DA and OPLS-DA, followed by an
integrated interpretation of the results from the different biological
compartments. Examples of conceptual integrative metabonomic
include studies of toxicity [131–134], the effects of various pre- and
probiotics on gut microbiota [58,135], nutritional studies [138] etc.
The disadvantage of this approach is information relating to the
common systematic variance across the different compartments and
the detection of intercompartment functional relationships are hard
to recover.
There are few published studies that use true statistical integration
for different sample types. Recently a systems-based approach
relating observed biomolecular changes in biological ﬂuids to drug
induced toxicity effects in liver tissues for in vivo models, using a
Table 1
Summary of published application of statistical data integration methods in the areas of (a) inter-platform integration (b) inter-sample type integration: integrative metabonomics
and (c) inter-omic integration.
Integration strategy Analytical components Chemometric method
Inter-platform 1H NMR and GC–EI–TOF–MS HPCA [62]
1H NMR and LC–MS HPCA and HPLS [93]
GC–MS and LC–MS CPCA [95,96] and CCA [95]
1H–13C HMBC NMR and Py–MAB–TOF–MS MFA [101]
LC–EI–MS PARAFAC and NPLS [112]
2D diffusion-edited 1H NMR PARAFAC [114] and congruence loadings [115]
1H and 31P NMR HET-STOCSY [124,125]
19F and 1H NMR HET-STOCSY [126]
1H NMR and UPLC–MS SHY [127,128]
1H NMR and CE SHY [135]
Inter-sample type integration:
Integrative metabonomics
Plasma and liver tissue Correlation [139]
Urine, plasma, liver, pancreas and kidney cortex Correlation [136]
Liver and feces Correlation [137]
Jejunum, ileum, colon, liver, spleen and kidney OSC-PLS and HPCA [140]
Urine, plasma, feces, liver and bile acids HPCA [F-P.J. Martin, Y. Wang, N. Sprenger et al,
Molecular Systems Biology 4 [2008], pp. 1–15]
Plasma, liver, pancreas, adrenal gland and kidney cortex NPCA, MCR-ALS, PARAFAC [141]
Inter-omic integration Metabonomics and genomics Correlation networks [160]
Proteomics and genomics Correlation networks [159]
Transcriptomics and metabolomics Correlation networks [158]
Proteomics, genomic and metabolomics Correlation [139]
Functional genomics and metabonomics PLS [161]
Metabonomics and proteomics O2PLS [162]
Transcriptomics and metabolites O2PLS [163]
Proteomics, genomic and metabolomics O2PLS [164]
Genomics and metabolomics mQTL [168–170]
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cross-tissue correlation network-based integration of molecular
proﬁling data has been employed [139]. Correlation analysis has
also been used to summarize intra- and inter-compartmental
metabolic correlations derived from pair-wise statistical analysis to
identify latent metabolic links between several biological compart-
ments, such as plasma, liver and kidney cortex [136,137]. Other
methods include, OSC-PLS and HPCAwhich have been used for the full
statistical integration of jejunum, ileum, colon, liver, spleen and
kidney samples, which enhanced and increased understanding of
physiological and pathological consequences of a patent Schistosoma
mansoni infection in mice [140]. HPCA has also been used to integrate
multicompartment metabolic data in a probiotic study [F-P.J.
Martin, Y. Wang, N. Sprenger et al, Molecular Systems Biology 4
(2008), pp. 1–15]. Spatiotemporal inter-organ metabolic control
functions were modeled by Montoliu et al. [141], with various 2-
and 3-way multivariate statistical approaches including PCA, multi-
way PCA (N-PCA) [142], multivariate curve resolution-alternating
least squares (MCR-ALS) [72] and PARAFAC to abstract the inter-
compartmental functional relationships between healthy mice plas-
ma, liver, pancreas, adrenal gland and kidney cortex. Of the
multivariate approaches MCR-ALS and PARAFAC appeared to be
better adapted for stepwise variable and compartment selection for
further correlation analysis because both methods provided an
overview of functional relationships across matrices and enabled
the characterization of compartment-speciﬁc metabolite signatures
(spectrotypes [71]), Fig. 3. Furthermore, the spectrotypes enabled the
Fig. 3. PARAFAC analysis. The ﬁrst mode loading describes the relative contribution of the each spectrotype associated with each individual. The second mode loading shows the four
spectrotypes obtained from the PARAFAC analysis. The third mode loading describes the relative contribution of each spectrotype in the individual compartments [141].
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differentiation between both speciﬁc and common biochemical
proﬁles associated with the different biological compartments [141].
A summary of published inter-sample type integration methods is
given in Table 1.
2.3. Integration of data from different -omic platforms:
inter-omic integration
In addition to characterizing inter-compartmental correlations
and integrating multiple analytical data types, it is also desirable to
integrate data from various -omics platforms. Bio-analytical measure-
ments of metabolites and the expression levels of genes and proteins
may give profound new insights into mechanisms of toxicology,
aging, disease etiology etc. and provide new surrogate biomarkers
of such processes. Systems biology aims to combine the molecular
components (transcripts, proteins, and metabolites) of an organism
and incorporate them into functional networks or models designed
to describe its molecular connectivities and dynamic activities.
While many of the functions of individual parts are unknown or
not well deﬁned, their biological role can sometimes be inferred
through association with other known parts, providing a better
understanding of the biological system as a whole. On a system-wide
scale the description requires three levels of information [13,143]:
(A) identiﬁcation of the components (structural annotation) and
characterization of their identity (functional annotation); (B) identi-
ﬁcation of molecules that interact with each component; and
(C) characterization of the behaviors of the transcripts, proteins,
and metabolites under various conditions [144].
Bioinformatic approaches in systems biology include biomarker
discovery and reconstruction of regulatory signals in biological
networks by, for example, mapping molecular proﬁles onto public
databases of functional and pathway information, such as the
Kyoto Encyclopedia of Genes and Genomes (KEGG) [145], Gene
Ontology [146], Interactome [147], etc. Metabolic pathway anno-
tation is now part of the post-genomic knowledge compilation
effort [145]. Such databases enable the rapid development of
knowledge-based methods for uncovering higher order systemic
operation of the cell and the organism from genomic and molecular
information.
There are several statistical issues that may directly impact on -omic
data merging and the interpretability of the results, one of the main
factors being the differences in dimensionality between each -omic
platform, leading to unbalanced integration i.e. metabonomics vs.
transcriptomics (100s metabolites vs. 10,000s genes). Sparsity refers to
the percent coverage of the metabolome using analytical instrumenta-
tion. Typically 10–100s of metabolites can be detected with NMR
spectroscopy, whereas 100–1000s of metabolites can be detected using
MS. Furthermore, the noise characteristics and level associatedwith the
analytical instruments and biological sample will directly impact the
choice of statistical method and data pre-processing procedures. When
different biological experiments have been conducted for each -omics
under identical conditions the replicates cannot be matched between -
omic data blocks. In such ‘unmatched replication’ experimental designs
only group-wise statistics can be compared. For example, one could
compare the means and standard deviations of gene expression and
metabolite levels (but not individual replicate values) when different
biological replicates have been used for transcriptomics and metabo-
lomics. Finally merging data from different biological experiments for
different -omicsmay be difﬁcult due to the timing of sample collections
e.g. urine and faeces can bemeasuredmuchmore frequently than tissue
samples which are usually collected once after sacriﬁce. In such
‘asynchronous’ experimental designs, replicates and even group-wise
statistics cannot easily be compared meaningfully across -omic data
blocks.
Tavazoie et al. [148] put forward a method now known as over
representation analysis and discovered distinct expression pattern
clusters in mRNA that were signiﬁcantly enriched for genes with
similar function [148]. Mootha et al. [149], introduced the concept of
Gene-Set Enrichment Analysis [149,150], in which a set of genes
involved in a signature are compared to existing knowledge about
gene pathways [151]. This allows a transition between simple
biological entities, such as genes, to a higher order description, such
as gene pathways, and lead to a synthetic view of the relevant
biological pathways and functions affected. Gene-Set Enrichment
Analysis is a generic method that can be easily extended to proteomic
data and metabolic proﬁle data, or Metabolite-Set Enrichment
Analysis. To our knowledge, no real attempt has been made to
integrate metabolomic markers to the known interactome — the
rapidly growing knowledge of protein–protein interaction (PPI)
networks for human, model organisms and host–pathogen which
may begin to provide network-based models for diseases
[147,152,153]. According to Sanchez et al. [153], the total number of
genes of an organism is less important than the complete repertoire of
interactions potentially encoded by its genome (i.e., the interactome)
[153]. Several interactions (protein–DNA, protein–RNA or protein–
protein) were initially included, but due to the presence of double-
hybrid and co-immunoprecipitation assays, most of the work has
focused on protein–protein interactions. Topological properties of the
entire metabolic network exhibit robustness against isolated random
genetic mutations and/or metabolic perturbations. Robustness of the
metabolic reaction network also depends on its high-level of plasticity
and regulation, that is at least partly mediated by gene variants,
transcriptional variation, protein abundance and modulation activity
through direct molecular interactions and covalent binding. Full
sequencing of various organisms now allows genome-scale metabolic
reconstruction approaches. The metabolic network of organisms or
tissues can then be inferred from the genome sequence. Such
strategies involving network-based predictions of metabolism have
been successfully applied to yeast [154] and a range of other micro-
organisms, as well as human metabolism are now complementary to
metabolic proﬁling [155,156]. A comprehensive review on integrated
-omics approaches for modeling of cellular networks is given by Joyce
et al. [157].
Metabolic phenotypes, or metabotypes [76] can be analyzed in a
statistical framework linking either the genomic, transcriptomic or
proteomic variation information with the metabolomic variation
information using appropriate statistical tools, such as correlation
networks [139,158–160] PLS [161], O2PLS [162–164] and PARAFAC
[165]. These statistical tools and concepts have been extended to
transgenomic analyses linking the microbiome and metabolic phe-
notype (metabotype), for a comprehensive review of such approaches
see reference [176]. The concept of ‘genetical genomics’ [166] was
introduced by Jansen and Nap [166], aiming at merging genome-wide
expression proﬁling and genome-wide genotyping in segregating
populations, using the statistical genetics used in the analysis of
quantitative trait loci (QTL). A subsequent paradigm shift was
introduced, know as expression QTL (eQTL) approaches [167]. The
genetical genomics paradigm can be extended to a metabolomic
context. When comparing the metabolome of different conditions
(genetics, toxicology pathology), it is impossible to assign a gene or a
genomic region to a metabolic feature. The use of Quantitative Trait
Locus mapping of metabolomic traits, or ‘mQTL,’ provides a very good
conceptual, analytical and mathematical framework to identify
genomic regions inﬂuencing metabolic proﬁles. This approach was
introduced in plants [168,169] and in rodent genetic intercrosses
targeting type 2 diabetes [170]. Altogether these studies apply the
genetical genomics concept to metabolomic traits, or genetical
metabolomics (Fig. 4). The resulting linkage maps (Fig. 4) allow the
identiﬁcation of associations between genomic sequence variants
and plasma metabolites. The horizontal axis summarizes metabo-
lome-wide 1H NMR spectrum variation. The vertical axis shows the
genomic position of N2000 microsatellite and SNP markers.
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Signiﬁcant associations are with a LOD score N3 (Pb10−3) are
reported (from Dumas et al. [170]).
The mQTL approach integrates variations obtained from metabo-
lome-wide proﬁling and genome-wide genotyping to identify genetic
variants or loci inﬂuencing metabolite levels: in tissues and bioﬂuids,
if a genetic variant affects the activity of a speciﬁc enzyme, a variation
in the levels of metabolic substrates or products is expected. The
concept of metabolome-wide association study (MWAS) [171]
concept was introduced to highlight the potential of metabolomic
markers in molecular epidemiology [171], just like genome-wide
association studies (GWAS) with the INTERMAP consortium [24]. The
mQTL, GWAS and MWAS approaches have now merged in human
epidemiology with several successful clinical applications [172–174].
In terms of validation of loci, the idea that a genome sequence variant
(QTL) could directly inﬂuence simultaneously the expression of its
gene (eQTL), its translation into a protein (protQTL), its effect on
metabolism (mQTL) and phenotypic outcome (pQTL) provides a
powerful self-validation tool [175]. However, occurrence of co-
localization is very rare (b10 loci in Arabidopsis thaliana genome),
suggesting the limits of cis-QTL effects. Ultimately, genetical genomic
andmQTL approaches require an independent validation for any locus
of interest identiﬁed, whether it is in an independent experimental
cross for animal models [170], or in an independent cohort for clinical
applications [173]. A summary of published inter-omic type integra-
tion methods is given in Table 1.
3. Conclusions and future requirements
Understanding the relationships between human genetic factors,
the risk of developing major diseases, the molecular basis of drug
efﬁcacy and toxicity as well the parameters deﬁning health will lead
to practical innovations in medicine, drug discovery and engineering.
Such an understanding requires intra- and inter-omic integration of
experimental data between different assay types, sample types and
across multiple levels of biological organization. It is clear that this
ﬁeld, though comparatively young, is developing fast and will yield
vital tools and techniques to increase our understanding of biological
processes at the systems level.
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We characterize the integrated response of a rat host to the liver fluke Fasciola hepatica using a
combination of 1H nuclearmagnetic resonance spectroscopic profiles (liver, kidney, intestine, brain,
spleen, plasma, urine, feces) and multiplex cytokine markers of systemic inflammation. Multi-
variate mathematical models were built to describe the main features of the infection at the systems
level. In addition to the expected modulation of hepatic choline and energy metabolism, we found
significant perturbations of the nucleotide balance in the brain, together with increased plasma IL-
13, suggesting a shift toward modulation of immune reactions to minimize inflammatory damage,
which may favor the co-existence of the parasite in the host. Subsequent analysis of brain extracts
from other trematode infection models (i.e. Schistosomamansoni, and Echinostoma caproni) did not
elicit a change in neural nucleotide levels, indicating that the neural effects of F. hepatica infection
are specific. We propose that the topographically extended response to invasion of the host as
characterized by the modulated global metabolic phenotype is stratified across several bio-
organizational levels and reflects the direct manipulation of host–nucleotide balance.
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Introduction
Fascioliasis is a re-emerging zoonotic disease caused by two
liver fluke species, Fasciola hepatica and F. gigantica. As many
as 17 million people might be infected with Fasciola spp.
(Keiser and Utzinger, 2009) and the disease is of considerable
economic and public health importance. At present, tricla-
bendazole is the only drug available for treatment of infected
human beings and livestock and worryingly, parasite resis-
tance to triclabendazole is already widespread in farm animals
(Fairweather, 2009). Hence, a deeper understanding of the
biology of this parasite is warranted to uncover novel
therapeutic targets. Fundamental investigations in well-
controlled host–parasite models hold promise for recovery of
metabolic biomarkers, at different bio-organizational levels.
This may promote the mechanistic understanding of the host
response to infection at the systems level with a view to
identifying drug targets.
The regulation of anymammalian system is such that events
originating in a discrete tissue or organ can trigger a cascade of
consequent events throughout the host system as the host
attempts to maintain homeostatic equilibrium (Lederberg,
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2000; Nicholson et al, 2002). Thus, the effects of a parasitic
infection are rarely confined to a single target tissue; instead a
network of molecular events can generally be detected
throughout the host system. Top-down systems biology driven
by metabolic phenotyping and metabonomics (Nicholson
et al, 1999; Holmes et al, 2008a; Li et al, 2008a, b; Tsang
et al, 2009) has been shown to be a useful tool for studying
host–parasite (Saric et al, 2008;Wang et al, 2008; Li et al, 2009)
and host–symbiont interactions (Nicholson et al, 2005; Martin
et al, 2007; Holmes et al, 2008b), and it is clear that any
transgenomic interaction can only be studied in vivo, as the
effects of microbial or parasitic modulations are panorganis-
mal (Wang et al, 2008; Saric et al, 2009).
In this study, we characterize and interpret the system-wide
effect of F. hepatica in the rat, using a metabolic profiling
strategy to develop mechanistic hypotheses. A multilevel
statistical approach was applied to the analysis of 1H nuclear
magnetic resonance (NMR) spectroscopy-generated data to
obtain an integrative profile of the global response of the host
based on differential metabolic, immunological, and bio-
metric responses across multiple tissues. We report novel
findings regarding the effect of F. hepatica on the neural
metabolite profile of the rat and show metabolic connections
between the liver, gut, and brain, which we compare with the
metabolic effects elicited by two separately assessed trematode
infections, namely Schistosoma mansoni and Echinostoma
caproni in a mouse model. Although F. hepatica-induced liver
damage has been described in detail before (Lim et al, 2007;
Marcos et al, 2008), no direct association with the central
nervous system has been found in the extant literature. The
findings from this study expose a potential mechanism of
parasite-induced immunemodulation and exemplify the value
of top-down systems approaches based on metabolic profiling
for recovering mechanistic information from a system without
a priori knowledge.
Results and discussion
Parasite burden, physiological monitoring,
and histology
Patent infection of rats with F. hepatica resulted in a mean
parasite burden of 5.5 (range¼2–10; s.d.¼2.6) on day 77
postinfection and a significant reduction of the mean packed
cell volume (PCV) at day 71 postinfection (uninfected control
rats: mean¼50.8%, s.d.¼2.8%; infected: mean¼42.0%, s.d.¼
3.8%). The mean bodyweight did not significantly differ
between infected and uninfected rats at any of the investigated
time points. Clear evidence of hepatic necrosis was found in
F. hepatica-infected rats (Supplementary Figure S1) together
with follicular hyperplasia of splenic white pulp and interstitial
lymphoplasmocytic inflammatory infiltrates in the kidney.
Multivariate statistical modeling of F. hepatica
infection
Assignment of metabolic components in the tissues and
biofluid profiles for both uninfected and infected rats were
made on the basis of extant literature (Coen et al, 2003; Holmes
et al, 2006; Beckonert et al, 2007; Li et al, 2009; Saric et al,
2009; Tsang et al, 2009), and in the case of the brain extract
spectra, from addition of authentic standards (assignments
provided in Supplementary Figure S2; Supplementary
Table SI).
The metabolic changes in the rat caused by patent infection
with F. hepatica were modeled separately for each biological
matrix through principal component analysis (PCA) and
projection to latent structure discriminant analysis (PLS-DA).
In brief, themetabolic profiles of F. hepatica-infected rats could
be differentiated from those of uninfected control rats through
PCA for all assessed biological compartments except the ileum
and the renal medulla. A list of important infection-discrimi-
natory metabolites is given in Table I together with the P-
values, validated by permutation testing, Figure 1.
Consistent changes in lipid metabolism, including elevated
choline and/or choline derivatives such as betaine, phospho-
choline, and glycerophosphocholine (GPC) occurred through-
out most tissues (Figure 1; Table I). This indicates a generally
increased usage of choline-derived metabolites that can be
further converted to phosphocholine (Zeisel et al, 2003; Li and
Vance, 2008), a basic component of membrane anabolism, or
used for the production of polyunsaturated fatty acids such as
arachidonic acid, which gives rise to pro-inflammatory
eicosanoic mediators (Calder, 2008, 2009). Prostaglandins,
for instance, exert multiple pro-inflammatory effects, such
as chemotaxis of neutrophils, which are typically the
first infiltrating cells at sites of tissue damage. Evidence of
inflammatory infiltrates was detected in the histological
and metabolic profiles of the liver, spleen, and kidney
(Supplementary Figure S1) and inflammation was implicated
biochemically in the colon and plasma. Increased
plasma intensities of O- and N-acetyl glycoprotein signals
were noted in F. hepatica-infected rats. Increased concentra-
tions of acetylated glycoproteins have been earlier identified
in Trichinella spiralis- and Trypanosoma brucei brucei-infected
mice (Martin et al, 2006; Wang et al, 2008) as inflammatory
markers and include acute phase reaction proteins, such
as a1 acid glycoprotein, haptoglobin, and transferrin,
which are produced in the liver and which show markedly
increased serum levels during such systemic responses to
inflammation (Schreiber et al, 1982; Bell et al, 1987a, b)
(Figure 1; Table I).
Other features of F. hepatica infection were specific to a
single biological compartment; for example hippurate, which
is only observed in the urine, was found to be decreased in
infected rats, reflecting a parasite-induced disturbance of the
gut-microbial composition or activity (Nicholls et al, 2003; Li
et al, 2008a, b). The liver, spleen and plasma showed the
greatest changes at the low molecular weight level, consistent
with the direct damage caused by the migrating larvae of F.
hepatica during the acute stage of an infection in the hepatic
tissue and the immunological activity in the spleen (Supple-
mentary Figure S1). The proliferation of B cells in the spleen
primary follicles as response to blood-borne antigens uses
amino acids and lipid fractions for the new cellular membrane
bilayers and organelles andmay account for themajor changes
in the metabolic profile of the spleen, and perhaps in other
tissue compartments. The depletion in hepatic glucose is more
likely to be related to the direct damage of the energy stores
and is consistent with elevated glucose levels in plasma.
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One of the strongest effects of infection with F. hepatica
manifested in the neurochemical profiles, further highlighting
the ability of the parasite to impact on remote tissue. Clear
visual separation of the infected and uninfected animals
was achieved in the PCA and PLS-DA scores plots (Figure 2A
and B) of the neural profiles, with a model predictivity (Q2Y)
of 0.46. The pattern of differentiating metabolites in the
neurochemical profiles as extracted from the orthogonal
PLS-DA (O-PLS-DA) coefficients was composed of a signif-
icant increase in the relative levels of inosine, tyrosine, and
phenylalanine. Conversely, the relative tissue concentrations
of GPC, succinate, inosine mono-, di-, and triphosphate,
adenosine, and adenosine mono-, di-, and triphosphate
were lower in the brains of infected animals (Figure 2C
and D).
Secretion of nucleotide-degrading enzymes occurs in a
variety of ecto- and endoparasitic organisms, such as ticks,
blood sucking insects, and helminths and serves the primary
purpose of minimizing immune reactions in the host organism
to prolong their survival (Parshad and Guraya, 1977; Ribeiro
and Francischetti, 2003). For example, adenosine deaminase
and 50-nucleotidase have been found in secretory channels of
T. spiralis and F. gigantica (Gounaris, 2002; Ali, 2008). The
former catalyzes the intracellular conversion of adenosine to
inosine, whereas the latter hydrolyzes inosinemonophosphate
(Figure 2E).
We observed a substantial shift of adenosine and phos-
phorylated nucleotides to inosine in the host brain, which
indicates an attenuated inflammatory response and may be
suggestive that F. hepatica, similarly to F. gigantica, secretes
nucleotide-degrading enzymes. Both inosine and adenosine
induce mast cell degranulation, an event that has a central
function in localized inflammatory response, an important
mediator of type I hypersensitivity reactions, with adenosine
being the more potent activator (Marquardt et al, 1978;
Tilley et al, 2000). Furthermore, inosine, which was believed
to be inert for a long time, has been proven to effectively
suppress pro-inflammatory cytokines such as IFN-g,
TNF-a, and IL-12 (Hasko et al, 2000, 2004; Mabley et al,
2003) in vitro and in vivo.
We assessed the concentrations of selected plasma cyto-
kines and found the levels of both IL-13 and IL-5 to be
significantly higher in F. hepatica-infected rats compared with
the control group on day 22 postinfection. IL-13 maintained a
significant increase on day 43 postinfection (Figure 2E). An
enhanced Th2 immune response such as that suggested by the
increase in both IL-5 and IL-13 would serve to counteract
mechanisms of inflammation. IL-13 is also an important
direct negative regulator of inflammatory cytokines in macro-
phages (Minty et al, 1993). Minimization of such an intense
immune reaction, and hence prolongation of the period
in which the parasite can remain undetected by the host at
earlier stages of infection, is clearly beneficial for the survival
of the worms.
Comparison of the systemic effects of F. hepatica
with S. mansoni and E. caproni
To ascertain the specificity of the global metabolic response of
the rat to F. hepatica across different tissue compartments,
particularly with respect to the observed modulation of the
neural nucleotide balance, two further rodent-trematode
models were compared, namely S. mansoni and E. caproni,
in a murine host. Both trematodes induced a biochemical
response across a range of biological compartments, but
whereas S. mansoni caused pathology in the spleen and liver
(Li et al, 2009), no overt necrosis was found in any tissue after
E. caproni infection (Saric et al, 2009). At a global level,
E. caproni infection was predominantly characterized by
Table I Candidate biomarkers extracted through O-PLS-DA of F. hepatica-infected and uninfected rats within selected tissue compartments
pl, plasma; ur, urine; fw, fecal water; li, liver; sp, spleen; rc, renal cortex; je, jejenum; co, colon; red: relatively increased; blue: decreased levels caused by infectionwith
F. hepatica; *o0.001.
Corresponding P-values are listed.
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malabsorption of amino acids, which manifested predomi-
nantly in the biochemical profiles of the small intestine and
liver. Altered amino-acid levels and energy metabolism were
also a core signature of S. mansoni infection with disturbed
levels of choline-containing membrane components in the
liver and intestinal tissues.
As the altered neural nucleotide signature was one of the
strongest metabolic responses in rats infected with F. hepatica,
we directly compared the metabolic profiles of brain extracts
with those from S. mansoni and E. caproni in the mouse.
S. mansoni infection induced obvious changes in the meta-
bolic composition of the host brain, as indicated by the PCA
and PLS-DA scores plots (Supplementary Figure S3), with the
PLS-DA model indicating a predictive value (Q2Y) of 0.61.
Infection with S. mansoni was characterized by higher levels
of glutamine, but lower concentrations of g-aminobutyric
acid (GABA), choline, phosphocholine, and scyllo-inositol
(Supplementary Figure S3C). The E. caproni-infected animals
could not be statistically differentiated from the correspond-
ing control group based on the brain extract spectra
(Q2Y¼0.21, data not shown), indicating that the in-
fection did not systematically alter the brain biochemistry of
the host.
Although both S. mansoni and F. hepatica induced a marked
perturbation of the neurochemical profiles in their host
animals, the patterns of differentiating metabolites were
distinct for these two trematode-rodent models, with the
exception of the common effect of decreasing concentrations
of lipid degradation products, such as choline, phospho-
choline, and GPC, all of which have a function in cell
membrane formation. In contrast to the perturbed immuno-
logical function suggested by the altered nucleotide levels in
the brains of F. hepatica-infected animals, modulation of the
neural metabolite profile by S. mansoni infection suggested
the dominant effect related to the neurotransmitters, as
supported by depleted levels of GABA and increased tissue
concentrations of glutamine, which is a substrate for both
excitatory and inhibitory neurotransmitters, including GABA.
However, as neural GABA decreased in infected animals, the
increased concentrations of glutamine are more likely to be indi-
cative of a detoxification process. Compensatory locations for
ammonium detoxification are muscle cells and the brain, com-
bining ammonia and glutamate to glutamine (Kreis et al, 1991;
Olde Damink et al, 2002), which could also contribute to the
relatively higher levels of glutamine in the brain extracts of S.
mansoni-infected mice documented in the current investigation.
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Systems impact of the modulation of the neural
metabolic phenotype of F. hepatica infection:
multivariate modeling and integration of
physiological compartments
Metabolic correlates of the six important discriminatory
spectral regions containing inosine, GPC, succinate, tyrosine,
phenylalanine, and the overlapped regions containing
adenosine and the phosphorylated nucleotides in the brain
tissue of F. hepatica-infected rats were identified in each of the
other tissue or biofluid matrices. Sequential correlations
between the integrated-discriminatory signals in the brain
spectra tissue were made with the whole spectra from each
tissue and with the spectra from biofluids obtained at day 71
postinfection (Figure 3; Supplementary Table SII). Here,
univariate correlation of single signals was preferred
over a multivariate approach to maximize information
recovery and to infer direct inter-compartmental links between
the metabolites. A comprehensive list of compartment-specific
correlations with the neural metabolites is provided in
Supplementary Table SII. The liver, urine, and spleen showed
the highest number of components correlatedwith the selected
brain metabolites. The high degree of correlation between the
metabolic markers in the brain and the liver spectra across
the tissue compartments (Figure 3A) may simply relate to the
magnitude of spectral changes in both organs and does
not necessarily imply any causal relationships between
metabolites. The gross changes in the hepatic metabolite
profile are reflective of direct mechanical damage of the liver
tissue by the migration and feeding of the juvenile fluke,
whereas the effect of the parasite on remote organs such as the
brain is more difficult to rationalize. Hepatic dysfunction in
F. hepatica infection is known to result in increased circulating
toxins, such as ammonia, thiols, and phenols (Zaki et al,
1983), which are typically released after hepatic failure,
because of reduced ability to degrade aromatic amino acids
and ammonia. Animals infected with F. hepatica showed
increased neural concentrations of phenylalanine and tyro-
sine. Indeed, it has been shown that hepatic failure induces an
increased passive permeability of the blood–brain barrier for
several substances, among which phenylalanine and tyrosine
were found to increase up to 30% in the host brain (Zaki et al,
1984).
A recurrent theme across multiple levels of this host–parasite
system was the inflammatory response, which manifested at
both the level of structural damage and that of the metabolite
signature. The increased signal intensities of plasma acetyl
glycoprotein fragments were statistically associated with all
six cerebral markers of infection underscoring the presence
and global effect of a strong infection-induced inflammatory
response (Figure 3B; Supplementary Table SII). Interestingly, a
shift has been observed in the brain nucleotides inosine and
adenosine in favor of inosine, which has been shown to have
anti-inflammatory effects at the posttranscriptional level
(Hasko et al, 2000), including suppression of pro-inflamma-
tory cytokines (e.g. IFN-g and TNF-a) and minimizing
macrophage-mediated mechanisms of inflammation (Hasko
et al, 2000, 2004; Liaudet et al, 2002). This shift may be directly
induced by nucleotide-degrading secretory enzymes of
F. hepatica. Significant direct correlations between the selected
neural indices of F. hepatica infection and compounds
involved in lipid metabolism were detected.
In addition to the correlations driven by the liver pathology,
direct metabolic interactions such as plasma glucose being
anti-correlated with brain succinate and 2-ketoglutarate,
suggestive of an interaction through glycolysis and the
tricarboxylic acid cycle, were found. Another example of such
co-variation is the inverse correlation between cerebral
tyrosine and urinary hippurate, deriving from gut-microbial/
mammalian co-metabolism. Direct alteration of urinary
metabolite signatures through gut-microbial species seems to
be a common feature of many host–parasite models
(Martin et al, 2006; Li et al, 2008a; Saric et al, 2008; Wang
et al, 2008). Here, the negative correlations of cerebral
adenosine with urinary dimethylglycine and the bile acids,
which are co-metabolized by gut microbiota, strengthens the
notion of a bidirectional communication between gut and
brain (gut–brain axis). This leads to the hypothesis
that nucleotide-initiated immunoactivity has a function in
the changed gut-microbial dynamics observed in parasitic
infections.
In conclusion, we have characterized the global metabolic
phenotype of a host–parasite system and have shown a clear
effect of a trematode infection on the biochemical composition
of the host brain using ametabolic profiling strategy to develop
and pursue hypotheses relating to the observed neurochemical
changes in the rat. F. hepatica induced a focussed response,
primarily associated with the hypothesized worm-induced
shift from adenosine toward inosine and the subsequent
induction of anti-inflammatory cytokines. The coherence
of the histological, metabolic, and cytokine data further
facilitated elucidation of general and specific metabolic events
and provided a means of probing inter-compartmental co-
variation of metabolites. Thus, the application of a top-down
systems approach has been shown to be of value in driving the
articulation of novelmechanistic hypotheses relating to parasitic
invasion and has wide application in molecular parasitology.
Materials and methods
F. hepatica-rat model and experimental design
Experimental procedures were carried out at the Swiss Tropical and
Public Health Institute (Swiss TPH; Basel, Switzerland), adhering to
local and national guidelines of animal welfare (permission no. 2070
and 2081). A total of 24 Wistar female rats were purchased from RCC
(Itingen, Switzerland) and kept under environmentally controlled
conditions (temperature: 251C; relative humidity: 60–70%; light/dark
cycle: 12/12 h). Rats were acclimatized for 1 week and all animals had
free access to commercially available rodent diet obtained from Nafag
(Gossau, Switzerland) and community tap water.
Rats were individually marked and group housed with four animals
per cage. Twelve rats were orally infected with 20–25 F. hepatica
metacercariae each (Cullompton isolate) obtained from Mr G Graham
(Addleston, UK). The remaining 12 rats were left uninfected and
served as controls.
The body weight of each animal was measured throughout the
experiment. On day 1 pre-infection and days 1, 4, 8, 15, 22, 28, 36, 43,
57, and 71 postinfection, urine and feces were collected into Petri
dishes by rubbing the abdomen of the rats gently. Approximately 50ml
of blood was collected from the tail tips collected into hematocrit
capillaries (Sodium [Na] heparin coated) and spun at 10 500 g for
4min. The PCV was calculated and expressed as a percentage of the
plasma ratio to red blood cells (Li et al, 2008a).
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All animals were euthanized on day 77 postinfection using CO2,
and the worm burden was determined in each infected animal by
removing adult flukes from the livers and bile ducts on dissection.
The whole brains of rats, regardless of their infection status, were
removed on dissection and the left hemispheres were transferred into
cryo-tubes, snap frozen in liquid nitrogen and stored at801C pending
1H NMR spectroscopic data acquisition. In addition, the left lateral
lobe of the liver, the left kidney, spleen, and three parts of the
intestine (colon, ileum, and jejunum) were removed and stored in the
same manner as the brain for 1H NMR spectroscopic data acquisition.
The right brain hemispheres, the right kidney, and parts of the
spleen, liver, and intestines were transferred into separate Eppendorf
tubes containing 4% buffered formalin for subsequent histological
examination.
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Methodology relating to the S. mansoni- and E. caproni-mouse
models has been described earlier (Saric et al, 2008, 2009; Li et al,
2009) and followed a similar protocol to that described for F. hepatica
infection in the rat.
Sample preparation for 1H NMR spectroscopy
Each brain sample was placed in a mortar, mashed using a 1ml
mixture of H2O and acetonitrile (1:1, v:v) and transferred into a glass
tube. Another 2ml of the solvent mixture was used to rinse the mortar
twice and transferred into the same glass tube. The brain homogenate
was centrifuged for 6min at 10 000 g. The supernatant was collected
into a new glass vial, evaporated overnight and lyophilized. The
resultant dry mass was resuspended into 0.55ml of D2O until
completely dissolved and transferred into a 5mm-outer-diameter
NMR tube for subsequent analyses. Urine, plasma, and fecal pellets
were prepared for conventional high-resolution 1H NMR data
acquisition as described earlier (Saric et al, 2008), whereas tissue
metabolic fingerprints were acquired through magic angle spinning
(MAS) 1H NMR (Saric et al, 2009).
The extraction protocol for the S. mansoni-mouse model was
slightly extended to gain additional information regarding potential
changes in the lipid metabolic profile, as a pharmacological interven-
tion was involved in the original study protocol. Each brain sample
obtained from mice infected with S. mansoni and the corresponding
uninfected control mice was transferred into a 2ml Eppendorf tube
containing a metal bead, 0.75ml of water, and 0.75ml of methanol.
The Eppendorf tubewas placed in the tissue lyser and shaken for 5min
at the speed of 22Hz. The resulting brain homogenate was transferred
into a glass tube. A further 0.75ml of each liquid was used to rinse the
Eppendorf tube and transferred into the same glass tube. A total of
1.5ml of chloroform was added into the mixture and centrifuged at
2500 g for 30min. The aqueous and the chloroform phases were
transferred into a new glass tube each and both were left to evaporate
overnight and lyophilized. Before 1H NMR analysis, the powder
obtained from the aqueous phase was dissolved in 0.55ml phosphate
buffer (D2O:H2O¼9:1, v:v, 0.01% of sodium 3-(trimethylsilyl) propionate-
2,2,3,3-d4 ([TSP)], pH¼7.4), whereas the dry mass of the chloroform
fraction was dissolved in deuterated chloroform (CDCl3).
Acquisition of 1H NMR spectral data
All 1H NMR spectra from rat and mouse brain extracts, urine, plasma,
and fecal water were recorded on a Bruker Avance 600 NMR
spectrometer (Bruker; Rheinstetten, Germany), operating at
600.13MHz for proton frequency. A 5-mm triple resonance probe
with inverse detection for proton frequency was used (Bruker), using a
standard one-dimensional NMR experiment with pulse sequence
(recycle delay (RD)-901-t1-901-tm-901-acquisition time). Optimal water
suppression was achieved by irradiating the water frequency during
the RD set to 2 s and the mixing time of 100ms. The 901 pulse length
was adjusted to 10.62ms for the brain extracts of both the F. hepatica rat
and the E. caproni-mouse models and 13.5ms for the S. mansoni-
mouse model. A total of 128 scans were acquired for each sample into
32k data points using a spectral width of 20 p.p.m. All free induction
decays were multiplied by an exponential function equivalent to a
0.3Hz line-broadening factor before Fourier transformation. Liver,
spleen, kidney, and intestinal samples were acquired by an MASm
probe, an NMR semi-solid state method using the parameters
described elsewhere (Saric et al, 2009).
Assignments of the spectral peaks were made from the literature
(Nicholson et al, 1995; Coen et al, 2003; Li et al, 2008a, 2009; Saric
et al, 2008) and confirmed through statistical total correlation
spectroscopy (STOCSY) (Cloarec et al, 2005), and through standard
two-dimensional NMR experiments conducted on selected samples,
including correlation spectroscopy (Ernst et al, 1986), total correlation
spectroscopy (Bax and Davies, 1985), and J-resolved NMR spectro-
scopy (Foxall et al, 1993). For selected brain samples, high-
performance liquid chromatography (HPLC) was performed to isolate
chemical components relating to unidentified-discriminatory metabo-
lites with spectral regions at chemical shifts of d 6.15 (doublet), d 8.60
(singlet), d 8.27 (singlet), and d 4.02 (multiplet). For this purpose,
fractionswere separated using an Agilent 1100HPLCwith Eclipse XDB-
C18 column, 5mm, 4.6150mm (Agilent), attached to an Esquire
6000 mass spectrometer (MS; Bruker; Rheinstetten, Germany). An
aliquot of 100ml of brain extract was injected at a flow rate of 1ml/min
and signals were detected byUVat 214nm and byMS in positivemode.
A gradient of 98%water to 2%acetonitrilewas used for the first 25min
and a standard gradient sequence was applied for the remaining
25min. Fractions were collected over the first 8min and then
lyophilized and resuspended in D2O for NMR analysis. Inosine,
inosine monophosphate, inosine diphosphate, inosine triphosphate,
adenosine, adenosine monophosphate, adenosine diphosphate, and
adenosine triphosphatewere confirmed by adding authentic standards
purchased from Sigma Aldrich (Gilingham; Dorset, UK).
Data processing and analysis
The raw spectra were processed with an in-house developed MATLAB
script to reduce phase and baseline distortions and manually
calibrated to the lactate CH3 signal at d 1.33 (spectra of brain extracts,
plasma, and tissue) or automatically to sodium 3-(trimethylsilyl)
[2,2,3,3-2H4] propionate (TSP) at a spectral position d 0.00 (urine and
fecal water). The region containing the residual water resonance was
removed to avoid any interferencewith the analysis (i.e. d 4.55–5.40 in
brain extracts, d 4.2–8.0 in plasma, d 4.63–5.15 in fecal extracts, d
4.23–5.32 in urine, and a similar region ofBd 4.7–5.2 was removed in
each tissue spectral dataset). Before statistical analysis, probabilistic
quotient normalizationwas applied to all spectra and a peak alignment
script was implemented in MATLAB to minimize chemical shift
variation (Veselkov et al, 2009).
In a first step, PCAwas applied to the processed spectral data to gain
an overview of the degree of differentiation between infected and
uninfected animals or inherent groupings in each tissue and biofluid
spectral dataset (Eriksson et al, 2001). PCA reduces the multivariate
data to a lower-dimensionality scores plot, without requiring any
earlier class information and delivers a snapshot of the similarity
between observations (i.e. brain spectra) based on the linear
combination of the spectral components. In a second step, PLS-DA
was applied, as a supervisedmethod,which uses earlier information of
class membership, and hence optimizes separation (Eriksson et al,
2001) and extraction of biomarkers associated with the infection.
O-PLS-DA is a further development of PLS-DA applied for optimal
recovery of biomarkers (Trygg andWold, 2002), and removes systematic
variation unrelated to infection status through an orthogonal filter.
The O-PLS-DA model was built by using an X-matrix containing all
spectral information and a binary dummy matrix, as Y-determining
class affiliation, for example infected or controls. Sevenfold cross-
validation was applied (Bro et al, 2008) to validate the models and
calculate the goodness of prediction Q2. To validate the statistical
power of the discriminatory metabolites, the P-values were calculated
for each data point using 10 000 permutations and back projected to
the O-PLS-DA plot, whereby regions that significantly differentiate
infected from non-infected animals at a level of Pp0.05 are coded in
red (Pitman, 1938).
For assessing the direct impact of the cerebral metabolic changes
caused by F. hepatica infection, a further development of the STOCSY
(Cloarec et al, 2005) and the statistical heterospectroscopy (Crockford
et al, 2006) method has been applied between two data matrices
whereby the selected regions occupied by each of the eight cerebral
biomarkers were integrated in MATLAB and represent the
Y-matrix. The spectral information of each other biological matrix
(e.g. biofluids and all other tissues) constituted the second matrix (X)
for calculating correlation structures between the spectral peaks and
the integrated metabolite information. To reduce the display complex-
ity and to avoid including artifacts and noise, spectral peaks were
picked by applying a threshold of 100 the s.d. calculated from the
first 500 data points, which consist of noise only. A 10 000-fold
permutation was embedded in the correlation script and only
correlations with Pp0.05 are displayed.
Cytokine multiplex quantification
Plasma from five F. hepatica-infected rats and five uninfected rats from
earlier NMR spectral preparation (e.g. 0.9% saline (NaCl) in
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D2O:H2O¼1:1), over six different time points, were tested by a
‘Mesoscale Multiplex Assay’ (MS6000 Rat Demonstration 7-Plex Ultra-
Sensitive kit, Meso Scale Discovery). The rat demonstration ‘7-Plex
Ultra-Sensitivity kit’ was used for this purpose, which includes IFN-g,
IL-1b, IL-4, IL-5, IL-13, KC/GRO, and TNF-a. Each samplewas assessed
using duplicates and split in 15ml per well in a 96-well plate. The
method was used according to the manufacturer’s specifications
(Meso Scale Discovery, Rat cytokine assays: Rat demonstration 7-Plex
Ultra-Sensitive kit), with the exception of the incubation time, which
was extended to 4 h to counteract the 1:1 dilution. An MSD Sector
imager was used to read the plates (Meso Scale Discovery, Sector
Imager 6000).
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (http://www.nature.com/msb).
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